inReport	Chr	Start	Stop	MapLoc	NbGID	Ref	VarType	Call	Flank	Zygosity	A.Depth	A.Ratio	PhasedGID	A.Index	RepeatTag	Filter	MIM Gene ID	MIM Stat	MIM Pheno IDs	MIM Inheritance	CGD Condition	CGD Inheritance	CGD Allelic Condition	CGD Manifestation Categories	CGD Intervention Categories	CGD References	TestCode	EntrezGeneID	Gene Symbol	FuncRegion	ExIn_ID	pfamName	pfamId	Function	Transcript	Protein	Strand	Primary	cHGVS	pHGVS	CodonChange	PolarChange	MutationName	dbSNP Note	dbSNP Allele Count	dbSNP Allele Freq	dbSNP Mul Tag	1000G EAS AF	1000G AF	ESP6500 AC	ESP6500 AF	ExAC Filter	ExAC EAS HomoAlt Count	ExAC EAS AC	ExAC EAS AF	ExAC HomoAlt Count	ExAC AC	ExAC AF	GAD EAS HomoAlt Count	GAD EAS AC	GAD EAS AF	GAD HomoAlt Count	GAD AC	GAD AF	rsID	Panel ID	Panel AlleleCount	Panel AlleleFreq	PhyloP Primates	PhyloP Vertebrates	PhyloP Placental Mammals	Ens SIFT Score	Ens Polyphen2HumVar Score	Ens Polyphen2HumDiv Score	Ens Condel Score	Ens Condel Pred	Cosmic MutName	Cosmic Site	Cosmic Histology	Cosmic MutStat	Cosmic ID	HGMD ID	HGMD MutName	HGMD Disease	HGMD pmID	HGMD Pred	ClinVar SuspectReason	ClinVar ID	ClinVar RevStat	ClinVar Significant	AutoInterpStatus
InExcel	1	3334482	3334483	1p36.32	.	A	snv	C	CC.CC	het-ref	40	0.15	.	2	.	DUBIOUS	605557	P	615373(MK)	NN	Cardiomyopathy, dilated, ILL; Left ventricular noncompaction 8	AD	.	Cardiovascular	Cardiovascular	23768516|21551322|18506004	.	63976	PRDM16	C11	EX11	.	.	missense	NM_022114.3	NP_071397.3	+	Y	c.2783A>C	p.H928P | p.His928Pro	CAC=>CCC	P+=>NP	NM_022114.3(PRDM16): c.2783A>C (p.H928P)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	1	5.98587e-05	0	3	1.24673e-05	.	.	4025	0.064800	0.460	3.124	1.853	0.3	0.015	0.006	0.029	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
Pass	1	3638673	3638674	1p36.32	.	C	snv	T	AC.GC	het-ref	261	0.52	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C4	EX5	P53 DNA-binding domain	PF00870.13	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.519C>T	p.(T173=) | p.(Thr173=)	ACC=>ACT	.	NM_005427.3(TP73): c.519C>T (p.(T173=))	;maf-5-some-pop	125058	0.807097	U	0.5268	0.736022	13000	0.849462	PASS	1130	8606	0.518011	40280	120050	0.810062	2228	8829	5.13254e-01	81508	197470	8.05067e-01	rs1801174	.	4024	0.486300	-0.424	-0.240	-0.983	.	.	.	.	.	ENST00000378295: c.519C>T (p.T173T)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3997495	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	3644348	3644349	1p36.32	.	A	snv	G	CC.GG	het-ref	220	0.44	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC7	IVS8	.	.	intron	NM_005427.3	NP_005418.1	+	Y	c.985+15A>G	.	.	.	NM_005427.3(TP73): c.985+15A>G	;maf-5-some-pop,maf-5-all-pops	18862	0.704326	U	0.3353	0.64996	12056	0.787823	PASS	39	568	0.380282	3585	13854	0.723979	514	3134	3.16310e-01	30974	86373	6.89583e-01	rs2181486	.	4024	0.302700	-0.480	-0.807	-0.434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	1	3644714	3644715	1p36.32	.	C	snv	T	GC.GT	het-ref	174	0.48	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C8	EX9	.	.	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.1008C>T	p.(A336=) | p.(Ala336=)	GCC=>GCT	.	NM_005427.3(TP73): c.1008C>T (p.(A336=))	;maf-5-some-pop	124244	0.057339	U	0.2163	0.0784744	13006	0.050054	PASS	224	8558	0.228441	368	119236	0.056451	456	3919	2.28088e-01	685	12812	5.26216e-02	rs12046074	.	4024	0.211000	-1.114	0.367	0.096	.	.	.	.	.	ENST00000378295: c.1008C>T (p.A336A)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5021024	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	3644753	3644754	1p36.32	.	T	snv	C	CA.GG	het-ref	201	0.49	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C8	EX9	P53 tetramerisation motif	PF07710.6	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.1047T>C	p.(H349=) | p.(His349=)	CAT=>CAC	.	NM_005427.3(TP73): c.1047T>C (p.(H349=))	;maf-5-some-pop	124704	0.068322	U	0.2163	0.110024	13006	0.086575	PASS	220	8590	0.227939	520	119696	0.066577	458	3928	2.28478e-01	928	14892	6.10138e-02	rs12048341	.	4024	0.211700	-1.070	-0.454	-1.467	.	.	.	.	.	ENST00000378295: c.1047T>C (p.H349H)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021026	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	3649402	3649403	1p36.32	.	G	snv	A	GC.CA	het-ref	175	0.51	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C13E	EX14E	.	.	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.1671G>A	p.(A557=) | p.(Ala557=)	GCG=>GCA	.	NM_005427.3(TP73): c.1671G>A (p.(A557=))	;maf-5-some-pop	116954	0.052961	U	0.2143	0.0571086	12974	0.028981	PASS	211	8340	0.229137	318	111946	0.052775	431	3833	2.24283e-01	624	11547	4.88282e-02	rs61735051	.	4024	0.205300	0.313	-0.109	-2.906	.	.	.	.	.	ENST00000378295: c.1671G>A (p.A557A)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021043	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	3649561	3649562	1p36.32	.	G	snv	A	GC.GA	het-ref	198	0.48	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C13E	EX14E	.	.	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.1830G>A	p.(A610=) | p.(Ala610=)	GCG=>GCA	.	NM_005427.3(TP73): c.1830G>A (p.(A610=))	;maf-5-some-pop	48542	0.104507	U	0.2123	0.107827	12808	0.075812	PASS	104	3074	0.329538	226	43534	0.104126	344	3071	2.30868e-01	643	11561	6.37314e-02	rs9662633	.	4024	0.205800	-0.642	-3.391	-3.522	.	.	.	.	.	ENST00000378295: c.1830G>A (p.A610A)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3689642	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	11205057	11205058	1p36.22	.	C	snv	T	AT.GC	hom-alt	440	1.00	.	0	.	PASS	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C32	EX33	FAT domain	PF02259.18	coding-synon	NM_004958.3	NP_004949.1	-	Y	c.4731G>A	p.(A1577=) | p.(Ala1577=)	GCG=>GCA	.	NM_004958.3(MTOR): c.4731G>A (p.(A1577=))	;maf-5-some-pop	126404	0.672756	U	0.8165	0.547524	13006	0.545902	PASS	2906	8652	0.820273	29595	121396	0.677922	5712	14029	8.13464e-01	60870	169036	6.86792e-01	rs1057079	.	4024	0.791500	-0.886	0.078	-1.369	.	.	.	.	.	ENST00000361445: c.4731G>A (p.A1577A)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4142146	.	.	.	.	.	no_record	516654	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	1	11288757	11288758	1p36.22	.	G	snv	A	AC.TT	hom-alt	606	1.00	.	0	.	PASS	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C18	EX19	Domain of unknown function (DUF3385)	PF11865.3	coding-synon	NM_004958.3	NP_004949.1	-	Y	c.2997C>T	p.(N999=) | p.(Asn999=)	AAC=>AAT	.	NM_004958.3(MTOR): c.2997C>T (p.(N999=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126323	0.741211	U	0.9187	0.700479	13006	0.617561	PASS	3666	8654	0.919228	34459	121316	0.742886	7281	15837	9.18300e-01	71307	184932	7.51689e-01	rs1064261	.	4024	0.925200	-1.120	-0.406	-0.484	.	.	.	.	.	ENST00000361445: c.2997C>T (p.N999N)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4142152	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	11301713	11301714	1p36.22	.	A	snv	G	GC.TC	hom-alt	610	1.00	.	0	.	PASS	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C9	EX10	.	.	coding-synon	NM_004958.3	NP_004949.1	-	Y	c.1437T>C	p.(D479=) | p.(Asp479=)	GAT=>GAC	.	NM_004958.3(MTOR): c.1437T>C (p.(D479=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126354	0.713907	U	0.878	0.639577	13006	0.585345	PASS	3363	8652	0.881068	32381	121346	0.716975	6647	15108	8.78168e-01	66792	178432	7.25735e-01	rs1135172	.	4024	0.868500	-1.408	0.008	-0.429	.	.	.	.	.	ENST00000361445: c.1437T>C (p.D479D)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4142157	.	.	.	.	.	no_record	516653	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	1	11854456	11854457	1p36.22	.	G	snv	A	AC.AA	hom-alt	486	1.00	.	0	.	PASS	607093	P	181500(SK);188050(SK);236250(MK);601634(SK);607093(SK)	AD;AR	Homocystinuria due to MTHFR deficiency	AR	.	Biochemical; Cardiovascular; Hematologic; Neurologic	Biochemical; Cardiovascular; Hematologic	23124942|22947400|22856671|22807619|22773907|22721898|22665071|22646290|22578003|20850942|20356773|20236116|19697151|18708589|18658082|17409006|16216822|16145688|15979034|15896655|12673793|12142069|11938441|11508552|11274424|11170082|10961793|10923034|10862840|10679944|10536004|10384377|10323741|9878639|9372726|9341863|9244205|9133512|9068801|8994411|8940272|8892013|8826441|8691945|8456826|7920641|7726158|7647779|7564788|3889647|1998339|1866027|1627352	.	4524	MTHFR	C7	EX8	.	.	coding-synon	NM_005957.4	NP_005948.3	-	Y	c.1305C>T	p.(F435=) | p.(Phe435=)	TTC=>TTT	.	NM_005957.4(MTHFR): c.1305C>T (p.(F435=))	MixedObserved;maf-5-some-pop	126414	0.967013	U	0.996	0.902955	13006	0.890512	PASS	4318	8654	0.998960	57567	121406	0.969656	8611	17235	9.99246e-01	117918	240229	9.75525e-01	rs4846051	.	4024	0.998000	-0.556	0.176	-0.249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	167306	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	1	11856377	11856378	1p36.22	.	G	snv	A	CG.CT	het-ref	207	0.47	.	2	.	PASS	607093	P	181500(SK);188050(SK);236250(MK);601634(SK);607093(SK)	AD;AR	Homocystinuria due to MTHFR deficiency	AR	.	Biochemical; Cardiovascular; Hematologic; Neurologic	Biochemical; Cardiovascular; Hematologic	23124942|22947400|22856671|22807619|22773907|22721898|22665071|22646290|22578003|20850942|20356773|20236116|19697151|18708589|18658082|17409006|16216822|16145688|15979034|15896655|12673793|12142069|11938441|11508552|11274424|11170082|10961793|10923034|10862840|10679944|10536004|10384377|10323741|9878639|9372726|9341863|9244205|9133512|9068801|8994411|8940272|8892013|8826441|8691945|8456826|7920641|7726158|7647779|7564788|3889647|1998339|1866027|1627352	.	4524	MTHFR	C4	EX5	Methylenetetrahydrofolate reductase	PF02219.12	missense	NM_005957.4	NP_005948.3	-	Y	c.665C>T	p.A222V | p.Ala222Val	GCC=>GTC	NP=>NP	NM_005957.4(MTHFR): c.665C>T (p.A222V)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,microattr-tpa,submitted-by-lsdb	126404	0.301359	U	0.2956	0.245407	13006	0.270567	PASS	441	8650	0.305202	6624	121396	0.303667	829	5066	2.93715e-01	14288	77385	3.14254e-01	rs1801133	.	4024	0.414500	0.655	5.223	2.514	0.06	0.947	0.997	0.713	deleterious	ENST00000376592: c.665C>T (p.A222V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	146404	CM950819	NM_005957.4(MTHFR): c.665C>T (p.A222V)	"Cardiovascular disease, association with"	7647779	DFP	no_record	3520	reviewed_by_expert_panel	drug_response	Likely Benign
HHReport	1	17380496	17380497	1p36.13	.	G	snv	T	AG.GC	hom-alt	378	1.00	.	0	.	PASS	185470	C	115310(MK);171300(MK);606764(MK);606864(MK);612359(MK)	AD	Cowden-like syndrome; Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma; Paragangliomas 4	AD	.	Oncologic	Oncologic	22328163|21565294|21366490|21348866|20503330|20301715|19576851|19351833|19251979|18678321|18057081|17848412|17804857|17667967|17652212|17200167|17102084|16522703|16317055|15479192|15328326|14685938|14500403|12364472|12213855|12000816|11404820|490809	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HE15;HG15;HR14;MC58;MH43	6390	SDHB	C1	EX1	.	.	coding-synon	NM_003000.2	NP_002991.2	-	Y	c.18C>A	p.(A6=) | p.(Ala6=)	GCC=>GCA	.	NM_003000.2(SDHB): c.18C>A (p.(A6=))	SingleClassTriAllelic;maf-5-some-pop	117776	0.971463	U	0.996	0.957069	13002	0.951469	PASS	4193	8410	0.998573	53297	112768	0.972102	8514	17045	9.99004e-01	112147	230285	9.73663e-01	rs2746462	.	4024	0.998300	-1.537	0.034	-0.152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	44641	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	1	22965437	22965438	1p36.12	.	A	snv	G	GG.GC	het-ref	323	0.51	.	2	.	PASS	120550	C	613652(MK)	NN	C1q deficiency	AR	.	Allergy/Immunology/Infectious; Dermatologic; Renal	Allergy/Immunology/Infectious	22576477|20560256|10776791|9225968|8840296|7594474|6445507|6319055	.	712	C1QA	C2E	EX3E	Collagen triple helix repeat (20 copies)	PF01391.13	coding-synon	NM_015991.2	NP_057075.1	+	Y	c.276A>G	p.(G92=) | p.(Gly92=)	GGA=>GGG	.	NM_015991.2(C1QA): c.276A>G (p.(G92=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	86984	0.543157	U	0.6111	0.616414	12962	0.487965	PASS	1029	5856	0.616974	11213	81976	0.538682	2703	9100	5.90526e-01	27353	105988	4.85498e-01	rs172378	.	4024	0.587200	-0.215	-1.057	-0.601	.	.	.	.	.	ENST00000374642: c.276A>G (p.G92G)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3721050	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	23208924	23208925	1p36.12	.	G	snv	A	CC.GA	het-ref	152	0.52	.	2	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C6	EX6	Fibronectin type III domain	PF00041.16	coding-synon	NM_004442.6	NP_004433.2	+	Y	c.1377G>A	p.(P459=) | p.(Pro459=)	CCG=>CCA	.	NM_004442.6(EPHB2): c.1377G>A (p.(P459=))	;maf-5-some-pop,maf-5-all-pops	126376	0.140027	U	0.4901	0.214457	13006	0.118022	PASS	1163	8632	0.518999	1906	121368	0.136955	2380	9072	5.25974e-01	3850	33738	1.37005e-01	rs2229872	.	4024	0.538300	-0.475	-0.845	-2.146	.	.	.	.	.	ENST00000374632: c.1377G>A (p.P459P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1178395	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	23208924	23208925	1p36.12	.	G	snv	A	CC.GA	het-ref	152	0.52	.	2	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C6	EX6	Fibronectin type III domain	PF00041.16	coding-synon	NM_017449.3	NP_059145.2	+	N	c.1377G>A	p.(P459=) | p.(Pro459=)	CCG=>CCA	.	NM_017449.3(EPHB2): c.1377G>A (p.(P459=))	;maf-5-some-pop,maf-5-all-pops	126376	0.140027	U	0.4901	0.214457	13006	0.118022	PASS	1163	8632	0.518999	1906	121368	0.136955	2380	9072	5.25974e-01	3850	33738	1.37005e-01	rs2229872	.	4024	0.538300	-0.475	-0.845	-2.146	.	.	.	.	.	ENST00000374632: c.1377G>A (p.P459P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1178395	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	27101259	27101260	1p36.11	.	G	snv	A	AC.GG	het-ref	360	0.48	.	2	.	PASS	603024	P	614607(MK)	NN	Mental retardation, autosomal dominant 14; Coffin-Siris syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22426309|22426308	.	8289	ARID1A	C18	EX18	.	.	coding-synon	NM_006015.4	NP_006006.3	+	Y	c.4542G>A	p.(T1514=) | p.(Thr1514=)	ACG=>ACA	.	NM_006015.4(ARID1A): c.4542G>A (p.(T1514=))	;	126252	0.000269	U	0.003	0.000599042	.	.	PASS	0	8648	0.003585	0	121244	0.000256	0	56	3.24751e-03	0	57	2.31538e-04	rs560211386	.	4024	0.006700	-0.188	-3.051	-2.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	1	29630454	29630455	1p35.3	.	C	snv	T	TA.CA	het-ref	174	0.50	.	2	.	PASS	602454	C	.	NN	.	.	.	.	.	.	.	10076	PTPRU	C17	EX17	.	.	coding-synon	NM_005704.4	NP_005695.3	+	Y	c.2595C>T	p.(Y865=) | p.(Tyr865=)	TAC=>TAT	.	NM_005704.4(PTPRU): c.2595C>T (p.(Y865=))	;maf-5-some-pop,maf-5-all-pops	125598	0.267584	U	0.6419	0.3752	13006	0.201907	PASS	1808	8612	0.649210	5561	120590	0.263115	3648	11172	6.47953e-01	11620	65633	2.66998e-01	rs2295061	.	4024	0.623000	0.561	0.354	-0.503	.	.	.	.	.	ENST00000345512: c.2595C>T (p.Y865Y)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1748343	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	36225947	36225948	1p34.3	.	T	snv	C	TG.TG	het-ref	101	0.44	.	2	.	PASS	605434	P	.	NN	.	.	.	.	.	.	.	63967	CLSPN	C8	EX8	.	.	missense	NM_022111.3	NP_071394.2	-	Y	c.1574A>G	p.N525S | p.Asn525Ser	AAC=>AGC	P0=>P0	NM_022111.3(CLSPN): c.1574A>G (p.N525S)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123876	0.279158	U	0.7401	0.453674	13006	0.288713	PASS	2728	8648	0.794403	7118	118868	0.271806	5489	13732	7.96890e-01	14332	65883	2.69473e-01	rs7537203	.	4024	0.803900	0.482	3.032	1.907	0.01	0.995	0.999	0.863	deleterious	ENST00000318121: c.1574A>G (p.N525S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5425390	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	40363053	40363054	1p34.2	.	G	snv	C	CA.TG	hom-alt	435	1.00	.	0	.	PASS	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	C3E	EX3E	.	.	missense	NM_001033082.2	NP_001028254.2	-	Y	c.1175C>G	p.T392S | p.Thr392Ser	ACT=>AGT	P0=>P0	NM_001033082.2(MYCL1): c.1175C>G (p.T392S)	;maf-5-some-pop,genotype-conflict	124716	0.888435	U	1	0.935703	13006	0.903660	PASS	4321	8652	0.999422	47130	119708	0.886457	8550	17114	9.99183e-01	94259	212501	8.84234e-01	rs3134614	.	4024	0.996800	-0.120	1.584	1.316	1	0.001	0	0.000	neutral	ENST00000397332: c.1175C>G (p.T392S)	prostate [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3927628	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	45291907	45291908	1p34.1	.	G	snv	A	GG.TG	het-ref	272	0.48	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC19	IVS19	.	.	intron	NM_001166292.1	NP_001159764.1	-	Y	c.3114+14C>T	.	.	.	NM_001166292.1(PTCH2): c.3114+14C>T	;maf-5-some-pop,maf-5-all-pops	116580	0.196449	U	0.2887	0.195687	13006	0.161848	PASS	266	8180	0.267971	2042	111572	0.196483	599	4547	2.64915e-01	4396	45659	1.86952e-01	rs11211040	.	4024	0.257700	0.655	1.571	2.608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	1	45292172	45292173	1p34.1	.	G	snv	A	CC.TC	het-ref	364	0.50	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C18	EX18	Patched family	PF02460.13	missense	NM_001166292.1	NP_001159764.1	-	Y	c.2963C>T	p.T988M | p.Thr988Met	ACG=>ATG	P0=>NP	NM_001166292.1(PTCH2): c.2963C>T (p.T988M)	;maf-5-some-pop,genotype-conflict	124658	0.044795	U	0.1677	0.0628994	13004	0.016072	PASS	101	8582	0.159170	225	119650	0.044037	234	2832	1.64498e-01	505	11413	4.66488e-02	rs11573590	.	4024	0.158100	-0.137	0.884	-0.012	0.09	0.747	0.934	0.571	deleterious	ENST00000372192: c.2963C>T (p.T988M)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	RSS	1162381	.	.	.	.	.	no_record	415448	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	1	45292865	45292866	1p34.1	.	G	snv	A	GC.TC	het-ref	327	0.48	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C16	EX16	.	.	coding-synon	NM_001166292.1	NP_001159764.1	-	Y	c.2487C>T	p.(D829=) | p.(Asp829=)	GAC=>GAT	.	NM_001166292.1(PTCH2): c.2487C>T (p.(D829=))	SingleClassTriAllelic;maf-5-some-pop	126232	0.160276	U	0.1964	0.147764	13006	0.139474	PASS	206	8622	0.221990	1683	121224	0.160793	397	3654	2.11900e-01	3413	39935	1.62217e-01	rs2295996	.	4024	0.253200	-0.484	0.247	-0.186	.	.	.	.	.	ENST00000372192: c.2487C>T (p.D829D)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3751243	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	45293517	45293518	1p34.1	.	A	snv	G	TT.GC	hom-alt	474	1.00	.	0	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C14	EX14	Patched family	PF02460.13	coding-synon	NM_001166292.1	NP_001159764.1	-	Y	c.2055T>C	p.(A685=) | p.(Ala685=)	GCT=>GCC	.	NM_001166292.1(PTCH2): c.2055T>C (p.(A685=))	;maf-5-some-pop,maf-5-all-pops	125538	0.386990	U	0.4911	0.445487	13006	0.424419	PASS	1014	8582	0.484386	9301	120530	0.384560	2025	8274	4.80655e-01	18446	93493	3.80942e-01	rs7525308	.	4024	0.512900	-0.226	1.242	0.371	.	.	.	.	.	ENST00000372192: c.2055T>C (p.A685A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3751244	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	45293751	45293752	1p34.1	.	T	snv	C	GC.TC	het-ref	278	0.50	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C14	EX14	Patched family	PF02460.13	coding-synon	NM_001166292.1	NP_001159764.1	-	Y	c.1821A>G	p.(E607=) | p.(Glu607=)	GAA=>GAG	.	NM_001166292.1(PTCH2): c.1821A>G (p.(E607=))	;maf-5-some-pop,maf-5-all-pops	126330	0.190604	U	0.2897	0.21266	13006	0.179456	PASS	287	8630	0.259212	2288	121322	0.189694	618	4597	2.66555e-01	4700	46927	1.91426e-01	rs2295997	.	4024	0.258000	0.455	1.636	0.610	.	.	.	.	.	ENST00000372192: c.1821A>G (p.E607E)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019415	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	45307505	45307506	1p34.1	.	G	snv	A	GT.TC	het-ref	179	0.45	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC2	IVS2	.	.	intron	NM_001166292.1	NP_001159764.1	-	Y	c.265+13C>T	.	.	.	NM_001166292.1(PTCH2): c.265+13C>T	MixedObserved;maf-5-some-pop,maf-5-all-pops	126362	0.367698	U	0.4454	0.372005	13006	0.339074	PASS	813	8640	0.431134	8586	121354	0.367520	1648	7488	4.34238e-01	17983	92094	3.74116e-01	rs3795720	.	4024	0.456500	0.561	1.263	0.562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
HHReport	1	45796898	45796899	1p34.1	.	C	snv	G	TG.GT	het-ref	304	0.45	.	2	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	C14	EX14	NUDIX domain	PF14815.1	coding-synon	NM_001128425.1	NP_001121897.1	-	Y	c.1431G>C	p.(T477=) | p.(Thr477=)	ACG=>ACC	.	NM_001128425.1(MUTYH): c.1431G>C (p.(T477=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126402	0.005103	U	0.0308	0.0103834	13006	0.004152	PASS	4	8650	0.028092	8	121394	0.004885	7	427	2.47565e-02	13	1120	4.54804e-03	rs74318065	.	4024	0.029800	-1.789	0.428	-0.542	.	.	.	.	.	ENST00000372098: c.1422G>C (p.T474T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4417650	.	.	.	.	.	no_record	183787	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Certain
HHReport	1	45797504	45797505	1p34.1	.	C	snv	G	CA.TG	hom-alt	450	1.00	.	0	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	C12	EX12	.	.	missense	NM_001128425.1	NP_001121897.1	-	Y	c.1014G>C	p.Q338H | p.Gln338His	CAG=>CAC	P0=>P+	NM_001128425.1(MUTYH): c.1014G>C (p.Q338H)	MixedObserved;maf-5-some-pop,maf-5-all-pops	102302	0.297502	U	0.3909	0.313498	13002	0.254115	PASS	570	6868	0.430256	4266	97294	0.296678	1215	6423	3.96923e-01	10375	65945	2.89123e-01	rs3219489	.	4024	0.376700	-0.140	-0.078	0.240	0.11	0.152	0.315	0.285	neutral	ENST00000372098: c.1005G>C (p.Q335H)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3751252	.	.	.	.	.	no_record	41767	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	1	45805879	45805880	1p34.1	.	G	snv	A	AA.TC	het-ref	182	0.49	.	2	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	IC1	IVS1	.	.	intron	NM_001128425.1	NP_001121897.1	-	Y	c.36+11C>T	.	.	.	NM_001128425.1(MUTYH): c.36+11C>T	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118836	0.003854	U	0.0308	0.00678914	13006	0.000384	PASS	4	8408	0.028782	6	113828	0.003725	7	425	2.47266e-02	9	814	3.32968e-03	rs2275602	.	4024	0.029800	0.655	3.358	2.770	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	138310	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely Deleterious
Pass	1	47685454	47685455	1p33	.	T	snv	C	TG.TT	hom-alt	304	1.00	.	0	.	PASS	187040	C	187040(MK)	NN	.	.	.	.	.	.	.	6886	TAL1	C3E	EX4E	.	.	coding-synon	NM_003189.2	NP_003180.1	-	Y	c.933A>G	p.(K311=) | p.(Lys311=)	AAA=>AAG	.	NM_003189.2(TAL1): c.933A>G (p.(K311=))	SingleClassTriAllelic;	121376	0.999992	U	1	1	.	.	PASS	4183	8366	1.000000	58183	116368	0.999991	8507	17014	1.00000e+00	120080	240161	9.99996e-01	rs927462	.	4024	0.998500	-1.479	0.517	-0.035	.	.	.	.	.	ENST00000371884: c.933A>G (p.K311K)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3751261	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	51873950	51873951	1p32.3	.	G	snv	A	TC.TA	hom-alt	405	1.00	.	0	.	PASS	600051	P	.	NN	.	.	.	.	.	.	.	2060	EPS15	C15	EX15	.	.	coding-synon	NM_001981.2	NP_001972.1	-	Y	c.1329C>T	p.(Y443=) | p.(Tyr443=)	TAC=>TAT	.	NM_001981.2(EPS15): c.1329C>T (p.(Y443=))	;maf-5-some-pop	126378	0.738174	U	0.9921	0.822684	13006	0.729279	PASS	4270	8652	0.993528	33523	121370	0.734687	8505	17127	9.93215e-01	67251	179906	7.30707e-01	rs1065754	.	4024	0.989800	-0.360	-0.289	-0.339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	65310488	65310489	1p31.3	.	T	snv	C	AA.GG	het-ref	313	0.53	.	2	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	C15	EX16	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_002227.2	NP_002218.2	-	Y	c.2199A>G	p.(P733=) | p.(Pro733=)	CCA=>CCG	.	NM_002227.2(JAK1): c.2199A>G (p.(P733=))	;maf-5-some-pop,genotype-conflict	125712	0.296686	U	0.2996	0.372604	12692	0.349196	PASS	457	8612	0.313632	5997	120704	0.293536	873	5468	3.17022e-01	11906	72460	2.94323e-01	rs2230588	.	4024	0.283500	-2.706	-3.681	-4.134	.	.	.	.	.	ENST00000342505: c.2199A>G (p.P733P)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3751351	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	65321387	65321388	1p31.3	.	G	snv	A	TC.GG	het-ref	190	0.45	.	2	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC9	IVS10	.	.	intron	NM_002227.2	NP_002218.2	-	Y	c.1459-7C>T	.	.	.	NM_002227.2(JAK1): c.1459-7C>T	;maf-5-some-pop,maf-5-all-pops	122370	0.359214	U	0.3065	0.402556	11980	0.380134	PASS	472	8458	0.326437	7970	117362	0.357364	919	5608	3.27417e-01	16690	86661	3.58548e-01	rs310229	.	4024	0.300400	-0.977	0.022	-0.186	.	.	.	.	.	ENST00000342505: c.1459-7C>T (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5019821	.	.	.	.	.	.	.	.	.	Benign
Pass	1	70225922	70225923	1p31.1	.	G	snv	A	GT.CC	het-ref	317	0.50	.	2	.	PASS	614453	C	.	NN	.	.	.	.	.	.	.	57554	LRRC7	C1	EX1	.	.	coding-synon	NM_020794.2	NP_065845.1	+	Y	c.36G>A	p.(V12=) | p.(Val12=)	GTG=>GTA	.	NM_020794.2(LRRC7): c.36G>A (p.(V12=))	;maf-5-some-pop	125186	0.065806	U	0.127	0.0766773	13002	0.046301	PASS	76	8530	0.121102	307	120178	0.065353	135	2081	1.21270e-01	738	16737	6.82953e-02	rs1340770	.	4024	0.121000	0.557	2.887	1.450	.	.	.	.	.	ENST00000035383: c.36G>A (p.V12V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3997651	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	78435701	78435702	1p31.1	.	A	del	.	CT.AA	het-ref	77	0.29	.	2	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC1	IVS1	.	.	intron	NM_003902.3	NP_003893.2	-	Y	c.121-3delT	.	.	.	NM_003902.3(FUBP1): c.121-3delT	MixedObserved;	441	0.011338	U	.	.	.	.	InbreedingCoeff_Filter	0	5684	0.341133	0	78662	0.354301	.	.	.	.	.	.	rs202224025	.	4024	0.478100	-0.672	0.039	0.423	.	.	.	.	.	ENST00000370768: c.121-3delT (p.?)	bone [NS|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	3730287	.	.	.	.	.	.	.	.	.	Benign
Pass	1	110466337	110466338	1p13.3	.	C	snv	A	AC.GC	het-ref	117	0.53	.	2	.	PASS	120420	C	.	NN	.	.	.	.	.	.	.	1435	CSF1	C6	EX6	Macrophage colony stimulating factor-1 (CSF-1)	PF05337.6	coding-synon	NM_000757.5	NP_000748.3	+	Y	c.1095C>A	p.(T365=) | p.(Thr365=)	ACC=>ACA	.	NM_000757.5(CSF1): c.1095C>A (p.(T365=))	;maf-5-some-pop,maf-5-all-pops	125742	0.552250	U	0.4018	0.430112	13006	0.464632	PASS	783	8624	0.431586	19707	120734	0.557316	1634	7483	4.34049e-01	41212	139145	5.68171e-01	rs333970	.	4024	0.408300	0.467	-0.476	-0.766	.	.	.	.	.	ENST00000369802: c.1095C>A (p.T365T)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3750219	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	110466465	110466466	1p13.3	.	T	snv	C	AC.GC	het-ref	135	0.46	.	2	.	PASS	120420	C	.	NN	.	.	.	.	.	.	.	1435	CSF1	C6	EX6	Macrophage colony stimulating factor-1 (CSF-1)	PF05337.6	missense	NM_000757.5	NP_000748.3	+	Y	c.1223T>C	p.L408P | p.Leu408Pro	CTG=>CCG	NP=>NP	NM_000757.5(CSF1): c.1223T>C (p.L408P)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125650	0.383136	U	0.5972	0.421526	13006	0.395510	PASS	1456	8622	0.587451	9042	120642	0.381542	2892	10007	5.80385e-01	17896	91977	3.74533e-01	rs1058885	.	4024	0.599900	-2.386	-2.085	-2.705	.	.	.	.	.	ENST00000369802: c.1223T>C (p.L408P)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	3747493	CM066774	NM_000757.5(CSF1): c.1223T>C (p.L408P)	"Periodontitis, assoc. with ?"	16844084	DP	.	.	.	.	Likely Benign
Pass	1	113456545	113456546	1p13.2	.	A	snv	T	CC.TC	hom-alt	302	1.00	.	0	.	PASS	600682	P	245340(MK);610021(MK);616095(MK)	AD	Hyperinsulinemic hypoglycemia, familial, 7; Erythrocyte lactate transporter defect	AD	.	Endocrine; Musculoskeletal; Renal	Endocrine; Musculoskeletal; Renal	17701893|12502513|11207177|10590411|3775384|3395514|3395513|1358043	.	6566	SLC16A1	C4E	EX5E	.	.	missense	NM_003051.3	NP_003042.3	-	Y	c.1470T>A	p.D490E | p.Asp490Glu	GAT=>GAA	P-=>P-	NM_003051.3(SLC16A1): c.1470T>A (p.D490E)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126396	0.600359	U	0.6647	0.676717	13006	0.666231	PASS	1893	8648	0.663275	22245	121388	0.597209	3873	11544	6.69295e-01	43973	145489	5.90837e-01	rs1049434	.	4024	0.654100	-0.265	0.490	0.270	1	0	0	0.000	neutral	ENST00000369626: c.1470T>A (p.D490E)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4142166	.	.	.	.	.	no_record	130315	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	1	120508066	120508067	1p12	.	G	snv	T	AA.AA	het-ref	199	0.51	.	2	.	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC10	IVS10	.	.	intron	NM_024408.3	NP_077719.2	-	Y	c.1681+9C>A	.	.	.	NM_024408.3(NOTCH2): c.1681+9C>A	;	126414	0.000451	U	0.005	0.000998403	.	.	PASS	0	8650	0.006012	0	121406	0.000428	1	123	7.13209e-03	1	125	5.08415e-04	rs192886452	.	4024	0.006000	0.557	0.109	-0.354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	282715	criteria_provided,_single_submitter	Likely_benign	Likely Benign
InExcel	1	120572546	120572547	1p12	.	T	snv	C	CA.TG	het-ref	39	0.20	.	2	dup	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C2	EX2	.	.	missense	NM_024408.3	NP_077719.2	-	Y	c.137A>G	p.N46S | p.Asn46Ser	AAT=>AGT	P0=>P0	NM_024408.3(NOTCH2): c.137A>G (p.N46S)	;maf-5-some-pop,maf-5-all-pops	18032	0.473602	U	.	.	.	.	InbreedingCoeff_Filter	0	1158	0.481865	0	18032	0.473602	0	3455	4.55324e-01	0	41628	4.40760e-01	rs61788900	.	4024	0.455500	0.477	2.519	1.904	0.18	0.093	0.126	0.063	neutral	ENST00000256646: c.137A>G (p.N46S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3773408	.	.	.	.	.	.	.	.	.	Unknown
InExcel	1	120572571	120572572	1p12	.	C	snv	T	TT.AT	het-ref	33	0.20	.	2	dup	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C2	EX2	.	.	missense	NM_024408.3	NP_077719.2	-	Y	c.112G>A	p.E38K | p.Glu38Lys	GAA=>AAA	P-=>P+	NM_024408.3(NOTCH2): c.112G>A (p.E38K)	;maf-5-some-pop,maf-5-all-pops	16954	0.469919	U	.	.	.	.	InbreedingCoeff_Filter	0	1086	0.476980	0	16954	0.469919	0	3490	4.55971e-01	0	42006	4.43354e-01	rs61788901	.	4024	0.444800	-0.225	0.502	0.171	0.08	0.018	0.01	0.300	neutral	ENST00000256646: c.112G>A (p.E38K)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	1736165	.	.	.	.	.	.	.	.	.	Unknown
InExcel	1	120611963	120611964	1p11.2	.	G	snv	C	GC.CA	het-ref	164	0.23	.	2	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	.	.	missense	NM_024408.3	NP_077719.2	-	Y	c.57C>G	p.C19W | p.Cys19Trp	TGC=>TGG	P0=>NP	NM_024408.3(NOTCH2): c.57C>G (p.C19W)	SingleClassTriAllelic;maf-5-some-pop	99638	0.449317	U	.	.	.	.	InbreedingCoeff_Filter	0	7660	0.471540	3	99638	0.449317	0	7071	4.66979e-01	2	89294	4.43318e-01	rs11810554	.	4024	0.469700	0.184	0.738	1.760	0.18	0.006	0.113	0.056	neutral	ENST00000256646: c.57C>G (p.C19W)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	132738	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	1	120612002	120612004	1p11.2	.	GG	del	.	GC.GG	het-ref	133	0.16	.	2	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	EGF-like domain;Ankyrin repeat;LNR domain;NOTCH protein;Calcium-binding EGF domain;NOTCH protein;Domain of unknown function (DUF3454);Human growth factor-like EGF;Ankyrin repeats (3 copies);Ankyrin repeat;Ankyrin repeats (many copies);Ankyrin repeats (many copies)	PF00008.22;PF00023.25;PF00066.12;PF06816.8;PF07645.10;PF07684.7;PF11936.3;PF12661.2;PF12796.2;PF13606.1;PF13637.1;PF13857.1	frameshift	NM_024408.3	NP_077719.2	-	Y	c.15C[4>2] (std: c.15C[2] alt: c.17_18delCC )	p.P6Rfs*27 | p.Pro6Argfs*27	.	.	NM_024408.3(NOTCH2): c.15C[2] (p.P6Rfs*27)	;maf-5-some-pop,maf-5-all-pops	92738	0.405713	U	.	.	.	.	InbreedingCoeff_Filter	0	7164	0.370743	0	92738	0.405713	0	1281	1.14212e-01	0	22958	1.79964e-01	rs372504208	.	4024	0.387700	.	.	.	.	.	.	.	.	ENST00000256646: c.17_18delCC (p.P6fs*27)	NS [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	132830	.	.	.	.	.	no_record	218795	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
InExcel	1	120612005	120612006	1p11.2	.	G	snv	A	GG.CG	het-ref	171	0.20	.	2	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	.	.	coding-synon	NM_024408.3	NP_077719.2	-	Y	c.15C>T	p.(R5=) | p.(Arg5=)	CGC=>CGT	.	NM_024408.3(NOTCH2): c.15C>T (p.(R5=))	SingleClassTriAllelic;maf-5-some-pop	101190	0.460302	U	0.4315	0.39397	.	.	InbreedingCoeff_Filter	16	7610	0.478055	259	96182	0.463756	34	6663	4.62708e-01	600	88037	4.51171e-01	rs4021006	.	4024	0.474900	0.184	0.742	0.543	.	.	.	.	.	ENST00000256646: c.15C>T (p.R5R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1320072	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	1	144856887	144856888	1q21.1	.	C	snv	T	AG.AG	het-ref	82	0.23	.	2	dup	DUBIOUS	608117	C	.	NN	.	.	.	.	.	.	.	9659	PDE4DIP	C40	EX40	.	.	coding-synon	NM_001198834.2	NP_001185763.2	-	Y	c.6597G>A	p.(L2199=) | p.(Leu2199=)	CTG=>CTA	.	NM_001198834.2(PDE4DIP): c.6597G>A (p.(L2199=))	;	114824	0.028104	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8248	0.126334	0	114824	0.028104	0	1762	1.09632e-01	0	5867	2.44005e-02	rs3853915	.	4024	0.137700	0.455	0.272	1.042	.	.	.	.	.	ENST00000369356: c.6597G>A (p.L2199L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4142479	.	.	.	.	.	.	.	.	.	Unknown
InExcel	1	152278813	152278814	1q21.3	.	C	snv	T	GC.GT	het-ref	251	0.23	.	2	trf;dup	PASS	135940	C	146700(MK);605803(SK)	AD	Icthyosis vulgaris	AD/AR	.	Dermatologic	General	22989708|22962861|22951058|22299762|21790526|21712002|21692775|17291859|17030239|16815158|16550169|16444271|12838398|12473059	.	2312	FLG	C2E	EX3E	Filaggrin	PF03516.8	missense	NM_002016.1	NP_002007.1	-	Y	c.8548G>A	p.G2850S | p.Gly2850Ser	GGC=>AGC	P0=>P0	NM_002016.1(FLG): c.8548G>A (p.G2850S)	SingleClassTriAllelic;maf-5-some-pop	90080	0.111490	U	.	.	12886	0.060298	VQSRTrancheSNP99.80to99.90	0	5598	0.349946	0	90080	0.111490	0	2076	2.74023e-01	31	11613	7.16127e-02	rs2184952	.	4024	0.403800	0.306	-0.506	-0.915	0.99	1	1	0.500	deleterious	ENST00000368799: c.8548G>A (p.G2850S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4142676	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	152278855	152278856	1q21.3	.	T	snv	G	AC.TC	het-ref	176	0.39	.	2	trf;dup	PASS	135940	C	146700(MK);605803(SK)	AD	Icthyosis vulgaris	AD/AR	.	Dermatologic	General	22989708|22962861|22951058|22299762|21790526|21712002|21692775|17291859|17030239|16815158|16550169|16444271|12838398|12473059	.	2312	FLG	C2E	EX3E	.	.	missense	NM_002016.1	NP_002007.1	-	Y	c.8506A>C	p.S2836R | p.Ser2836Arg	AGT=>CGT	P0=>P+	NM_002016.1(FLG): c.8506A>C (p.S2836R)	SingleClassTriAllelic;maf-5-some-pop	120530	0.189330	U	.	.	12928	0.084081	InbreedingCoeff_Filter	0	8634	0.397846	0	120530	0.189330	0	6485	3.94849e-01	0	40672	1.77547e-01	rs11582087	.	4024	0.408100	0.254	-0.164	-0.204	0.3	0.99	0.998	0.470	deleterious	ENST00000368799: c.8506A>C (p.S2836R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_leukaemia_of_ambiguous_lineage|NS|NS]	CSV	5803225	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	156846232	156846233	1q23.1	.	G	snv	A	CA.CG	hom-alt	659	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C14	EX14	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_001007792.1	NP_001007793.1	+	Y	c.1566G>A	p.(Q522=) | p.(Gln522=)	CAG=>CAA	.	NM_001007792.1(NTRK1): c.1566G>A (p.(Q522=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.220030	U	0.3204	0.212859	13006	0.193603	PASS	545	8560	0.355257	3033	120002	0.220330	1069	6030	3.50459e-01	6246	54107	2.20248e-01	rs6334	.	4024	0.332300	0.561	0.588	0.773	.	.	.	.	.	ENST00000524377: c.1674G>A (p.Q558Q)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3750439	.	.	.	.	.	no_record	292889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	1	156846232	156846233	1q23.1	.	G	snv	A	CA.CG	hom-alt	659	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_001012331.1	NP_001012331.1	+	N	c.1656G>A	p.(Q552=) | p.(Gln552=)	CAG=>CAA	.	NM_001012331.1(NTRK1): c.1656G>A (p.(Q552=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.220030	U	0.3204	0.212859	13006	0.193603	PASS	545	8560	0.355257	3033	120002	0.220330	1069	6030	3.50459e-01	6246	54107	2.20248e-01	rs6334	.	4024	0.332300	0.561	0.588	0.773	.	.	.	.	.	ENST00000524377: c.1674G>A (p.Q558Q)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3750439	.	.	.	.	.	no_record	292889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	1	156846232	156846233	1q23.1	.	G	snv	A	CA.CG	hom-alt	659	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C14	EX14	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_002529.3	NP_002520.2	+	N	c.1674G>A	p.(Q558=) | p.(Gln558=)	CAG=>CAA	.	NM_002529.3(NTRK1): c.1674G>A (p.(Q558=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.220030	U	0.3204	0.212859	13006	0.193603	PASS	545	8560	0.355257	3033	120002	0.220330	1069	6030	3.50459e-01	6246	54107	2.20248e-01	rs6334	.	4024	0.332300	0.561	0.588	0.773	.	.	.	.	.	ENST00000524377: c.1674G>A (p.Q558Q)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3750439	.	.	.	.	.	no_record	292889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	1	162737115	162737116	1q23.3	.	C	snv	G	CT.TG	het-ref	320	0.48	.	2	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	C9	EX12	.	.	coding-synon	NM_001014796.1	NP_001014796.1	+	Y	c.1260C>G	p.(L420=) | p.(Leu420=)	CTC=>CTG	.	NM_001014796.1(DDR2): c.1260C>G (p.(L420=))	;maf-5-some-pop,maf-5-all-pops	126320	0.229101	U	0.4077	0.348442	13006	0.257266	PASS	704	8618	0.404038	4196	121312	0.224174	1396	6865	3.98294e-01	8513	55460	2.25484e-01	rs2298258	.	4024	0.411800	0.655	0.027	0.034	.	.	.	.	.	ENST00000367922: c.1260C>G (p.L420L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3997042	.	.	.	.	.	no_record	259929	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
InExcel	1	179078169	179078169	1q25.2	.	.	ins	ACCC	CA.CC	het-ref	20	0.18	.	2	.	PASS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	C12E	EX12E	F-actin binding	PF08919.5	frameshift	NM_007314.3	NP_009298.1	-	Y	c.2232_2233insGGGT	p.W745Gfs*24 | p.Trp745Glyfs*24	.	.	NM_007314.3(ABL2): c.2232_2233insGGGT (p.W745Gfs*24)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0.00000e+00	0	0	0.00000e+00	.	.	4024	0.008700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
InExcel	1	179078172	179078173	1q25.2	.	A	snv	C	CC.CC	het-ref	15	0.15	.	2	.	DUBIOUS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	C12E	EX12E	.	.	coding-synon	NM_007314.3	NP_009298.1	-	Y	c.2229T>G	p.(G743=) | p.(Gly743=)	GGT=>GGG	.	NM_007314.3(ABL2): c.2229T>G (p.(G743=))	MixedObserved;	98510	0.003756	U	.	.	.	.	VQSRTrancheSNP99.95to100.00	0	7286	0.002196	0	98510	0.003756	0	33	2.86608e-03	0	1269	7.75426e-03	rs774330058	.	4024	0.111300	-0.321	-1.228	-0.925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
Pass	1	182551336	182551337	1q25.3	.	A	snv	C	AG.TC	hom-alt	238	1.00	.	0	.	PASS	180435	C	601518(MK)	NN	Prostate cancer, hereditary, 1	AD	.	Oncologic	Oncologic	18575592|17224235|16054567|12915880|12022038|11799394	.	6041	RNASEL	C3	EX4	.	.	missense	NM_021133.3	NP_066956.1	-	Y	c.1623T>G	p.D541E | p.Asp541Glu	GAT=>GAG	P-=>P-	NM_021133.3(RNASEL): c.1623T>G (p.D541E)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126390	0.535683	U	0.7093	0.479832	13006	0.472167	PASS	2272	8650	0.721618	18084	121382	0.537988	4523	12453	7.21997e-01	36337	131423	5.39729e-01	rs627928	.	4024	0.712000	-1.655	-1.926	-1.577	1	0	0	0.000	neutral	.	.	.	.	.	CM034674	NM_021133.3(RNASEL): c.1623T>G (p.D541E)	"Prostate cancer, association with"	12915880	DP	.	.	.	.	Likely Benign
Pass	1	182554556	182554557	1q25.3	.	C	snv	T	TT.GG	hom-alt	398	1.00	.	0	.	PASS	180435	C	601518(MK)	NN	Prostate cancer, hereditary, 1	AD	.	Oncologic	Oncologic	18575592|17224235|16054567|12915880|12022038|11799394	.	6041	RNASEL	C1	EX2	Protein kinase domain;Lipopolysaccharide kinase (Kdo/WaaP) family;Protein tyrosine kinase	PF00069.20;PF06293.9;PF07714.12	missense	NM_021133.3	NP_066956.1	-	Y	c.1385G>A	p.R462Q | p.Arg462Gln	CGA=>CAA	P+=>P0	NM_021133.3(RNASEL): c.1385G>A (p.R462Q)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126372	0.305819	U	0.2421	0.230631	13006	0.280793	PASS	234	8648	0.229070	6316	121364	0.308922	478	4022	2.33186e-01	12551	75436	3.06593e-01	rs486907	.	4024	0.220400	0.650	0.253	0.102	0.04	0.85	0.998	0.676	deleterious	ENST00000367559: c.1385G>A (p.R462Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3750683	CM020962	NM_021133.3(RNASEL): c.1385G>A (p.R462Q)	"Prostate cancer, association with ?"	11941539	DP	no_record	13006	no_assertion_criteria_provided	risk_factor	Likely Benign
Pass	1	201981217	201981218	1q32.1	.	C	snv	G	GG.GC	het-ref	225	0.47	.	2	.	PASS	602191	P	.	NN	.	.	.	.	.	.	.	1999	ELF3	C2	EX3	Sterile alpha motif (SAM)/Pointed domain	PF02198.11	coding-synon	NM_001114309.1	NP_001107781.1	+	Y	c.297C>G	p.(G99=) | p.(Gly99=)	GGC=>GGG	.	NM_001114309.1(ELF3): c.297C>G (p.(G99=))	SingleClassTriAllelic;maf-5-some-pop	126240	0.258270	U	0.3363	0.338259	13006	0.295556	PASS	529	8624	0.350881	4290	121232	0.254966	1025	5972	3.46243e-01	8207	60906	2.47408e-01	rs11543979	.	4024	0.358100	-1.059	-0.361	-0.198	.	.	.	.	.	ENST00000359651: c.297C>G (p.G99G)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	146735	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	203152800	203152801	1q32.1	.	T	snv	C	TC.CC	hom-alt	377	1.00	.	0	.	PASS	601525	C	181500(SK);611960(SK)	AD	.	.	.	.	.	.	.	1116	CHI3L1	C5	EX5	Glycosyl hydrolases family 18	PF00704.23	missense	NM_001276.2	NP_001267.2	-	Y	c.433A>G	p.R145G | p.Arg145Gly	AGA=>GGA	P+=>P0	NM_001276.2(CHI3L1): c.433A>G (p.R145G)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126300	0.452019	U	0.3839	0.373003	13006	0.414424	PASS	601	8594	0.370026	13424	121292	0.455281	1233	6461	3.74942e-01	26886	111099	4.51369e-01	rs880633	.	4024	0.361600	0.533	1.732	2.153	0	0.155	0.177	0.458	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	206647786	206647787	1q32.1	.	T	snv	C	AT.GT	hom-alt	627	1.00	.	0	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C2	EX4	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_014002.3	NP_054721.1	+	Y	c.201T>C	p.(I67=) | p.(Ile67=)	ATT=>ATC	.	NM_014002.3(IKBKE): c.201T>C (p.(I67=))	;maf-5-some-pop,genotype-conflict	125810	0.860695	U	0.9732	0.899161	13006	0.845917	PASS	4123	8640	0.976389	44708	120802	0.859100	8228	16833	9.76845e-01	91382	211495	8.61031e-01	rs1539243	.	.	.	-0.974	-0.036	0.005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	206651106	206651107	1q32.1	.	G	snv	A	AC.GA	het-ref	178	0.45	.	2	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C6	EX8	Protein kinase domain	PF00069.20	coding-synon	NM_014002.3	NP_054721.1	+	Y	c.717G>A	p.(T239=) | p.(Thr239=)	ACG=>ACA	.	NM_014002.3(IKBKE): c.717G>A (p.(T239=))	;maf-5-some-pop,maf-5-all-pops	32458	0.323403	U	0.6131	0.315495	12912	0.194160	PASS	397	1900	0.680000	1222	27450	0.324845	2403	7414	6.43241e-01	7109	44421	2.66543e-01	rs2297545	.	.	.	-2.447	-4.093	-3.856	.	.	.	.	.	ENST00000367120: c.717G>A (p.T239T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	425146	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	206669464	206669465	1q32.1	.	C	snv	T	AC.TC	het-ref	205	0.47	.	2	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C20E	EX22E	.	.	missense	NM_014002.3	NP_054721.1	+	Y	c.2138C>T	p.P713L | p.Pro713Leu	CCT=>CTT	NP=>NP	NM_014002.3(IKBKE): c.2138C>T (p.P713L)	;maf-5-some-pop	126360	0.191216	U	0.1935	0.148163	13006	0.159234	PASS	193	8644	0.212980	2588	121352	0.192992	388	3726	2.16477e-01	5467	49045	1.99586e-01	rs3748022	.	.	.	0.655	1.405	1.401	0.44	0.008	0.007	0.013	neutral	ENST00000367120: c.2138C>T (p.P713L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1178403	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	226555301	226555302	1q42.12	.	A	snv	G	CC.CC	het-ref	290	0.50	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C17	EX17	Poly(ADP-ribose) polymerase, regulatory domain	PF02877.9	missense	NM_001618.3	NP_001609.2	-	Y	c.2285T>C	p.V762A | p.Val762Ala	GTG=>GCG	NP=>NP	NM_001618.3(PARP1): c.2285T>C (p.V762A)	;maf-5-some-pop	126334	0.201585	U	0.4365	0.196885	13006	0.123328	PASS	833	8618	0.437573	3399	121326	0.201779	1703	7697	4.46358e-01	7526	52358	2.12670e-01	rs1136410	.	.	.	0.533	5.053	2.122	0.05	0.764	0.403	0.629	deleterious	ENST00000366794: c.2285T>C (p.V762A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3997295	CM042761	NM_001618.3(PARP1): c.2285T>C (p.V762A)	"Prostate cancer, susceptibility, association with"	15342424	DFP	.	.	.	.	Likely Benign
Pass	1	226570839	226570840	1q42.12	.	T	snv	C	TG.TT	het-ref	266	0.47	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C8	EX8	.	.	coding-synon	NM_001618.3	NP_001609.2	-	Y	c.1056A>G	p.(K352=) | p.(Lys352=)	AAA=>AAG	.	NM_001618.3(PARP1): c.1056A>G (p.(K352=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	126368	0.793674	U	0.5635	0.789337	13006	0.860065	PASS	1390	8642	0.564916	39108	121360	0.793853	2635	9562	5.54512e-01	77527	193022	7.83903e-01	rs1805415	.	.	.	-0.215	0.129	-0.019	.	.	.	.	.	ENST00000366794: c.1056A>G (p.K352K)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3746819	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	226573363	226573364	1q42.12	.	A	snv	G	TC.GC	het-ref	285	0.49	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C7	EX7	PADR1 (NUC008) domain	PF08063.7	coding-synon	NM_001618.3	NP_001609.2	-	Y	c.852T>C	p.(A284=) | p.(Ala284=)	GCT=>GCC	.	NM_001618.3(PARP1): c.852T>C (p.(A284=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126294	0.426521	U	0.7946	0.516573	13006	0.407735	PASS	2807	8642	0.805253	12034	121286	0.422802	5686	14003	8.12051e-01	24697	104491	4.24557e-01	rs1805414	.	.	.	-2.070	-1.323	-0.721	.	.	.	.	.	ENST00000366794: c.852T>C (p.A284A)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4143411	CM071915	NM_001618.3(PARP1): c.852T>C (p.A284A)	"Colorectal adenoma, assoc. with ?"	17283177	DP	.	.	.	.	Likely Benign
Pass	1	226578098	226578099	1q42.12	.	T	snv	C	AG.GC	hom-alt	324	1.00	.	0	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC4	IVS4	.	.	intron	NM_001618.3	NP_001609.2	-	Y	c.617+12A>G	.	.	.	NM_001618.3(PARP1): c.617+12A>G	;maf-5-some-pop	126316	0.807997	U	0.9315	0.857628	13006	0.823312	PASS	3784	8640	0.936458	39743	121308	0.805948	7582	16175	9.38334e-01	81393	199100	8.09837e-01	rs1805403	.	.	.	-2.128	-0.821	-1.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	1	226589957	226589958	1q42.12	.	G	snv	A	TG.TC	het-ref	305	0.54	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C2	EX2	Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region	PF00645.13	coding-synon	NM_001618.3	NP_001609.2	-	Y	c.243C>T	p.(D81=) | p.(Asp81=)	GAC=>GAT	.	NM_001618.3(PARP1): c.243C>T (p.(D81=))	;maf-5-some-pop,maf-5-all-pops	126340	0.208928	U	0.4365	0.218251	13006	0.147701	PASS	835	8630	0.437543	3496	121332	0.208544	1703	7701	4.46538e-01	7684	53622	2.17839e-01	rs1805404	.	.	.	-0.142	1.501	0.547	.	.	.	.	.	ENST00000366794: c.243C>T (p.D81D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3997296	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	228612837	228612838	1q42.13	.	G	snv	T	CG.AT	het-ref	188	0.45	.	2	.	PASS	602820	P	.	NN	.	.	.	.	.	.	.	8290	HIST3H3	C1E	EX1E	Core histone H2A/H2B/H3/H4	PF00125.19	coding-synon	NM_003493.2	NP_003484.1	-	Y	c.189C>A	p.(I63=) | p.(Ile63=)	ATC=>ATA	.	NM_003493.2(HIST3H3): c.189C>A (p.(I63=))	;maf-5-some-pop,maf-5-all-pops	126386	0.815644	U	0.6895	0.690296	13006	0.726665	PASS	1897	8632	0.661608	42225	121378	0.820816	3772	11369	6.59149e-01	87671	205157	8.33111e-01	rs2230656	.	.	.	-0.150	1.205	-0.047	.	.	.	.	.	ENST00000366696: c.189C>A (p.I63I)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4143485	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	1	237801769	237801770	1q43	.	T	snv	C	CT.AG	hom-alt	349	1.00	.	0	.	PASS	180902	C	600996(MK);604772(MK)	NN	Ventricular tachycardia, catecholaminergic polymorphic, 1; Arrhythmogenic right ventricular dysplasia 2  	AD	.	Cardiovascular	Cardiovascular	20301310|19926015|17875969|11208676|11159936|11157710	.	6262	RYR2	C45	EX45	RIH domain	PF01365.16	coding-synon	NM_001035.2	NP_001026.2	+	Y	c.6906T>C	p.(L2302=) | p.(Leu2302=)	CTT=>CTC	.	NM_001035.2(RYR2): c.6906T>C (p.(L2302=))	;maf-5-some-pop	125778	0.987057	U	1	0.954872	11938	0.959206	PASS	4313	8626	1.000000	59073	120770	0.988391	8624	17248	1.00000e+00	120935	243896	9.90642e-01	rs707189	.	4024	0.998500	-0.215	0.467	0.281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	43819	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	1	243736210	243736211	1q44	.	T	del	.	AC.TT	het-ref	136	0.51	.	2	.	PASS	611223	P	615937(MK)	NN	.	.	.	.	.	.	.	10000	AKT3	IC8	IVS8	.	.	intron	NM_181690.2	NP_859029.1	-	Y	c.819+17delA	.	.	.	NM_181690.2(AKT3): c.819+17delA	MixedObserved;	773	0.056921	U	0.498	0.482029	.	.	InbreedingCoeff_Filter	13	6148	0.436727	160	85250	0.435613	.	.	.	.	.	.	rs66631932	.	4024	0.433900	0.240	1.820	0.865	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	1	248525779	248525780	1q44	.	C	snv	T	CC.CT	hom-alt	401	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	127074	OR2T4	C1E	EX1E	7 transmembrane receptor (rhodopsin family);Olfactory receptor	PF00001.16;PF13853.1	missense	NM_001004696.1	NP_001004696.1	+	Y	c.898C>T	p.P300S | p.Pro300Ser	CCT=>TCT	NP=>P0	NM_001004696.1(OR2T4): c.898C>T (p.P300S)	SingleClassTriAllelic;maf-5-some-pop	126396	0.229770	U	0.4276	0.294329	13006	0.189374	PASS	757	8636	0.426586	3604	121388	0.227106	1608	7479	4.34068e-01	7546	56549	2.29678e-01	rs28698997	.	4024	0.438600	0.585	-0.160	0.407	0.04	0.356	0.36	0.462	neutral	ENST00000366475: c.898C>T (p.P300S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3751110	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	25469501	25469502	2p23.3	.	C	snv	T	TC.AG	hom-alt	455	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	C6	EX6	.	.	coding-synon	NM_153759.3	NP_715640.2	-	Y	c.699G>A	p.(L233=) | p.(Leu233=)	CTG=>CTA	.	NM_153759.3(DNMT3A): c.699G>A (p.(L233=))	;maf-5-some-pop	121896	0.192631	U	0.3204	0.223842	12960	0.204938	PASS	422	8546	0.314767	2295	116888	0.191294	859	5411	3.15143e-01	4760	46010	1.89557e-01	rs2276598	.	4024	0.322800	-1.551	0.591	0.079	.	.	.	.	.	ENST00000321117: c.1266G>A (p.L422L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001621	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	25469501	25469502	2p23.3	.	C	snv	T	TC.AG	hom-alt	455	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	C9	EX10	.	.	coding-synon	NM_175629.2	NP_783328.1	-	N	c.1266G>A	p.(L422=) | p.(Leu422=)	CTG=>CTA	.	NM_175629.2(DNMT3A): c.1266G>A (p.(L422=))	;maf-5-some-pop	121896	0.192631	U	0.3204	0.223842	12960	0.204938	PASS	422	8546	0.314767	2295	116888	0.191294	859	5411	3.15143e-01	4760	46010	1.89557e-01	rs2276598	.	4024	0.322800	-1.551	0.591	0.079	.	.	.	.	.	ENST00000321117: c.1266G>A (p.L422L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001621	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	25469912	25469913	2p23.3	.	C	snv	T	GA.AC	hom-alt	348	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC5	IVS5	.	.	intron	NM_153759.3	NP_715640.2	-	Y	c.555+7G>A	.	.	.	NM_153759.3(DNMT3A): c.555+7G>A	;maf-5-some-pop,maf-5-all-pops	122732	0.712512	U	0.6131	0.614018	13006	0.686299	PASS	1481	8324	0.608361	30313	117724	0.716702	2974	10179	5.96589e-01	62536	173338	7.13249e-01	rs2276599	.	4024	0.592900	-1.581	-0.094	-0.435	.	.	.	.	.	ENST00000321117: c.1122+7G>A (p.?)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5468672	.	.	.	.	.	.	.	.	.	Benign
Pass	2	25469912	25469913	2p23.3	.	C	snv	T	GA.AC	hom-alt	348	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC8	IVS9	.	.	intron	NM_175629.2	NP_783328.1	-	N	c.1122+7G>A	.	.	.	NM_175629.2(DNMT3A): c.1122+7G>A	;maf-5-some-pop,maf-5-all-pops	122732	0.712512	U	0.6131	0.614018	13006	0.686299	PASS	1481	8324	0.608361	30313	117724	0.716702	2974	10179	5.96589e-01	62536	173338	7.13249e-01	rs2276599	.	4024	0.592900	-1.581	-0.094	-0.435	.	.	.	.	.	ENST00000321117: c.1122+7G>A (p.?)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5468672	.	.	.	.	.	.	.	.	.	Benign
Pass	2	29416365	29416366	2p23.2	.	G	snv	C	CT.TC	hom-alt	707	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	missense	NM_004304.4	NP_004295.2	-	Y	c.4587C>G	p.D1529E | p.Asp1529Glu	GAC=>GAG	P-=>P-	NM_004304.4(ALK): c.4587C>G (p.D1529E)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126368	0.464493	U	0.7292	0.572883	13006	0.433492	PASS	2430	8638	0.746469	14197	121360	0.460020	4819	12855	7.45477e-01	29583	115007	4.67736e-01	rs1881421	.	4024	0.756000	-0.357	-0.064	-1.464	1	0	0	0.000	neutral	ENST00000389048: c.4587C>G (p.D1529E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3758201	.	.	.	.	.	no_record	133476	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	29416480	29416481	2p23.2	.	T	snv	C	CC.TG	hom-alt	665	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	missense	NM_004304.4	NP_004295.2	-	Y	c.4472A>G	p.K1491R | p.Lys1491Arg	AAG=>AGG	P+=>P+	NM_004304.4(ALK): c.4472A>G (p.K1491R)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126400	0.335119	U	0.7312	0.415136	13006	0.223358	PASS	2440	8642	0.747628	8650	121392	0.331818	4836	12874	7.46492e-01	18527	84463	3.43097e-01	rs1881420	.	4024	0.756200	0.454	0.820	0.089	0.27	0.005	0.001	0.034	neutral	ENST00000389048: c.4472A>G (p.K1491R)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1130802	.	.	.	.	.	no_record	133474	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	29416571	29416572	2p23.2	.	T	snv	C	GA.CT	hom-alt	627	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	missense	NM_004304.4	NP_004295.2	-	Y	c.4381A>G	p.I1461V | p.Ile1461Val	ATC=>GTC	NP=>NP	NM_004304.4(ALK): c.4381A>G (p.I1461V)	;clinically-assoc,submitted-by-lsdb,genotype-conflict	126282	0.996967	U	1	0.992212	13006	0.990312	PASS	4327	8654	1.000000	60296	121274	0.997163	8621	17242	1.00000e+00	122036	244651	9.97558e-01	rs1670283	.	4024	0.999000	-0.224	-0.190	-0.248	1	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	133472	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	29445457	29445458	2p23.2	.	G	snv	T	GC.CC	hom-alt	370	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C21	EX21	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.3375C>A	p.(G1125=) | p.(Gly1125=)	GGC=>GGA	.	NM_004304.4(ALK): c.3375C>A (p.(G1125=))	;maf-5-some-pop,maf-5-all-pops	124446	0.330722	U	0.7173	0.415935	13006	0.221436	PASS	2351	8562	0.737795	8232	119438	0.327149	4685	12657	7.36643e-01	17926	82485	3.36333e-01	rs3795850	.	4024	0.742500	0.455	-2.058	-1.829	.	.	.	.	.	ENST00000389048: c.3375C>A (p.G1125G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	5351767	.	.	.	.	.	no_record	335694	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
InExcel	2	29451789	29451790	2p23.2	.	T	snv	C	CC.CC	het-ref	30	0.19	.	2	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.2775A>G	p.(G925=) | p.(Gly925=)	GGA=>GGG	.	NM_004304.4(ALK): c.2775A>G (p.(G925=))	;	117088	0.000786	U	.	.	.	.	VQSRTrancheSNP99.90to99.95	0	8558	0.000351	0	117088	0.000786	0	544	5.76760e-02	0	4979	2.97598e-02	rs777406442	.	4024	0.118000	-1.235	-0.395	-1.919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
InExcel	2	29451792	29451793	2p23.2	.	A	snv	C	CC.CC	het-ref	23	0.15	.	2	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.2772T>G	p.(G924=) | p.(Gly924=)	GGT=>GGG	.	NM_004304.4(ALK): c.2772T>G (p.(G924=))	;	114694	0.001404	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	8490	0.000471	0	114694	0.001404	0	1726	1.41568e-01	0	12811	7.04706e-02	rs749286400	.	4024	0.125200	0.459	0.993	0.796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	239814	criteria_provided,_single_submitter	Benign	Unknown
InExcel	2	29451798	29451799	2p23.2	.	T	snv	C	CC.CC	het-ref	14	0.09	.	2	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.2766A>G	p.(G922=) | p.(Gly922=)	GGA=>GGG	.	NM_004304.4(ALK): c.2766A>G (p.(G922=))	MixedObserved;	112494	0.000356	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	8488	0.000236	0	112494	0.000356	0	830	7.63429e-02	0	6888	4.25411e-02	rs778543123	.	4024	0.026100	0.459	2.059	1.960	.	.	.	.	.	ENST00000389048: c.2766A>G (p.G922G)	prostate [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	4133808	.	.	.	.	.	.	.	.	.	VUS
Pass	2	29455266	29455267	2p23.2	.	A	snv	G	CC.CC	het-ref	264	0.45	.	2	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C15	EX15	Glycine rich protein	PF12810.2	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.2535T>C	p.(G845=) | p.(Gly845=)	GGT=>GGC	.	NM_004304.4(ALK): c.2535T>C (p.(G845=))	;maf-5-some-pop,maf-5-all-pops	126318	0.607657	U	0.1746	0.5	13006	0.661387	PASS	125	8628	0.174664	24282	121310	0.612101	269	3051	1.76952e-01	48751	149770	6.08322e-01	rs2256740	.	4024	0.171500	-1.007	-0.922	-1.203	.	.	.	.	.	ENST00000389048: c.2535T>C (p.G845G)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	148825	.	.	.	.	.	no_record	259268	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	29543662	29543663	2p23.2	.	T	snv	C	CA.TG	het-ref	265	0.47	.	2	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C7	EX7	MAM domain	PF00629.18	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.1500A>G	p.(Q500=) | p.(Gln500=)	CAA=>CAG	.	NM_004304.4(ALK): c.1500A>G (p.(Q500=))	SingleClassTriAllelic;maf-5-some-pop	126410	0.867866	U	0.9206	0.776558	13006	0.790943	PASS	3559	8650	0.908092	46888	121402	0.871633	7099	15649	9.07294e-01	96227	216269	8.78278e-01	rs2293564	.	4024	0.912500	-0.140	0.058	-0.038	.	.	.	.	.	ENST00000389048: c.1500A>G (p.Q500Q)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4133810	.	.	.	.	.	no_record	259266	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	29940528	29940529	2p23.2	.	A	snv	T	GA.GG	hom-alt	549	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C2	EX2	.	.	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.702T>A	p.(P234=) | p.(Pro234=)	CCT=>CCA	.	NM_004304.4(ALK): c.702T>A (p.(P234=))	SingleClassTriAllelic;maf-5-some-pop	126400	0.727753	U	0.7827	0.589257	13006	0.627018	PASS	2515	8646	0.760352	34225	121392	0.733467	4788	12845	7.44983e-01	70228	182599	7.41718e-01	rs2246745	.	4024	0.770900	-0.313	0.673	0.148	.	.	.	.	.	ENST00000389048: c.702T>A (p.P234P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4416269	.	.	.	.	.	no_record	259274	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	30143498	30143499	2p23.1	.	G	snv	C	AG.AG	hom-alt	533	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C1	EX1	.	.	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.27C>G	p.(L9=) | p.(Leu9=)	CTC=>CTG	.	NM_004304.4(ALK): c.27C>G (p.(L9=))	;maf-5-some-pop	27578	0.894735	U	0.998	0.89377	9800	0.909286	PASS	461	922	1.000000	9031	22570	0.894949	5268	10540	9.99621e-01	56407	124133	9.06623e-01	rs4358080	.	4024	0.997300	-0.998	0.508	0.269	.	.	.	.	.	ENST00000389048: c.27C>G (p.L9L)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3749653	.	.	.	.	.	no_record	259269	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	38298149	38298150	2p22.2	.	A	snv	G	CC.TC	hom-alt	206	1.00	.	0	.	PASS	601771	C	231300(MK);604229(MK)	AR	Glaucoma, primary open angle, adult-onset; Peters anomaly; Glaucoma 3A, primary congenital; Glaucoma, primary open angle glaucoma, juvenile-onset 	AR	.	Ophthalmologic	Ophthalmologic; Pharmacogenomic	23218701|22128238|21081970|19807744|19643970|17718864|15733270|15342693|12372064|11774072|11730663|11403040|10655546|10227395|9497261|9463332|9097971	.	1545	CYP1B1	C2E	EX3E	Cytochrome P450	PF00067.17	coding-synon	NM_000104.3	NP_000095.2	-	Y	c.1347T>C	p.(D449=) | p.(Asp449=)	GAT=>GAC	.	NM_000104.3(CYP1B1): c.1347T>C (p.(D449=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126370	0.621967	U	0.9087	0.620208	13006	0.453714	PASS	3502	8654	0.899122	25202	121362	0.622040	7000	15532	9.00510e-01	52574	156172	6.34263e-01	rs1056837	.	4024	0.877200	-3.074	-2.060	-1.835	.	.	.	.	.	ENST00000260630: c.1347T>C (p.D449D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3758225	.	.	.	.	.	no_record	166970	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	46583278	46583278	2p21	.	.	ins	G	CC.CC	hom-alt	305	0.95	.	0	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.218-12_218-11insG	.	.	.	NM_001430.4(EPAS1): c.218-12_218-11insG	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	105734	0.350256	U	.	.	.	.	VQSRTrancheINDEL97.00to99.00	2017	7376	0.732240	7325	106408	0.348038	.	.	.	.	.	.	rs61586942	.	4024	0.769400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	46583279	46583279	2p21	.	.	ins	T	CC.CC	hom-alt	374	1.00	.	0	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.218-11_218-10insT	.	.	.	NM_001430.4(EPAS1): c.218-11_218-10insT	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	103910	0.381484	U	.	.	.	.	VQSRTrancheINDEL95.00to96.00	2109	7550	0.747417	7704	107718	0.367998	3863	8782	7.74563e-01	15288	52942	3.09407e-01	rs142684263	.	4024	0.763400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	46583280	46583281	2p21	.	C	snv	T	CC.CT	hom-alt	396	1.00	.	0	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.218-9C>T	.	.	.	NM_001430.4(EPAS1): c.218-9C>T	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	91771	0.501978	U	0.001	0.0662939	.	.	PASS	2328	8000	0.762750	9868	113276	0.403748	.	.	.	.	.	.	rs75984373	.	4024	0.714200	-0.361	0.826	0.922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	336246	criteria_provided,_single_submitter	Benign	Benign
Pass	2	46596950	46596951	2p21	.	T	snv	A	CC.TT	het-ref	145	0.49	.	2	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC6	IVS6	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.780-15T>A	.	.	.	NM_001430.4(EPAS1): c.780-15T>A	MixedObserved;maf-5-some-pop	90338	0.048086	U	0.0992	0.0794728	13006	0.072044	PASS	47	7144	0.128919	218	85330	0.046244	105	1818	1.06453e-01	372	7414	3.11165e-02	rs17035079	.	4024	0.113800	0.533	0.154	0.040	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	336252	criteria_provided,_single_submitter	Benign	Benign
Pass	2	46609571	46609572	2p21	.	A	snv	C	TC.CC	het-ref	253	0.51	.	2	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	C15	EX15	.	.	missense	NM_001430.4	NP_001421.2	+	Y	c.2296A>C	p.T766P | p.Thr766Pro	ACC=>CCC	P0=>NP	NM_001430.4(EPAS1): c.2296A>C (p.T766P)	;maf-5-some-pop	126316	0.062423	U	0.126	0.163339	13006	0.147778	PASS	78	8646	0.132431	1037	121308	0.058257	168	2280	1.32189e-01	1653	12452	5.05973e-02	rs59901247	.	4024	0.133400	-0.313	-0.199	0.030	0.28	0.003	0.001	0.032	neutral	ENST00000263734: c.2296A>C (p.T766P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3736259	.	.	.	.	.	no_record	336274	criteria_provided,_single_submitter	Benign	Likely Benign
HHReport	2	47601105	47601106	2p21	.	T	snv	C	CA.GT	hom-alt	703	1.00	.	0	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	C3	EX3	Thyroglobulin type-1 repeat	PF00086.13	missense	NM_002354.2	NP_002345.2	+	Y	c.344T>C	p.M115T | p.Met115Thr	ATG=>ACG	NP=>P0	NM_002354.2(EPCAM): c.344T>C (p.M115T)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126358	0.525586	U	0.8323	0.666134	13006	0.566738	PASS	2952	8650	0.826705	17704	121350	0.519786	5973	14345	8.31691e-01	34881	126143	5.12364e-01	rs1126497	.	4024	0.820300	-0.119	0.245	0.160	1	0	0	0.000	neutral	ENST00000263735: c.344T>C (p.M115T)	prostate [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3927762	.	.	.	.	.	no_record	183700	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	2	47604175	47604176	2p21	.	C	snv	T	AA.GC	het-ref	190	0.43	.	2	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	C5	EX5	.	.	missense	NM_002354.2	NP_002345.2	+	Y	c.515C>T	p.T172M | p.Thr172Met	ACG=>ATG	P0=>NP	NM_002354.2(EPCAM): c.515C>T (p.T172M)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126292	0.005305	U	0.0685	0.0141773	13006	0.000923	PASS	18	8650	0.065549	18	121284	0.004939	54	1248	7.23730e-02	54	1319	5.35852e-03	rs74531854	.	4024	0.070100	-0.188	-1.011	-0.534	0.07	0.32	0.985	0.419	neutral	ENST00000263735: c.515C>T (p.T172M)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	148851	.	.	.	.	.	no_record	132748	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	2	47630549	47630550	2p21	.	C	snv	G	GC.GG	hom-alt	301	1.00	.	0	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC1	IVS1	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.211+9C>G	.	.	.	NM_000251.2(MSH2): c.211+9C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	85170	0.511964	U	0.8145	0.628395	12684	0.475875	PASS	2047	6418	0.804924	10041	80162	0.504691	5066	12433	8.15600e-01	25312	98964	4.73557e-01	rs2303426	.	4024	0.806200	-1.252	-1.260	-1.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36573	reviewed_by_expert_panel	Benign	Benign
HHReport	2	47635523	47635524	2p21	.	T	del	.	AC.TT	het-ref	79	0.22	.	2	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC1	IVS1	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.212-16delT	.	.	.	NM_000251.2(MSH2): c.212-16delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	5362	0.121783	0	74540	0.151100	.	.	.	.	.	.	rs201372136	.	4024	0.174000	0.383	-0.606	-0.120	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	183770	criteria_provided,_multiple_submitters,_no_conflicts	Likely_benign	Benign
InExcel	2	47641559	47641561	2p21	.	AA	del	.	GT.aa	het-ref	20	0.45	.	2	(A)n|Simple_repeat|Simple_repeat|+|27;trf	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.942+3_942+4delAA	.	.	.	NM_000251.2(MSH2): c.942+3_942+4delAA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	2.000000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	336427	criteria_provided,_multiple_submitters,_no_conflicts	Uncertain_significance	Benign
HHReport	2	47693958	47693959	2p21	.	G	snv	A	TC.TT	het-ref	240	0.47	.	2	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC10	IVS10	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.1661+12G>A	.	.	.	NM_000251.2(MSH2): c.1661+12G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126066	0.355441	U	0.6548	0.483427	12998	0.378674	PASS	1861	8644	0.657682	8454	121058	0.350146	3735	11331	6.57251e-01	16411	84217	3.42599e-01	rs3732183	.	4024	0.653800	-2.737	-0.844	-0.383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36567	reviewed_by_expert_panel	Benign	Benign
HHReport	2	47703499	47703500	2p21	.	T	snv	C	TT.TG	het-ref	209	0.46	.	2	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC12	IVS12	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.2006-6T>C	.	.	.	NM_000251.2(MSH2): c.2006-6T>C	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	124500	0.116120	U	0.3631	0.131989	13006	0.072582	PASS	536	8578	0.349965	1121	119492	0.115455	1091	6106	3.54464e-01	2267	28222	1.14730e-01	rs2303428	.	4024	0.351100	0.477	1.985	2.330	.	.	.	.	.	ENST00000233146: c.2006-6T>C (p.?)	breast [NS|NS|NS]	carcinoma [lobular_carcinoma|tubulo-lobular|NS]	CSV	133154	CS951474	NM_000251.2(MSH2): c.2006-6T>C	"High-grade dysplasia/cancer in ulcerative colitis, association"	7797014	DP	no_record	36571	reviewed_by_expert_panel	Benign	Benign
HHReport	2	48010487	48010488	2p16.3	.	G	snv	A	CG.GG	het-ref	234	0.43	.	2	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	C1	EX1	.	.	missense	NM_000179.2	NP_000170.1	+	Y	c.116G>A	p.G39E | p.Gly39Glu	GGG=>GAG	P0=>P-	NM_000179.2(MSH6): c.116G>A (p.G39E)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	96138	0.213402	U	0.2758	0.200879	11656	0.179650	PASS	231	6792	0.290489	1894	91130	0.214090	493	4150	2.52218e-01	3965	41416	1.81453e-01	rs1042821	.	4024	0.250500	0.313	0.459	0.838	1	0.608	0.975	0.210	neutral	ENST00000234420: c.116G>A (p.G39E)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3749667	CM092149	NM_000179.2(MSH6): c.116G>A (p.G39E)	"Colorectal cancer, assoc. with ?"	18523027	DP	no_record	36581	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	2	48030691	48030692	2p16.3	.	T	snv	A	AC.TT	het-ref	376	0.49	.	2	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	C5	EX5	MutS domain V	PF00488.16	coding-synon	NM_000179.2	NP_000170.1	+	Y	c.3306T>A	p.(T1102=) | p.(Thr1102=)	ACT=>ACA	.	NM_000179.2(MSH6): c.3306T>A (p.(T1102=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126358	0.021582	U	0.2153	0.0493211	13006	0.004459	PASS	189	8632	0.210264	196	121350	0.020437	335	3491	2.02494e-01	349	4857	1.97275e-02	rs2020910	.	4024	0.196800	-1.272	-1.311	-2.714	.	.	.	.	.	ENST00000234420: c.3306T>A (p.T1102T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021075	.	.	.	.	.	no_record	36589	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	2	48030837	48030838	2p16.3	.	A	snv	T	TT.AA	het-ref	248	0.50	.	2	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC5	IVS5	.	.	intron	NM_000179.2	NP_000170.1	+	Y	c.3438+14A>T	.	.	.	NM_000179.2(MSH6): c.3438+14A>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125892	0.404132	U	0.619	0.400958	13006	0.314624	PASS	1651	8628	0.616829	10612	120884	0.404264	3354	10767	6.24391e-01	22061	101116	4.11134e-01	rs2020911	.	4025	0.633400	-0.326	-0.353	-0.449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	42471	reviewed_by_expert_panel	Benign	Benign
HHReport	2	48032740	48032741	2p16.3	.	T	del	.	GA.TT	het-ref	72	0.21	.	2	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC6	IVS6	.	.	intron	NM_000179.2	NP_000170.1	+	Y	c.3557-16delT	.	.	.	NM_000179.2(MSH6): c.3557-16delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	5948	0.168628	32	90548	0.138645	.	.	.	.	.	.	rs749755872	.	4024	0.303700	0.242	0.285	0.029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	89417	reviewed_by_expert_panel	Uncertain_significance	Benign
Pass	2	58388695	58388696	2p16.1	.	A	snv	G	TG.GA	hom-alt	397	1.00	.	0	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	C12	EX12	FANCL C-terminal domain	PF11793.3	coding-synon	NM_001114636.1	NP_001108108.1	-	Y	c.996T>C	p.(S332=) | p.(Ser332=)	TCT=>TCC	.	NM_001114636.1(FANCL): c.996T>C (p.(S332=))	;maf-5-some-pop,microattr-tpa	126060	0.650960	U	0.5883	0.70647	13004	0.704091	PASS	1391	8638	0.564019	25916	121052	0.648663	2745	9633	5.58824e-01	51698	158013	6.43900e-01	rs848291	.	.	.	-0.851	-0.055	-0.713	.	.	.	.	.	ENST00000233741: c.981T>C (p.S327S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001713	.	.	.	.	.	no_record	257495	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	58388695	58388696	2p16.1	.	A	snv	G	TG.GA	hom-alt	397	1.00	.	0	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	C12	EX12	FANCL C-terminal domain	PF11793.3	coding-synon	NM_018062.3	NP_060532.2	-	N	c.981T>C	p.(S327=) | p.(Ser327=)	TCT=>TCC	.	NM_018062.3(FANCL): c.981T>C (p.(S327=))	;maf-5-some-pop,microattr-tpa	126060	0.650960	U	0.5883	0.70647	13004	0.704091	PASS	1391	8638	0.564019	25916	121052	0.648663	2745	9633	5.58824e-01	51698	158013	6.43900e-01	rs848291	.	.	.	-0.851	-0.055	-0.713	.	.	.	.	.	ENST00000233741: c.981T>C (p.S327S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001713	.	.	.	.	.	no_record	257495	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
InExcel	2	58390218	58390219	2p16.1	.	A	del	.	tt.aa	het-ref	41	0.14	.	2	AT_rich|Low_complexity|Low_complexity|+|25	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC9	IVS9	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.791-10delT	.	.	.	NM_001114636.1(FANCL): c.791-10delT	MixedObserved;	8131	0.001107	U	.	.	12118	0.042416	PASS	0	6336	0.066288	0	88224	0.092061	.	.	.	.	.	.	rs374236117	.	.	.	-1.640	-0.900	-0.622	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
InExcel	2	58390218	58390219	2p16.1	.	A	del	.	tt.aa	het-ref	41	0.14	.	2	AT_rich|Low_complexity|Low_complexity|+|25	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC9	IVS9	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.776-10delT	.	.	.	NM_018062.3(FANCL): c.776-10delT	MixedObserved;	8131	0.001107	U	.	.	12118	0.042416	PASS	0	6336	0.066288	0	88224	0.092061	.	.	.	.	.	.	rs374236117	.	.	.	-1.640	-0.900	-0.622	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	58453843	58453843	2p16.1	.	.	ins	A	AG.AA	het-ref	96	0.40	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC4	IVS4	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.273+19_273+20insT	.	.	.	NM_001114636.1(FANCL): c.273+19_273+20insT	MixedObserved;maf-5-some-pop,maf-5-all-pops	13385	0.098394	U	0.2827	0.259585	.	.	PASS	28	6412	0.351216	630	90432	0.367890	.	.	.	.	.	.	rs372101290	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	58453843	58453843	2p16.1	.	.	ins	A	AG.AA	het-ref	96	0.40	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC4	IVS4	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.273+19_273+20insT	.	.	.	NM_018062.3(FANCL): c.273+19_273+20insT	MixedObserved;maf-5-some-pop,maf-5-all-pops	13385	0.098394	U	0.2827	0.259585	.	.	PASS	28	6412	0.351216	630	90432	0.367890	.	.	.	.	.	.	rs372101290	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	61749836	61749837	2p15	.	A	snv	G	AG.AG	het-ref	131	0.45	.	2	.	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC2	IVS3	.	.	intron	NM_003400.3	NP_003391.1	-	Y	c.229-19T>C	.	.	.	NM_003400.3(XPO1): c.229-19T>C	;	118862	0.000412	U	0.003	0.000798722	.	.	PASS	0	8324	0.003964	0	113854	0.000395	0	68	3.95395e-03	0	89	3.64990e-04	rs201554476	.	4024	0.005200	0.455	0.739	0.902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	69173519	69173520	2p13.3	.	C	snv	T	CA.GT	het-ref	187	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	200504	GKN2	C5	EX5	BRICHOS domain	PF04089.9	missense	NM_182536.2	NP_872342.2	-	Y	c.388G>A	p.V130M | p.Val130Met	GTG=>ATG	NP=>NP	NM_182536.2(GKN2): c.388G>A (p.V130M)	;	126322	0.002375	U	0.0228	0.00479233	.	.	PASS	3	8654	0.029119	3	121314	0.002275	6	503	2.92000e-02	6	548	2.22659e-03	rs146849599	.	4024	0.031800	-2.110	-0.830	-0.761	0.16	0.018	0.125	0.060	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	2	74140788	74140789	2p13.1	.	T	snv	C	TT.CT	het-ref	152	0.49	.	2	.	PASS	102545	C	155310(MK)	AD	.	.	.	.	.	.	.	72	ACTG2	IC5	IVS6	.	.	intron	NM_001615.3	NP_001606.1	+	Y	c.613+16T>C	.	.	.	NM_001615.3(ACTG2): c.613+16T>C	;maf-5-some-pop,maf-5-all-pops	125310	0.647434	U	0.5288	0.60004	13006	0.619637	PASS	1024	8614	0.490597	25801	120302	0.649407	2144	8476	4.96835e-01	53218	158325	6.58420e-01	rs891698	.	4024	0.495000	-0.213	0.501	0.103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	84800604	84800605	2p11.2	.	C	snv	A	GC.GC	hom-alt	403	1.00	.	0	.	PASS	603336	C	.	NN	.	.	.	.	.	.	.	1768	DNAH6	C11	EX12	.	.	coding-synon	NM_001370.1	NP_001361.1	+	Y	c.1818C>A	p.(A606=) | p.(Ala606=)	GCC=>GCA	.	NM_001370.1(DNAH6): c.1818C>A (p.(A606=))	;maf-5-some-pop	126344	0.945878	U	0.997	0.929712	13006	0.908811	PASS	4308	8652	0.997920	54437	121336	0.946545	7175	14375	9.98264e-01	96759	203641	9.48889e-01	rs11891970	.	4024	0.996500	-0.494	0.026	0.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	402734	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	2	141027925	141027926	2q22.1	.	A	snv	G	AC.AA	het-ref	202	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC85	IVS85	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.13143-11T>C	.	.	.	NM_018557.2(LRP1B): c.13143-11T>C	;maf-5-some-pop	124792	0.176341	U	0.3085	0.167732	13006	0.129632	PASS	479	8450	0.330533	2144	119784	0.176701	930	5508	3.22747e-01	4436	44021	1.80694e-01	rs3748865	.	4024	0.329800	-0.262	0.320	0.051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	141032087	141032088	2q22.1	.	C	snv	T	CG.GT	het-ref	264	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C85	EX85	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.13047G>A	p.(T4349=) | p.(Thr4349=)	ACG=>ACA	.	NM_018557.2(LRP1B): c.13047G>A (p.(T4349=))	;maf-5-some-pop,maf-5-all-pops	126080	0.599056	U	0.6508	0.486222	13006	0.531985	PASS	2034	8596	0.685784	23146	121072	0.603723	4096	11810	6.86309e-01	47408	149628	6.09443e-01	rs1386356	.	4024	0.690600	-0.254	-0.957	-0.237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	141260667	141260668	2q22.1	.	A	snv	G	CG.TA	het-ref	314	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C54	EX54	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.8526T>C	p.(Y2842=) | p.(Tyr2842=)	TAT=>TAC	.	NM_018557.2(LRP1B): c.8526T>C (p.(Y2842=))	;maf-5-some-pop,maf-5-all-pops	126248	0.548753	U	0.7222	0.543131	13006	0.532754	PASS	2438	8650	0.751445	18705	121240	0.548985	4948	13042	7.56233e-01	37632	134430	5.47639e-01	rs4444457	.	4024	0.742000	-0.131	0.239	0.127	.	.	.	.	.	ENST00000389484: c.8526T>C (p.Y2842Y)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3757652	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	141274575	141274576	2q22.1	.	T	snv	C	TT.TG	het-ref	207	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C50	EX50	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.8031A>G	p.(Q2677=) | p.(Gln2677=)	CAA=>CAG	.	NM_018557.2(LRP1B): c.8031A>G (p.(Q2677=))	;maf-5-some-pop,maf-5-all-pops	125986	0.712111	U	0.4167	0.642372	13004	0.746693	PASS	714	8622	0.404083	31564	120978	0.714998	1398	6941	4.03125e-01	63768	175065	7.13648e-01	rs4954672	.	4024	0.405100	0.460	1.486	1.969	.	.	.	.	.	ENST00000389484: c.8031A>G (p.Q2677Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001201	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	141294285	141294286	2q22.1	.	A	del	.	AG.AA	het-ref	43	0.22	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC45	IVS45	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.7514-8delT	.	.	.	NM_018557.2(LRP1B): c.7514-8delT	MixedObserved;	2555	0.030920	U	.	.	.	.	InbreedingCoeff_Filter	0	6366	0.424599	0	92842	0.405775	.	.	.	.	.	.	rs755359693	.	4024	0.242000	0.000	0.000	0.000	.	.	.	.	.	ENST00000389484: c.7514-8delT (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	1613440	.	.	.	.	.	.	.	.	.	Benign
Pass	2	141528434	141528435	2q22.1	.	T	snv	C	TT.TC	hom-alt	488	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC34	IVS34	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5626+15A>G	.	.	.	NM_018557.2(LRP1B): c.5626+15A>G	;maf-5-some-pop	124890	0.045808	U	0.1687	0.102037	13006	0.063509	PASS	114	8638	0.162538	384	119882	0.043459	163	1923	1.65633e-01	546	7253	3.84632e-02	rs13382825	.	4024	0.163800	0.477	0.294	0.086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	141528591	141528592	2q22.1	.	T	snv	C	AA.GA	hom-alt	504	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC33	IVS33	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5501-17A>G	.	.	.	NM_018557.2(LRP1B): c.5501-17A>G	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	121046	0.872685	U	.	.	13006	0.838382	PASS	4306	8622	0.999420	46312	121046	0.872685	6273	12553	9.99443e-01	74104	168451	8.76245e-01	rs7599219	.	4024	0.997300	-0.220	-0.177	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	141533661	141533662	2q22.1	.	T	snv	C	GA.TT	hom-alt	554	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC33	IVS33	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5500+5A>G	.	.	.	NM_018557.2(LRP1B): c.5500+5A>G	;maf-5-some-pop	126370	0.872478	U	0.999	0.855232	13006	0.838382	PASS	4322	8654	0.999422	46495	121362	0.873189	5835	11676	9.99486e-01	76283	173504	8.75787e-01	rs996361	.	4024	0.997300	-0.186	1.003	0.695	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	141571328	141571329	2q22.1	.	T	snv	C	CC.GA	hom-alt	549	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C32	EX32	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.5256A>G	p.(S1752=) | p.(Ser1752=)	TCA=>TCG	.	NM_018557.2(LRP1B): c.5256A>G (p.(S1752=))	SingleClassTriAllelic;maf-5-some-pop	126272	0.869741	U	0.9871	0.845248	13006	0.836998	PASS	4230	8652	0.988789	46238	121264	0.870753	8425	17044	9.88631e-01	93573	213843	8.70526e-01	rs3749010	.	4024	0.989800	-0.119	-2.302	-3.718	.	.	.	.	.	ENST00000389484: c.5256A>G (p.S1752S)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4133144	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	141598473	141598473	2q22.1	.	.	ins	T	AA.AA	hom-alt	421	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC30	IVS30	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5114+13_5114+14insA	.	.	.	NM_018557.2(LRP1B): c.5114+13_5114+14insA	;maf-5-some-pop	125318	0.993864	U	0.999	0.977636	12520	0.978115	PASS	4307	8634	0.998842	59383	120584	0.992279	7541	15100	9.98809e-01	102998	207322	9.93350e-01	rs35745624	.	4024	0.997000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	141643776	141643777	2q22.1	.	A	snv	C	TG.TT	het-ref	251	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C24	EX24	.	.	missense	NM_018557.2	NP_061027.2	-	Y	c.3894T>G	p.N1298K | p.Asn1298Lys	AAT=>AAG	P0=>P+	NM_018557.2(LRP1B): c.3894T>G (p.N1298K)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	0.804	0.985	0.04	0.423	0.706	0.486	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	2	141707867	141707868	2q22.1	.	G	snv	T	CA.GC	hom-alt	607	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C20	EX20	Low-density lipoprotein receptor domain class A	PF00057.13	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.3072C>A	p.(A1024=) | p.(Ala1024=)	GCC=>GCA	.	NM_018557.2(LRP1B): c.3072C>A (p.(A1024=))	;maf-5-some-pop,maf-5-all-pops	125844	0.180088	U	0.249	0.275759	13006	0.223205	PASS	236	8538	0.233896	2349	120836	0.176123	511	4030	2.36087e-01	4584	42381	1.73182e-01	rs6748626	.	4024	0.249500	-0.244	0.297	0.700	.	.	.	.	.	ENST00000389484: c.3072C>A (p.A1024A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3757654	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	141751591	141751592	2q22.1	.	G	snv	A	CC.TC	hom-alt	615	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C16	EX16	Low-density lipoprotein receptor domain class A	PF00057.13	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.2616C>T	p.(D872=) | p.(Asp872=)	GAC=>GAT	.	NM_018557.2(LRP1B): c.2616C>T (p.(D872=))	;maf-5-some-pop,maf-5-all-pops	125966	0.392804	U	0.6141	0.509585	13006	0.398739	PASS	1514	8556	0.598761	9757	120958	0.387969	2974	10150	5.91147e-01	19264	93579	3.81799e-01	rs13007735	.	4024	0.606400	-1.948	-0.410	-1.115	.	.	.	.	.	ENST00000389484: c.2616C>T (p.D872D)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4964776	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	141816620	141816621	2q22.1	.	A	snv	G	CT.AC	hom-alt	381	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C9	EX9	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.1239T>C	p.(V413=) | p.(Val413=)	GTT=>GTC	.	NM_018557.2(LRP1B): c.1239T>C (p.(V413=))	;maf-5-some-pop	124672	0.982747	U	1	0.945288	12988	0.940484	PASS	4309	8618	1.000000	58112	119664	0.984314	6584	13168	1.00000e+00	97249	196498	9.87844e-01	rs1525579	.	4024	0.998500	-0.213	-0.430	0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	170010984	170010985	2q31.1	.	T	snv	C	CT.GG	hom-alt	409	1.00	.	0	.	PASS	600073	C	222448(MK)	AR	Donnai-Barrow syndrome; Faciooculoacousticorenal syndrome	AR	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Ophthalmologic; Renal	Audiologic/Otolaryngologic; General	20301732|18553518|17632512|12923867|9475100|8266995	.	4036	LRP2	C66	EX66	.	.	missense	NM_004525.2	NP_004516.2	-	Y	c.12280A>G	p.K4094E | p.Lys4094Glu	AAG=>GAG	P+=>P-	NM_004525.2(LRP2): c.12280A>G (p.K4094E)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126266	0.762755	U	0.5208	0.777955	13006	0.801322	PASS	1018	8632	0.484129	35867	121258	0.762127	2093	8463	4.91121e-01	72354	187260	7.61343e-01	rs2075252	.	4024	0.464700	-0.119	4.492	1.341	1	0	0	0.000	neutral	ENST00000263816: c.12280A>G (p.K4094E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001308	.	.	.	.	.	no_record	129500	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	175436939	175436940	2q31.1	.	G	snv	A	GC.GA	hom-alt	386	1.00	.	0	.	PASS	602357	P	614493(MK)	NN	Wiskott-Aldrich syndrome 2	AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic 	Allergy/Immunology/Infectious; Hematologic	22231303	.	7456	WIPF1	C4	EX5	.	.	missense	NM_001077269.1	NP_001070737.1	-	Y	c.593C>T	p.P198L | p.Pro198Leu	CCG=>CTG	NP=>NP	NM_001077269.1(WIPF1): c.593C>T (p.P198L)	;maf-5-some-pop,genotype-conflict	124926	0.939724	U	0.9881	0.907947	13000	0.923000	PASS	4236	8634	0.990618	53219	119918	0.941051	8486	17103	9.92284e-01	109519	231343	9.44728e-01	rs4972450	.	4024	0.990600	-0.443	1.086	0.765	0.95	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	403608	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	2	198257794	198257795	2q33.1	.	T	snv	C	AA.AC	het-ref	233	0.49	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C24	EX24	.	.	coding-synon	NM_012433.2	NP_036565.2	-	Y	c.3657A>G	p.(V1219=) | p.(Val1219=)	GTA=>GTG	.	NM_012433.2(SF3B1): c.3657A>G (p.(V1219=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	126306	0.673547	U	0.5218	0.71845	13006	0.735968	PASS	1283	8620	0.543271	28148	121298	0.671693	2487	9232	5.35685e-01	54898	161990	6.58410e-01	rs4685	.	.	.	-0.320	0.528	0.660	.	.	.	.	.	ENST00000335508: c.3657A>G (p.V1219V)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3757859	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	198265172	198265173	2q33.1	.	T	snv	A	tt.aa	het-ref	205	0.47	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC18	IVS18	.	.	intron	NM_012433.2	NP_036565.2	-	Y	c.2719-15A>T	.	.	.	NM_012433.2(SF3B1): c.2719-15A>T	MixedObserved;maf-5-some-pop,maf-5-all-pops	121847	0.669011	U	0.5169	0.717851	.	.	PASS	1216	8456	0.537015	26598	116840	0.666912	2184	8297	5.29754e-01	46562	139414	6.54077e-01	rs788017	.	.	.	0.338	-0.162	-0.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	198265525	198265526	2q33.1	.	A	snv	G	TT.CC	het-ref	283	0.48	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C18	EX18	.	.	coding-synon	NM_012433.2	NP_036565.2	-	Y	c.2631T>C	p.(G877=) | p.(Gly877=)	GGT=>GGC	.	NM_012433.2(SF3B1): c.2631T>C (p.(G877=))	;maf-5-some-pop,maf-5-all-pops	126296	0.672658	U	0.5099	0.716653	13004	0.735082	PASS	1253	8640	0.536111	28077	121288	0.670841	2428	9123	5.29361e-01	54783	161755	6.57872e-01	rs788018	.	.	.	-0.119	0.011	0.337	.	.	.	.	.	ENST00000335508: c.2631T>C (p.G877G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3757860	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	198267770	198267770	2q33.1	.	.	ins	AA	AG.AA	het-ref	160	0.45	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC12	IVS12	.	.	intron	NM_012433.2	NP_036565.2	-	Y	c.1720-12_1720-11insTT	.	.	.	NM_012433.2(SF3B1): c.1720-12_1720-11insTT	;maf-5-some-pop,maf-5-all-pops	122916	0.676055	U	0.5179	0.717452	12518	0.735501	PASS	1226	8298	0.547120	27333	117908	0.674297	.	.	.	.	.	.	rs3217350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	198283304	198283305	2q33.1	.	T	snv	C	GT.TT	het-ref	175	0.45	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C5	EX5	.	.	coding-synon	NM_012433.2	NP_036565.2	-	Y	c.423A>G	p.(K141=) | p.(Lys141=)	AAA=>AAG	.	NM_012433.2(SF3B1): c.423A>G (p.(K141=))	;maf-5-some-pop,maf-5-all-pops	126236	0.674388	U	0.5179	0.720647	13006	0.739351	PASS	1264	8640	0.538426	28199	121228	0.672477	2442	9113	5.31618e-01	54479	160602	6.58415e-01	rs788023	.	.	.	-0.131	2.297	1.509	.	.	.	.	.	ENST00000335508: c.423A>G (p.K141K)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1129389	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	202151162	202151163	2q33.1	.	A	snv	G	AT.TT	het-ref	273	0.46	.	2	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	IC7	IVS9	.	.	intron	NM_001228.4	NP_001219.2	+	Y	c.1356-19A>G	.	.	.	NM_001228.4(CASP8): c.1356-19A>G	SingleClassTriAllelic;maf-5-some-pop	126294	0.716273	U	0.6964	0.745208	13006	0.742888	PASS	2140	8632	0.704819	31400	121286	0.715078	4230	12119	7.03366e-01	61313	172049	7.01319e-01	rs3769818	.	4024	0.706500	-0.119	0.824	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	202151162	202151163	2q33.1	.	A	snv	G	AT.TT	het-ref	273	0.46	.	2	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	IC7	IVS9	.	.	intron	NM_033355.3	NP_203519.1	+	N	c.1305-19A>G	.	.	.	NM_033355.3(CASP8): c.1305-19A>G	SingleClassTriAllelic;maf-5-some-pop	126294	0.716273	U	0.6964	0.745208	13006	0.742888	PASS	2140	8632	0.704819	31400	121286	0.715078	4230	12119	7.03366e-01	61313	172049	7.01319e-01	rs3769818	.	4024	0.706500	-0.119	0.824	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	209101905	209101906	2q34	.	A	del	.	GG.AA	hom-alt	225	0.98	.	0	.	PASS	147700	C	137800(SK)	AD	.	.	.	.	.	.	.	3417	IDH1	IC7	IVS9	.	.	intron	NM_005896.2	NP_005887.2	-	Y	c.1155-13delT	.	.	.	NM_005896.2(IDH1): c.1155-13delT	MixedObserved;|MixedObserved;maf-5-some-pop	0|99835	0|0.050944	U	0.999	0.982628	.	.	PASS	3360	6818	0.992813	46845	95642	0.989753	.	.	.	.	.	.	rs200686278|rs57383668	.	4024	0.998300	-1.042	-0.803	-1.515	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	212251863	212251864	2q34	.	T	snv	C	TA.AC	het-ref	254	0.49	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	C27	EX27	.	.	coding-synon	NM_005235.2	NP_005226.1	-	Y	c.3195A>G	p.(V1065=) | p.(Val1065=)	GTA=>GTG	.	NM_005235.2(ERBB4): c.3195A>G (p.(V1065=))	;maf-5-some-pop	126340	0.292489	U	0.2887	0.223043	13006	0.252730	PASS	399	8638	0.308057	5687	121332	0.295355	881	5367	3.11167e-01	11872	73672	3.00432e-01	rs3748962	.	4024	0.298500	-0.899	-1.087	-1.971	.	.	.	.	.	ENST00000342788: c.3195A>G (p.V1065V)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	3757923	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	212285339	212285343	2q34	.	AAAG	del	.	TA.AA	het-ref	205	0.45	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC24	IVS24	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.2965-7_2965-4delCTTT	.	.	.	NM_005235.2(ERBB4): c.2965-7_2965-4delCTTT	MixedObserved;maf-5-some-pop	124550	0.060699	U	0.0694	0.138379	12514	0.129615	PASS	19	8510	0.080846	758	119542	0.057444	50	1423	8.27518e-02	1222	12845	5.23709e-02	rs138150601	.	4024	0.085500	.	.	.	.	.	.	.	.	ENST00000342788: c.2965-7_2965-4delCTTT (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020445	.	.	.	.	.	.	.	.	.	Benign
Pass	2	212578379	212578380	2q34	.	A	del	.	TT.AA	het-ref	36	0.25	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC7	IVS7	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.884-7delT	.	.	.	NM_005235.2(ERBB4): c.884-7delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	5054	0.439058	U	0.4028	0.442891	.	.	InbreedingCoeff_Filter	46	5560	0.439568	990	85506	0.462821	.	.	.	.	.	.	rs67894136	.	4024	0.427900	-1.918	-1.161	-1.327	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
HHReport	2	215595163	215595164	2q35	.	G	snv	A	GC.TG	het-ref	240	0.46	.	2	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	C10	EX10	.	.	missense	NM_000465.2	NP_000456.2	-	Y	c.1972C>T	p.R658C | p.Arg658Cys	CGC=>TGC	P+=>P0	NM_000465.2(BARD1): c.1972C>T (p.R658C)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126370	0.007834	U	0.0139	0.00539137	13006	0.005920	PASS	0	8654	0.010746	4	121362	0.007935	0	192	1.11317e-02	10	2071	8.41384e-03	rs3738888	.	4024	0.011900	0.650	5.338	2.728	0	0.346	0.995	0.554	deleterious	ENST00000260947: c.1972C>T (p.R658C)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3782109	CM067650	NM_000465.2(BARD1): c.1972C>T (p.R658C)	"Lung cancer, susceptibility to, association with"	16741161	DP	no_record	136500	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Certain
HHReport	2	215632255	215632256	2q35	.	A	snv	G	AC.TG	hom-alt	624	1.00	.	0	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	C6	EX6	Ankyrin repeat;Ankyrin repeats (3 copies);Ankyrin repeat;Ankyrin repeats (many copies);Ankyrin repeats (many copies)	PF00023.25;PF12796.2;PF13606.1;PF13637.1;PF13857.1	coding-synon	NM_000465.2	NP_000456.2	-	Y	c.1518T>C	p.(H506=) | p.(His506=)	CAT=>CAC	.	NM_000465.2(BARD1): c.1518T>C (p.(H506=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126312	0.811720	U	0.9484	0.770567	13006	0.713824	PASS	3937	8650	0.953873	40550	121304	0.813419	7825	16435	9.52864e-01	83030	201220	8.17708e-01	rs2070093	.	4024	0.939600	-0.212	0.115	-0.323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	183704	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	2	215657182	215657183	2q35	.	A	del	.	tt.aa	het-ref	69	0.33	.	2	AT_rich|Low_complexity|Low_complexity|+|28	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	IC2	IVS2	.	.	intron	NM_000465.2	NP_000456.2	-	Y	c.216-14delT	.	.	.	NM_000465.2(BARD1): c.216-14delT	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5205	0.428818	U	0.381	0.444888	.	.	PASS	1	834	0.456835	92	30538	0.438437	.	.	.	.	.	.	rs56130510	.	4024	0.458000	-0.376	-0.395	-0.947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	142007	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
Pass	2	225346645	225346646	2q36.2	.	T	snv	C	AA.TG	het-ref	263	0.44	.	2	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	C14	EX14	Cullin family	PF00888.17	coding-synon	NM_003590.4	NP_003581.1	-	Y	c.1992A>G	p.(Q664=) | p.(Gln664=)	CAA=>CAG	.	NM_003590.4(CUL3): c.1992A>G (p.(Q664=))	;maf-5-some-pop,maf-5-all-pops	126256	0.186455	U	0.2401	0.232628	13006	0.174381	PASS	337	8644	0.278343	2425	121248	0.184547	647	4476	2.76228e-01	4581	42805	1.84114e-01	rs2070127	.	4024	0.260700	-0.766	1.606	0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259092	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	225362477	225362478	2q36.2	.	C	snv	T	AA.TG	het-ref	166	0.45	.	2	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	C12	EX12	Cullin family	PF00888.17	missense	NM_003590.4	NP_003581.1	-	Y	c.1699G>A	p.V567I | p.Val567Ile	GTT=>ATT	NP=>NP	NM_003590.4(CUL3): c.1699G>A (p.V567I)	;maf-5-some-pop	126222	0.128432	U	0.2391	0.139377	13006	0.071198	PASS	331	8618	0.277210	1388	121214	0.127980	665	4689	2.72205e-01	2841	32304	1.31438e-01	rs3738952	.	4024	0.260200	0.650	3.142	2.937	0.19	0.017	0	0.050	neutral	.	.	.	.	.	.	.	.	.	.	no_record	259091	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	2	225367668	225367669	2q36.2	.	C	snv	T	AA.GC	het-ref	182	0.54	.	2	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC10	IVS10	.	.	intron	NM_003590.4	NP_003581.1	-	Y	c.1485+13G>A	.	.	.	NM_003590.4(CUL3): c.1485+13G>A	;maf-5-some-pop,maf-5-all-pops	126162	0.187529	U	0.2401	0.232628	13006	0.175227	PASS	335	8638	0.277842	2450	121154	0.185665	666	4688	2.72780e-01	4845	45268	1.85403e-01	rs3754629	.	4024	0.260700	-0.254	-0.376	-0.176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259090	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	2	234669143	234669144	2q37.1	.	G	snv	A	AC.GA	het-ref	213	0.46	.	2	.	PASS	191740	C	143500(NK);218800(MK);237900(MK);601816(NK);606785(MK)	AR	Crigler-Najjar syndrome, type I; Crigler-Najjar syndrome, type II; Gilbert syndrome	AD/AR	Allelic with Breast milk jaundice (AD/AR)	Gastrointestinal	Gastrointestinal; Pharmacogenomic	24065680|23992562|23926009|23430851|23403257|23279026|23241680|23162302|23099197|22710376|22676194|18518849|16712705|12983120|11906189|11370628|11316168|11061796|11003624|10412811|9621515|9580649|9413009|8690398|8528206|8276413|7989595|7565971|5685361|3546653|1734381|1531971|805737	.	54658	UGT1A1	C1	EX1	UDP-glucoronosyl and UDP-glucosyl transferase	PF00201.13	missense	NM_000463.2	NP_000454.1	+	Y	c.211G>A	p.G71R | p.Gly71Arg	GGA=>AGA	P0=>P+	NM_000463.2(UGT1A1): c.211G>A (p.G71R)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126330	0.021206	U	0.1379	0.034345	13006	0.001307	PASS	113	8642	0.152395	134	121322	0.020664	225	2654	1.53873e-01	269	5442	2.21034e-02	rs4148323	.	4024	0.178400	0.650	2.128	2.890	0.13	0.712	0.975	0.510	deleterious	ENST00000305208: c.211G>A (p.G71R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4415616	CM930722	NM_000463.2(UGT1A1): c.211G>A (p.G71R)	"Hyperbilirubinaemia, association with"	17850628	DFP	no_record	12280	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	2	240003869	240003870	2q37.3	.	G	snv	A	CT.GG	hom-alt	272	1.00	.	0	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	C20	EX21	Histone deacetylase domain	PF00850.14	coding-synon	NM_006037.3	NP_006028.2	-	Y	c.2565C>T	p.(P855=) | p.(Pro855=)	CCC=>CCT	.	NM_006037.3(HDAC4): c.2565C>T (p.(P855=))	;maf-5-some-pop,maf-5-all-pops	126400	0.535783	U	0.6885	0.595248	13006	0.506074	PASS	2056	8646	0.687717	17909	121392	0.533330	4090	11851	6.87094e-01	36703	132056	5.36255e-01	rs1063639	.	4024	0.732100	0.454	-0.693	-0.680	.	.	.	.	.	ENST00000345617: c.2565C>T (p.P855P)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4133597	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	240011716	240011717	2q37.3	.	T	snv	C	CC.GT	het-ref	139	0.43	.	2	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	C17	EX18	Histone deacetylase domain	PF00850.14	coding-synon	NM_006037.3	NP_006028.2	-	Y	c.2361A>G	p.(T787=) | p.(Thr787=)	ACA=>ACG	.	NM_006037.3(HDAC4): c.2361A>G (p.(T787=))	;maf-5-some-pop	125382	0.047200	U	0.0367	0.033746	13006	0.032677	PASS	12	8614	0.054330	190	120374	0.047759	30	859	4.98202e-02	445	12296	5.01186e-02	rs61752234	.	4024	0.057200	-1.945	-2.476	-2.670	.	.	.	.	.	ENST00000345617: c.2361A>G (p.T787T)	kidney [NS|NS|NS]	carcinoma [clear_cell_renal_cell_carcinoma|NS|NS]	CSV	3773957	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	240029735	240029736	2q37.3	.	T	snv	C	GG.CG	hom-alt	490	1.00	.	0	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC14	IVS15	.	.	intron	NM_006037.3	NP_006028.2	-	Y	c.2097+10A>G	.	.	.	NM_006037.3(HDAC4): c.2097+10A>G	;maf-5-some-pop,maf-5-all-pops	123122	0.833807	U	0.8224	0.838658	12996	0.788935	PASS	2996	8488	0.840716	41226	118114	0.833601	5997	14292	8.34618e-01	85625	203501	8.36757e-01	rs7585225	.	4024	0.841900	-0.279	0.141	-0.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	2	242793272	242793273	2q37.3	.	A	snv	G	TC.GC	hom-alt	523	1.00	.	0	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	C5E	EX5E	.	.	coding-synon	NM_005018.2	NP_005009.2	-	Y	c.804T>C	p.(A268=) | p.(Ala268=)	GCT=>GCC	.	NM_005018.2(PDCD1): c.804T>C (p.(A268=))	SingleClassTriAllelic;maf-5-some-pop	124124	0.629210	U	0.7321	0.647963	13004	0.586358	PASS	2256	8580	0.724476	23802	119116	0.628421	4574	12522	7.27769e-01	49522	154619	6.32559e-01	rs2227981	.	4024	0.755700	-2.293	-3.827	-3.849	.	.	.	.	.	ENST00000334409: c.804T>C (p.A268A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3758140	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	242793432	242793433	2q37.3	.	G	snv	A	CG.CT	het-ref	255	0.52	.	2	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	C5E	EX5E	.	.	missense	NM_005018.2	NP_005009.2	-	Y	c.644C>T	p.A215V | p.Ala215Val	GCC=>GTC	NP=>NP	NM_005018.2(PDCD1): c.644C>T (p.A215V)	;maf-5-some-pop	122386	0.084912	U	0.4454	0.136781	13006	0.012456	PASS	1049	8590	0.487311	1626	117378	0.082699	2112	8427	4.90227e-01	3634	22273	9.12275e-02	rs2227982	.	4024	0.520600	0.555	1.234	0.892	0.22	0.34	0.894	0.149	neutral	ENST00000334409: c.644C>T (p.A215V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4989211	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	2	242800899	242800900	2q37.3	.	G	snv	A	CC.CC	het-ref	136	0.45	.	2	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	IC1	IVS1	.	.	intron	NM_005018.2	NP_005009.2	-	Y	c.76+15C>T	.	.	.	NM_005018.2(PDCD1): c.76+15C>T	;maf-5-some-pop	38054	0.151049	U	0.4722	0.152157	12966	0.023677	PASS	568	3734	0.595072	807	33046	0.150881	1757	6848	5.03603e-01	2993	18492	9.82019e-02	rs35933396	.	.	.	0.305	-0.282	-0.314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	3	10128965	10128966	3p25.3	.	T	del	.	CC.tt	het-ref	42	0.53	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC33	IVS34	.	.	intron	NM_001018115.1	NP_001018125.1	+	Y	c.3466+18delT	.	.	.	NM_001018115.1(FANCD2): c.3466+18delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	18072	0.370241	U	0.4296	0.368011	.	.	PASS	0	2350	0.165106	1	38400	0.213958	.	.	.	.	.	.	rs535944248	.	4024	0.095700	-0.384	-0.204	-0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	3	10128965	10128966	3p25.3	.	T	del	.	CC.tt	het-ref	42	0.53	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC33	IVS34	.	.	intron	NM_033084.3	NP_149075.2	+	N	c.3466+18delT	.	.	.	NM_033084.3(FANCD2): c.3466+18delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	18072	0.370241	U	0.4296	0.368011	.	.	PASS	0	2350	0.165106	1	38400	0.213958	.	.	.	.	.	.	rs535944248	.	4024	0.095700	-0.384	-0.204	-0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	3	30686413	30686414	3p24.1	.	A	snv	G	GC.AG	het-ref	226	0.49	.	2	.	PASS	190182	C	133239(MK);610168(MK);614331(MK)	AD	Loeys-Dietz syndrome, type 2B; Loeys-Dietz syndrome, type 1B	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	19996017|19542084|19006214|16928994|16251899|16027248|15731757|15235604	.	7048	TGFBR2	IC3	IVS3	.	.	intron	NM_001024847.2	NP_001020018.1	+	Y	c.338+7A>G	.	.	.	NM_001024847.2(TGFBR2): c.338+7A>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125728	0.374157	U	0.7054	0.412939	13006	0.321544	PASS	2041	8604	0.689679	8816	120720	0.372548	4147	11929	6.93950e-01	17884	90755	3.69668e-01	rs1155705	.	4024	0.687900	-0.726	-1.327	-1.364	.	.	.	.	.	ENST00000359013: c.338+7A>G (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019240	.	.	.	.	.	no_record	36867	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	3	30713841	30713842	3p24.1	.	C	snv	T	AA.GA	het-ref	261	0.44	.	2	.	PASS	190182	C	133239(MK);610168(MK);614331(MK)	AD	Loeys-Dietz syndrome, type 2B; Loeys-Dietz syndrome, type 1B	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	19996017|19542084|19006214|16928994|16251899|16027248|15731757|15235604	.	7048	TGFBR2	C5	EX5	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_001024847.2	NP_001020018.1	+	Y	c.1242C>T	p.(N414=) | p.(Asn414=)	AAC=>AAT	.	NM_001024847.2(TGFBR2): c.1242C>T (p.(N414=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125756	0.057015	U	0.2986	0.103435	13006	0.018299	PASS	357	8642	0.295302	526	120748	0.055090	823	5217	3.02575e-01	1169	13292	5.42110e-02	rs2228048	.	4024	0.256200	-0.312	-0.997	-1.139	.	.	.	.	.	ENST00000359013: c.1242C>T (p.N414N)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020533	.	.	.	.	.	no_record	44652	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	3	37067239	37067240	3p22.2	.	T	snv	A	GG.TC	het-ref	202	0.52	.	2	.	PASS	120436	C	158320(MK);276300(MK);609310(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 2; Mismatch repair cancer syndrome; Endometrial cancer; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	20301390|19156169|18457354|17440981|16042583|15662714|15520370|15264268|15235030|15077197|10577927|10072435|9927033|9634524|8751876|8145827|8128251|7815421|7661930|6020987|5684233|4063166	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4292	MLH1	C12	EX12	.	.	missense	NM_000249.3	NP_000240.1	+	Y	c.1151T>A	p.V384D | p.Val384Asp	GTT=>GAT	NP=>P-	NM_000249.3(MLH1): c.1151T>A (p.V384D)	;clinically-assoc,submitted-by-lsdb	126296	0.002874	U	0.0258	0.00519169	13006	0.000077	PASS	3	8646	0.038515	3	121288	0.002779	7	622	3.60622e-02	7	637	2.58750e-03	rs63750447	.	4024	0.044200	0.455	4.821	2.158	0	0.997	1	0.911	deleterious	ENST00000231790: c.1151T>A (p.V384D)	NS [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	RSS	26085	CM981292	NM_000249.3(MLH1): c.1151T>A (p.V384D)	"Colorectal cancer, non-polyposis ?"	9526167	DM	no_record	41632	reviewed_by_expert_panel	Benign	VUS
Pass	3	41280826	41280827	3p22.1	.	C	snv	T	GA.CT	het-ref	222	0.48	.	2	.	PASS	116806	C	114500(MK);114550(MK);132600(MK);167000(MK);615075(MK)	AD	Mental retardation, autosomal dominant, 19	AD	.	Neurologic	General	23033978	.	1499	CTNNB1	C14E	EX15E	.	.	coding-synon	NM_001904.3	NP_001895.1	+	Y	c.2340C>T	p.(D780=) | p.(Asp780=)	GAC=>GAT	.	NM_001904.3(CTNNB1): c.2340C>T (p.(D780=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118088	0.028098	U	0.1468	0.043131	13006	0.001845	PASS	75	8142	0.139155	221	113080	0.027432	165	2361	1.37957e-01	572	7641	3.12802e-02	rs2293303	.	4024	0.144900	0.557	4.488	2.679	.	.	.	.	.	ENST00000349496: c.2340C>T (p.D780D)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5008346	.	.	.	.	.	no_record	128869	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	3	47125384	47125385	3p21.31	.	G	snv	A	TG.GC	het-ref	351	0.49	.	2	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C12	EX12	.	.	missense	NM_014159.6	NP_054878.5	-	Y	c.5885C>T	p.P1962L | p.Pro1962Leu	CCC=>CTC	NP=>NP	NM_014159.6(SETD2): c.5885C>T (p.P1962L)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126382	0.531682	U	0.5327	0.469848	13006	0.471321	PASS	1302	8648	0.542438	17779	121374	0.534233	2563	9362	5.42913e-01	36612	132662	5.38978e-01	rs4082155	.	4024	0.541500	-0.145	0.765	0.333	0.34	0	0	0.023	neutral	ENST00000409792: c.5885C>T (p.P1962L)	prostate [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	149375	.	.	.	.	.	no_record	135202	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	3	47162660	47162661	3p21.31	.	A	snv	G	CG.TT	hom-alt	678	1.00	.	0	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C3	EX3	.	.	coding-synon	NM_014159.6	NP_054878.5	-	Y	c.3465T>C	p.(N1155=) | p.(Asn1155=)	AAT=>AAC	.	NM_014159.6(SETD2): c.3465T>C (p.(N1155=))	;maf-5-some-pop,maf-5-all-pops	126204	0.636050	U	0.6577	0.678315	13006	0.644779	PASS	2030	8652	0.682039	24642	121196	0.634303	4028	11751	6.81375e-01	50756	156876	6.37459e-01	rs6767907	.	4024	0.682400	-0.119	-0.236	-0.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	586533	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	3	47162885	47162886	3p21.31	.	C	snv	T	TC.AT	het-ref	371	0.51	.	2	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C3	EX3	.	.	missense	NM_014159.6	NP_054878.5	-	Y	c.3240G>A	p.M1080I | p.Met1080Ile	ATG=>ATA	NP=>NP	NM_014159.6(SETD2): c.3240G>A (p.M1080I)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125986	0.054101	U	0.124	0.0553115	13006	0.015993	PASS	88	8612	0.140502	516	120978	0.054051	174	2386	1.38512e-01	1240	14930	6.14798e-02	rs76208147	.	4024	0.139900	0.585	1.391	2.718	0.17	0.035	0.216	0.061	neutral	ENST00000409792: c.3240G>A (p.M1080I)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	149377	.	.	.	.	.	no_record	135235	no_assertion_provided	not_provided	Likely Benign
Pass	3	52676065	52676066	3p21.1	.	A	del	.	AC.AA	het-ref	53	0.31	.	2	.	PASS	606083	P	.	NN	.	.	.	.	.	.	.	55193	PBRM1	IC9	IVS10	.	.	intron	NM_018313.4	NP_060783.3	-	Y	c.996-5delT	.	.	.	NM_018313.4(PBRM1): c.996-5delT	MixedObserved;	182	0.016484	U	.	.	.	.	PASS	0	8364	0.160091	1	116916	0.189752	.	.	.	.	.	.	rs376663529	.	4024	0.135700	0.377	0.407	0.383	.	.	.	.	.	ENST00000356770: c.900-5delT (p.?)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5943950	.	.	.	.	.	.	.	.	.	Benign
InExcel	3	52696310	52696310	3p21.1	.	.	ins	A	AG.AA	het-ref	34	0.14	.	2	.	PASS	606083	P	.	NN	.	.	.	.	.	.	.	55193	PBRM1	IC3	IVS4	.	.	intron	NM_018313.4	NP_060783.3	-	Y	c.385-19_385-18insT	.	.	.	NM_018313.4(PBRM1): c.385-19_385-18insT	;	60081	0.128809	U	.	.	.	.	PASS	0	4788	0.124896	0	68006	0.115946	.	.	.	.	.	.	rs781206124	.	4024	0.108100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	3	67548726	67548729	3p14.1	.	AAG	del	.	TA.AA	het-ref	99	0.53	.	2	.	PASS	603922	P	.	NN	.	.	.	.	.	.	.	8801	SUCLG2	IC7	IVS7	.	.	intron	NM_001177599.1	NP_001171070.1	-	Y	c.758-10_758-8delCTT	.	.	.	NM_001177599.1(SUCLG2): c.758-10_758-8delCTT	;maf-5-some-pop	123044	0.123631	U	0.3006	0.196685	11366	0.098979	PASS	390	8364	0.310378	1292	118036	0.120531	813	5243	3.07579e-01	2830	29501	1.20847e-01	rs150352166	.	1340	0.977600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257602	criteria_provided,_single_submitter	Benign	Benign
Pass	3	105422843	105422844	3q13.11	.	C	snv	T	CC.GT	hom-alt	258	1.00	.	0	.	PASS	604491	P	.	NN	.	.	.	.	.	.	.	868	CBLB	C10	EX11	.	.	coding-synon	NM_170662.3	NP_733762.2	-	Y	c.1581G>A	p.(T527=) | p.(Thr527=)	ACG=>ACA	.	NM_170662.3(CBLB): c.1581G>A (p.(T527=))	;maf-5-some-pop,maf-5-all-pops	126338	0.731474	U	0.7788	0.750998	13006	0.736891	PASS	2510	8636	0.764243	32590	121330	0.730668	4993	13129	7.61543e-01	65450	178805	7.26726e-01	rs2305037	.	4024	0.760700	-1.655	-0.753	-0.818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	3	119534152	119534153	3q13.33	.	C	snv	T	AT.CT	het-ref	190	0.45	.	2	.	PASS	603065	P	.	NN	.	.	.	.	.	.	.	8856	NR1I2	IC5	IVS6	.	.	intron	NM_003889.3	NP_003880.3	+	Y	c.938-17C>T	.	.	.	NM_003889.3(NR1I2): c.938-17C>T	SingleClassTriAllelic;maf-5-some-pop	126172	0.247202	U	0.4663	0.319688	13006	0.242427	PASS	931	8628	0.469402	4137	121164	0.244206	1871	8011	4.64621e-01	7933	58693	2.38545e-01	rs2276707	.	4024	0.471900	0.561	0.929	0.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	3	121351315	121351315	3q13.33	.	.	ins	GGCTCAGGCTCA	cg.gg	hom-alt	238	0.99	.	0	trf	PASS	601306	P	.	NN	.	.	.	.	.	.	.	3059	HCLS1	C11	EX12	.	.	cds-ins	NM_005335.4	NP_005326.2	-	Y	c.1092TGAGCC[2>4] (std: c.1092TGAGCC[4] alt: c.1103_1104insTGAGCCTGAGCC )	p.P364_E365[6>8] (std: p.P364_E365[8] alt: p.E375_N376insPEPE ) | p.Pro364_Glu365[6>8] (std: p.Pro364_Glu365[8] alt: p.Glu375_Asn376insProGluProGlu )	.	.	NM_005335.4(HCLS1): c.1092TGAGCC[4] (p.P364_E365[8])	;maf-5-some-pop,maf-5-all-pops	5008	0.241214	U	0.4563	0.241214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs150627065	.	4024	0.433200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	3	121353253	121353254	3q13.33	.	T	snv	C	GG.AC	hom-alt	536	1.00	.	0	.	PASS	601306	P	.	NN	.	.	.	.	.	.	.	3059	HCLS1	C9	EX10	.	.	missense	NM_005335.4	NP_005326.2	-	Y	c.703A>G	p.T235A | p.Thr235Ala	ACC=>GCC	P0=>NP	NM_005335.4(HCLS1): c.703A>G (p.T235A)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126146	0.697771	U	0.8492	0.651558	13006	0.711364	PASS	3121	8648	0.849445	30684	121138	0.699681	6247	14683	8.51583e-01	60367	168567	6.89526e-01	rs2070179	.	4024	0.844200	-0.197	2.606	1.472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	3	134670523	134670524	3q22.2	.	C	snv	T	AG.TT	het-ref	305	0.52	.	2	.	PASS	600600	P	.	NN	.	.	.	.	.	.	.	2047	EPHB1	C3	EX3	Ephrin receptor ligand binding domain	PF01404.14	coding-synon	NM_004441.4	NP_004432.1	+	Y	c.435C>T	p.(S145=) | p.(Ser145=)	AGC=>AGT	.	NM_004441.4(EPHB1): c.435C>T (p.(S145=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125768	0.463512	U	0.2123	0.48143	12368	0.487872	PASS	172	8620	0.188979	13549	120760	0.462769	340	3332	1.93182e-01	27050	112946	4.58910e-01	rs7644369	.	.	.	0.655	3.398	2.578	.	.	.	.	.	ENST00000398015: c.435C>T (p.S145S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3759780	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	3	138433567	138433568	3q22.3	.	C	snv	T	AA.GA	hom-alt	571	1.00	.	0	.	PASS	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC6	IVS6	.	.	intron	NM_006219.2	NP_006210.1	-	Y	c.1051-7G>A	.	.	.	NM_006219.2(PIK3CB): c.1051-7G>A	;maf-5-some-pop,genotype-conflict	125458	0.625540	U	0.9841	0.701877	13004	0.560289	PASS	4240	8648	0.990287	24427	120450	0.622366	7721	15597	9.90034e-01	44445	135605	6.25288e-01	rs497900	.	4024	0.988800	-1.135	-2.169	-1.834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	3	142168330	142168331	3q23	.	C	snv	T	TC.TG	hom-alt	587	1.00	.	0	.	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	C47E	EX47E	FATC domain	PF02260.15	coding-synon	NM_001184.3	NP_001175.2	-	Y	c.7875G>A	p.(Q2625=) | p.(Gln2625=)	CAG=>CAA	.	NM_001184.3(ATR): c.7875G>A (p.(Q2625=))	;maf-5-some-pop	126394	0.866655	U	0.9266	0.916334	13006	0.897816	PASS	3749	8654	0.930206	45665	121386	0.864605	7516	16093	9.33036e-01	91046	211108	8.57410e-01	rs1802904	.	4024	0.941400	-1.079	0.319	-0.397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	93669	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
InExcel	3	142241692	142241692	3q23	.	.	ins	A	AG.AA	het-ref	25	0.15	.	2	.	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	IC22	IVS22	.	.	intron	NM_001184.3	NP_001175.2	-	Y	c.4153-10_4153-9insT	.	.	.	NM_001184.3(ATR): c.4153-10_4153-9insT	MixedObserved;rs-cluster-nonoverlapping-alleles	81661	0.080210	U	.	.	.	.	PASS	0	5816	0.263583	0	81728	0.246011	.	.	.	.	.	.	rs112116713	.	4024	0.207300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	195738	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely Benign
Pass	3	178922273	178922274	3q26.32	.	C	snv	A	AC.TA	het-ref	125	0.48	.	2	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC4	IVS5	.	.	intron	NM_006218.2	NP_006209.2	+	Y	c.1060-17C>A	.	.	.	NM_006218.2(PIK3CA): c.1060-17C>A	;maf-5-some-pop,maf-5-all-pops	125494	0.562330	U	0.248	0.584665	11872	0.669727	PASS	267	8620	0.253480	20164	120486	0.561401	596	4499	2.62853e-01	39539	135497	5.55106e-01	rs2699896	.	4024	0.274600	-0.256	0.397	0.175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259957	criteria_provided,_single_submitter	Benign	Benign
Pass	3	186504406	186504407	3q27.3	.	A	snv	G	AA.CA	het-ref	134	0.46	.	2	.	PASS	601102	P	.	NN	.	.	.	.	.	.	.	1974	EIF4A2	C7	EX7	.	.	coding-synon	NM_001967.3	NP_001958.2	+	Y	c.744A>G	p.(K248=) | p.(Lys248=)	AAA=>AAG	.	NM_001967.3(EIF4A2): c.744A>G (p.(K248=))	;maf-5-some-pop	126200	0.016363	U	0.0744	0.0299521	13006	0.008688	PASS	26	8650	0.073757	43	121192	0.015801	55	1311	7.60088e-02	91	3732	1.51609e-02	rs11538612	.	.	.	0.528	2.701	2.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	3	186504912	186504913	3q27.3	.	C	snv	T	TA.AG	het-ref	125	0.52	.	2	.	PASS	601102	P	.	NN	.	.	.	.	.	.	.	1974	EIF4A2	IC7	IVS7	.	.	intron	NM_001967.3	NP_001958.2	+	Y	c.772-3C>T	.	.	.	NM_001967.3(EIF4A2): c.772-3C>T	;maf-5-some-pop	126236	0.016358	U	0.0744	0.0299521	13006	0.008688	PASS	26	8654	0.073723	43	121228	0.015797	55	1309	7.58929e-02	91	3728	1.51541e-02	rs75837460	.	.	.	-0.412	0.209	-0.399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	1803703	1803704	4p16.3	.	T	snv	C	AA.GG	het-ref	249	0.47	.	2	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	C6	EX7	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF13895.1;PF13927.1	coding-synon	NM_000142.4	NP_000133.1	+	Y	c.882T>C	p.(N294=) | p.(Asn294=)	AAT=>AAC	.	NM_000142.4(FGFR3): c.882T>C (p.(N294=))	;maf-5-some-pop	122356	0.170764	U	0.0744	0.207468	13004	0.213934	PASS	13	8478	0.049658	1985	117348	0.169198	17	778	4.52483e-02	3747	39074	1.59869e-01	rs2234909	.	4024	0.050700	-1.982	-0.914	-1.576	.	.	.	.	.	ENST00000340107: c.882T>C (p.N294N)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1428695	.	.	.	.	.	no_record	255346	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	4	55141054	55141055	4q12	.	A	snv	G	CC.GA	hom-alt	732	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	C11	EX12	.	.	coding-synon	NM_006206.4	NP_006197.1	+	Y	c.1701A>G	p.(P567=) | p.(Pro567=)	CCA=>CCG	.	NM_006206.4(PDGFRA): c.1701A>G (p.(P567=))	;maf-5-some-pop,genotype-conflict	126412	0.986837	U	1	0.957668	13006	0.958865	PASS	4325	8650	1.000000	59312	121404	0.988040	8620	17241	9.99942e-01	120667	243535	9.90278e-01	rs1873778	.	4024	0.999000	-4.136	-5.707	-5.312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259949	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	4	55161390	55161391	4q12	.	T	snv	C	GA.GA	hom-alt	494	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	C22E	EX23E	.	.	coding-synon	NM_006206.4	NP_006197.1	+	Y	c.3222T>C	p.(D1074=) | p.(Asp1074=)	GAT=>GAC	.	NM_006206.4(PDGFRA): c.3222T>C (p.(D1074=))	;	126418	0.998916	U	1	0.997204	13006	0.996771	PASS	4325	8652	0.999884	60582	121410	0.998987	8621	17244	9.99884e-01	122830	245847	9.99232e-01	rs7685117	.	4024	0.998500	-0.355	-0.112	-0.918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259953	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	4	55948107	55948108	4q12	.	A	snv	G	AT.TG	hom-alt	332	1.00	.	0	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC29	IVS29	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.3848+15T>C	.	.	.	NM_002253.2(KDR): c.3848+15T>C	;	126360	0.998488	U	1	0.996805	13006	0.997616	PASS	4325	8650	1.000000	60501	121352	0.998558	8621	17242	1.00000e+00	122527	245393	9.98620e-01	rs2412617	.	4024	0.998500	-1.102	-0.881	-1.194	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	518355	no_assertion_criteria_provided	Benign	Benign
Pass	4	55968052	55968053	4q12	.	A	snv	C	tt.tc	het-ref	170	0.44	.	2	L1PA10|LINE|L1|-|389	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC15	IVS15	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.2266+11T>G	.	.	.	NM_002253.2(KDR): c.2266+11T>G	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	124900	0.345308	U	0.3135	0.292931	13006	0.282562	PASS	454	8466	0.319631	7880	119892	0.347496	849	5326	3.10048e-01	16976	87427	3.58801e-01	rs7655964	.	4024	0.291700	-0.686	-1.720	-1.898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	4	55972973	55972974	4q12	.	T	snv	A	GC.TG	het-ref	292	0.48	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	C11	EX11	Immunoglobulin domain	PF13895.1	missense	NM_002253.2	NP_002244.1	-	Y	c.1416A>T	p.Q472H | p.Gln472His	CAA=>CAT	P0=>P+	NM_002253.2(KDR): c.1416A>T (p.Q472H)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126054	0.219509	U	0.4653	0.211861	13006	0.193911	PASS	977	8644	0.463674	3520	121046	0.219826	2057	8271	4.79756e-01	7252	54567	2.22166e-01	rs1870377	.	4024	0.490300	-0.290	-0.007	-0.160	0.1	0.012	0.011	0.287	neutral	ENST00000263923: c.1416A>T (p.Q472H)	autonomic_ganglia [sinonasal_and_nasal_cavity|NS|NS]	olfactory_neuroblastoma [NS|NS|NS]	CSV	149673	.	.	.	.	.	no_record	134603	no_assertion_provided	not_provided	Likely Benign
Pass	4	55976947	55976947	4q12	.	.	ins	A	AT.AA	het-ref	140	0.74	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC7	IVS7	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.977-13_977-12insT	.	.	.	NM_002253.2(KDR): c.977-13_977-12insT	;rs-cluster-nonoverlapping-alleles	84506	0.071794	U	.	.	.	.	PASS	88	6550	0.443359	729	94528	0.395047	.	.	.	.	.	.	rs753790740	.	4024	0.443100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	4	55979557	55979558	4q12	.	C	snv	T	TA.AC	het-ref	250	0.48	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	C7	EX7	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin V-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF07686.12;PF13895.1;PF13927.1	missense	NM_002253.2	NP_002244.1	-	Y	c.889G>A	p.V297I | p.Val297Ile	GTA=>ATA	NP=>NP	NM_002253.2(KDR): c.889G>A (p.V297I)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126334	0.110659	U	0.1667	0.152556	13006	0.142703	PASS	94	8654	0.138895	883	121326	0.108930	205	2483	1.43959e-01	1673	25800	1.04825e-01	rs2305948	.	4024	0.146600	0.563	3.257	1.298	0.05	0.999	1	0.836	deleterious	ENST00000263923: c.889G>A (p.V297I)	autonomic_ganglia [sinonasal_and_nasal_cavity|NS|NS]	olfactory_neuroblastoma [NS|NS|NS]	CSV	1131107	CM074307	NM_002253.2(KDR): c.889G>A (p.V297I)	"Coronary heart disease, association with"	17707181	DFP	no_record	134616	no_assertion_provided	not_provided	Likely Benign
Pass	4	66197803	66197804	4q13.1	.	C	snv	T	GC.CC	het-ref	276	0.48	.	2	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	C17	EX17	.	.	coding-synon	NM_004439.5	NP_004430.4	-	Y	c.2895G>A	p.(G965=) | p.(Gly965=)	GGG=>GGA	.	NM_004439.5(EPHA5): c.2895G>A (p.(G965=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125664	0.345747	U	0.4613	0.326677	13006	0.282946	PASS	742	8584	0.419967	7616	120656	0.346539	1522	7216	4.21397e-01	15317	84521	3.45893e-01	rs7349683	.	4024	0.423500	0.561	0.921	1.458	.	.	.	.	.	ENST00000273854: c.2895G>A (p.G965G)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	5619001	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	66280170	66280171	4q13.1	.	C	snv	T	TG.GC	het-ref	233	0.44	.	2	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC6	IVS6	.	.	intron	NM_004439.5	NP_004430.4	-	Y	c.1528-10G>A	.	.	.	NM_004439.5(EPHA5): c.1528-10G>A	SingleClassTriAllelic;maf-5-some-pop	126008	0.189139	U	0.2857	0.180911	13006	0.113102	PASS	374	8572	0.294447	2641	121000	0.189479	742	5098	2.96706e-01	5673	48449	1.97845e-01	rs2305351	.	4024	0.300900	-0.127	1.051	0.043	.	.	.	.	.	ENST00000273854: c.1528-10G>A (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	149681	.	.	.	.	.	.	.	.	.	Benign
Pass	4	84383809	84383810	4q21.23	.	C	snv	T	GG.TT	hom-alt	711	1.00	.	0	dup	PASS	611143	P	.	NN	.	.	.	.	.	.	.	84142	FAM175A	C9E	EX9E	.	.	missense	NM_139076.2	NP_620775.2	-	Y	c.1042G>A	p.A348T | p.Ala348Thr	GCC=>ACC	NP=>P0	NM_139076.2(FAM175A): c.1042G>A (p.A348T)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126400	0.430364	U	0.6756	0.41893	13006	0.327234	PASS	1908	8654	0.664317	12271	121392	0.430836	3871	11510	6.67401e-01	26121	108936	4.42599e-01	rs12642536	.	4024	0.647100	-0.293	0.821	1.330	0.03	0.48	0.844	0.523	deleterious	ENST00000321945: c.1042G>A (p.A348T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760790	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	106155184	106155185	4q24	.	C	snv	G	AC.TC	hom-alt	643	1.00	.	0	.	PASS	612839	P	614286(MK)	NN	.	.	.	.	.	.	.	54790	TET2	C1	EX3	.	.	missense	NM_001127208.2	NP_001120680.1	+	Y	c.86C>G	p.P29R | p.Pro29Arg	CCT=>CGT	NP=>P+	NM_001127208.2(TET2): c.86C>G (p.P29R)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126018	0.061832	U	0.2093	0.0924521	13006	0.020375	PASS	176	8550	0.207135	417	121010	0.060565	332	3507	2.04323e-01	854	15396	6.26873e-02	rs12498609	.	4024	0.214000	0.591	1.982	1.250	0.01	0.628	0.939	0.625	deleterious	ENST00000305737: c.86C>G (p.P29R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020248	.	.	.	.	.	no_record	135316	no_assertion_provided	not_provided	Likely Benign
Pass	4	106155184	106155185	4q24	.	C	snv	G	AC.TC	hom-alt	643	1.00	.	0	.	PASS	612839	P	614286(MK)	NN	.	.	.	.	.	.	.	54790	TET2	C1E	EX3E	.	.	missense	NM_017628.4	NP_060098.3	+	N	c.86C>G	p.P29R | p.Pro29Arg	CCT=>CGT	NP=>P+	NM_017628.4(TET2): c.86C>G (p.P29R)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126018	0.061832	U	0.2093	0.0924521	13006	0.020375	PASS	176	8550	0.207135	417	121010	0.060565	332	3507	2.04323e-01	854	15396	6.26873e-02	rs12498609	.	4024	0.214000	0.591	1.982	1.250	0.04	0.997	1	0.815	deleterious	ENST00000305737: c.86C>G (p.P29R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020248	.	.	.	.	.	no_record	135316	no_assertion_provided	not_provided	Likely Benign
Pass	4	143007418	143007419	4q31.21	.	A	snv	G	GG.AA	het-ref	137	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC20	IVS24	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.2375-10T>C	.	.	.	NM_003866.2(INPP4B): c.2375-10T>C	;maf-5-some-pop,maf-5-all-pops	121938	0.709451	U	0.626	0.604832	12996	0.594875	PASS	1679	8070	0.652045	30083	116930	0.713931	3443	10773	6.42014e-01	62115	171607	7.12399e-01	rs336324	.	4024	0.637700	0.533	0.001	-0.091	.	.	.	.	.	ENST00000513000: c.2375-10T>C (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4002952	.	.	.	.	.	.	.	.	.	Benign
Pass	4	143033777	143033778	4q31.21	.	T	snv	C	TG.AG	het-ref	271	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C19	EX23	.	.	coding-synon	NM_003866.2	NP_003857.2	-	Y	c.2193A>G	p.(L731=) | p.(Leu731=)	CTA=>CTG	.	NM_003866.2(INPP4B): c.2193A>G (p.(L731=))	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop	126230	0.081296	U	0.0764	0.0748802	13006	0.054360	PASS	15	8610	0.059814	557	121222	0.081561	21	1014	5.89603e-02	1059	20380	8.30427e-02	rs3822141	.	4024	0.065900	-2.252	-1.489	-3.782	.	.	.	.	.	ENST00000513000: c.2193A>G (p.L731L)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019421	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	143043403	143043404	4q31.21	.	C	snv	T	AA.AA	het-ref	156	0.58	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC17	IVS21	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.2018-6G>A	.	.	.	NM_003866.2(INPP4B): c.2018-6G>A	;maf-5-some-pop	125600	0.126545	U	0.0754	0.100839	13006	0.105720	PASS	12	8524	0.058071	1147	120592	0.127612	19	976	5.80538e-02	2234	30842	1.28478e-01	rs13133767	.	4024	0.066600	0.585	0.317	0.057	.	.	.	.	.	ENST00000513000: c.2018-6G>A (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019492	.	.	.	.	.	.	.	.	.	Benign
Pass	4	143067053	143067054	4q31.21	.	G	snv	A	CC.CC	het-ref	302	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C15	EX19	.	.	coding-synon	NM_003866.2	NP_003857.2	-	Y	c.1659C>T	p.(G553=) | p.(Gly553=)	GGC=>GGT	.	NM_003866.2(INPP4B): c.1659C>T (p.(G553=))	;maf-5-some-pop	126378	0.117307	U	0.0615	0.0958466	13006	0.091266	PASS	20	8640	0.062616	1039	121370	0.118192	24	1043	6.05340e-02	2075	29623	1.20379e-01	rs35390852	.	4024	0.065100	-0.355	-0.328	-0.385	.	.	.	.	.	ENST00000513000: c.1659C>T (p.G553G)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760412	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	143130033	143130034	4q31.21	.	A	snv	T	AG.AA	hom-alt	516	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC10	IVS14	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.967+15T>A	.	.	.	NM_003866.2(INPP4B): c.967+15T>A	SingleClassTriAllelic;maf-5-some-pop	126216	0.929058	U	0.9683	0.903355	13006	0.901507	PASS	3925	8618	0.954166	52538	121208	0.930120	6811	14239	9.56665e-01	96476	206380	9.33162e-01	rs1907123	.	4024	0.947300	-0.540	-0.336	-0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	4	143235864	143235865	4q31.21	.	C	snv	G	AC.CC	hom-alt	452	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C5	EX9	.	.	coding-synon	NM_003866.2	NP_003857.2	-	Y	c.423G>C	p.(G141=) | p.(Gly141=)	GGG=>GGC	.	NM_003866.2(INPP4B): c.423G>C (p.(G141=))	SingleClassTriAllelic;maf-5-some-pop	126340	0.185040	U	0.4623	0.199481	13006	0.088421	PASS	1060	8638	0.499537	3014	121332	0.184444	1851	7625	4.85731e-01	5758	43536	1.86105e-01	rs3756122	.	4024	0.528600	0.561	1.148	2.873	.	.	.	.	.	ENST00000513000: c.423G>C (p.G141G)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760413	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	4	153268227	153268228	4q31.3	.	A	del	.	AC.aa	het-ref	48	0.19	.	2	A-rich|Low_complexity|Low_complexity|+|65	PASS	606278	P	.	NN	.	.	.	.	.	.	.	55294	FBXW7	IC2	IVS3	.	.	intron	NM_033632.3	NP_361014.1	-	Y	c.585-5delT	.	.	.	NM_033632.3(FBXW7): c.585-5delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	4318	0.346920	0	67974	0.364051	.	.	.	.	.	.	rs780809685	.	4024	0.297700	-0.374	0.618	0.325	.	.	.	.	.	ENST00000281708: c.585-5delT (p.?)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5895336	.	.	.	.	.	.	.	.	.	Benign
Pass	4	187516879	187516880	4q35.2	.	A	snv	G	AG.GA	het-ref	300	0.47	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C25	EX26	.	.	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.13101T>C	p.(S4367=) | p.(Ser4367=)	TCT=>TCC	.	NM_005245.3(FAT1): c.13101T>C (p.(S4367=))	;maf-5-some-pop,maf-5-all-pops	125722	0.423991	U	0.5724	0.491813	12458	0.454086	PASS	1685	8594	0.627531	11858	120714	0.421177	3344	10703	6.20752e-01	24447	104711	4.25329e-01	rs1298865	.	4024	0.617800	-0.128	-0.432	-0.690	.	.	.	.	.	ENST00000441802: c.13101T>C (p.S4367S)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4158951	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187519205	187519206	4q35.2	.	C	snv	G	GG.TT	hom-alt	545	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C22	EX23	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.12177G>C	p.K4059N | p.Lys4059Asn	AAG=>AAC	P+=>P0	NM_005245.3(FAT1): c.12177G>C (p.K4059N)	;	125772	0.995420	U	1	0.997404	12102	0.995207	PASS	4313	8626	1.000000	59821	120764	0.995338	8622	17244	1.00000e+00	121963	245049	9.95341e-01	rs1280097	.	4024	0.998500	-1.086	-0.105	-0.151	1	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187521036	187521037	4q35.2	.	C	snv	A	AA.AT	het-ref	241	0.51	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC21	IVS22	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.12103+15G>T	.	.	.	NM_005245.3(FAT1): c.12103+15G>T	;maf-5-some-pop,maf-5-all-pops	121074	0.320919	U	0.377	0.284744	12088	0.283752	PASS	673	8294	0.410538	6096	116066	0.322480	1370	6732	3.98249e-01	12544	75617	3.17540e-01	rs10009030	.	4024	0.396100	-0.123	-0.790	-0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	4	187524463	187524464	4q35.2	.	G	snv	A	CC.CG	het-ref	331	0.48	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C18	EX19	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.11216C>T	p.A3739V | p.Ala3739Val	GCG=>GTG	NP=>NP	NM_005245.3(FAT1): c.11216C>T (p.A3739V)	;maf-5-some-pop	125454	0.021235	U	0.1181	0.0367412	12162	0.000658	PASS	66	8596	0.123197	160	120446	0.020590	130	2101	1.21938e-01	360	6062	2.47029e-02	rs74511500	.	4024	0.123500	0.563	2.131	1.122	0.4	0.015	0.062	0.017	neutral	ENST00000441802: c.11216C>T (p.A3739V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4967292	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187525019	187525020	4q35.2	.	A	snv	C	AG.GG	het-ref	293	0.45	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C18	EX19	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.10660T>G	p.S3554A | p.Ser3554Ala	TCT=>GCT	P0=>NP	NM_005245.3(FAT1): c.10660T>G (p.S3554A)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125614	0.431043	U	0.5774	0.51278	12114	0.471603	PASS	1710	8604	0.631799	12365	120606	0.427649	3384	10779	6.25450e-01	25285	105950	4.30579e-01	rs2637777	.	4024	0.623300	-0.905	0.568	0.336	0.25	0.002	0	0.037	neutral	ENST00000441802: c.10660T>G (p.S3554A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	4984957	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187532694	187532695	4q35.2	.	C	snv	T	CA.GG	het-ref	355	0.52	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C13	EX14	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.9698G>A	p.R3233H | p.Arg3233His	CGT=>CAT	P+=>P+	NM_005245.3(FAT1): c.9698G>A (p.R3233H)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0.00000e+00	0	3	1.21893e-05	.	.	4024	0.000200	0.650	6.055	2.776	0.01	0.961	0.999	0.810	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	4	187534362	187534363	4q35.2	.	G	snv	A	GC.TT	het-ref	308	0.50	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C12	EX13	.	.	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.9363C>T	p.(N3121=) | p.(Asn3121=)	AAC=>AAT	.	NM_005245.3(FAT1): c.9363C>T (p.(N3121=))	;maf-5-some-pop,maf-5-all-pops	125706	0.592088	U	0.6657	0.611422	12470	0.622213	PASS	2025	8606	0.686614	21553	120698	0.591286	4002	11694	6.78464e-01	44146	145924	5.93472e-01	rs2249916	.	4024	0.674500	-2.912	-1.033	-3.183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187534374	187534375	4q35.2	.	A	snv	G	AC.TC	het-ref	304	0.48	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C12	EX13	.	.	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.9351T>C	p.(D3117=) | p.(Asp3117=)	GAT=>GAC	.	NM_005245.3(FAT1): c.9351T>C (p.(D3117=))	;maf-5-some-pop,maf-5-all-pops	125682	0.439864	U	0.2808	0.417931	12468	0.473292	PASS	376	8602	0.286213	12140	120674	0.440774	718	4779	2.77140e-01	24597	108349	4.40586e-01	rs2249917	.	4024	0.289000	-1.751	-0.691	-1.615	.	.	.	.	.	ENST00000441802: c.9351T>C (p.D3117D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003024	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187538329	187538330	4q35.2	.	G	snv	A	AC.GC	het-ref	251	0.47	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C10	EX11	Cadherin domain	PF00028.12	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.8904C>T	p.(A2968=) | p.(Ala2968=)	GCC=>GCT	.	NM_005245.3(FAT1): c.8904C>T (p.(A2968=))	;maf-5-some-pop	125066	0.438880	U	0.2808	0.416134	11820	0.475465	PASS	370	8576	0.285331	11972	120058	0.439829	708	4708	2.76551e-01	24044	106017	4.39777e-01	rs1280099	.	4024	0.288500	-0.381	0.478	0.024	.	.	.	.	.	ENST00000441802: c.8904C>T (p.A2968A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5425426	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187538941	187538942	4q35.2	.	T	snv	G	CT.GG	het-ref	314	0.50	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C9	EX10	Cadherin domain	PF00028.12	missense	NM_005245.3	NP_005236.2	-	Y	c.8798A>C	p.Q2933P | p.Gln2933Pro	CAA=>CCA	P0=>NP	NM_005245.3(FAT1): c.8798A>C (p.Q2933P)	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	125588	0.556845	U	0.631	0.592053	12110	0.623369	PASS	1764	8620	0.643735	18985	120580	0.555382	3497	10960	6.35436e-01	38652	136458	5.54937e-01	rs1280098	.	4024	0.636700	-0.127	3.287	0.780	1	0	0	0.000	neutral	ENST00000441802: c.8798A>C (p.Q2933P)	urinary_tract [bladder|NS|NS]	carcinoma [NS|NS|NS]	CSV	4005726	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187542426	187542427	4q35.2	.	T	snv	C	CC.GT	het-ref	371	0.50	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C9	EX10	.	.	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.5313A>G	p.(T1771=) | p.(Thr1771=)	ACA=>ACG	.	NM_005245.3(FAT1): c.5313A>G (p.(T1771=))	;	125418	0.000502	U	0.0069	0.00159744	12200	0.000082	PASS	0	8604	0.004998	0	120410	0.000457	0	75	4.35035e-03	0	92	3.74520e-04	rs186222414	.	4024	0.007000	-0.336	-0.418	-1.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	4	187557892	187557893	4q35.2	.	T	snv	C	CG.GA	het-ref	353	0.51	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C4	EX5	Cadherin domain	PF00028.12	missense	NM_005245.3	NP_005236.2	-	Y	c.3818A>G	p.H1273R | p.His1273Arg	CAC=>CGC	P+=>P+	NM_005245.3(FAT1): c.3818A>G (p.H1273R)	;maf-5-some-pop,maf-5-all-pops	125768	0.589927	U	0.6786	0.645767	11954	0.633763	PASS	2028	8626	0.686761	21533	120760	0.587612	3964	11664	6.76252e-01	43903	144906	5.88537e-01	rs328418	.	4024	0.671200	-0.215	4.275	1.353	1	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187584770	187584771	4q35.2	.	C	snv	G	TA.AG	hom-alt	422	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC1	IVS2	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.3266-4G>C	.	.	.	NM_005245.3(FAT1): c.3266-4G>C	;maf-5-some-pop	120482	0.967987	U	1	0.983427	12236	0.962488	PASS	3912	7826	0.999872	54032	115474	0.967317	8424	16849	9.99941e-01	108883	224966	9.67696e-01	rs172903	.	4024	0.998300	-0.120	-0.174	-0.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	4	187627791	187627792	4q35.2	.	T	snv	C	TC.GG	hom-alt	676	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	Cadherin domain	PF00028.12	missense	NM_005245.3	NP_005236.2	-	Y	c.3190A>G	p.R1064G | p.Arg1064Gly	AGA=>GGA	P+=>P0	NM_005245.3(FAT1): c.3190A>G (p.R1064G)	;maf-5-some-pop,maf-5-all-pops	125754	0.760302	U	0.5	0.745807	12328	0.827223	PASS	1068	8616	0.497795	35556	120746	0.760903	2144	8601	4.98667e-01	71292	185929	7.55103e-01	rs11939575	.	4024	0.502000	-0.186	4.093	1.172	1	0	0	0.000	neutral	ENST00000441802: c.3190A>G (p.R1064G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003034	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187628397	187628398	4q35.2	.	C	snv	G	AA.AA	hom-alt	857	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	Cadherin domain	PF00028.12	missense	NM_005245.3	NP_005236.2	-	Y	c.2584G>C	p.V862L | p.Val862Leu	GTT=>CTT	NP=>NP	NM_005245.3(FAT1): c.2584G>C (p.V862L)	SingleClassTriAllelic;maf-5-some-pop	125666	0.743733	U	0.502	0.689097	12420	0.775523	PASS	1068	8614	0.498026	34100	120658	0.746001	2146	8602	4.98956e-01	68753	182599	7.42647e-01	rs1877731	.	4024	0.501700	-0.322	0.799	0.228	1	0.001	0	0.000	neutral	ENST00000441802: c.2584G>C (p.V862L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003036	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187629139	187629140	4q35.2	.	G	snv	C	AA.AA	hom-alt	632	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.1842C>G	p.F614L | p.Phe614Leu	TTC=>TTG	NP=>NP	NM_005245.3(FAT1): c.1842C>G (p.F614L)	;maf-5-some-pop,genotype-conflict	125636	0.745296	U	0.502	0.690495	11936	0.780077	PASS	1066	8592	0.498603	34215	120628	0.747571	2141	8595	4.98608e-01	69011	183028	7.43786e-01	rs367863	.	4024	0.501000	-0.120	0.600	0.860	0.97	0	0	0.000	neutral	ENST00000441802: c.1842C>G (p.F614L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003038	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	4	187630589	187630590	4q35.2	.	G	snv	A	GC.CC	hom-alt	707	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.392C>T	p.A131V | p.Ala131Val	GCG=>GTG	NP=>NP	NM_005245.3(FAT1): c.392C>T (p.A131V)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125744	0.183047	U	0.2768	0.261382	12572	0.204661	PASS	317	8620	0.267633	2503	120736	0.179797	658	4667	2.70582e-01	4824	43255	1.75705e-01	rs3733415	.	4024	0.281300	0.591	3.013	2.704	0.01	0.565	0.977	0.599	deleterious	ENST00000441802: c.392C>T (p.A131V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4416272	.	.	.	.	.	.	.	.	.	Likely Benign
HHReport	5	230979	230980	5p15.33	.	A	snv	G	CT.TT	hom-alt	568	1.00	.	0	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC6	IVS6	.	.	intron	NM_004168.2	NP_004159.2	+	Y	c.771-11A>G	.	.	.	NM_004168.2(SDHA): c.771-11A>G	SingleClassTriAllelic;maf-5-some-pop	126308	0.880142	U	0.628	0.858427	13006	0.912579	PASS	1903	8622	0.664347	47377	121300	0.881039	3787	11387	6.60269e-01	95476	216094	8.77896e-01	rs2288461	.	4024	0.688900	-1.009	-0.208	-0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259248	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
HHReport	5	231110	231111	5p15.33	.	T	snv	C	CC.AC	het-ref	264	0.48	.	2	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C7	EX7	FAD binding domain	PF00890.19	coding-synon	NM_004168.2	NP_004159.2	+	Y	c.891T>C	p.(P297=) | p.(Pro297=)	CCT=>CCC	.	NM_004168.2(SDHA): c.891T>C (p.(P297=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125786	0.705659	U	0.3363	0.653355	13004	0.768687	PASS	458	8582	0.328129	31200	120778	0.707828	877	5508	3.20009e-01	62110	172135	7.01378e-01	rs1126417	.	4024	0.314400	-0.748	0.363	-0.222	.	.	.	.	.	ENST00000264932: c.891T>C (p.P297P)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4159838	.	.	.	.	.	no_record	130283	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
InExcel	5	256434	256436	5p15.33	.	CT	del	.	GA.CT	het-ref	36	0.11	.	2	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC14	IVS14	.	.	intron	NM_004168.2	NP_004159.2	+	Y	c.1909-14_1909-13delCT	.	.	.	NM_004168.2(SDHA): c.1909-14_1909-13delCT	;	121134	0.000008	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8654	0.000000	0	121134	0.000008	0	0	0.00000e+00	0	0	0.00000e+00	rs372662724	.	4024	2.000000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	353206	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely Benign
InExcel	5	256471	256472	5p15.33	.	G	snv	A	GT.AT	het-ref	54	0.11	.	2	dup	DUBIOUS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C15E	EX15E	Fumarate reductase flavoprotein C-term	PF02910.15	coding-synon	NM_004168.2	NP_004159.2	+	Y	c.1932G>A	p.(V644=) | p.(Val644=)	GTG=>GTA	.	NM_004168.2(SDHA): c.1932G>A (p.(V644=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	123626	0.178231	U	0.2312	0.335264	13006	0.278256	PASS	17	8310	0.086643	2406	118618	0.171601	32	1040	6.25752e-02	4345	37286	1.55600e-01	rs6961	.	4024	0.303700	-0.893	-1.213	-1.663	.	.	.	.	.	ENST00000264932: c.1932G>A (p.V644V)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4963172	.	.	.	.	.	no_record	130278	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Unknown
InExcel	5	256483	256485	5p15.33	.	TT	del	.	AC.TG	het-ref	46	0.09	.	2	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C15E	EX15E	Fumarate reductase flavoprotein C-term	PF02910.15	frameshift	NM_004168.2	NP_004159.2	+	Y	c.1944T[3>1] (std: c.1944T[1] alt: c.1945_1946delTT )	p.L649Efs*4 | p.Leu649Glufs*4	.	.	NM_004168.2(SDHA): c.1944T[1] (p.L649Efs*4)	;	120154	0.013499	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8146	0.096612	0	120154	0.013499	0	0	0.00000e+00	0	2	8.28096e-06	rs112307877	.	4024	0.230900	.	.	.	.	.	.	.	.	ENST00000264932: c.1944_1945delTT (p.L649fs*4)	NS [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	111560	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	7889215	7889216	5p15.31	.	G	snv	A	TT.CG	het-ref	110	0.47	.	2	.	PASS	602568	P	236270(MK);601634(SK)	AR	Homocystinuria-megaloblastic anemia, cobalamin E type	AR	.	Biochemical; Hematologic; Neurologic; Renal	Biochemical	15979034|15714522|15060097|10444342|9427140|6700644|3812589|2860337	.	4552	MTRR	C8	EX9	FAD binding domain	PF00667.15	coding-synon	NM_002454.2	NP_002445.2	+	Y	c.1155G>A	p.(L385=) | p.(Leu385=)	TTG=>TTA	.	NM_002454.2(MTRR): c.1155G>A (p.(L385=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126316	0.056944	U	0.1696	0.0680911	13006	0.027680	PASS	126	8640	0.186343	330	121308	0.056484	258	3158	1.83157e-01	790	15039	6.10870e-02	rs2287779	.	4024	0.161000	0.655	2.040	2.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	138292	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	5	7889303	7889304	5p15.31	.	C	snv	T	GC.GC	het-ref	190	0.44	.	2	.	PASS	602568	P	236270(MK);601634(SK)	AR	Homocystinuria-megaloblastic anemia, cobalamin E type	AR	.	Biochemical; Hematologic; Neurologic; Renal	Biochemical	15979034|15714522|15060097|10444342|9427140|6700644|3812589|2860337	.	4552	MTRR	C8	EX9	FAD binding domain	PF00667.15	missense	NM_002454.2	NP_002445.2	+	Y	c.1243C>T	p.R415C | p.Arg415Cys	CGC=>TGC	P+=>P0	NM_002454.2(MTRR): c.1243C>T (p.R415C)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126394	0.057044	U	0.1696	0.0678914	13006	0.027680	PASS	130	8642	0.187109	339	121386	0.056596	262	3166	1.83558e-01	799	15069	6.11964e-02	rs2287780	.	4024	0.161000	0.655	1.083	2.355	0.05	0.913	0.999	0.710	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	138293	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	5	35857176	35857177	5p13.2	.	G	snv	C	AA.TT	hom-alt	238	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	IC1	IVS1	.	.	intron	NM_002185.3	NP_002176.2	+	Y	c.82+16G>C	.	.	.	NM_002185.3(IL7R): c.82+16G>C	;maf-5-some-pop	126370	0.639788	U	0.4236	0.647364	13006	0.742811	PASS	768	8648	0.419981	25754	121362	0.639475	1526	7246	4.20546e-01	49639	152286	6.27239e-01	rs1353252	.	4024	0.409800	-0.120	-1.121	-1.234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	258579	criteria_provided,_single_submitter	Benign	Benign
Pass	5	35861067	35861068	5p13.2	.	T	snv	C	CA.CA	hom-alt	455	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C2	EX2	.	.	missense	NM_002185.3	NP_002176.2	+	Y	c.197T>C	p.I66T | p.Ile66Thr	ATC=>ACC	NP=>P0	NM_002185.3(IL7R): c.197T>C (p.I66T)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126338	0.626755	U	0.4256	0.59984	13006	0.700907	PASS	774	8632	0.423077	24636	121330	0.627866	1539	7277	4.22345e-01	48639	152154	6.18920e-01	rs1494558	.	4024	0.410500	-2.304	0.130	0.111	0.65	0	0	0.003	neutral	ENST00000303115: c.197T>C (p.I66T)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	RSS	149813	.	.	.	.	.	no_record	14839	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	35871189	35871190	5p13.2	.	G	snv	A	TC.TC	hom-alt	515	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C4	EX4	Fibronectin type III domain	PF00041.16	missense	NM_002185.3	NP_002176.2	+	Y	c.412G>A	p.V138I | p.Val138Ile	GTC=>ATC	NP=>NP	NM_002185.3(IL7R): c.412G>A (p.V138I)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126280	0.652526	U	0.4812	0.666933	13006	0.745810	PASS	966	8642	0.474080	26551	121272	0.651931	1927	8173	4.74072e-01	51928	157347	6.39773e-01	rs1494555	.	4024	0.471700	-1.213	-0.421	-0.900	0.52	0	0.001	0.009	neutral	ENST00000303115: c.412G>A (p.V138I)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	RSS	149814	.	.	.	.	.	no_record	14840	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	35871272	35871273	5p13.2	.	C	snv	T	CA.GA	hom-alt	512	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C4	EX4	Fibronectin type III domain	PF00041.16	coding-synon	NM_002185.3	NP_002176.2	+	Y	c.495C>T	p.(H165=) | p.(His165=)	CAC=>CAT	.	NM_002185.3(IL7R): c.495C>T (p.(H165=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125760	0.126885	U	0.1528	0.128594	13006	0.135091	PASS	113	8626	0.153953	1022	120752	0.126814	211	2630	1.52694e-01	2103	31100	1.26505e-01	rs2228141	.	4024	0.144100	-0.812	-0.338	-0.761	.	.	.	.	.	ENST00000303115: c.495C>T (p.H165H)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761218	.	.	.	.	.	no_record	137585	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	5	38496636	38496637	5p13.1	.	C	snv	T	AT.TG	hom-alt	392	1.00	.	0	.	PASS	151443	C	601559(MK)	NN	Stuve-Wiedemann syndrome	AR	.	Musculoskeletal; Neurologic	General	20447141|19371797|18546280|14740318|12514358|9674906|9674905|9382147|8728692|4105362	.	3977	LIFR	C12	EX13	.	.	missense	NM_002310.5	NP_002301.1	-	Y	c.1732G>A	p.D578N | p.Asp578Asn	GAT=>AAT	P-=>P0	NM_002310.5(LIFR): c.1732G>A (p.D578N)	;maf-5-some-pop	126408	0.022182	U	0.2411	0.052516	13006	0.001384	PASS	270	8648	0.252428	271	121400	0.020931	573	4417	2.56117e-01	576	5271	2.14112e-02	rs3729740	.	4024	0.262900	0.563	0.165	0.323	0.44	0	0	0.013	neutral	ENST00000263409: c.1732G>A (p.D578N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003522	.	.	.	.	.	no_record	353625	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	5	38953665	38953665	5p13.1	.	.	ins	A	AG.AA	hom-alt	216	0.97	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC27	IVS27	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.2698-11_2698-10insT	.	.	.	NM_152756.3(RICTOR): c.2698-11_2698-10insT	;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	118832	0.937466	U	0.9881	0.934105	12356	0.892927	PASS	4029	8354	0.982164	50015	113824	0.937614	.	.	.	.	.	.	rs33912683	.	4024	0.987800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	5	38955795	38955796	5p13.1	.	G	snv	A	TG.AG	hom-alt	258	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	C26	EX26	Rapamycin-insensitive companion of mTOR RasGEF_N domain	PF14663.1	missense	NM_152756.3	NP_689969.2	-	Y	c.2510C>T	p.S837F | p.Ser837Phe	TCC=>TTC	P0=>NP	NM_152756.3(RICTOR): c.2510C>T (p.S837F)	SingleClassTriAllelic;maf-5-some-pop	126154	0.392092	U	0.4494	0.363818	13006	0.361833	PASS	983	8620	0.474710	9646	121146	0.393261	1923	8095	4.70475e-01	19537	96667	3.94199e-01	rs2043112	.	4024	0.469700	0.650	2.374	1.258	0.69	0.045	0.051	0.005	neutral	ENST00000296782: c.2510C>T (p.S837F)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003525	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	5	38978758	38978759	5p13.1	.	A	del	.	TT.AA	het-ref	36	0.15	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC8	IVS8	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.754-7delT	.	.	.	NM_152756.3(RICTOR): c.754-7delT	MixedObserved;	8756	0.006396	U	.	.	12426	0.043457	PASS	0	4950	0.089293	0	68564	0.126889	.	.	.	.	.	.	rs756295969	.	4024	0.226100	-1.172	0.722	0.028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	5	40777531	40777531	5p13.1	.	.	ins	TA	AT.AT	het-ref	154	0.47	.	2	.	PASS	602739	P	.	NN	.	.	.	.	.	.	.	5562	PRKAA1	IC2	IVS2	.	.	intron	NM_206907.3	NP_996790.3	-	Y	c.269+15_269+16insTA	.	.	.	NM_206907.3(PRKAA1): c.269+15_269+16insTA	;maf-5-some-pop,maf-5-all-pops	125257	0.307831	U	0.5536	0.360823	11314	0.289818	PASS	1262	8604	0.551023	6012	120252	0.305617	2508	9131	5.55211e-01	11681	71325	3.01874e-01	rs144157386	.	4024	0.530800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	5	56111750	56111751	5q11.2	.	G	snv	C	GC.AG	het-ref	220	0.50	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C1	EX1	.	.	coding-synon	NM_005921.1	NP_005912.1	+	Y	c.351G>C	p.(A117=) | p.(Ala117=)	GCG=>GCC	.	NM_005921.1(MAP3K1): c.351G>C (p.(A117=))	;maf-5-some-pop,maf-5-all-pops	6622	0.712474	U	0.5704	0.685703	.	.	PASS	2	10	0.500000	496	1614	0.795539	8	23	5.75000e-01	2658	6709	7.83579e-01	rs28710284	.	4024	0.576000	0.500	0.953	1.518	.	.	.	.	.	ENST00000399503: c.351G>C (p.A117A)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4159917	.	.	.	.	.	no_record	518361	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	5	56152415	56152416	5q11.2	.	C	snv	A	GC.TG	het-ref	208	0.46	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	IC1	IVS1	.	.	intron	NM_005921.1	NP_005912.1	+	Y	c.483-11C>A	.	.	.	NM_005921.1(MAP3K1): c.483-11C>A	;maf-5-some-pop,maf-5-all-pops	125162	0.609722	U	0.245	0.526158	11798	0.698932	PASS	192	8514	0.208833	24001	120154	0.613205	386	3565	2.07316e-01	48346	148869	6.06999e-01	rs832567	.	4024	0.224700	-0.824	-1.363	-1.859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	518362	criteria_provided,_single_submitter	Benign	Benign
Pass	5	56161786	56161787	5q11.2	.	G	snv	A	AC.TC	het-ref	279	0.50	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C6	EX6	.	.	coding-synon	NM_005921.1	NP_005912.1	+	Y	c.1284G>A	p.(T428=) | p.(Thr428=)	ACG=>ACA	.	NM_005921.1(MAP3K1): c.1284G>A (p.(T428=))	;maf-5-some-pop,genotype-conflict	125626	0.846162	U	0.7183	0.804313	11926	0.853010	PASS	2113	8588	0.703773	43726	120618	0.847900	4257	12124	7.04392e-01	88055	207109	8.42770e-01	rs832575	.	4024	0.728100	-0.988	0.707	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	518363	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	56177442	56177443	5q11.2	.	G	snv	A	TT.AT	het-ref	290	0.48	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	missense	NM_005921.1	NP_005912.1	+	Y	c.2416G>A	p.D806N | p.Asp806Asn	GAT=>AAT	P-=>P0	NM_005921.1(MAP3K1): c.2416G>A (p.D806N)	;maf-5-some-pop,genotype-conflict	125656	0.593493	U	0.2431	0.476438	11924	0.650117	PASS	196	8612	0.206572	23152	120648	0.598352	381	3548	2.05705e-01	46827	146215	5.95096e-01	rs702689	.	4024	0.222900	0.655	3.482	2.778	0.32	0.111	0.649	0.033	neutral	ENST00000399503: c.2416G>A (p.D806N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003564	.	.	.	.	.	no_record	518364	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	5	56177742	56177743	5q11.2	.	G	snv	A	CA.TC	het-ref	357	0.49	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	missense	NM_005921.1	NP_005912.1	+	Y	c.2716G>A	p.V906I | p.Val906Ile	GTC=>ATC	NP=>NP	NM_005921.1(MAP3K1): c.2716G>A (p.V906I)	;maf-5-some-pop,maf-5-all-pops	125570	0.762547	U	0.5704	0.708267	12028	0.798470	PASS	1382	8604	0.569967	35726	120562	0.764802	2756	9787	5.67889e-01	71723	186262	7.58346e-01	rs832582	.	4024	0.574800	-0.977	0.798	0.764	1	0	0	0.000	neutral	ENST00000399503: c.2716G>A (p.V906I)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4416190	.	.	.	.	.	no_record	518365	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	5	56177848	56177851	5q11.2	.	CAA	del	.	TT.ca	het-ref	221	0.46	.	2	(CAA)n|Simple_repeat|Simple_repeat|+|26;trf	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	cds-del	NM_005921.1	NP_005912.1	+	Y	c.2824ACA[8>7] (std: c.2824ACA[7] alt: c.2845_2847delACA )	p.T942[8>7] (std: p.T942[7] alt: p.T949del ) | p.Thr942[8>7] (std: p.Thr942[7] alt: p.Thr949del )	.	.	NM_005921.1(MAP3K1): c.2824ACA[7] (p.T942[7])	MixedObserved;	18	0.555556	U	.	.	.	.	PASS	1185	8360	0.558493	31046	115872	0.739281	.	.	.	.	.	.	rs5868032	.	4024	0.564400	.	.	.	.	.	.	.	.	ENST00000399503: c.2822_2824delCAA (p.T949delT)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	VUO	4594439	.	.	.	.	.	no_record	435819	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	5	56178216	56178217	5q11.2	.	A	snv	C	CT.GA	het-ref	316	0.50	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	coding-synon	NM_005921.1	NP_005912.1	+	Y	c.3190A>C	p.(R1064=) | p.(Arg1064=)	AGA=>CGA	.	NM_005921.1(MAP3K1): c.3190A>C (p.(R1064=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125622	0.763003	U	0.5704	0.708267	11978	0.799466	PASS	1387	8600	0.571163	35789	120614	0.765276	2759	9792	5.68047e-01	71789	186340	7.58689e-01	rs832583	.	4024	0.574800	-0.121	3.377	1.503	.	.	.	.	.	ENST00000399503: c.3190A>C (p.R1064R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4159918	.	.	.	.	.	no_record	518366	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	5	67522721	67522722	5q13.1	.	C	snv	T	TA.GT	hom-alt	642	1.00	.	0	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	C1	EX2	Variant SH3 domain	PF07653.12	coding-synon	NM_181523.2	NP_852664.1	+	Y	c.219C>T	p.(Y73=) | p.(Tyr73=)	TAC=>TAT	.	NM_181523.2(PIK3R1): c.219C>T (p.(Y73=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125828	0.317171	U	0.6746	0.419329	13006	0.293326	PASS	2145	8634	0.701181	6939	120820	0.312937	4255	12096	7.01787e-01	14130	77153	3.13528e-01	rs706713	.	4024	0.701800	-1.062	-1.908	-2.419	.	.	.	.	.	ENST00000521381: c.219C>T (p.Y73Y)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	4407349	.	.	.	.	.	no_record	159722	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	5	67522850	67522851	5q13.1	.	A	snv	C	TA.GT	hom-alt	420	1.00	.	0	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	IC1	IVS2	.	.	intron	NM_181523.2	NP_852664.1	+	Y	c.334+14A>C	.	.	.	NM_181523.2(PIK3R1): c.334+14A>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	121068	0.335572	U	0.7034	0.42492	13002	0.293878	PASS	2273	8580	0.727506	7273	116060	0.331716	4135	11432	7.24461e-01	13204	71127	3.22817e-01	rs706714	.	4024	0.719200	0.533	0.075	0.475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	159723	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
Pass	5	67588147	67588148	5q13.1	.	G	snv	A	AT.TC	het-ref	174	0.47	.	2	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	C7	EX8	.	.	missense	NM_181523.2	NP_852664.1	+	Y	c.978G>A	p.M326I | p.Met326Ile	ATG=>ATA	NP=>NP	NM_181523.2(PIK3R1): c.978G>A (p.M326I)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126396	0.176026	U	0.1657	0.220447	13006	0.238275	PASS	122	8652	0.169903	2281	121388	0.174193	252	3000	1.74115e-01	4710	43538	1.77051e-01	rs3730089	.	4024	0.189400	0.563	2.948	1.498	0.47	0	0	0.011	neutral	ENST00000521381: c.978G>A (p.M326I)	skin [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	3727824	CM080497	NM_181523.2(PIK3R1): c.978G>A (p.M326I)	"Colon cancer, incr. risk, association with"	18245521	DFP	no_record	135039	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	5	79950724	79950724	5q14.1	.	.	ins	CCGCAGCGC	gg.cc	hom-alt	312	0.99	.	0	trf	PASS	600887	P	600887(MK)	NN	Endometrial carcinoma	AD	.	Oncologic	Oncologic	21128252|8782829	C1021;FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	4437	MSH3	C1	EX1	.	.	cds-ins	NM_002439.4	NP_002430.3	+	Y	c.181_189dupGCAGCGCCC	p.A61_P63dup (alt: p.P63_P64insAAP ) | p.Ala61_Pro63dup (alt: p.Pro63_Pro64insAlaAlaPro )	.	.	NM_002439.4(MSH3): c.181_189dupGCAGCGCCC (p.A61_P63dup)	ObservedTooLong;rs-cluster-nonoverlapping-alleles	39914	0.043243	U	.	.	.	.	PASS	19	1928	0.092842	95	40412	0.042710	30	362	5.12748e-02	261	4988	4.41502e-02	rs758718643	.	4024	0.263700	.	.	.	.	.	.	.	.	ENST00000265081: c.178_179insCCGCAGCGC (p.P63_P64insAAP)	adrenal_gland [adrenal_gland|NS|NS]	adrenal_cortical_adenoma [cortisol_producing|NS|NS]	CSV	5061231	.	.	.	.	.	no_record	518369	no_assertion_criteria_provided	Benign	Benign
HHReport	5	80149980	80149981	5q14.1	.	A	snv	G	AC.GA	hom-alt	623	1.00	.	0	.	PASS	600887	P	600887(MK)	NN	Endometrial carcinoma	AD	.	Oncologic	Oncologic	21128252|8782829	C1021;FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	4437	MSH3	C21	EX21	MutS domain V	PF00488.16	missense	NM_002439.4	NP_002430.3	+	Y	c.2846A>G	p.Q949R | p.Gln949Arg	CAG=>CGG	P0=>P+	NM_002439.4(MSH3): c.2846A>G (p.Q949R)	;maf-5-some-pop,genotype-conflict	126232	0.874255	U	1	0.902157	13006	0.855221	PASS	4312	8636	0.999305	46317	121224	0.873103	8602	17215	9.99361e-01	93891	214386	8.73327e-01	rs184967	.	4024	0.997800	-0.119	0.470	-0.255	1	0.001	0	0.000	neutral	ENST00000265081: c.2846A>G (p.Q949R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160036	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	5	112111309	112111310	5q22.2	.	A	del	.	tt.aa	het-ref	56	0.23	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	IC3	IVS5	.	.	intron	NM_001127510.2	NP_001120982.1	+	Y	c.423-16delA	.	.	.	NM_001127510.2(APC): c.423-16delA	MixedObserved;	40	0.025000	U	.	.	.	.	PASS	0	5066	0.227201	15	74382	0.260184	.	.	.	.	.	.	rs775769881	.	4024	0.400100	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	181781	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
Pass	5	112162853	112162854	5q22.2	.	T	snv	C	TA.GG	hom-alt	544	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C11	EX13	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.1458T>C	p.(Y486=) | p.(Tyr486=)	TAT=>TAC	.	NM_001127510.2(APC): c.1458T>C (p.(Y486=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126126	0.575282	U	0.6647	0.509984	13004	0.462165	PASS	1977	8602	0.679144	21255	121118	0.577982	3926	11602	6.73986e-01	43904	143908	5.85411e-01	rs2229992	.	4024	0.640200	0.533	0.491	0.135	.	.	.	.	.	ENST00000457016: c.1458T>C (p.Y486Y)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1432175	.	.	.	.	.	no_record	42238	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	112164560	112164561	5q22.2	.	G	snv	A	GC.AG	hom-alt	414	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C13	EX15	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.1635G>A	p.(A545=) | p.(Ala545=)	GCG=>GCA	.	NM_001127510.2(APC): c.1635G>A (p.(A545=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126154	0.648826	U	0.8165	0.666134	13004	0.586435	PASS	2910	8606	0.823030	25918	121146	0.648111	5806	14130	8.21798e-01	52792	159619	6.49301e-01	rs351771	.	4024	0.801400	-0.254	1.170	0.422	.	.	.	.	.	ENST00000457016: c.1635G>A (p.A545A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760868	.	.	.	.	.	no_record	42239	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	112175769	112175770	5q22.2	.	G	snv	A	AC.GA	hom-alt	708	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.4479G>A	p.(T1493=) | p.(Thr1493=)	ACG=>ACA	.	NM_001127510.2(APC): c.4479G>A (p.(T1493=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126062	0.649244	U	0.8165	0.665535	13002	0.586218	PASS	2924	8648	0.822734	25933	121054	0.648570	5824	14170	8.21735e-01	52779	159537	6.49581e-01	rs41115	.	4024	0.801700	-1.128	0.417	0.212	.	.	.	.	.	ENST00000457016: c.4479G>A (p.T1493T)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3760869	.	.	.	.	.	no_record	42242	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	112176324	112176325	5q22.2	.	G	snv	A	GG.GC	hom-alt	640	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.5034G>A	p.(G1678=) | p.(Gly1678=)	GGG=>GGA	.	NM_001127510.2(APC): c.5034G>A (p.(G1678=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125824	0.652006	U	0.8165	0.666733	13004	0.590126	PASS	2909	8594	0.823598	26051	120816	0.651396	5806	14128	8.21873e-01	53006	159652	6.52440e-01	rs42427	.	4024	0.801900	-0.127	0.011	-0.040	.	.	.	.	.	ENST00000457016: c.5034G>A (p.G1678G)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760870	.	.	.	.	.	no_record	42243	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	112176558	112176559	5q22.2	.	T	snv	G	TC.TC	hom-alt	616	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.5268T>G	p.(S1756=) | p.(Ser1756=)	TCT=>TCG	.	NM_001127510.2(APC): c.5268T>G (p.(S1756=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125798	0.651409	U	0.8165	0.666933	13002	0.587986	PASS	2915	8634	0.822330	26034	120790	0.650766	5813	14155	8.21342e-01	52989	159750	6.51318e-01	rs866006	.	4024	0.802400	-2.343	-0.899	-1.028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	42245	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	112176755	112176756	5q22.2	.	T	snv	A	GG.CT	hom-alt	730	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	missense	NM_001127510.2	NP_001120982.1	+	Y	c.5465T>A	p.V1822D | p.Val1822Asp	GTC=>GAC	NP=>P-	NM_001127510.2(APC): c.5465T>A (p.V1822D)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	125952	0.800781	U	0.9008	0.865415	13002	0.826257	PASS	3507	8638	0.901829	38872	120944	0.798105	7017	15562	9.02982e-01	77927	194769	7.93764e-01	rs459552	.	4024	0.902600	-0.265	1.161	0.139	0.37	0	0	0.019	neutral	ENST00000457016: c.5465T>A (p.V1822D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760871	.	.	.	.	.	no_record	21030	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	112177170	112177171	5q22.2	.	G	snv	A	CC.GT	hom-alt	844	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.5880G>A	p.(P1960=) | p.(Pro1960=)	CCG=>CCA	.	NM_001127510.2(APC): c.5880G>A (p.(P1960=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126022	0.649514	U	0.8165	0.666534	13002	0.586910	PASS	2915	8628	0.822439	25923	121014	0.648809	5814	14150	8.21814e-01	52777	159530	6.49732e-01	rs465899	.	4024	0.802400	-0.269	-0.566	-0.820	.	.	.	.	.	ENST00000457016: c.5880G>A (p.P1960P)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3760872	.	.	.	.	.	no_record	42247	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	149450131	149450132	5q32	.	T	snv	C	TG.GC	het-ref	112	0.44	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	C7	EX8	.	.	missense	NM_005211.3	NP_005202.2	-	Y	c.1085A>G	p.H362R | p.His362Arg	CAC=>CGC	P+=>P+	NM_005211.3(CSF1R): c.1085A>G (p.H362R)	;maf-5-some-pop	19928	0.127810	U	0.381	0.153355	12606	0.073774	PASS	38	686	0.364431	106	14920	0.119236	681	3460	3.89903e-01	1051	11670	9.75198e-02	rs10079250	.	4024	0.359100	0.459	0.969	2.123	0.05	0.09	0.074	0.352	neutral	ENST00000286301: c.1085A>G (p.H362R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020476	.	.	.	.	.	no_record	352157	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	150886724	150886725	5q33.1	.	G	snv	A	TC.CT	hom-alt	379	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C22	EX22	.	.	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.12507C>T	p.(S4169=) | p.(Ser4169=)	AGC=>AGT	.	NM_001447.2(FAT2): c.12507C>T (p.(S4169=))	;maf-5-some-pop	119104	0.862775	U	0.9643	0.911941	13006	0.852299	PASS	4102	8596	0.977199	42472	114096	0.860617	8139	16682	9.75670e-01	83086	191835	8.61460e-01	rs7723266	.	4024	0.975400	-0.137	-1.819	-1.469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150886881	150886882	5q33.1	.	G	snv	A	CC.GT	hom-alt	745	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C22	EX22	.	.	missense	NM_001447.2	NP_001438.1	-	Y	c.12350C>T	p.P4117L | p.Pro4117Leu	CCG=>CTG	NP=>NP	NM_001447.2(FAT2): c.12350C>T (p.P4117L)	;maf-5-some-pop	126398	0.668729	U	0.8244	0.776957	13006	0.653621	PASS	3077	8646	0.845709	27676	121390	0.664264	6153	14564	8.44388e-01	55139	162213	6.58696e-01	rs1105168	.	4024	0.846900	-0.150	0.224	-0.078	0.41	0	0	0.015	neutral	ENST00000261800: c.12350C>T (p.P4117L)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761045	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150887184	150887184	5q33.1	.	.	ins	AGA	AG.AG	hom-alt	306	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC21	IVS21	.	.	intron	NM_001447.2	NP_001438.1	-	Y	c.12060-13_12060-12insTCT	.	.	.	NM_001447.2(FAT2): c.12060-13_12060-12insTCT	InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	116684	0.847554	U	0.9653	0.903355	12450	0.833655	PASS	4063	8506	0.977663	39962	111676	0.845052	8098	16578	9.76670e-01	80159	188616	8.44834e-01	rs75548276	.	4024	0.975600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	5	150891732	150891733	5q33.1	.	A	snv	G	CC.TG	hom-alt	434	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C20	EX20	.	.	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.11898T>C	p.(H3966=) | p.(His3966=)	CAT=>CAC	.	NM_001447.2(FAT2): c.11898T>C (p.(H3966=))	;maf-5-some-pop	126104	0.772759	U	0.9494	0.799521	13006	0.707827	PASS	4083	8652	0.971567	36506	121096	0.771652	8130	16744	9.70779e-01	74519	189939	7.74212e-01	rs2304028	.	4024	0.971200	-3.729	-5.246	-4.887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150901110	150901111	5q33.1	.	A	snv	G	AC.TC	hom-alt	762	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.11043T>C	p.(D3681=) | p.(Asp3681=)	GAT=>GAC	.	NM_001447.2(FAT2): c.11043T>C (p.(D3681=))	;maf-5-some-pop	126196	0.766253	U	0.9494	0.779553	13006	0.696063	PASS	4085	8652	0.971798	36007	121188	0.765703	8131	16746	9.70895e-01	73896	189366	7.69712e-01	rs3822699	.	4024	0.970900	-0.215	-1.506	-2.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150901260	150901261	5q33.1	.	C	snv	T	CA.AT	hom-alt	663	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	missense	NM_001447.2	NP_001438.1	-	Y	c.10893G>A	p.M3631I | p.Met3631Ile	ATG=>ATA	NP=>NP	NM_001447.2(FAT2): c.10893G>A (p.M3631I)	;maf-5-some-pop	124974	0.762743	U	0.9494	0.76897	13006	0.683684	PASS	4075	8624	0.972171	35374	119966	0.762483	8123	16727	9.71032e-01	73001	187599	7.66724e-01	rs6650971	.	4024	0.970700	0.563	0.242	0.346	0.76	0.003	0.002	0.001	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150901299	150901300	5q33.1	.	G	snv	A	AC.TA	hom-alt	648	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.10854C>T	p.(Y3618=) | p.(Tyr3618=)	TAC=>TAT	.	NM_001447.2(FAT2): c.10854C>T (p.(Y3618=))	;maf-5-some-pop	125330	0.761861	U	0.9484	0.764577	13006	0.680763	PASS	4074	8628	0.971836	35434	120322	0.761748	8121	16726	9.70749e-01	73014	187733	7.66170e-01	rs3734046	.	4024	0.970400	0.563	-0.554	-1.719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150901612	150901613	5q33.1	.	A	snv	G	TC.AA	hom-alt	517	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.10541T>C	p.L3514S | p.Leu3514Ser	TTG=>TCG	NP=>P0	NM_001447.2(FAT2): c.10541T>C (p.L3514S)	;maf-5-some-pop,genotype-conflict	124380	0.766385	U	0.9494	0.775759	13006	0.689989	PASS	4044	8594	0.970095	35356	119372	0.765992	8078	16660	9.69394e-01	72477	185822	7.68870e-01	rs2053028	.	4024	0.970700	-0.213	0.431	0.036	0.47	0.007	0	0.011	neutral	ENST00000261800: c.10541T>C (p.L3514S)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	292313	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150914183	150914184	5q33.1	.	A	snv	T	GC.GT	hom-alt	421	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C12	EX12	Cadherin domain	PF00028.12	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.9213T>A	p.(T3071=) | p.(Thr3071=)	ACT=>ACA	.	NM_001447.2(FAT2): c.9213T>A (p.(T3071=))	;maf-5-some-pop,genotype-conflict	126306	0.591769	U	0.8085	0.632788	13006	0.521682	PASS	3072	8634	0.843410	21812	121298	0.590076	6048	14431	8.37162e-01	44868	145977	5.94781e-01	rs1432643	.	4024	0.835200	-0.364	-0.769	-0.198	.	.	.	.	.	ENST00000261800: c.9213T>A (p.T3071T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761048	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150923404	150923405	5q33.1	.	A	snv	G	TG.AG	hom-alt	775	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C9	EX9	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.7283T>C	p.F2428S | p.Phe2428Ser	TTC=>TCC	NP=>P0	NM_001447.2(FAT2): c.7283T>C (p.F2428S)	;	126352	0.996763	U	1	0.997604	13006	0.996694	PASS	4323	8646	1.000000	60277	121344	0.996728	8622	17244	1.00000e+00	122272	245329	9.96810e-01	rs6892335	.	4024	0.998500	-0.215	0.824	1.375	0.63	0	0	0.004	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150925143	150925144	5q33.1	.	A	snv	G	AC.GG	hom-alt	741	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C9	EX9	Cadherin domain	PF00028.12	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.5544T>C	p.(P1848=) | p.(Pro1848=)	CCT=>CCC	.	NM_001447.2(FAT2): c.5544T>C (p.(P1848=))	;maf-5-some-pop	126370	0.809599	U	0.7302	0.815695	13006	0.866677	PASS	2303	8646	0.734212	40081	121362	0.809347	4689	12762	7.39912e-01	80982	198795	8.08484e-01	rs3797875	.	4024	0.737600	-0.349	-0.182	-0.047	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150930185	150930186	5q33.1	.	C	snv	T	GC.GA	het-ref	307	0.51	.	2	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C7	EX7	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.4543G>A	p.G1515S | p.Gly1515Ser	GGC=>AGC	P0=>P0	NM_001447.2(FAT2): c.4543G>A (p.G1515S)	;maf-5-some-pop,genotype-conflict	126340	0.099011	U	0.2083	0.116014	13006	0.054206	PASS	184	8640	0.206250	1333	121332	0.098309	345	3571	2.07087e-01	3282	27261	1.10970e-01	rs2278370	.	4024	0.204800	-0.834	0.331	-0.574	0.2	0.009	0.006	0.050	neutral	ENST00000261800: c.4543G>A (p.G1515S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150002	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150930344	150930345	5q33.1	.	C	snv	T	CA.GG	het-ref	317	0.50	.	2	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C7	EX7	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.4384G>A	p.V1462M | p.Val1462Met	GTG=>ATG	NP=>NP	NM_001447.2(FAT2): c.4384G>A (p.V1462M)	;maf-5-some-pop,genotype-conflict	126174	0.100932	U	0.2272	0.122404	13006	0.055205	PASS	201	8612	0.217255	1346	121166	0.100045	381	3749	2.17560e-01	3319	27693	1.12672e-01	rs2278371	.	4024	0.215200	-0.147	0.668	0.153	0.19	0.152	0.787	0.063	neutral	ENST00000261800: c.4384G>A (p.V1462M)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150003	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	150942918	150942919	5q33.1	.	A	snv	G	GT.GT	hom-alt	522	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C2	EX2	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.3541T>C	p.Y1181H | p.Tyr1181His	TAC=>CAC	P0=>P+	NM_001447.2(FAT2): c.3541T>C (p.Y1181H)	;	126420	0.996931	U	1	0.998403	13006	0.996079	PASS	4327	8654	1.000000	60329	121412	0.996870	8624	17248	1.00000e+00	122214	245225	9.96736e-01	rs6872614	.	4024	0.998500	-0.215	0.696	0.204	0.43	0	0	0.013	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	161128760	161128761	5q34	.	C	snv	G	GT.AG	hom-alt	289	1.00	.	0	.	PASS	137143	C	.	NN	.	.	.	.	.	.	.	2559	GABRA6	C9E	EX9E	.	.	coding-synon	NM_000811.2	NP_000802.2	+	Y	c.1344C>G	p.(V448=) | p.(Val448=)	GTC=>GTG	.	NM_000811.2(GABRA6): c.1344C>G (p.(V448=))	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	121386	0.989299	U	.	.	13006	0.962018	PASS	4326	8652	1.000000	59464	121386	0.989299	8620	17240	1.00000e+00	121099	244031	9.91690e-01	rs4277944	.	4024	0.998500	-0.120	0.504	0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	170837513	170837514	5q35.1	.	T	del	.	TC.TT	het-ref	138	0.48	.	2	.	PASS	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC10	IVS10	.	.	intron	NM_002520.6	NP_002511.1	+	Y	c.847-17delT	.	.	.	NM_002520.6(NPM1): c.847-17delT	MixedObserved;	699	0.080114	U	.	.	.	.	InbreedingCoeff_Filter	6	6608	0.373789	57	87784	0.337829	.	.	.	.	.	.	rs34323200	.	4024	0.260200	-0.346	0.314	-0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	5	176516630	176516631	5q35.2	.	G	snv	A	GG.TC	het-ref	179	0.49	.	2	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C1	EX2	.	.	missense	NM_213647.1	NP_998812.1	+	Y	c.28G>A	p.V10I | p.Val10Ile	GTC=>ATC	NP=>NP	NM_213647.1(FGFR4): c.28G>A (p.V10I)	;maf-5-some-pop,genotype-conflict	122524	0.240328	U	0.5069	0.228834	13006	0.170767	PASS	1137	8540	0.523419	3935	117516	0.240818	2303	8908	5.18027e-01	8595	60028	2.45654e-01	rs1966265	.	4024	0.528100	-1.652	-0.523	-0.406	0.62	0.004	0.016	0.004	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	176517460	176517461	5q35.2	.	T	snv	G	CG.CT	hom-alt	587	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C2	EX3	.	.	coding-synon	NM_213647.1	NP_998812.1	+	Y	c.162T>G	p.(R54=) | p.(Arg54=)	CGT=>CGG	.	NM_213647.1(FGFR4): c.162T>G (p.(R54=))	MixedObserved;maf-5-some-pop	123186	0.765128	U	0.9772	0.775958	13000	0.683231	PASS	4058	8580	0.972611	35131	118178	0.764669	8107	16687	9.71756e-01	71639	182693	7.71260e-01	rs446382	.	4024	0.969200	-0.648	-0.068	-0.467	.	.	.	.	.	ENST00000292408: c.162T>G (p.R54R)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761131	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	176517796	176517797	5q35.2	.	C	snv	T	CC.CT	hom-alt	552	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C3	EX4	.	.	missense	NM_213647.1	NP_998812.1	+	Y	c.407C>T	p.P136L | p.Pro136Leu	CCC=>CTC	NP=>NP	NM_213647.1(FGFR4): c.407C>T (p.P136L)	;maf-5-some-pop,genotype-conflict	126326	0.795474	U	1	0.807308	13006	0.721052	PASS	4323	8654	0.999538	38843	121318	0.794985	8613	17236	9.99420e-01	79772	196915	8.00754e-01	rs376618	.	4024	0.997500	0.313	1.259	1.120	0.32	0.019	0.008	0.025	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	176518783	176518784	5q35.2	.	C	snv	T	CG.TA	hom-alt	451	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C5	EX6	.	.	coding-synon	NM_213647.1	NP_998812.1	+	Y	c.702C>T	p.(R234=) | p.(Arg234=)	CGC=>CGT	.	NM_213647.1(FGFR4): c.702C>T (p.(R234=))	;maf-5-some-pop	126400	0.795340	U	1	0.807109	13006	0.721129	PASS	4322	8652	0.999538	38863	121392	0.794855	8613	17236	9.99420e-01	79841	197096	8.00702e-01	rs452885	.	4024	0.997500	-0.448	0.008	-0.073	.	.	.	.	.	ENST00000292408: c.702C>T (p.R234R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4159758	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	5	176520242	176520243	5q35.2	.	G	snv	A	CC.GG	het-ref	277	0.48	.	2	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C8	EX9	.	.	missense	NM_213647.1	NP_998812.1	+	Y	c.1162G>A	p.G388R | p.Gly388Arg	GGG=>AGG	P0=>P+	NM_213647.1(FGFR4): c.1162G>A (p.G388R)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	123448	0.320110	U	0.4633	0.299521	13000	0.242308	PASS	835	8496	0.449506	6465	118440	0.320981	1714	7695	4.48531e-01	13760	79372	3.26989e-01	rs351855	.	4024	0.433600	0.561	3.818	2.233	0.35	0.515	0.98	0.194	neutral	ENST00000292408: c.1162G>A (p.G388R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1567768	CM023917	NM_002011.3(FGFR4): c.1162G>A (p.G388R)	"Cancer, accelerated progression, association with"	11830541	DP	no_record	16326	no_assertion_criteria_provided	Pathogenic	Likely Benign
Pass	5	176522727	176522728	5q35.2	.	C	snv	T	TA.AG	hom-alt	471	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC12	IVS13	.	.	intron	NM_213647.1	NP_998812.1	+	Y	c.1821+4C>T	.	.	.	NM_213647.1(FGFR4): c.1821+4C>T	;maf-5-some-pop	102172	0.726677	U	0.9742	0.701877	13006	0.598416	PASS	3547	7510	0.971638	25848	97164	0.727955	7560	15579	9.70533e-01	58623	156575	7.29233e-01	rs42409	.	4024	0.968900	-1.036	-3.249	-3.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	5	176523596	176523597	5q35.2	.	A	snv	G	CT.CC	hom-alt	483	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC14	IVS15	.	.	intron	NM_213647.1	NP_998812.1	+	Y	c.2016-8A>G	.	.	.	NM_213647.1(FGFR4): c.2016-8A>G	;maf-5-some-pop	126036	0.765115	U	0.9762	0.785343	13006	0.688913	PASS	4090	8648	0.972595	35991	121028	0.764278	8141	16758	9.71704e-01	73986	188955	7.70999e-01	rs31776	.	4024	0.969200	-1.195	-1.715	-0.839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	5	176636881	176636882	5q35.3	.	C	snv	T	TG.GC	hom-alt	785	1.00	.	0	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	coding-synon	NM_022455.4	NP_071900.2	+	Y	c.1482C>T	p.(C494=) | p.(Cys494=)	TGC=>TGT	.	NM_022455.4(NSD1): c.1482C>T (p.(C494=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126176	0.306580	U	0.5298	0.468051	13006	0.354144	PASS	1191	8634	0.531388	6927	121168	0.299906	2503	9256	5.36953e-01	12984	71578	2.91373e-01	rs1363405	.	4024	0.533800	-0.332	1.213	0.891	.	.	.	.	.	ENST00000439151: c.1482C>T (p.C494C)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419701	.	.	.	.	.	no_record	96035	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	176637148	176637149	5q35.3	.	G	snv	A	GA.AC	hom-alt	793	1.00	.	0	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	coding-synon	NM_022455.4	NP_071900.2	+	Y	c.1749G>A	p.(E583=) | p.(Glu583=)	GAG=>GAA	.	NM_022455.4(NSD1): c.1749G>A (p.(E583=))	;maf-5-some-pop,maf-5-all-pops	120172	0.176464	U	.	.	12994	0.100431	PASS	1106	8632	0.512280	2686	120172	0.176464	2280	8838	5.16118e-01	5470	43608	1.78261e-01	rs3733874	.	4024	0.517100	0.591	2.319	1.382	.	.	.	.	.	ENST00000439151: c.1749G>A (p.E583E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419034	.	.	.	.	.	no_record	96038	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	176637239	176637240	5q35.3	.	G	snv	T	TG.TG	hom-alt	786	1.00	.	0	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	missense	NM_022455.4	NP_071900.2	+	Y	c.1840G>T	p.V614L | p.Val614Leu	GTG=>TTG	NP=>NP	NM_022455.4(NSD1): c.1840G>T (p.V614L)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	123456	0.178363	U	0.5119	0.228634	13006	0.099339	PASS	1106	8628	0.512286	2633	118448	0.176238	2255	8724	5.16641e-01	5248	41802	1.77970e-01	rs3733875	.	4024	0.517100	-2.213	-0.524	-0.383	0.57	0.001	0.001	0.006	neutral	ENST00000439151: c.1840G>T (p.V614L)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	4987203	.	.	.	.	.	no_record	96042	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	176637575	176637576	5q35.3	.	T	snv	C	CG.CT	hom-alt	698	1.00	.	0	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	missense	NM_022455.4	NP_071900.2	+	Y	c.2176T>C	p.S726P | p.Ser726Pro	TCT=>CCT	P0=>NP	NM_022455.4(NSD1): c.2176T>C (p.S726P)	;maf-5-some-pop,maf-5-all-pops	126332	0.200709	U	0.5119	0.249601	13006	0.126326	PASS	1111	8640	0.512500	3137	121324	0.198691	2311	8922	5.17517e-01	6433	49713	2.01939e-01	rs28932178	.	4024	0.517400	0.533	0.216	0.130	0.17	0.89	0.998	0.409	neutral	ENST00000439151: c.2176T>C (p.S726P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4418708	.	.	.	.	.	no_record	96043	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	176721943	176721944	5q35.3	.	C	snv	T	GA.CC	het-ref	369	0.50	.	2	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C22E	EX23E	.	.	coding-synon	NM_022455.4	NP_071900.2	+	Y	c.7575C>T	p.(D2525=) | p.(Asp2525=)	GAC=>GAT	.	NM_022455.4(NSD1): c.7575C>T (p.(D2525=))	;	125890	0.001215	U	0	0.000199681	13006	0.000692	PASS	0	8628	0.000000	2	120882	0.001257	0	0	0.00000e+00	3	406	1.65023e-03	rs148891711	.	.	.	0.462	0.277	0.641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	352893	criteria_provided,_single_submitter	Likely_benign	VUS
Pass	5	180046343	180046344	5q35.3	.	G	snv	C	CG.TG	het-ref	136	0.45	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C19	EX19	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	missense	NM_182925.4	NP_891555.2	-	Y	c.2670C>G	p.H890Q | p.His890Gln	CAC=>CAG	P+=>P0	NM_182925.4(FLT4): c.2670C>G (p.H890Q)	;maf-5-some-pop,maf-5-all-pops	122620	0.623022	U	0.497	0.582668	12988	0.597013	PASS	997	8430	0.486358	23273	117612	0.624741	2078	8368	4.88785e-01	48517	151327	6.30130e-01	rs448012	.	4024	0.479400	0.455	1.588	0.126	0.04	0.32	0.243	0.449	neutral	ENST00000393347: c.2670C>G (p.H890Q)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	1486680	.	.	.	.	.	no_record	263039	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	180047862	180047863	5q35.3	.	C	snv	G	AG.CT	hom-alt	513	1.00	.	0	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC15	IVS15	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.2299+13G>C	.	.	.	NM_182925.4(FLT4): c.2299+13G>C	;maf-5-some-pop	121966	0.986463	U	1	0.960064	12996	0.953139	PASS	4253	8506	1.000000	57121	116958	0.987594	8558	17116	1.00000e+00	118724	239454	9.90617e-01	rs423086	.	4024	0.998500	-0.371	-0.991	-1.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263036	criteria_provided,_single_submitter	Benign	Benign
Pass	5	180052945	180052946	5q35.3	.	G	snv	A	CC.TA	het-ref	299	0.53	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C10	EX10	Immunoglobulin domain	PF13895.1	coding-synon	NM_182925.4	NP_891555.2	-	Y	c.1344C>T	p.(Y448=) | p.(Tyr448=)	TAC=>TAT	.	NM_182925.4(FLT4): c.1344C>T (p.(Y448=))	;maf-5-some-pop	124266	0.030419	U	0.1052	0.0341454	12994	0.026320	PASS	52	8602	0.106836	93	119258	0.030262	119	1887	1.09506e-01	218	7651	3.13836e-02	rs3736062	.	4024	0.093900	-0.347	-0.215	-0.786	.	.	.	.	.	ENST00000261937: c.1344C>T (p.Y448Y)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019233	.	.	.	.	.	no_record	263024	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	180055863	180055864	5q35.3	.	G	snv	A	TG.GG	het-ref	138	0.56	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC8	IVS8	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.1103+18C>T	.	.	.	NM_182925.4(FLT4): c.1103+18C>T	;maf-5-some-pop,maf-5-all-pops	115551	0.470589	U	0.3115	0.458466	12964	0.029235	PASS	323	8186	0.299902	11878	110544	0.471134	785	5164	3.04015e-01	24665	106257	4.71018e-01	rs438464	.	4024	0.319300	0.561	0.337	0.090	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263016	criteria_provided,_single_submitter	Benign	Benign
Pass	5	180057230	180057231	5q35.3	.	C	snv	A	CG.AG	het-ref	174	0.46	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C4	EX4	.	.	coding-synon	NM_182925.4	NP_891555.2	-	Y	c.507G>T	p.(L169=) | p.(Leu169=)	CTG=>CTT	.	NM_182925.4(FLT4): c.507G>T (p.(L169=))	;maf-5-some-pop	124330	0.073989	U	0.123	0.0593051	12998	0.061317	PASS	52	8596	0.116450	397	119322	0.074605	115	2024	1.17497e-01	870	18745	7.64596e-02	rs3736061	.	4024	0.103900	-0.314	0.349	1.411	.	.	.	.	.	ENST00000261937: c.507G>T (p.L169L)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	3721831	.	.	.	.	.	no_record	263064	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	5	180057355	180057356	5q35.3	.	C	snv	G	AG.TG	het-ref	181	0.55	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC3	IVS3	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.401-19G>C	.	.	.	NM_182925.4(FLT4): c.401-19G>C	;maf-5-some-pop,maf-5-all-pops	122216	0.131693	U	0.5317	0.171725	12988	0.090006	PASS	1335	8494	0.565811	1860	117208	0.129983	2712	9603	5.60399e-01	3842	31027	1.29881e-01	rs56188706	.	4024	0.548500	-1.169	-0.313	-1.229	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263060	criteria_provided,_single_submitter	Benign	Benign
Pass	6	26045736	26045737	6p22.2	.	C	snv	G	AC.GG	het-ref	113	0.44	.	2	.	PASS	602812	P	.	NN	.	.	.	.	.	.	.	8352	HIST1H3C	C1E	EX1E	.	.	coding-synon	NM_003531.2	NP_003522.1	+	Y	c.99C>G	p.(T33=) | p.(Thr33=)	ACC=>ACG	.	NM_003531.2(HIST1H3C): c.99C>G (p.(T33=))	;maf-5-some-pop,maf-5-all-pops	125454	0.148477	U	0.5149	0.216853	13004	0.075208	PASS	1234	8620	0.536427	2348	120446	0.145634	2445	9169	5.33702e-01	5003	37012	1.50886e-01	rs3752418	.	.	.	-4.293	-1.780	-4.367	.	.	.	.	.	ENST00000540144: c.99C>G (p.T33T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3761735	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	26271300	26271301	6p22.2	.	G	snv	A	AA.AG	het-ref	156	0.48	.	2	.	PASS	602815	P	.	NN	.	.	.	.	.	.	.	8355	HIST1H3G	C1E	EX1E	.	.	coding-synon	NM_003534.2	NP_003525.1	-	Y	c.312C>T	p.(L104=) | p.(Leu104=)	CTC=>CTT	.	NM_003534.2(HIST1H3G): c.312C>T (p.(L104=))	;	126376	0.001147	U	0.006	0.00119808	13006	0.000154	PASS	0	8646	0.012607	0	121368	0.001145	2	204	1.18275e-02	2	263	1.06796e-03	rs144684800	.	.	.	-0.300	-0.847	-1.614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	6	27114424	27114425	6p22.1	.	G	snv	A	TC.GG	het-ref	91	0.21	.	2	.	DUBIOUS	615045	P	.	NN	.	.	.	.	.	.	.	85236	HIST1H2BK	C1E	EX1	Core histone H2A/H2B/H3/H4;Histone-like transcription factor (CBF/NF-Y) and archaeal histone	PF00125.19;PF00808.18	coding-synon	NM_080593.2	NP_542160.1	-	Y	c.153C>T	p.(P51=) | p.(Pro51=)	CCC=>CCT	.	NM_080593.2(HIST1H2BK): c.153C>T (p.(P51=))	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	102250	0.241780	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	7436	0.348575	0	102250	0.241780	0	761	6.01011e-02	0	7954	4.67855e-02	rs202101103	.	4024	0.295500	-0.188	0.150	-1.001	.	.	.	.	.	ENST00000356950: c.153C>T (p.P51P)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1487539	.	.	.	.	.	.	.	.	.	Unknown
InExcel	6	29910335	29910336	6p22.1	.	C	snv	G	GC.GT	het-ref	124	0.17	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.6C>G	p.(A2=) | p.(Ala2=)	GCC=>GCG	.	NM_001242758.1(HLA-A): c.6C>G (p.(A2=))	SingleClassTriAllelic;maf-5-some-pop	111092	0.092293	U	.	.	.	.	PASS	0	8380	0.156325	0	111092	0.092293	0	582	4.29457e-02	0	7123	3.74800e-02	rs113772324	.	.	.	-0.355	-0.075	-0.075	.	.	.	.	.	ENST00000396634: c.6C>G (p.A2A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160500	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	29910339	29910340	6p22.1	.	A	snv	G	TC.TG	het-ref	139	0.18	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	missense	NM_001242758.1	NP_001229687.1	+	Y	c.10A>G	p.M4V | p.Met4Val	ATG=>GTG	NP=>NP	NM_001242758.1(HLA-A): c.10A>G (p.M4V)	;maf-5-some-pop	111270	0.092460	U	.	.	.	.	PASS	0	8394	0.155945	0	111270	0.092460	0	647	4.69999e-02	0	7767	3.97675e-02	rs79326316	.	.	.	-0.537	-1.517	-1.630	0.09	0.001	0	0.296	neutral	ENST00000396634: c.10A>G (p.M4V)	central_nervous_system [spinal_cord|NS|NS]	glioma [astrocytoma_Grade_II|fibrillary|NS]	RSS	4160501	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29910370	29910371	6p22.1	.	C	snv	T	CT.GG	het-ref	357	0.41	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	missense	NM_001242758.1	NP_001229687.1	+	Y	c.41C>T	p.S14L | p.Ser14Leu	TCG=>TTG	P0=>NP	NM_001242758.1(HLA-A): c.41C>T (p.S14L)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	114364	0.121507	U	.	.	12994	0.126058	PASS	0	8526	0.154469	306	114364	0.121507	73	2554	1.55732e-01	888	27385	1.23539e-01	rs2230954	.	.	.	0.478	-0.297	-0.164	0.1	0.003	0.001	0.286	neutral	ENST00000396634: c.41C>T (p.S14L)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4407066	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29910418	29910419	6p22.1	.	G	snv	T	CG.GA	het-ref	341	0.39	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+16G>T	.	.	.	NM_001242758.1(HLA-A): c.73+16G>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115034	0.119408	U	0.1349	0.147364	.	.	PASS	0	8354	0.150108	251	110026	0.118136	82	2488	1.48591e-01	861	26360	1.18526e-01	rs9260122	.	.	.	0.478	0.662	0.307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	29910420	29910421	6p22.1	.	A	del	.	GG.GG	het-ref	335	0.39	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+18delA	.	.	.	NM_001242758.1(HLA-A): c.73+18delA	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	114662	0.119708	U	0.1349	0.147364	12416	0.124517	VQSRTrancheINDEL97.00to99.00	0	8350	0.149940	250	109654	0.118445	82	2484	1.50327e-01	860	26348	1.20826e-01	rs9278464	.	.	.	0.391	-0.610	-0.744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	29910521	29910522	6p22.1	.	G	snv	C	CT.CT	het-ref	348	0.48	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.74-12G>C	.	.	.	NM_001242758.1(HLA-A): c.74-12G>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	99524	0.581980	U	0.6925	0.688498	.	.	PASS	1211	7020	0.607835	14897	94516	0.576336	3505	9949	6.77448e-01	43945	128952	6.43409e-01	rs9260130	.	.	.	-1.723	-1.691	-1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	29910556	29910557	6p22.1	.	T	snv	A	TC.TC	het-ref	454	0.46	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.97T>A	p.F33I | p.Phe33Ile	TTC=>ATC	NP=>NP	NM_001242758.1(HLA-A): c.97T>A (p.F33I)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	114528	0.091908	U	0.12	0.106829	.	.	PASS	23	8020	0.157107	199	109520	0.091225	45	2441	1.44695e-01	386	20900	8.72433e-02	rs1136659	.	.	.	-0.712	-2.503	-2.974	0.25	0.105	0.059	0.045	neutral	ENST00000396634: c.97T>A (p.F33I)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4596306	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29910557	29910558	6p22.1	.	T	snv	C	CT.CA	het-ref	550	0.55	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.98T>C	p.F33S | p.Phe33Ser	TTC=>TCC	NP=>P0	NM_001242758.1(HLA-A): c.98T>C (p.F33S)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115384	0.298118	U	0.375	0.372005	12890	0.349263	PASS	660	8152	0.408611	4520	110376	0.294765	1208	6102	3.72755e-01	9151	62364	2.82609e-01	rs2075684	.	.	.	-4.308	-0.649	-0.931	0.49	0.004	0	0.011	neutral	ENST00000396634: c.98T>C (p.F33S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	330510	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	29910580	29910581	6p22.1	.	C	snv	A	GC.GC	het-ref	134	0.13	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.121C>A	p.R41S | p.Arg41Ser	CGC=>AGC	P+=>P0	NM_001242758.1(HLA-A): c.121C>A (p.R41S)	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118106	0.063248	U	0.1042	0.124401	.	.	PASS	4	7962	0.066315	94	113098	0.060540	4	455	3.14270e-02	195	8769	3.99448e-02	rs1059423	.	.	.	0.478	0.397	0.232	0.04	0.002	0	0.349	neutral	ENST00000396634: c.121C>A (p.R41S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4594190	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	29910582	29910583	6p22.1	.	C	snv	T	CG.GG	het-ref	137	0.13	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.123C>T	p.(R41=) | p.(Arg41=)	CGC=>CGT	.	NM_001242758.1(HLA-A): c.123C>T (p.(R41=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118444	0.063161	U	0.1042	0.124401	.	.	PASS	4	8012	0.065776	97	113436	0.060457	4	451	3.11034e-02	193	8651	3.93979e-02	rs1059426	.	.	.	-0.346	-0.114	-0.257	.	.	.	.	.	ENST00000396634: c.123C>T (p.R41R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4594167	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	29910585	29910586	6p22.1	.	G	snv	A	GG.GA	het-ref	140	0.13	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.126G>A	p.(G42=) | p.(Gly42=)	GGG=>GGA	.	NM_001242758.1(HLA-A): c.126G>A (p.(G42=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118216	0.066074	U	0.131	0.136182	.	.	PASS	4	7826	0.076668	94	113208	0.062973	4	462	3.31754e-02	194	8710	4.01612e-02	rs12721672	.	.	.	0.478	0.156	0.043	.	.	.	.	.	ENST00000396634: c.126G>A (p.G42G)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4594279	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	29910603	29910604	6p22.1	.	C	snv	A	GC.GT	het-ref	160	0.15	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.144C>A	p.(A48=) | p.(Ala48=)	GCC=>GCA	.	NM_001242758.1(HLA-A): c.144C>A (p.(A48=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	115760	0.385669	U	0.3899	0.382388	.	.	PASS	395	7678	0.437093	5356	110752	0.385817	801	5879	3.91777e-01	10300	79139	3.63160e-01	rs12721675	.	.	.	-1.251	-0.938	-1.250	.	.	.	.	.	ENST00000396634: c.144C>A (p.A48A)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	451147	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29910697	29910698	6p22.1	.	G	snv	A	AG.GG	het-ref	440	0.45	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.238G>A	p.G80R | p.Gly80Arg	GGG=>AGG	P0=>P+	NM_001242758.1(HLA-A): c.238G>A (p.G80R)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125062	0.062721	U	0.0506	0.0808706	13006	0.079348	PASS	7	8610	0.051336	117	120054	0.061964	12	820	4.76467e-02	353	14969	6.10272e-02	rs1059449	.	.	.	0.478	1.102	0.889	0.05	0.014	0.003	0.346	neutral	ENST00000396634: c.238G>A (p.G80R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019429	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29910702	29910703	6p22.1	.	G	snv	T	CC.GA	het-ref	442	0.46	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.243G>T	p.(P81=) | p.(Pro81=)	CCG=>CCT	.	NM_001242758.1(HLA-A): c.243G>T (p.(P81=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	124686	0.062894	U	0.0506	0.0808706	13006	0.080117	PASS	7	8578	0.051177	117	119678	0.062142	11	815	4.73947e-02	371	15003	6.12182e-02	rs41541222	.	.	.	0.478	-0.864	-1.171	.	.	.	.	.	ENST00000396634: c.243G>T (p.P81P)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021059	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29910741	29910742	6p22.1	.	G	ref	G	CA.TC	het-alt	496	0.54	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.282C>G	p.H94Q | p.His94Gln	CAC=>CAG	P+=>P0	NM_001242758.1(HLA-A): c.282C>G (p.H94Q)	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	121864	0.341545	U	0.6706	0.680711	12982	0.361732	PASS	-1089	8312	0.372714	5805	116856	0.342498	.	.	.	.	.	.	rs78306866	.	.	.	-1.243	-0.383	-0.256	0.35	0.002	0	0.021	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29910749	29910750	6p22.1	.	C	snv	T	GA.TG	het-ref	453	0.48	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.290C>T	p.T97I | p.Thr97Ile	ACT=>ATT	P0=>NP	NM_001242758.1(HLA-A): c.290C>T (p.T97I)	MixedObserved;clinically-assoc,submitted-by-lsdb|MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	0|123198	0|0.085919	U	0.1379	0.124201	12980	0.049846	PASS	108	8484	0.164899	612	118190	0.084296	221	2596	1.53901e-01	1182	18091	7.68789e-02	rs199474456|rs199474457	.	.	.	-3.060	-2.369	-2.264	0.33	0.006	0.001	0.024	neutral	ENST00000396634: c.290C>T (p.T97I)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160508	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29910815	29910816	6p22.1	.	G	snv	A	CC.GC	het-ref	362	0.49	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.343+13G>A	.	.	.	NM_001242758.1(HLA-A): c.343+13G>A	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117188	0.065638	U	0.1181	0.0866613	12912	0.040505	PASS	34	8226	0.148796	210	112180	0.064700	111	2414	1.42773e-01	429	14556	6.29863e-02	rs41562315	.	.	.	0.478	1.490	1.471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	29910819	29910820	6p22.1	.	G	snv	C	CC.GG	het-ref	335	0.48	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.343+17G>C	.	.	.	NM_001242758.1(HLA-A): c.343+17G>C	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	117532	0.835049	U	0.9683	0.854832	12910	0.751433	PASS	3842	8354	0.958942	39238	112524	0.834169	7964	16430	9.69550e-01	82170	192948	8.46724e-01	rs9260142	.	.	.	-0.721	-0.432	-0.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	29911029	29911030	6p22.1	.	C	snv	T	CG.GG	het-ref	374	0.52	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.344-15C>T	.	.	.	NM_001242758.1(HLA-A): c.344-15C>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	77278	0.214459	U	0.1508	0.178714	8048	0.181163	PASS	378	5830	0.259520	3689	72270	0.216936	511	2867	1.88942e-01	5461	31624	1.61771e-01	rs9260151	.	.	.	0.478	-0.051	-0.168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	29911063	29911064	6p22.1	.	A	snv	G	AT.AT	het-ref	418	0.49	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.363A>G	p.I121M | p.Ile121Met	ATA=>ATG	NP=>NP	NM_001242758.1(HLA-A): c.363A>G (p.I121M)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	93144	0.559832	U	0.6865	0.661142	8228	0.486388	PASS	1445	6584	0.609356	15619	88136	0.554076	3506	9599	6.48406e-01	41234	116795	5.95972e-01	rs1136695	.	.	.	-0.389	-1.762	-1.641	0.23	0.007	0	0.042	neutral	ENST00000396634: c.363A>G (p.I121M)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4160516	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29911113	29911114	6p22.1	.	G	snv	A	CC.GC	het-ref	447	0.48	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.413G>A	p.R138Q | p.Arg138Gln	CGG=>CAG	P+=>P0	NM_001242758.1(HLA-A): c.413G>A (p.R138Q)	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	110554	0.549424	U	0.6766	0.64976	8366	0.504303	PASS	1669	7750	0.641161	16255	105546	0.544663	3651	10124	6.76919e-01	37303	115121	5.76759e-01	rs3173420	.	.	.	-1.798	-1.623	-2.037	0.31	0.014	0.002	0.028	neutral	ENST00000396634: c.413G>A (p.R138Q)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5019450	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29911148	29911149	6p22.1	.	C	snv	T	CC.TG	het-ref	499	0.52	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.448C>T	p.(L150=) | p.(Leu150=)	CTG=>TTG	.	NM_001242758.1(HLA-A): c.448C>T (p.(L150=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	116760	0.134490	U	0.1438	0.15635	8426	0.137906	PASS	128	8156	0.175821	1187	111752	0.133510	251	2767	1.62918e-01	2292	30536	1.27816e-01	rs1059506	.	.	.	-0.330	0.923	0.941	.	.	.	.	.	ENST00000396634: c.448C>T (p.L150L)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019453	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29911202	29911203	6p22.1	.	A	snv	C	CC.AG	het-ref	471	0.51	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.502A>C	p.K168Q | p.Lys168Gln	AAG=>CAG	P+=>P0	NM_001242758.1(HLA-A): c.502A>C (p.K168Q)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118856	0.244102	U	0.2143	0.339058	.	.	PASS	232	8402	0.230421	3796	113848	0.239925	442	3766	2.26513e-01	7976	56166	2.43465e-01	rs1059517	.	.	.	-2.126	-0.019	-0.300	1	0.002	0	0.000	neutral	ENST00000396634: c.502A>C (p.K168Q)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4593597	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29911224	29911225	6p22.1	.	A	snv	G	CC.TG	het-ref	442	0.53	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.524A>G	p.H175R | p.His175Arg	CAT=>CGT	P+=>P+	NM_001242758.1(HLA-A): c.524A>G (p.H175R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	119217	0.180402	U	0.1617	0.25639	.	.	VQSRTrancheINDEL99.00to99.50	145	8370	0.192115	2241	114210	0.177069	296	3116	1.83316e-01	4538	41273	1.74223e-01	rs1059536	.	.	.	-1.697	0.215	0.063	0.22	0	0	0.042	neutral	ENST00000396634: c.524A>G (p.H175R)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4594067	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29911227	29911228	6p22.1	.	A	ref	A	TG.GG	het-alt	400	0.47	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.527C>A	p.A176E | p.Ala176Glu	GCG=>GAG	NP=>P-	NM_001242758.1(HLA-A): c.527C>A (p.A176E)	MixedObserved;observed-mismatch|MixedObserved,SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	111223|116680	0.999991|0.250051	U	0.2817	0.189497	.	.	PASS	-539	8282	0.141753	2209	111672	0.254236	.	.	.	.	.	.	rs748036658|rs9256983	.	.	.	-7.138	-7.497	-7.540	0.41	0.003	0	0.015	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29911227	29911228	6p22.1	.	A	snv	T	TG.GG	het-ref	452	0.53	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.527C>T	p.A176V | p.Ala176Val	GCG=>GTG	NP=>NP	NM_001242758.1(HLA-A): c.527C>T (p.A176V)	MixedObserved,SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	116680	0.538036	U	0.5893	0.598043	.	.	PASS	1301	8282	0.577638	13809	111672	0.535345	2752	9560	5.75211e-01	34280	127661	5.65713e-01	rs9256983	.	.	.	-7.138	-7.497	-7.540	0.6	0.001	0	0.004	neutral	ENST00000396634: c.527A>T (p.E176V)	central_nervous_system [spinal_cord|NS|NS]	glioma [astrocytoma_Grade_II|fibrillary|NS]	RSS	3733674	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	29911306	29911307	6p22.1	.	G	snv	A	AC.CT	het-ref	87	0.10	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.606G>A	p.(T202=) | p.(Thr202=)	ACG=>ACA	.	NM_001242758.1(HLA-A): c.606G>A (p.(T202=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	114464	0.019954	U	.	.	.	.	PASS	0	8306	0.055020	0	114464	0.019954	0	82	5.20173e-03	0	325	1.41200e-03	rs199474578	.	.	.	-0.346	-1.992	-1.291	.	.	.	.	.	ENST00000396634: c.606G>A (p.T202T)	central_nervous_system [brain|NS|NS]	primitive_neuroectodermal_tumour-medulloblastoma [NS|NS|NS]	RSS	307018	.	.	.	.	.	.	.	.	.	VUS
InExcel	6	29911318	29911319	6p22.1	.	G	snv	T	AC.GG	het-ref	105	0.12	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.618G>T	p.(T206=) | p.(Thr206=)	ACG=>ACT	.	NM_001242758.1(HLA-A): c.618G>T (p.(T206=))	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	108798	0.373141	U	.	.	.	.	InbreedingCoeff_Filter	0	8168	0.271058	0	108798	0.373141	0	1493	1.23757e-01	0	42779	2.69037e-01	rs41554520	.	.	.	0.485	1.825	0.549	.	.	.	.	.	ENST00000396634: c.618G>T (p.T206T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761773	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	29911328	29911329	6p22.1	.	G	snv	A	GG.GC	het-ref	118	0.14	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.619+9G>A	.	.	.	NM_001242758.1(HLA-A): c.619+9G>A	;	113926	0.022822	U	.	.	.	.	PASS	0	8278	0.061247	0	113926	0.022822	0	102	6.58915e-03	0	569	2.51037e-03	rs200281525	.	.	.	0.485	0.624	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	29911892	29911893	6p22.1	.	C	snv	T	CC.GT	het-ref	215	0.51	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-6C>T	.	.	.	NM_001242758.1(HLA-A): c.620-6C>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	122902	0.376739	U	0.4514	0.386182	8430	0.327758	PASS	905	8466	0.444248	9511	117894	0.376338	1881	7354	4.67633e-01	19261	89870	3.88113e-01	rs9260172	.	.	.	-0.706	0.531	0.334	.	.	.	.	.	ENST00000396634: c.620-6C>T (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019213	.	.	.	.	.	.	.	.	.	Benign
Pass	6	29911894	29911895	6p22.1	.	T	snv	A	CG.CA	het-ref	211	0.51	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-4T>A	.	.	.	NM_001242758.1(HLA-A): c.620-4T>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117804	0.002020	U	.	.	.	.	PASS	0	8492	0.002708	2	117804	0.002020	47	1117	7.99227e-02	122	7484	3.44016e-02	rs9260173	.	.	.	-0.512	-0.148	-0.133	.	.	.	.	.	ENST00000396634: c.620-4T>A (p.?)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3948956	.	.	.	.	.	.	.	.	.	Unknown
Pass	6	29911911	29911912	6p22.1	.	A	snv	G	AC.CA	het-ref	213	0.56	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.633A>G	p.(T211=) | p.(Thr211=)	ACA=>ACG	.	NM_001242758.1(HLA-A): c.633A>G (p.(T211=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122750	0.007927	U	0.1815	0.131589	.	.	VQSRTrancheSNP99.60to99.80	0	8496	0.003060	0	117742	0.002667	0	1136	8.15272e-02	1	7786	3.61390e-02	rs1136749	.	.	.	-0.706	-0.727	-0.626	.	.	.	.	.	ENST00000396634: c.633A>G (p.T211T)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4160525	.	.	.	.	.	.	.	.	.	Unknown
Pass	6	29911920	29911921	6p22.1	.	C	snv	T	AC.CA	het-ref	192	0.56	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.642C>T	p.(T214=) | p.(Thr214=)	ACC=>ACT	.	NM_001242758.1(HLA-A): c.642C>T (p.(T214=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117460	0.002818	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8500	0.003647	0	117460	0.002818	0	1097	8.00029e-02	1	7658	3.62859e-02	rs1136754	.	.	.	-1.400	0.119	0.057	.	.	.	.	.	ENST00000396634: c.642C>T (p.T214T)	skin [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	4160526	.	.	.	.	.	.	.	.	.	VUS
Pass	6	29911927	29911928	6p22.1	.	C	snv	G	AC.CC	het-ref	179	0.53	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	missense	NM_001242758.1	NP_001229687.1	+	Y	c.649C>G	p.P217A | p.Pro217Ala	CCC=>GCC	NP=>NP	NM_001242758.1(HLA-A): c.649C>G (p.P217A)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117336	0.002838	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8498	0.003648	0	117336	0.002838	0	1118	8.20009e-02	1	8145	3.93874e-02	rs1059563	.	.	.	0.485	-0.003	0.334	0.04	0.001	0	0.349	neutral	ENST00000396634: c.649C>G (p.P217A)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3948957	.	.	.	.	.	.	.	.	.	VUS
Pass	6	29911929	29911930	6p22.1	.	C	snv	T	CC.AT	het-ref	177	0.53	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.651C>T	p.(P217=) | p.(Pro217=)	CCC=>CCT	.	NM_001242758.1(HLA-A): c.651C>T (p.(P217=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117088	0.002870	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8490	0.003769	0	117088	0.002870	0	1114	8.26409e-02	1	8136	3.98273e-02	rs1059564	.	.	.	-0.330	-0.054	-0.266	.	.	.	.	.	ENST00000396634: c.651C>T (p.P217P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3948958	.	.	.	.	.	.	.	.	.	VUS
Pass	6	29911930	29911931	6p22.1	.	A	snv	G	CC.TC	het-ref	172	0.53	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	missense	NM_001242758.1	NP_001229687.1	+	Y	c.652A>G	p.I218V | p.Ile218Val	ATC=>GTC	NP=>NP	NM_001242758.1(HLA-A): c.652A>G (p.I218V)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117034	0.002845	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8488	0.003770	0	117034	0.002845	0	1197	8.84962e-02	1	9000	4.41661e-02	rs9260179	.	.	.	-2.420	-1.653	-1.507	0.57	0.001	0	0.006	neutral	ENST00000396634: c.652A>G (p.I218V)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4160527	.	.	.	.	.	.	.	.	.	VUS
InExcel	6	31238850	31238851	6p21.33	.	T	snv	C	CC.GC	het-ref	214	0.22	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	.	.	coding-synon	NM_002117.5	NP_002108.4	-	Y	c.618A>G	p.(A206=) | p.(Ala206=)	GCA=>GCG	.	NM_002117.5(HLA-C): c.618A>G (p.(A206=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	120344	0.763727	U	.	.	13004	0.734236	PASS	2873	8606	0.828840	33934	120344	0.763727	5674	13818	8.30908e-01	68310	181959	7.66795e-01	rs2308604	.	.	.	-1.840	0.427	-0.004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31238908	31238909	6p21.33	.	G	snv	A	AC.TG	het-ref	176	0.19	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.560C>T	p.T187M | p.Thr187Met	ACG=>ATG	P0=>NP	NM_002117.5(HLA-C): c.560C>T (p.T187M)	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	113032	0.317521	U	0.3641	0.378794	.	.	InbreedingCoeff_Filter	110	7892	0.348834	561	108024	0.314680	267	3475	2.91282e-01	1218	49716	2.99288e-01	rs1050686	.	.	.	-4.896	-5.366	-5.533	0.08	0.599	0.646	0.507	deleterious	ENST00000376228: c.560C>T (p.T187M)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3722064	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31238909	31238910	6p21.33	.	T	snv	G	CG.GC	het-ref	174	0.19	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.559A>C	p.T187P | p.Thr187Pro	ACG=>CCG	P0=>NP	NM_002117.5(HLA-C): c.559A>C (p.T187P)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.378794	U	0.3641	0.378794	.	.	VQSRTrancheINDEL96.00to97.00	110	7900	0.355570	570	108348	0.316268	273	3519	2.92421e-01	1236	49557	2.98864e-01	rs1050685	.	.	.	-4.761	-3.834	-4.140	0.25	0.443	0.12	0.181	neutral	ENST00000376228: c.559A>C (p.T187P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3722061	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31238941	31238942	6p21.33	.	G	snv	T	CC.CA	het-ref	123	0.14	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.527C>A	p.A176E | p.Ala176Glu	GCG=>GAG	NP=>P-	NM_002117.5(HLA-C): c.527C>A (p.A176E)	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	112202	0.405875	U	0.4921	0.429113	12920	0.605960	PASS	466	7920	0.408460	5638	107194	0.404789	1273	6336	4.82927e-01	12214	78566	4.22389e-01	rs2308590	.	.	.	-3.123	-4.116	-4.565	0.43	0.003	0	0.013	neutral	ENST00000376228: c.527C>A (p.A176E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160739	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31238956	31238957	6p21.33	.	A	snv	C	CC.AC	het-ref	127	0.14	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.512T>G	p.L171W | p.Leu171Trp	TTG=>TGG	NP=>NP	NM_002117.5(HLA-C): c.512T>G (p.L171W)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	105806	0.684952	U	.	.	.	.	PASS	2090	7716	0.756480	23992	105806	0.684952	4928	12225	8.07250e-01	54448	149041	7.21064e-01	rs1050366	.	.	.	-2.460	0.369	-0.049	1	0	0	0.000	neutral	ENST00000376228: c.512T>G (p.L171W)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160742	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31238991	31238992	6p21.33	.	G	snv	C	GC.GC	het-ref	142	0.15	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_002117.5	NP_002108.4	-	Y	c.477C>G	p.(A159=) | p.(Ala159=)	GCC=>GCG	.	NM_002117.5(HLA-C): c.477C>G (p.(A159=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	110428	0.389964	U	0.3621	0.404952	.	.	InbreedingCoeff_Filter	8	7518	0.344507	263	105420	0.389253	21	3380	2.58055e-01	1194	66848	3.48996e-01	rs41550715	.	.	.	0.305	-0.451	-0.382	.	.	.	.	.	ENST00000376228: c.477C>G (p.A159A)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	3830080	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31239005	31239006	6p21.33	.	G	snv	T	GC.CA	het-ref	136	0.15	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.463C>A	p.R155S | p.Arg155Ser	CGC=>AGC	P+=>P0	NM_002117.5(HLA-C): c.463C>A (p.R155S)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	104534	0.346251	U	.	.	.	.	InbreedingCoeff_Filter	2	7360	0.333832	24	104534	0.346251	6	2958	2.39088e-01	495	56250	3.06196e-01	rs76907552	.	.	.	-0.692	-0.027	0.025	0.12	0.998	0.992	0.735	deleterious	ENST00000376228: c.463C>A (p.R155S)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	232488	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31239048	31239049	6p21.33	.	G	snv	T	GC.GA	het-ref	162	0.17	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_002117.5	NP_002108.4	-	Y	c.420C>A	p.(S140=) | p.(Ser140=)	TCC=>TCA	.	NM_002117.5(HLA-C): c.420C>A (p.(S140=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	118744	0.056592	U	0.0377	0.0539137	.	.	PASS	5	8288	0.042350	108	113736	0.056710	11	561	3.63342e-02	227	8267	3.67618e-02	rs1065406	.	.	.	-1.236	-0.750	-0.884	.	.	.	.	.	ENST00000376228: c.420C>A (p.S140S)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160745	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31239049	31239050	6p21.33	.	G	snv	A	CG.AC	het-ref	165	0.18	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.419C>T	p.S140F | p.Ser140Phe	TCC=>TTC	P0=>NP	NM_002117.5(HLA-C): c.419C>T (p.S140F)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115162	0.317961	U	0.2242	0.325879	12858	0.344377	PASS	133	8040	0.231095	2890	110154	0.317601	284	3395	2.31836e-01	5239	63831	3.15870e-01	rs713032	.	.	.	-4.240	-5.547	-6.427	0.82	0.032	0.004	0.002	neutral	ENST00000376228: c.419C>T (p.S140F)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160748	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31239056	31239057	6p21.33	.	C	snv	T	GT.AT	het-ref	189	0.20	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.412G>A	p.D138N | p.Asp138Asn	GAC=>AAC	P-=>P0	NM_002117.5(HLA-C): c.412G>A (p.D138N)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118798	0.259163	U	0.1627	0.256789	12852	0.280190	PASS	81	8286	0.180425	1726	113790	0.259267	164	2821	1.79476e-01	3132	55940	2.50830e-01	rs2308575	.	.	.	-3.984	-8.217	-8.536	0.33	0.003	0	0.024	neutral	ENST00000376228: c.412G>A (p.D138N)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160751	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31239100	31239101	6p21.33	.	G	snv	T	CA.AC	het-ref	589	0.63	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.368C>A	p.S123Y | p.Ser123Tyr	TCT=>TAT	P0=>P0	NM_002117.5(HLA-C): c.368C>A (p.S123Y)	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118274	0.655503	U	0.5179	0.64377	12730	0.856324	PASS	985	8196	0.492435	24258	113266	0.656022	2056	8010	5.05044e-01	49141	149306	6.59957e-01	rs1131115	.	.	.	-2.586	-5.358	-6.089	1	0.001	0	0.000	neutral	ENST00000376228: c.368C>A (p.S123Y)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160754	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31239111	31239111	6p21.33	.	.	ins	CC	TG.GA	het-ref	114	0.13	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_002117.5	NP_002108.4	-	Y	c.357_358insGG	p.Q120Gfs*32 | p.Gln120Glyfs*32	.	.	NM_002117.5(HLA-C): c.357_358insGG (p.Q120Gfs*32)	MixedObserved;	110794	0.003737	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8070	0.001611	0	110794	0.003737	0	46	2.86783e-03	0	249	1.08259e-03	rs748394002	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
InExcel	6	31239111	31239112	6p21.33	.	G	snv	A	TG.AG	het-ref	107	0.12	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_002117.5	NP_002108.4	-	Y	c.357C>T	p.(L119=) | p.(Leu119=)	CTC=>CTT	.	NM_002117.5(HLA-C): c.357C>T (p.(L119=))	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	109950	0.003738	U	.	.	.	.	PASS	0	8028	0.001619	0	109950	0.003738	0	46	2.91545e-03	0	242	1.07886e-03	rs201441823	.	.	.	0.305	0.640	0.709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
InExcel	6	31239113	31239115	6p21.33	.	GG	del	.	GA.GT	het-ref	102	0.12	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_002117.5	NP_002108.4	-	Y	c.353C[3>1] (std: c.353C[1] alt: c.354_355delCC )	p.L119Pfs*19 | p.Leu119Profs*19	.	.	NM_002117.5(HLA-C): c.353C[1] (p.L119Pfs*19)	MixedObserved;observed-mismatch	0	0	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8026	0.001620	0	109878	0.003731	.	.	.	.	.	.	rs778339286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	6	31239448	31239449	6p21.33	.	C	snv	G	TA.TT	het-ref	419	0.51	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.270G>C	p.K90N | p.Lys90Asn	AAG=>AAC	P+=>P0	NM_002117.5(HLA-C): c.270G>C (p.K90N)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125850	0.160087	U	0.0516	0.141773	8440	0.170261	PASS	17	8630	0.054114	1729	120842	0.160846	26	901	5.22986e-02	3469	38859	1.58721e-01	rs28626310	.	.	.	-3.594	-5.643	-6.044	0.33	0.028	0.007	0.026	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31323295	31323296	6p21.33	.	A	snv	G	AA.CC	het-ref	127	0.51	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C4	EX4	Immunoglobulin C1-set domain	PF07654.10	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.693T>C	p.(G231=) | p.(Gly231=)	GGT=>GGC	.	NM_005514.6(HLA-B): c.693T>C (p.(G231=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126174	0.850033	U	0.8284	0.877196	13000	0.836231	PASS	2815	8610	0.813124	43821	121166	0.848910	5594	13893	8.10371e-01	89539	209317	8.53282e-01	rs1050747	.	.	.	-0.391	-0.019	-0.113	.	.	.	.	.	ENST00000412585: c.693T>C (p.G231G)	kidney [NS|NS|NS]	carcinoma [clear_cell_renal_cell_carcinoma|NS|NS]	CSV	3774227	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31323352	31323353	6p21.33	.	G	snv	A	AC.TG	het-ref	188	0.48	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C4	EX4	.	.	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.636C>T	p.(H212=) | p.(His212=)	CAC=>CAT	.	NM_005514.6(HLA-B): c.636C>T (p.(H212=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126199	0.396992	U	0.4018	0.40016	13006	0.421344	PASS	530	8636	0.359426	9657	121192	0.396858	1095	6285	3.64432e-01	19973	98004	3.98873e-01	rs2257269	.	.	.	-2.627	-2.865	-2.511	.	.	.	.	.	ENST00000412585: c.636C>T (p.H212H)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761863	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31323944	31323945	6p21.33	.	A	snv	C	CC.GC	het-ref	94	0.19	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	.	.	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.618T>G	p.(A206=) | p.(Ala206=)	GCT=>GCG	.	NM_005514.6(HLA-B): c.618T>G (p.(A206=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	107236	0.806641	U	0.8204	0.873802	.	.	PASS	2014	7268	0.738580	33888	102228	0.803351	4861	11184	8.11965e-01	76685	169181	8.48714e-01	rs2596493	.	.	.	-2.465	-0.230	-0.650	.	.	.	.	.	ENST00000412585: c.618T>G (p.A206A)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	4006326	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31323952	31323953	6p21.33	.	C	snv	G	CT.CA	het-ref	64	0.14	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	.	.	missense	NM_005514.6	NP_005505.2	-	Y	c.610G>C	p.E204Q | p.Glu204Gln	GAG=>CAG	P-=>P0	NM_005514.6(HLA-B): c.610G>C (p.E204Q)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	97138	0.662089	U	0.8165	0.810903	.	.	PASS	1669	6586	0.703006	21082	92130	0.654000	4409	10020	7.98406e-01	52908	123330	7.25087e-01	rs1131285	.	.	.	-0.699	0.340	0.204	1	0	0	0.000	neutral	ENST00000412585: c.610G>C (p.E204Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4006327	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31323957	31323958	6p21.33	.	T	snv	G	GC.TG	het-ref	60	0.13	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.605A>C	p.K202T | p.Lys202Thr	AAG=>ACG	P+=>P0	NM_005514.6(HLA-B): c.605A>C (p.K202T)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	88726	0.748991	U	0.8075	0.866014	12214	0.708695	PASS	1297	5800	0.645862	24690	83718	0.741991	4000	9064	7.73247e-01	62658	137465	8.13046e-01	rs1131279	.	.	.	-0.700	0.251	0.205	1	0	0	0.000	neutral	ENST00000412585: c.605A>C (p.K202T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3734024	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31323959	31323960	6p21.33	.	G	snv	C	TT.TC	het-ref	58	0.13	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.603C>G	p.D201E | p.Asp201Glu	GAC=>GAG	P-=>P-	NM_005514.6(HLA-B): c.603C>G (p.D201E)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	82477	0.590625	U	0.8036	0.802316	12210	0.467568	VQSRTrancheINDEL99.00to99.50	1106	5368	0.616244	14349	77470	0.576933	3792	8608	7.60290e-01	43174	101235	6.75332e-01	rs1131275	.	.	.	-0.699	0.283	-0.082	1	0	0	0.000	neutral	ENST00000412585: c.603C>G (p.D201E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [NS|NS|NS]	CSV	3734025	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31324002	31324003	6p21.33	.	T	snv	A	AC.CG	het-ref	145	0.26	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.560A>T	p.E187V | p.Glu187Val	GAG=>GTG	P-=>NP	NM_005514.6(HLA-B): c.560A>T (p.E187V)	MixedObserved,SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	106302	0.381611	U	0.5218	0.485024	12624	0.490098	PASS	355	7252	0.435604	3699	101294	0.376498	989	5416	4.79462e-01	6631	63536	3.81492e-01	rs2308466	.	.	.	-3.687	-4.258	-4.771	0.23	0.049	0.004	0.045	neutral	ENST00000412585: c.560A>T (p.E187V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3733865	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31324003	31324004	6p21.33	.	C	snv	G	CT.GC	het-ref	146	0.26	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.559G>C	p.E187Q | p.Glu187Gln	GAG=>CAG	P-=>P0	NM_005514.6(HLA-B): c.559G>C (p.E187Q)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	106500	0.382366	U	0.5218	0.485024	12636	0.488841	PASS	356	7244	0.437327	3744	101492	0.377301	982	5455	4.81125e-01	6625	64029	3.82724e-01	rs2523600	.	.	.	-2.049	-1.058	-1.312	0.45	0.329	0.197	0.115	neutral	ENST00000412585: c.559G>C (p.E187Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3733866	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324023	31324024	6p21.33	.	C	snv	A	TC.GC	hom-alt	565	0.99	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.539G>T	p.R180L | p.Arg180Leu	CGG=>CTG	P+=>NP	NM_005514.6(HLA-B): c.539G>T (p.R180L)	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	99494	0.502422	U	0.5655	0.4998	.	.	InbreedingCoeff_Filter	1183	7798	0.604258	4917	94486	0.502561	2723	9753	6.42236e-01	10710	91275	4.66455e-01	rs697742	.	.	.	-0.891	-1.411	-1.333	0.66	0.03	0.002	0.004	neutral	ENST00000412585: c.539G>T (p.R180L)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761864	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324035	31324036	6p21.33	.	T	snv	A	CC.CA	het-ref	373	0.68	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.527A>T	p.E176V | p.Glu176Val	GAG=>GTG	P-=>NP	NM_005514.6(HLA-B): c.527A>T (p.E176V)	SingleClassTriAllelic;maf-5-some-pop	110618	0.416831	U	0.3839	0.425519	.	.	InbreedingCoeff_Filter	163	7558	0.393226	1944	105610	0.416419	584	6088	4.26869e-01	4877	83475	4.19009e-01	rs151341293	.	.	.	-2.615	-6.462	-6.376	0.6	0.016	0.001	0.005	neutral	ENST00000412585: c.527A>T (p.E176V)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4160793	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324050	31324051	6p21.33	.	C	snv	A	CC.AC	het-ref	378	0.69	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.512G>T	p.W171L | p.Trp171Leu	TGG=>TTG	NP=>NP	NM_005514.6(HLA-B): c.512G>T (p.W171L)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118628	0.063990	U	0.12	0.0678914	12752	0.044699	VQSRTrancheSNP99.60to99.80	45	8280	0.162802	48	113620	0.063818	130	2847	1.67234e-01	158	13405	5.65297e-02	rs41551018	.	.	.	-0.898	1.459	0.177	0.1	0.284	0.847	0.373	neutral	ENST00000412585: c.512G>T (p.W171L)	kidney [NS|NS|NS]	carcinoma [clear_cell_renal_cell_carcinoma|NS|NS]	CSV	3774228	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324063	31324064	6p21.33	.	T	snv	A	GG.GA	het-ref	386	0.71	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.499A>T	p.T167S | p.Thr167Ser	ACC=>TCC	P0=>P0	NM_005514.6(HLA-B): c.499A>T (p.T167S)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118748	0.065146	U	0.12	0.0682907	12720	0.050786	PASS	44	8308	0.163096	50	113740	0.065008	131	2849	1.67352e-01	152	13663	5.75323e-02	rs41541519	.	.	.	-2.763	0.150	-0.714	0.19	0.003	0.001	0.050	neutral	ENST00000412585: c.499A>T (p.T167S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4006328	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31324076	31324077	6p21.33	.	C	snv	G	GC.GT	het-ref	143	0.27	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.486G>C	p.(T162=) | p.(Thr162=)	ACG=>ACC	.	NM_005514.6(HLA-B): c.486G>C (p.(T162=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	113740	0.386953	U	0.3373	0.393371	.	.	InbreedingCoeff_Filter	88	7784	0.315391	1959	108732	0.386657	220	4254	3.29155e-01	4836	73607	3.94777e-01	rs709053	.	.	.	-2.220	-1.378	-0.809	.	.	.	.	.	ENST00000412585: c.486G>C (p.T162T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160794	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31324085	31324086	6p21.33	.	G	snv	C	GC.GC	het-ref	140	0.26	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.477C>G	p.(A159=) | p.(Ala159=)	GCC=>GCG	.	NM_005514.6(HLA-B): c.477C>G (p.(A159=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	116896	0.450708	U	0.4742	0.48762	.	.	InbreedingCoeff_Filter	93	8122	0.416523	2456	111888	0.449056	365	6630	4.61378e-01	6245	94100	4.67383e-01	rs709054	.	.	.	-3.946	-1.261	-1.174	.	.	.	.	.	ENST00000412585: c.477C>G (p.A159A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160795	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31324099	31324100	6p21.33	.	G	snv	T	GC.CA	het-ref	143	0.25	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.463C>A	p.R155S | p.Arg155Ser	CGC=>AGC	P+=>P0	NM_005514.6(HLA-B): c.463C>A (p.R155S)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	110432	0.413204	U	.	.	.	.	InbreedingCoeff_Filter	125	8060	0.437097	1033	110432	0.413205	400	7017	4.71573e-01	2544	85474	4.24568e-01	rs1050654	.	.	.	-2.445	-0.762	-0.595	0.12	0.005	0	0.261	neutral	ENST00000412585: c.463C>A (p.R155S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4006329	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324150	31324151	6p21.33	.	C	snv	T	GT.AT	hom-alt	443	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.412G>A	p.D138N | p.Asp138Asn	GAC=>AAC	P-=>P0	NM_005514.6(HLA-B): c.412G>A (p.D138N)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	109082	0.454493	U	0.4792	0.464257	12502	0.436490	PASS	720	7696	0.497531	9368	104074	0.454023	1335	7483	4.89661e-01	17894	93874	4.62179e-01	rs709055	.	.	.	-0.712	-4.124	-4.183	0.34	0.002	0.001	0.023	neutral	ENST00000412585: c.412G>A (p.D138N)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4006331	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324199	31324200	6p21.33	.	G	snv	C	AT.CT	hom-alt	393	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.363C>G	p.S121R | p.Ser121Arg	AGC=>AGG	P0=>P+	NM_005514.6(HLA-B): c.363C>G (p.S121R)	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	89200	0.661536	U	0.8681	0.799121	11524	0.597449	PASS	2528	6614	0.856819	20470	84192	0.653352	6028	13103	9.03905e-01	49733	122687	7.07603e-01	rs1140412	.	.	.	-1.868	-1.001	-0.787	0.46	0.003	0.007	0.012	neutral	ENST00000412585: c.363C>G (p.S121R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160800	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31324488	31324488	6p21.33	.	.	ins	GGAG	GC.CG	het-ref	49	0.10	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_005514.6	NP_005505.2	-	Y	c.319_320insCTCC	p.G107Afs*33 | p.Gly107Alafs*33	.	.	NM_005514.6(HLA-B): c.319_320insCTCC (p.G107Afs*33)	ObservedTooLong;rs-cluster-nonoverlapping-alleles	105042	0.133328	U	.	.	12214	0	VQSRTrancheINDEL99.00to99.50	42	7604	0.129406	1206	105042	0.133328	147	1478	1.04202e-01	2706	18997	9.69848e-02	rs375356947	.	.	.	.	.	.	.	.	.	.	.	ENST00000412585: c.319_320insCTCC (p.G107fs*33)	thyroid [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	5957933	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31324492	31324493	6p21.33	.	C	del	.	CG.AG	het-ref	43	0.09	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_005514.6	NP_005505.2	-	Y	c.315delG	p.R106Afs*45 | p.Arg106Alafs*45	.	.	NM_005514.6(HLA-B): c.315delG (p.R106Afs*45)	MixedObserved,SingleClassTriAllelic;clinically-assoc,submitted-by-lsdb|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|105704	0|0.129825	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	35	7588	0.126911	1083	105704	0.129825	100	1218	8.41276e-02	2098	16403	8.09026e-02	rs41549513|rs749699159	.	.	.	0.448	0.307	0.207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	6	31324494	31324497	6p21.33	.	GGT	del	.	CA.TC	het-ref	43	0.09	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	cds-indel	NM_005514.6	NP_005505.2	-	Y	c.311_313delACC	p.N104_L105delinsM | p.Asn104_Leu105delinsMet	.	.	NM_005514.6(HLA-B): c.311_313delACC (p.N104_L105delinsM)	MixedObserved;observed-mismatch	93420	0.146072	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	29	6316	0.150412	1022	93428	0.146059	95	1187	9.55101e-02	2049	16172	9.14240e-02	rs770563406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	31324515	31324516	6p21.33	.	C	snv	A	GT.AG	hom-alt	499	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.292G>T	p.D98Y | p.Asp98Tyr	GAC=>TAC	P-=>P0	NM_005514.6(HLA-B): c.292G>T (p.D98Y)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	107498	0.598272	U	0.6419	0.703874	12594	0.481658	PASS	1395	6904	0.639050	19517	102490	0.593112	3222	8750	6.74946e-01	42997	113568	6.15071e-01	rs1131215	.	.	.	-6.206	-2.257	-2.027	0.49	0.15	0.05	0.024	neutral	ENST00000412585: c.292G>T (p.D98Y)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1443267	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324524	31324526	6p21.33	.	CC	del	.	TG.TG	hom-alt	502	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_005514.6	NP_005505.2	-	Y	c.282_283delGG	p.Q94Hfs*4 | p.Gln94Hisfs*4	.	.	NM_005514.6(HLA-B): c.282_283delGG (p.Q94Hfs*4)	MixedObserved;maf-5-some-pop,maf-5-all-pops,observed-mismatch	105006	0.696503	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	1363	6816	0.627494	27072	105006	0.696503	3100	8499	6.44743e-01	60831	145444	7.30852e-01	rs750527298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324528	31324528	6p21.33	.	.	ins	TT	TG.GG	hom-alt	498	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_005514.6	NP_005505.2	-	Y	c.279_280insAA	p.Q94Nfs*58 | p.Gln94Asnfs*58	.	.	NM_005514.6(HLA-B): c.279_280insAA (p.Q94Nfs*58)	;	97467	0.735900	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	1315	6376	0.634881	26638	101688	0.705354	3189	8314	6.92256e-01	61835	144766	7.67208e-01	rs749557905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324530	31324531	6p21.33	.	C	snv	T	GG.CT	hom-alt	505	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.277G>A	p.A93T | p.Ala93Thr	GCC=>ACC	NP=>P0	NM_005514.6(HLA-B): c.277G>A (p.A93T)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	106466	0.703999	U	0.6389	0.709864	12278	0.647744	PASS	1304	6204	0.640716	26495	101458	0.703710	3400	8376	7.21074e-01	63780	147513	7.67122e-01	rs1131204	.	.	.	-1.745	-0.169	-0.875	0.54	0.016	0.001	0.008	neutral	ENST00000412585: c.277G>A (p.A93T)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	5021513	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324535	31324536	6p21.33	.	T	snv	G	TG.AG	hom-alt	508	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.272A>C	p.Y91S | p.Tyr91Ser	TAC=>TCC	P0=>P0	NM_005514.6(HLA-B): c.272A>C (p.Y91S)	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.366813	U	0.4345	0.366813	12432	0	PASS	583	6140	0.408306	6090	100234	0.313427	1753	5344	4.80662e-01	16199	58940	3.38701e-01	rs1071816	.	.	.	-1.502	-0.795	-1.353	0.19	0.001	0	0.050	neutral	ENST00000412585: c.272A>C (p.Y91S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4160817	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324546	31324547	6p21.33	.	G	snv	C	GT.TT	hom-alt	540	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.261C>G	p.N87K | p.Asn87Lys	AAC=>AAG	P0=>P+	NM_005514.6(HLA-B): c.261C>G (p.N87K)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	102320	0.345670	U	0.5853	0.454872	12530	0.205188	PASS	637	5820	0.465636	6175	97312	0.340051	2164	5845	5.46160e-01	17697	60311	3.41226e-01	rs1065386	.	.	.	-1.610	-0.549	-0.885	0.04	0.101	0.047	0.356	neutral	ENST00000412585: c.261C>G (p.N87K)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [plasma_cell_myeloma|NS|NS]	RSS	329391	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324548	31324549	6p21.33	.	T	snv	C	GT.CC	hom-alt	547	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.259A>G	p.N87D | p.Asn87Asp	AAC=>GAC	P0=>P-	NM_005514.6(HLA-B): c.259A>G (p.N87D)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	102256	0.344743	U	0.5853	0.454872	12534	0.188527	PASS	640	5802	0.465874	6159	97248	0.339071	2163	5823	5.46350e-01	17658	60057	3.39904e-01	rs1050570	.	.	.	-3.744	-3.846	-3.541	0.05	0.03	0.004	0.347	neutral	ENST00000412585: c.259A>G (p.N87D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [plasma_cell_myeloma|NS|NS]	RSS	329392	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324585	31324586	6p21.33	.	C	snv	T	CA.GG	hom-alt	678	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.222G>A	p.(P74=) | p.(Pro74=)	CCG=>CCA	.	NM_005514.6(HLA-B): c.222G>A (p.(P74=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	83616	0.311412	U	0.7133	0.641174	12584	0.327638	PASS	419	4272	0.344101	5818	78608	0.290403	1641	3610	4.25607e-01	19189	46031	3.07974e-01	rs1050556	.	.	.	-0.379	-1.128	-0.813	.	.	.	.	.	ENST00000412585: c.222G>A (p.P74P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4006338	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324602	31324603	6p21.33	.	C	snv	T	CT.TC	hom-alt	695	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.205G>A	p.E69K | p.Glu69Lys	GAG=>AAG	P-=>P+	NM_005514.6(HLA-B): c.205G>A (p.E69K)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.484824	U	0.4256	0.484824	.	.	PASS	51	3866	0.111743	998	73910	0.095995	896	2216	2.79445e-01	6025	19115	1.35398e-01	rs9266178	.	.	.	-0.833	-2.372	-3.012	0.08	0	0	0.300	neutral	ENST00000412585: c.205G>A (p.E69K)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160819	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324603	31324604	6p21.33	.	T	snv	C	TC.CT	hom-alt	695	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.204A>G	p.(R68=) | p.(Arg68=)	AGA=>AGG	.	NM_005514.6(HLA-B): c.204A>G (p.(R68=))	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	55046	0.130273	U	.	.	12070	0	PASS	51	2776	0.159942	983	55046	0.130273	879	2332	2.90918e-01	5796	19629	1.40059e-01	rs9266179	.	.	.	-0.525	0.109	-0.418	.	.	.	.	.	ENST00000412585: c.204A>G (p.R68R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160820	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324614	31324615	6p21.33	.	C	snv	T	CG.GG	hom-alt	702	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.193G>A	p.A65T | p.Ala65Thr	GCG=>ACG	NP=>P0	NM_005514.6(HLA-B): c.193G>A (p.A65T)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	91460	0.105434	U	0.256	0.211262	12694	0.086498	PASS	51	4886	0.133852	719	86452	0.099304	604	2300	2.00035e-01	4255	21080	1.12126e-01	rs1050529	.	.	.	0.448	-0.314	-0.088	0.12	0.987	0.998	0.697	deleterious	ENST00000412585: c.193G>A (p.A65T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160821	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324640	31324641	6p21.33	.	T	snv	A	AC.GG	hom-alt	645	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.167A>T	p.Q56L | p.Gln56Leu	CAG=>CTG	P0=>NP	NM_005514.6(HLA-B): c.167A>T (p.Q56L)	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	103338	0.106447	U	0.2054	0.198682	12604	0.061409	PASS	65	6422	0.102305	1171	98330	0.101749	421	2450	1.73907e-01	4891	26128	1.29120e-01	rs1050518	.	.	.	0.368	0.891	1.476	0.01	0.983	0.998	0.835	deleterious	ENST00000412585: c.167A>T (p.Q56L)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	4160822	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324642	31324643	6p21.33	.	G	snv	C	TG.GT	hom-alt	634	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.165C>G	p.(T55=) | p.(Thr55=)	ACC=>ACG	.	NM_005514.6(HLA-B): c.165C>G (p.(T55=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	103894	0.378684	U	0.3631	0.375799	12602	0.342882	PASS	473	6254	0.327630	9669	98886	0.378830	1620	5770	4.20186e-01	24566	86628	4.19165e-01	rs1050517	.	.	.	-0.382	-0.080	-0.055	.	.	.	.	.	ENST00000412585: c.165C>G (p.T55T)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	4160823	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324663	31324664	6p21.33	.	T	snv	G	AC.GA	hom-alt	629	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.144A>C	p.(S48=) | p.(Ser48=)	TCA=>TCC	.	NM_005514.6(HLA-B): c.144A>C (p.(S48=))	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	106726	0.130793	U	0.2629	0.22524	12492	0.033782	PASS	112	7194	0.156936	1423	101718	0.126143	450	2800	2.02079e-01	4833	27034	1.37491e-01	rs9266184	.	.	.	-0.424	-0.788	-0.875	.	.	.	.	.	ENST00000412585: c.144A>C (p.S48S)	urinary_tract [bladder|NS|NS]	carcinoma [NS|NS|NS]	CSV	4006339	.	.	.	.	.	.	.	.	.	Unknown
Pass	6	31324665	31324666	6p21.33	.	A	snv	T	TG.GA	hom-alt	623	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.142T>A	p.S48T | p.Ser48Thr	TCA=>ACA	P0=>P0	NM_005514.6(HLA-B): c.142T>A (p.S48T)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	109620	0.127431	U	0.245	0.197484	12476	0	PASS	113	7596	0.152054	1434	104612	0.124078	452	2743	2.04457e-01	4866	26810	1.43020e-01	rs713031	.	.	.	-3.242	-3.083	-2.734	0.18	0.001	0	0.056	neutral	ENST00000412585: c.142T>A (p.S48T)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	3253076	.	.	.	.	.	.	.	.	.	Unknown
Pass	6	31324701	31324702	6p21.33	.	C	snv	T	CA.GG	hom-alt	662	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.106G>A	p.V36M | p.Val36Met	GTG=>ATG	NP=>NP	NM_005514.6(HLA-B): c.106G>A (p.V36M)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	98452	0.504947	U	0.6994	0.676518	12186	0.449204	PASS	868	7194	0.563942	10412	93444	0.495751	3277	9519	6.90183e-01	30808	101936	5.49348e-01	rs1050486	.	.	.	0.448	1.274	0.660	0.09	0.101	0.434	0.304	neutral	ENST00000412585: c.106G>A (p.V36M)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761868	.	.	.	.	.	.	.	.	.	Unknown
Pass	6	31324704	31324705	6p21.33	.	A	snv	C	GG.GG	hom-alt	667	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.103T>G	p.S35A | p.Ser35Ala	TCC=>GCC	P0=>NP	NM_005514.6(HLA-B): c.103T>G (p.S35A)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	96382	0.571735	U	0.7312	0.705072	12082	0.548171	PASS	1523	6930	0.674459	14455	91374	0.564428	4209	10465	7.70732e-01	40080	114822	6.23870e-01	rs1131170	.	.	.	-4.197	-0.541	-0.833	1	0.003	0	0.000	neutral	ENST00000412585: c.103T>G (p.S35A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761869	.	.	.	.	.	.	.	.	.	Unknown
Pass	6	31324710	31324711	6p21.33	.	A	snv	G	GT.GA	hom-alt	690	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.97T>C	p.Y33H | p.Tyr33His	TAC=>CAC	P0=>P+	NM_005514.6(HLA-B): c.97T>C (p.Y33H)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	90342	0.167574	U	0.1647	0.158347	12070	0.107125	PASS	51	6320	0.109810	1701	85334	0.168116	284	2312	1.59514e-01	3886	32152	1.65325e-01	rs2596492	.	.	.	-3.831	-7.550	-7.871	0.55	0.837	0.921	0.327	neutral	ENST00000412585: c.97T>C (p.Y33H)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5019352	.	.	.	.	.	.	.	.	.	Unknown
Pass	6	31324741	31324742	6p21.33	.	T	snv	C	GG.GA	hom-alt	592	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.74-8A>G	.	.	.	NM_005514.6(HLA-B): c.74-8A>G	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	78328	0.823537	U	0.9266	0.894169	.	.	PASS	2260	5198	0.925741	25251	73320	0.818712	6210	12769	9.55620e-01	68246	152786	8.46816e-01	rs147324178	.	.	.	-2.049	-0.571	-0.821	.	.	.	.	.	ENST00000412585: c.74-8A>G (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160824	.	.	.	.	.	.	.	.	.	Benign
Pass	6	31324749	31324750	6p21.33	.	G	snv	A	GG.GC	het-ref	338	0.50	.	2	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.74-16C>T	.	.	.	NM_005514.6(HLA-B): c.74-16C>T	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	69590	0.015419	U	0.1071	0.0453275	.	.	VQSRTrancheSNP99.80to99.90	2	3836	0.030240	10	64582	0.013100	122	1257	9.67370e-02	238	4684	2.41329e-02	rs41558815	.	.	.	0.435	2.058	1.799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
Pass	6	31324846	31324847	6p21.33	.	C	snv	G	CT.CC	hom-alt	804	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.73+16G>C	.	.	.	NM_005514.6(HLA-B): c.73+16G>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	58128	0.260563	U	0.4196	0.331869	.	.	PASS	356	4334	0.398708	2115	53120	0.253840	1220	4757	4.29487e-01	7532	34839	2.51956e-01	rs9266198	.	.	.	0.448	0.819	0.614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	31324920	31324921	6p21.33	.	C	snv	T	GG.GC	hom-alt	618	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C1	EX1	.	.	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.15G>A	p.(A5=) | p.(Ala5=)	GCG=>GCA	.	NM_005514.6(HLA-B): c.15G>A (p.(A5=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	81330	0.152465	U	0.1895	0.158946	12346	0.118257	PASS	240	5550	0.266486	1669	76322	0.152040	702	3293	2.59741e-01	4411	23509	1.29649e-01	rs1050459	.	.	.	-0.497	-1.090	-1.376	.	.	.	.	.	ENST00000412585: c.15G>A (p.A5A)	upper_aerodigestive_tract [mouth|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	3722060	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	31324924	31324925	6p21.33	.	A	snv	G	CC.TG	hom-alt	587	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C1	EX1	.	.	missense	NM_005514.6	NP_005505.2	-	Y	c.11T>C	p.M4T | p.Met4Thr	ATG=>ACG	NP=>P0	NM_005514.6(HLA-B): c.11T>C (p.M4T)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	82180	0.601862	U	0.8452	0.792332	.	.	PASS	2030	5936	0.812837	14909	77172	0.589501	4762	10065	8.63208e-01	37736	87304	6.02188e-01	rs1050458	.	.	.	-1.590	-0.068	-0.217	0.12	0	0	0.261	neutral	ENST00000412585: c.11T>C (p.M4T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3722059	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32172064	32172065	6p21.32	.	T	snv	G	AA.CC	hom-alt	234	1.00	.	0	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C19	EX19	EGF-like domain	PF00008.22	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.2967A>C	p.(G989=) | p.(Gly989=)	GGA=>GGC	.	NM_004557.3(NOTCH4): c.2967A>C (p.(G989=))	;maf-5-some-pop,genotype-conflict	121246	0.918414	U	0.9921	0.963259	8434	0.903367	PASS	4239	8520	0.997535	49037	116238	0.916482	8531	17097	9.97957e-01	101467	220711	9.15570e-01	rs1044506	.	4024	0.992300	-0.121	-0.242	-0.232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32184704	32184705	6p21.32	.	G	snv	A	CA.TG	hom-alt	500	1.00	.	0	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC11	IVS11	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.1861+17C>T	.	.	.	NM_004557.3(NOTCH4): c.1861+17C>T	;maf-5-some-pop,maf-5-all-pops	121300	0.774460	U	0.9137	0.824481	8440	0.769668	PASS	3433	8524	0.896997	35249	116292	0.772306	6868	15339	8.95238e-01	71651	184229	7.64214e-01	rs3134798	.	4024	0.897600	-0.521	-0.405	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	32188296	32188297	6p21.32	.	G	snv	C	CC.CC	het-ref	224	0.44	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C6	EX6	Calcium-binding EGF domain	PF07645.10	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.1044C>G	p.(G348=) | p.(Gly348=)	GGC=>GGG	.	NM_004557.3(NOTCH4): c.1044C>G (p.(G348=))	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	118848	0.318928	U	0.2976	0.320288	.	.	PASS	161	8434	0.201684	6007	113840	0.318869	322	3296	1.92771e-01	12414	74890	3.13781e-01	rs423023	.	4024	0.186100	-2.269	-1.291	-1.465	.	.	.	.	.	ENST00000375023: c.1044C>G (p.G348G)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	3830202	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32188382	32188383	6p21.32	.	T	snv	C	GG.CT	het-ref	269	0.48	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C6	EX6	Calcium-binding EGF domain	PF07645.10	missense	NM_004557.3	NP_004548.3	-	Y	c.958A>G	p.T320A | p.Thr320Ala	ACC=>GCC	P0=>NP	NM_004557.3(NOTCH4): c.958A>G (p.T320A)	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	122656	0.401073	U	0.2212	0.343051	8440	0.400237	PASS	134	8528	0.173194	10236	117648	0.403543	264	2879	1.67598e-01	21043	97403	4.01414e-01	rs422951	.	4024	0.210500	-1.194	-0.142	-1.001	0.49	0.003	0	0.011	neutral	ENST00000375023: c.958A>G (p.T320A)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	451253	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32188602	32188603	6p21.32	.	C	snv	T	CA.TG	het-ref	295	0.47	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	EGF-like domain	PF00008.22	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.852G>A	p.(Q284=) | p.(Gln284=)	CAG=>CAA	.	NM_004557.3(NOTCH4): c.852G>A (p.(Q284=))	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126360	0.304487	U	0.1935	0.267772	13006	0.284100	PASS	84	8648	0.140379	6157	121352	0.306002	172	2350	1.36248e-01	12563	75439	3.06513e-01	rs520803	.	4024	0.149400	-1.656	-1.906	-0.977	.	.	.	.	.	ENST00000375023: c.852G>A (p.Q284Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003968	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32188639	32188640	6p21.32	.	T	snv	C	AG.CT	het-ref	290	0.46	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	Human growth factor-like EGF	PF12661.2	missense	NM_004557.3	NP_004548.3	-	Y	c.815A>G	p.D272G | p.Asp272Gly	GAC=>GGC	P-=>P0	NM_004557.3(NOTCH4): c.815A>G (p.D272G)	MixedObserved;maf-5-some-pop,maf-5-all-pops	125970	0.304295	U	0.1935	0.267772	13006	0.282869	PASS	81	8636	0.140111	6081	120962	0.305807	170	2346	1.36063e-01	12445	75114	3.05804e-01	rs520692	.	4024	0.149100	0.402	2.812	0.865	0.34	0.001	0.001	0.023	neutral	ENST00000375023: c.815A>G (p.D272G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003969	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32188641	32188642	6p21.32	.	T	snv	C	TC.GG	het-ref	294	0.46	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	EGF-like domain;Human growth factor-like EGF	PF00008.22;PF12661.2	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.813A>G	p.(P271=) | p.(Pro271=)	CCA=>CCG	.	NM_004557.3(NOTCH4): c.813A>G (p.(P271=))	;maf-5-some-pop	125940	0.309640	U	0.2421	0.280152	13006	0.283408	PASS	164	8636	0.200208	6197	120932	0.310861	325	3324	1.92785e-01	12640	76188	3.10298e-01	rs520688	.	4024	0.187400	-4.087	-1.224	-1.539	.	.	.	.	.	ENST00000375023: c.813A>G (p.P271P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3722800	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32189031	32189032	6p21.32	.	T	snv	C	TA.GT	het-ref	279	0.44	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C4	EX4	.	.	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.522A>G	p.(T174=) | p.(Thr174=)	ACA=>ACG	.	NM_004557.3(NOTCH4): c.522A>G (p.(T174=))	;maf-5-some-pop,maf-5-all-pops	121084	0.309983	U	0.2421	0.279952	8438	0.283479	PASS	158	8494	0.199082	6005	116076	0.311279	320	3295	1.92330e-01	12363	74226	3.10975e-01	rs415929	.	4024	0.187900	-2.250	-3.742	-4.223	.	.	.	.	.	ENST00000375023: c.522A>G (p.T174T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019317	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32190389	32190390	6p21.32	.	T	snv	G	CT.GG	het-ref	186	0.50	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C3	EX3	.	.	missense	NM_004557.3	NP_004548.3	-	Y	c.349A>C	p.K117Q | p.Lys117Gln	AAG=>CAG	P+=>P0	NM_004557.3(NOTCH4): c.349A>C (p.K117Q)	;maf-5-some-pop	125848	0.360038	U	0.5109	0.398762	13006	0.372213	PASS	923	8630	0.462341	7979	120840	0.358433	1758	7576	4.62289e-01	15010	82535	3.51497e-01	rs915894	.	4024	0.513200	-0.217	1.853	0.361	0.51	0	0	0.009	neutral	ENST00000375023: c.349A>C (p.K117Q)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4417696	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32190405	32190406	6p21.32	.	A	snv	G	TC.CC	hom-alt	372	1.00	.	0	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C3	EX3	Human growth factor-like EGF	PF12661.2	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.333T>C	p.(G111=) | p.(Gly111=)	GGT=>GGC	.	NM_004557.3(NOTCH4): c.333T>C (p.(G111=))	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	126224	0.383564	U	0.5615	0.460663	13006	0.403967	PASS	1074	8640	0.498843	9240	121216	0.380379	2076	8305	4.98260e-01	17670	89388	3.74937e-01	rs443198	.	4024	0.546200	-3.068	-2.396	-3.487	.	.	.	.	.	ENST00000375023: c.333T>C (p.G111G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4417276	CM030916	NM_004557.3(NOTCH4): c.333T>C (p.G111G)	"Alopecia universalis, association with ?"	12589427	DP	.	.	.	.	Likely Benign
Pass	6	32190870	32190871	6p21.32	.	T	snv	A	GG.GG	het-ref	114	0.47	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC1	IVS1	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.74-8A>T	.	.	.	NM_004557.3(NOTCH4): c.74-8A>T	;maf-5-some-pop,maf-5-all-pops	126138	0.075045	U	0.1339	0.11262	13006	0.080348	PASS	100	8618	0.154096	539	121130	0.073491	209	2667	1.54680e-01	982	17283	7.02807e-02	rs2854049	.	4024	0.138700	-0.542	0.325	0.028	.	.	.	.	.	ENST00000375023: c.74-8A>T (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019502	.	.	.	.	.	.	.	.	.	Benign
Pass	6	32944093	32944094	6p21.32	.	G	snv	C	CT.TA	het-ref	270	0.49	.	2	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	C5	EX5	.	.	coding-synon	NM_001199455.1	NP_001186384.1	+	Y	c.678G>C	p.(L226=) | p.(Leu226=)	CTG=>CTC	.	NM_001199455.1(BRD2): c.678G>C (p.(L226=))	;maf-5-some-pop	121342	0.064462	U	0.0208	0.0477236	8440	0.056991	PASS	6	8518	0.026532	270	116334	0.065183	8	384	2.24142e-02	617	15786	6.54380e-02	rs15912	.	4024	0.017900	0.643	0.679	0.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	32945529	32945530	6p21.32	.	G	snv	C	TT.TA	hom-alt	658	1.00	.	0	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	IC7	IVS7	.	.	intron	NM_001199455.1	NP_001186384.1	+	Y	c.1330-4G>C	.	.	.	NM_001199455.1(BRD2): c.1330-4G>C	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,microattr-tpa,rs-cluster-nonoverlapping-alleles	121070	0.952366	U	0.995	0.979832	8434	0.940479	PASS	4213	8512	0.994948	52573	116062	0.951181	8459	17021	9.93985e-01	108682	228287	9.50594e-01	rs3097644	.	4024	0.990600	-2.938	-0.354	-0.633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	95242	criteria_provided,_single_submitter	Benign	Benign
Pass	6	32948425	32948426	6p21.32	.	C	snv	T	TC.AG	het-ref	384	0.51	.	2	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	C13E	EX13E	.	.	coding-synon	NM_001199455.1	NP_001186384.1	+	Y	c.2442C>T	p.(S814=) | p.(Ser814=)	TCC=>TCT	.	NM_001199455.1(BRD2): c.2442C>T (p.(S814=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,genotype-conflict	121264	0.069617	U	0.0397	0.0605032	8440	0.063389	PASS	9	8518	0.041324	293	116256	0.070009	17	597	3.48389e-02	675	16755	6.94692e-02	rs2071876	.	4024	0.029100	0.643	2.007	0.871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	33288270	33288271	6p21.32	.	A	snv	G	GC.TA	het-ref	255	0.44	.	2	.	PASS	603186	P	.	NN	.	.	.	.	.	.	.	1616	DAXX	C4	EX4	Daxx Family	PF03344.10	coding-synon	NM_001141970.1	NP_001135442.1	-	Y	c.1173T>C	p.(Y391=) | p.(Tyr391=)	TAT=>TAC	.	NM_001141970.1(DAXX): c.1173T>C (p.(Y391=))	;maf-5-some-pop	126212	0.292492	U	0.2619	0.220847	13006	0.218899	PASS	246	8610	0.244135	5800	121204	0.295452	552	4322	2.50667e-01	11892	73597	2.99058e-01	rs1059231	.	4024	0.251200	0.523	0.230	0.277	.	.	.	.	.	ENST00000266000: c.1137T>C (p.Y379Y)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	5019618	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	35423540	35423541	6p21.31	.	G	snv	T	GC.AT	het-ref	240	0.47	.	2	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	C2	EX2	.	.	missense	NM_021922.2	NP_068741.1	+	Y	c.266G>T	p.R89L | p.Arg89Leu	CGA=>CTA	P+=>NP	NM_021922.2(FANCE): c.266G>T (p.R89L)	SingleClassTriAllelic;clinically-assoc,submitted-by-lsdb	126400	0.001028	U	0.0149	0.00359425	.	.	PASS	1	8650	0.010751	1	121392	0.000923	2	186	1.07839e-02	2	232	9.42492e-04	rs45600543	.	.	.	0.561	0.230	0.560	1	0.084	0.52	0.006	neutral	.	.	.	.	.	.	.	.	.	.	no_record	134334	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	VUS
Pass	6	35423661	35423662	6p21.31	.	A	snv	C	CC.GA	hom-alt	608	1.00	.	0	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	C2	EX2	.	.	coding-synon	NM_021922.2	NP_068741.1	+	Y	c.387A>C	p.(P129=) | p.(Pro129=)	CCA=>CCC	.	NM_021922.2(FANCE): c.387A>C (p.(P129=))	SingleClassTriAllelic;maf-5-some-pop	126212	0.723394	U	0.7133	0.777955	13006	0.735660	PASS	2035	8638	0.683839	31791	121204	0.721140	4023	11776	6.83142e-01	64526	177387	7.21009e-01	rs4713867	.	.	.	-1.389	-1.018	-0.891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	261435	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	6	36651970	36651971	6p21.2	.	C	snv	A	AG.CG	het-ref	328	0.51	.	2	.	PASS	116899	C	.	NN	.	.	.	.	.	.	.	1026	CDKN1A	C1	EX3	.	.	missense	NM_078467.2	NP_510867.1	+	Y	c.93C>A	p.S31R | p.Ser31Arg	AGC=>AGA	P0=>P+	NM_078467.2(CDKN1A): c.93C>A (p.S31R)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	124792	0.152213	U	0.4881	0.25619	13006	0.127557	PASS	1039	8574	0.484371	2497	119784	0.147866	2115	8446	4.90818e-01	5396	37219	1.52389e-01	rs1801270	.	4024	0.488600	-1.383	-0.583	-0.519	1	0.001	0	0.000	neutral	ENST00000244741: c.93C>A (p.S31R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762017	CM940226	NM_078467.2(CDKN1A): c.93C>A (p.S31R)	"Cancer, association with"	7655464	DFP	no_record	17565	no_assertion_criteria_provided	Benign	Likely Benign
Pass	6	36652338	36652339	6p21.2	.	C	snv	G	CA.GG	hom-alt	344	1.00	.	0	.	PASS	116899	C	.	NN	.	.	.	.	.	.	.	1026	CDKN1A	IC1	IVS3	.	.	intron	NM_078467.2	NP_510867.1	+	Y	c.445+16C>G	.	.	.	NM_078467.2(CDKN1A): c.445+16C>G	SingleClassTriAllelic;maf-5-some-pop	124556	0.372162	U	0.6121	0.503594	13006	0.387821	PASS	1536	8542	0.596465	9174	119548	0.366656	3119	10255	5.97611e-01	18481	88744	3.64117e-01	rs3176352	.	4024	0.583000	-0.216	0.976	0.746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	41903781	41903782	6p21.1	.	A	snv	C	AG.GG	het-ref	223	0.48	.	2	.	PASS	123834	C	.	NN	.	.	.	.	.	.	.	896	CCND3	C5E	EX5E	Cyclin, C-terminal domain	PF02984.14	missense	NM_001760.3	NP_001751.1	-	Y	c.775T>G	p.S259A | p.Ser259Ala	TCT=>GCT	P0=>NP	NM_001760.3(CCND3): c.775T>G (p.S259A)	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop	124610	0.546272	U	0.504	0.592452	13006	0.624327	PASS	1175	8536	0.529991	18016	119602	0.544339	2412	9098	5.29693e-01	36046	131230	5.37405e-01	rs1051130	.	4024	0.557700	-0.352	-0.033	-0.245	0.41	0.001	0	0.015	neutral	ENST00000372991: c.775T>G (p.S259A)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	451455	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	51890822	51890823	6p12.2	.	G	snv	A	GA.CG	het-ref	167	0.46	.	2	.	PASS	606702	C	263200(MK)	AR	Polycystic kidney disease, autosomal recessive	AR	.	Allergy/Immunology/Infectious; Endocrine; Gastrointestinal; Renal	Allergy/Immunology/Infectious; Gastrointestinal; Pulmonary; Pharmacogenomic; Renal	24162162|24114580|23941846|23041322|22882926|22464505|21896375|21046169|20301501|16523049|15706593|15108277|13764315|12728091|12506140|11919560|7554350|4688793|2702087	.	5314	PKHD1	C31	EX32	.	.	missense	NM_138694.3	NP_619639.3	-	Y	c.3785C>T	p.A1262V | p.Ala1262Val	GCT=>GTT	NP=>NP	NM_138694.3(PKHD1): c.3785C>T (p.A1262V)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125640	0.465170	U	0.381	0.354633	13006	0.392357	PASS	558	8576	0.356343	14368	120632	0.469759	1100	6129	3.56586e-01	30218	117708	4.79928e-01	rs9296669	.	4024	0.326500	0.655	-0.049	-0.700	0.68	0.001	0	0.002	neutral	ENST00000371117: c.3785C>T (p.A1262V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4004072	.	.	.	.	.	no_record	96399	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	6	93956646	93956647	6q16.1	.	A	snv	T	CC.GC	het-ref	137	0.48	.	2	.	PASS	602190	P	.	NN	.	.	.	.	.	.	.	2045	EPHA7	C15	EX15	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_004440.3	NP_004431.1	-	Y	c.2589T>A	p.(A863=) | p.(Ala863=)	GCT=>GCA	.	NM_004440.3(EPHA7): c.2589T>A (p.(A863=))	;	126272	0.000721	U	0.004	0.000798722	.	.	PASS	1	8636	0.010074	1	121264	0.000717	0	191	1.10815e-02	0	191	7.76322e-04	rs55780501	.	4024	0.008200	0.482	0.496	1.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
InExcel	6	106534484	106534484	6q21	.	.	ins	T	AA.TT	het-ref	39	0.15	.	2	.	PASS	603423	P	.	NN	.	.	.	.	.	.	.	639	PRDM1	IC1	IVS1	.	.	intron	NM_001198.3	NP_001189.2	+	Y	c.42+14_42+15insT	.	.	.	NM_001198.3(PRDM1): c.42+14_42+15insT	DuplicateObserved;	17073	0.933052	U	.	.	.	.	VQSRTrancheINDEL97.00to99.00	0	712	0.064607	0	19402	0.120039	.	.	.	.	.	.	rs760651087	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	106553434	106553435	6q21	.	C	snv	T	CC.GA	het-ref	330	0.49	.	2	.	PASS	603423	P	.	NN	.	.	.	.	.	.	.	639	PRDM1	C5	EX5	.	.	missense	NM_001198.3	NP_001189.2	+	Y	c.1400C>T	p.P467L | p.Pro467Leu	CCG=>CTG	NP=>NP	NM_001198.3(PRDM1): c.1400C>T (p.P467L)	;clinically-assoc,submitted-by-lsdb	125284	0.000519	U	0.006	0.00119808	.	.	PASS	0	8616	0.005919	0	120276	0.000491	1	113	6.55757e-03	1	123	5.01145e-04	rs77256382	.	.	.	0.655	6.103	2.715	0.06	0.887	0.999	0.669	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	135084	no_assertion_provided	not_provided	VUS
Pass	6	110777961	110777962	6q21	.	A	snv	G	TT.TT	het-ref	236	0.46	.	2	.	PASS	608276	C	.	NN	.	.	.	.	.	.	.	85413	SLC22A16	C2	EX2	.	.	coding-synon	NM_033125.3	NP_149116.2	-	Y	c.312T>C	p.(N104=) | p.(Asn104=)	AAT=>AAC	.	NM_033125.3(SLC22A16): c.312T>C (p.(N104=))	;maf-5-some-pop,maf-5-all-pops	126384	0.256567	U	0.4107	0.314097	13006	0.270414	PASS	777	8626	0.418038	4220	121376	0.254194	1512	7171	4.15758e-01	8304	61775	2.50914e-01	rs6907567	.	4024	0.451000	-1.096	-0.175	-0.211	.	.	.	.	.	ENST00000368919: c.312T>C (p.N104N)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761423	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	110778127	110778128	6q21	.	T	snv	C	GA.GA	het-ref	270	0.51	.	2	.	PASS	608276	C	.	NN	.	.	.	.	.	.	.	85413	SLC22A16	C2	EX2	.	.	missense	NM_033125.3	NP_149116.2	-	Y	c.146A>G	p.H49R | p.His49Arg	CAT=>CGT	P+=>P+	NM_033125.3(SLC22A16): c.146A>G (p.H49R)	;maf-5-some-pop,maf-5-all-pops	125030	0.258458	U	0.4097	0.313898	13006	0.270414	PASS	777	8626	0.417807	4206	120022	0.256145	1509	7157	4.15621e-01	8240	61391	2.50471e-01	rs714368	.	4024	0.451000	-1.875	0.507	-0.837	0.25	0	0	0.037	neutral	ENST00000368919: c.146A>G (p.H49R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761426	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	117631463	117631463	6q22.1	.	.	ins	TAA	TT.ta	het-ref	81	0.43	.	2	(TAA)n|Simple_repeat|Simple_repeat|+|27	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC39	IVS39	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.6234-20_6234-19insTTA	.	.	.	NM_002944.2(ROS1): c.6234-20_6234-19insTTA	MixedObserved,FlankMismatchGenomeLonger;|MixedObserved;maf-5-some-pop	0|98251	0|0.741977	U	0.0774	0.0283546	.	.	PASS	150	5012	0.225060	1446	93256	0.176289	.	.	.	.	.	.	rs2243387|rs71554877	.	4024	0.413800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	117641015	117641016	6q22.1	.	G	snv	A	TC.AA	het-ref	282	0.48	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC36	IVS36	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5940+15C>T	.	.	.	NM_002944.2(ROS1): c.5940+15C>T	;maf-5-some-pop	125454	0.023347	U	0.0496	0.0375399	13006	0.015454	PASS	15	8636	0.069708	100	120446	0.022757	37	1180	6.84375e-02	219	5769	2.35646e-02	rs2071974	.	4024	0.068100	-2.366	-0.259	-0.303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	117642417	117642418	6q22.1	.	A	snv	C	AC.TA	het-ref	344	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC35	IVS35	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5777+4T>G	.	.	.	NM_002944.2(ROS1): c.5777+4T>G	SingleClassTriAllelic;maf-5-some-pop	126006	0.023269	U	0.0496	0.0375399	13006	0.015454	PASS	15	8646	0.069628	100	120998	0.022678	36	1177	6.85099e-02	219	5732	2.34166e-02	rs55708202	.	4024	0.068300	-0.119	-2.631	-2.490	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	117662681	117662682	6q22.1	.	A	snv	G	CA.CT	het-ref	326	0.51	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C29	EX29	.	.	coding-synon	NM_002944.2	NP_002935.2	-	Y	c.4783T>C	p.(L1595=) | p.(Leu1595=)	TTG=>CTG	.	NM_002944.2(ROS1): c.4783T>C (p.(L1595=))	;maf-5-some-pop	126246	0.024151	U	0.0615	0.0401358	13006	0.015224	PASS	24	8638	0.081153	110	121238	0.023491	53	1403	8.14088e-02	237	6011	2.44330e-02	rs3752564	.	4024	0.081300	-0.290	-1.888	-1.788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	117678082	117678083	6q22.1	.	A	snv	G	AT.GA	hom-alt	608	1.00	.	0	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC24	IVS24	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.3855-5T>C	.	.	.	NM_002944.2(ROS1): c.3855-5T>C	;maf-5-some-pop,maf-5-all-pops	125590	0.462831	U	0.4762	0.394569	13006	0.425419	PASS	866	8598	0.455338	13453	120582	0.465667	1714	7629	4.51313e-01	26712	111997	4.69101e-01	rs2243384	.	4024	0.457500	-0.400	0.054	0.057	.	.	.	.	.	ENST00000368508: c.3855-5T>C (p.?)	lung [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	3726793	.	.	.	.	.	.	.	.	.	Benign
Pass	6	117708970	117708971	6q22.1	.	C	snv	T	GG.TC	het-ref	300	0.47	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C13	EX13	.	.	coding-synon	NM_002944.2	NP_002935.2	-	Y	c.1986G>A	p.(E662=) | p.(Glu662=)	GAG=>GAA	.	NM_002944.2(ROS1): c.1986G>A (p.(E662=))	;maf-5-some-pop	126232	0.065776	U	0.0308	0.0644968	13006	0.062125	PASS	4	8654	0.020337	374	121224	0.065829	7	378	2.19156e-02	718	16335	6.64516e-02	rs9489143	.	4024	0.012400	0.561	0.123	-0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	117725577	117725578	6q22.1	.	T	snv	A	GG.AG	het-ref	290	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C5	EX5	.	.	coding-synon	NM_002944.2	NP_002935.2	-	Y	c.303A>T	p.(L101=) | p.(Leu101=)	CTA=>CTT	.	NM_002944.2(ROS1): c.303A>T (p.(L101=))	;maf-5-some-pop	126366	0.554659	U	0.5675	0.67512	13006	0.599185	PASS	1404	8650	0.577572	19424	121358	0.549688	2913	10070	5.85329e-01	37471	132275	5.38632e-01	rs2243378	.	4024	0.562600	-1.231	-1.117	-0.837	.	.	.	.	.	ENST00000368508: c.303A>T (p.L101L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3761460	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	117730818	117730819	6q22.1	.	G	snv	A	AG.GA	het-ref	188	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC3	IVS3	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.229-14C>T	.	.	.	NM_002944.2(ROS1): c.229-14C>T	;maf-5-some-pop,maf-5-all-pops	125928	0.282701	U	0.2738	0.360224	13006	0.316623	PASS	295	8612	0.266837	5388	120920	0.279491	631	4676	2.71639e-01	10201	66099	2.68936e-01	rs2273601	.	4024	0.263400	-1.975	-0.169	-0.164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	127476515	127476516	6q22.33	.	G	snv	A	CT.TG	het-ref	116	0.42	.	2	.	PASS	610574	P	.	NN	.	.	.	.	.	.	.	84870	RSPO3	C4	EX4	Thrombospondin type 1 domain	PF00090.14	coding-synon	NM_032784.3	NP_116173.2	+	Y	c.567G>A	p.(L189=) | p.(Leu189=)	CTG=>CTA	.	NM_032784.3(RSPO3): c.567G>A (p.(L189=))	;maf-5-some-pop,maf-5-all-pops	126120	0.538075	U	0.494	0.532748	13006	0.553360	PASS	1330	8590	0.550291	17712	121112	0.538295	2675	9561	5.55678e-01	35279	131031	5.33544e-01	rs1892172	.	4024	0.533800	-0.224	1.152	1.352	.	.	.	.	.	ENST00000356698: c.567G>A (p.L189L)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1568095	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	137519587	137519588	6q23.3	.	A	snv	C	CT.GA	hom-alt	713	1.00	.	0	.	PASS	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	C7E	EX7E	.	.	coding-synon	NM_000416.2	NP_000407.1	-	Y	c.1050T>G	p.(S350=) | p.(Ser350=)	TCT=>TCG	.	NM_000416.2(IFNGR1): c.1050T>G (p.(S350=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126328	0.130217	U	0.1062	0.0940495	13006	0.128633	PASS	61	8648	0.120143	1223	121320	0.131710	121	2124	1.23145e-01	2415	32382	1.31564e-01	rs11914	.	4024	0.116600	-1.264	-1.353	-1.543	.	.	.	.	.	ENST00000367739: c.1050T>G (p.S350S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761497	.	.	.	.	.	no_record	355554	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	6	137540369	137540370	6q23.3	.	A	snv	G	GA.CG	hom-alt	267	1.00	.	0	.	PASS	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	IC1	IVS1	.	.	intron	NM_000416.2	NP_000407.1	-	Y	c.85+10T>C	.	.	.	NM_000416.2(IFNGR1): c.85+10T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	93842	0.484389	U	0.5873	0.502396	12996	0.428209	PASS	1109	6804	0.591270	9469	88834	0.483373	2612	9134	5.74177e-01	21649	96262	4.29987e-01	rs7749390	.	4024	0.584500	-0.981	0.565	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	355562	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	6	138195961	138195964	6q23.3	.	CTC	del	.	TT.CT	hom-alt	348	1.00	.	0	.	PASS	191163	P	.	NN	.	.	.	.	.	.	.	7128	TNFAIP3	IC1	IVS2	.	.	intron	NM_006290.3	NP_006281.1	+	Y	c.296-20_296-18delCTC	.	.	.	NM_006290.3(TNFAIP3): c.296-20_296-18delCTC	MixedObserved;maf-5-some-pop,maf-5-all-pops	125226	0.607478	U	0.8482	0.533946	12518	0.482505	PASS	3069	8596	0.846208	23626	120218	0.610541	6201	14502	8.52557e-01	47851	148396	6.15991e-01	rs71670547	.	4033	0.851100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	6	152129076	152129077	6q25.1	.	T	snv	C	TC.GG	het-ref	207	0.48	.	2	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C1	EX3	.	.	coding-synon	NM_001122742.1	NP_001116214.1	+	Y	c.30T>C	p.(S10=) | p.(Ser10=)	TCT=>TCC	.	NM_001122742.1(ESR1): c.30T>C (p.(S10=))	SingleClassTriAllelic;maf-5-some-pop	124498	0.465421	U	0.378	0.466454	13006	0.478856	PASS	549	8538	0.363317	12936	119490	0.465378	1130	6239	3.63282e-01	25995	111995	4.62106e-01	rs2077647	.	4024	0.395100	-1.096	-1.304	-1.276	.	.	.	.	.	ENST00000440973: c.30T>C (p.S10S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3761554	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	152420094	152420095	6q25.1	.	G	snv	A	AC.GT	het-ref	177	0.47	.	2	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C8E	EX10E	.	.	coding-synon	NM_001122742.1	NP_001116214.1	+	Y	c.1782G>A	p.(T594=) | p.(Thr594=)	ACG=>ACA	.	NM_001122742.1(ESR1): c.1782G>A (p.(T594=))	;maf-5-some-pop,genotype-conflict	124824	0.189258	U	0.2014	0.188698	13006	0.171998	PASS	202	8546	0.211561	2236	119816	0.189282	418	3775	2.19349e-01	4843	47531	1.93849e-01	rs2228480	.	4024	0.229400	-0.269	-1.214	-3.007	.	.	.	.	.	ENST00000440973: c.1782G>A (p.T594T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761556	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	152716745	152716746	6q25.2	.	A	snv	G	GT.TT	het-ref	171	0.44	.	2	.	PASS	608441	C	610743(MK);612998(MK)	NN	Emery-Dreifuss muscular dystrophy 4, autosomal dominant; Spinocerebellar ataxia, autosomal recessive 8	AD/AR	.	Cardiovascular; Musculoskeletal	Cardiovascular	20301609|20301553|19542096|17761684|17503513|17159980	.	23345	SYNE1	C50	EX51	.	.	coding-synon	NM_033071.3	NP_149062.1	-	Y	c.7638T>C	p.(N2546=) | p.(Asn2546=)	AAT=>AAC	.	NM_033071.3(SYNE1): c.7638T>C (p.(N2546=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-0.038	-0.489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	6	152716745	152716746	6q25.2	.	A	snv	G	GT.TT	het-ref	171	0.44	.	2	.	PASS	608441	C	610743(MK);612998(MK)	NN	Emery-Dreifuss muscular dystrophy 4, autosomal dominant; Spinocerebellar ataxia, autosomal recessive 8	AD/AR	.	Cardiovascular; Musculoskeletal	Cardiovascular	20301609|20301553|19542096|17761684|17503513|17159980	.	23345	SYNE1	C49	EX51	.	.	coding-synon	NM_182961.3	NP_892006.3	-	N	c.7617T>C	p.(N2539=) | p.(Asn2539=)	AAT=>AAC	.	NM_182961.3(SYNE1): c.7617T>C (p.(N2539=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-0.038	-0.489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	6	157405929	157405930	6q25.3	.	G	snv	A	GC.TC	het-ref	327	0.50	.	2	.	PASS	614556	C	614562(MK)	NN	Mental retardation, autosomal dominant, 12; Coffin-Siris syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22426309|22426308|22405089	.	57492	ARID1B	C6	EX6	.	.	coding-synon	NM_020732.3	NP_065783.3	+	Y	c.2172G>A	p.(A724=) | p.(Ala724=)	GCG=>GCA	.	NM_020732.3(ARID1B): c.2172G>A (p.(A724=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126358	0.518099	U	0.5734	0.495208	13006	0.472628	PASS	1312	8632	0.554217	16778	121350	0.519044	2612	9461	5.48846e-01	34393	128607	5.22746e-01	rs3734441	.	4024	0.524600	-0.808	-2.570	-3.111	.	.	.	.	.	ENST00000346085: c.2172G>A (p.A724A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1487405	.	.	.	.	.	no_record	126320	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	6	160670281	160670282	6q25.3	.	A	snv	C	AG.AA	hom-alt	395	1.00	.	0	.	PASS	602608	P	.	NN	.	.	.	.	.	.	.	6582	SLC22A2	C4	EX4	Sugar (and other) transporter;Major Facilitator Superfamily	PF00083.19;PF07690.11	missense	NM_003058.3	NP_003049.2	-	Y	c.808T>G	p.S270A | p.Ser270Ala	TCT=>GCT	P0=>NP	NM_003058.3(SLC22A2): c.808T>G (p.S270A)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126394	0.892099	U	0.8641	0.86262	13006	0.879133	PASS	3315	8650	0.876301	48522	121386	0.893316	6425	14716	8.72732e-01	96928	215240	8.98916e-01	rs316019	.	4024	0.873300	-2.734	0.184	-0.415	0.01	0.394	0.267	0.532	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	6	162622196	162622197	6q26	.	C	snv	T	TG.TG	het-ref	274	0.49	.	2	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	C4	EX4	.	.	missense	NM_004562.2	NP_004553.2	-	Y	c.500G>A	p.S167N | p.Ser167Asn	AGC=>AAC	P0=>P0	NM_004562.2(PARK2): c.500G>A (p.S167N)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126396	0.069559	U	0.3393	0.117412	13006	0.039213	PASS	731	8630	0.399537	952	121388	0.067585	1370	6758	3.91814e-01	1882	17204	6.99338e-02	rs1801474	.	.	.	-0.152	1.216	0.769	0.41	0.012	0.004	0.015	neutral	ENST00000366898: c.500G>A (p.S167N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3761635	CM992652	NM_004562.2(PARK2): c.500G>A (p.S167N)	"Parkinson disease, in heterozygosity, association"	10511432	DP	no_record	41223	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	6	162683814	162683816	6q26	.	AA	del	.	GT.aa	het-ref	42	0.44	.	2	(A)n|Simple_repeat|Simple_repeat|+|26	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC2	IVS2	.	.	intron	NM_004562.2	NP_004553.2	-	Y	c.172-19_172-18delTT	.	.	.	NM_004562.2(PARK2): c.172-19_172-18delTT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	1058	0.096408	1	19070	0.121342	.	.	.	.	.	.	rs776185117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	7	2946460	2946461	7p22.2	.	T	snv	C	GG.CG	het-ref	184	0.46	.	2	.	PASS	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	C24E	EX25E	.	.	coding-synon	NM_032415.4	NP_115791.3	-	Y	c.3276A>G	p.(R1092=) | p.(Arg1092=)	CGA=>CGG	.	NM_032415.4(CARD11): c.3276A>G (p.(R1092=))	;maf-5-some-pop,maf-5-all-pops	122026	0.519594	U	0.6508	0.596446	13006	0.546594	PASS	1760	8486	0.647301	15658	117018	0.516305	3525	11034	6.43757e-01	31951	123594	5.08982e-01	rs1124581	.	4024	0.622300	-1.183	0.454	0.161	.	.	.	.	.	ENST00000396946: c.3276A>G (p.R1092R)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762618	.	.	.	.	.	no_record	402477	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	7	2962752	2962753	7p22.2	.	G	snv	A	CC.CC	hom-alt	400	1.00	.	0	.	PASS	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	IC15	IVS16	.	.	intron	NM_032415.4	NP_115791.3	-	Y	c.2142+13C>T	.	.	.	NM_032415.4(CARD11): c.2142+13C>T	;maf-5-some-pop,maf-5-all-pops	121946	0.672355	U	0.3849	0.505391	12990	0.634642	PASS	613	8422	0.395156	28093	116938	0.679505	1229	6529	3.82439e-01	57016	161338	6.78278e-01	rs2527509	.	.	.	-1.242	0.351	0.362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	402479	criteria_provided,_single_submitter	Benign	Benign
HHReport	7	6022625	6022626	7p22.1	.	C	snv	T	TG.AG	hom-alt	133	0.99	.	0	dup	DUBIOUS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC11	IVS11	.	.	intron	NM_000535.5	NP_000526.1	-	Y	c.2007-4G>A	.	.	.	NM_000535.5(PMS2): c.2007-4G>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	34370	0.155950	U	0.2778	0.16274	.	.	PASS	44	1654	0.256953	293	29362	0.154792	434	3080	2.86992e-01	1952	24029	1.60084e-01	rs140788589	.	4024	0.323100	0.561	0.601	-0.063	.	.	.	.	.	ENST00000265849: c.2007-4G>A (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5020045	.	.	.	.	.	no_record	91327	reviewed_by_expert_panel	Benign	Benign
HHReport	7	6026987	6026988	7p22.1	.	G	snv	A	AG.TC	hom-alt	676	1.00	.	0	dup	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	C11	EX11	.	.	missense	NM_000535.5	NP_000526.1	-	Y	c.1408C>T	p.P470S | p.Pro470Ser	CCT=>TCT	NP=>P0	NM_000535.5(PMS2): c.1408C>T (p.P470S)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126388	0.384317	U	0.3601	0.358227	13006	0.373827	PASS	615	8634	0.377345	9186	121380	0.385393	1261	6490	3.76276e-01	18823	95521	3.87906e-01	rs1805321	.	4024	0.400100	-0.145	-0.011	0.386	.	.	.	.	.	ENST00000265849: c.1408C>T (p.P470S)	skin [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	3736445	.	.	.	.	.	no_record	36685	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	7	6036979	6036980	7p22.1	.	G	snv	C	TC.GA	hom-alt	471	1.00	.	0	.	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	C7	EX7	.	.	coding-synon	NM_000535.5	NP_000526.1	-	Y	c.780C>G	p.(S260=) | p.(Ser260=)	TCC=>TCG	.	NM_000535.5(PMS2): c.780C>G (p.(S260=))	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb|MixedObserved;clinically-assoc,submitted-by-lsdb	125626|0	0.811671|0	U	0.879	0.83127	13006	0.823774	PASS	3667	8640	0.921875	39906	120618	0.810857	7328	15897	9.23064e-01	79497	196619	8.01512e-01	rs1805319|rs587779344	.	4024	0.928900	-2.835	-4.664	-5.634	.	.	.	.	.	ENST00000265849: c.780C>G (p.S260S)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4162330	.	.	.	.	.	no_record	36693	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	7	6037057	6037059	7p22.1	.	AA	del	.	TG.AA	het-alt	40	0.35	.	1	.	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC6	IVS6	.	.	intron	NM_000535.5	NP_000526.1	-	Y	c.706-5_706-4delTT	.	.	.	NM_000535.5(PMS2): c.706-5_706-4delTT	MixedObserved;	0	0	U	0.125	0.0916534	.	.	PASS	0	4704	0.255952	0	62852	0.146312	.	.	.	.	.	.	rs776641246	.	4024	2.000000	.	.	.	.	.	.	.	.	ENST00000265849: c.706-5_706-4delTT (p.?)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_III|anaplastic|NS]	CSV	1735836	.	.	.	.	.	no_record	218462	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
HHReport	7	6037057	6037059	7p22.1	.	AA	rep	A	TG.AA	het-alt	54	0.48	.	2	.	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC6	IVS6	.	.	intron	NM_000535.5	NP_000526.1	-	Y	c.706-5T[2>1] (std: c.706-5T[1] alt: c.706-4delT )	.	.	.	NM_000535.5(PMS2): c.706-5T[1]	MixedObserved;	0	0	U	0.4931	0.453075	.	.	InbreedingCoeff_Filter	0	4	1.000000	89	180	0.994444	.	.	.	.	.	.	rs776641246	.	4024	2.000000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
HHReport	7	6038721	6038722	7p22.1	.	T	snv	C	AG.AA	hom-alt	379	1.00	.	0	.	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC6	IVS6	.	.	intron	NM_000535.5	NP_000526.1	-	Y	c.705+17A>G	.	.	.	NM_000535.5(PMS2): c.705+17A>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126376	0.366090	U	0.3591	0.325679	13006	0.343918	PASS	575	8640	0.365509	8511	121368	0.367758	1182	6306	3.65608e-01	17259	90720	3.68445e-01	rs62456182	.	4024	2.000000	0.477	0.170	-0.080	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36692	reviewed_by_expert_panel	Benign	Benign
Pass	7	6431689	6431690	7p22.1	.	C	snv	T	GA.TT	hom-alt	247	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC3	IVS3	.	.	intron	NM_018890.3	NP_061485.1	+	Y	c.225+18C>T	.	.	.	NM_018890.3(RAC1): c.225+18C>T	;maf-5-some-pop,genotype-conflict	126402	0.565505	U	0.9008	0.691494	13006	0.542519	PASS	3560	8652	0.907305	20459	121394	0.560308	7162	15706	9.10810e-01	41438	137817	5.60122e-01	rs836478	.	.	.	-0.381	0.080	0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	7	50467940	50467941	7p12.2	.	C	snv	T	AA.AG	het-ref	394	0.54	.	2	.	PASS	603023	P	603023(MK)	NN	.	.	.	.	.	.	.	10320	IKZF1	C7E	EX8E	.	.	coding-synon	NM_006060.4	NP_006051.1	+	Y	c.1176C>T	p.(N392=) | p.(Asn392=)	AAC=>AAT	.	NM_006060.4(IKZF1): c.1176C>T (p.(N392=))	;maf-5-some-pop	81600	0.079167	U	0.1091	0.0589058	12762	0.048425	PASS	40	5314	0.157132	183	76592	0.080491	81	1665	9.90718e-02	386	12551	5.28023e-02	rs61731356	.	.	.	0.585	3.410	1.385	.	.	.	.	.	ENST00000331340_v65: c.1176C>T (p.N392N)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4162286	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	7	53103945	53103946	7p12.1	.	G	snv	C	GG.CC	het-ref	157	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	285877	POM121L12	C1E	EX1E	POM121 family	PF15229.1	coding-synon	NM_182595.3	NP_872401.3	+	Y	c.582G>C	p.(G194=) | p.(Gly194=)	GGG=>GGC	.	NM_182595.3(POM121L12): c.582G>C (p.(G194=))	SingleClassTriAllelic;maf-5-some-pop	125242	0.433625	U	0.3026	0.328874	12226	0.408228	PASS	330	8540	0.280679	12228	120234	0.437988	645	4746	2.75578e-01	25539	109069	4.43991e-01	rs12113170	.	4024	0.281600	0.561	-1.653	-1.678	.	.	.	.	.	ENST00000408890: c.582G>C (p.G194G)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4162293	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	7	55229254	55229255	7p11.2	.	G	snv	A	CA.GG	hom-alt	522	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C13	EX13	Growth factor receptor domain IV	PF14843.1	missense	NM_005228.3	NP_005219.2	+	Y	c.1562G>A	p.R521K | p.Arg521Lys	AGG=>AAG	P+=>P+	NM_005228.3(EGFR): c.1562G>A (p.R521K)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126372	0.287168	U	0.5238	0.292133	13006	0.202676	PASS	1228	8638	0.535888	5607	121364	0.286963	2409	9192	5.32993e-01	11551	71955	2.92248e-01	rs2227983	.	4024	0.510900	-0.165	-1.137	-1.106	0.49	0	0	0.011	neutral	ENST00000275493: c.1562G>A (p.R521K)	autonomic_ganglia [sinonasal_and_nasal_cavity|NS|NS]	olfactory_neuroblastoma [NS|NS|NS]	CSV	3721608	CM942312	NM_005228.3(EGFR): c.1562G>A (p.R521K)	"Altered transmembrane signaling, association with ?"	7937865	DP	no_record	134021	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	7	55238873	55238874	7p11.2	.	T	snv	A	AC.GG	hom-alt	345	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C16	EX16	Growth factor receptor domain IV	PF14843.1	coding-synon	NM_005228.3	NP_005219.2	+	Y	c.1887T>A	p.(T629=) | p.(Thr629=)	ACT=>ACA	.	NM_005228.3(EGFR): c.1887T>A (p.(T629=))	SingleClassTriAllelic;maf-5-some-pop	126352	0.374660	U	0.5347	0.390375	13006	0.322467	PASS	1248	8644	0.541185	8872	121344	0.374011	2482	9331	5.40990e-01	18027	92507	3.75797e-01	rs2227984	.	4024	0.517600	-0.379	-1.067	-0.735	.	.	.	.	.	ENST00000275493: c.1887T>A (p.T629T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762772	.	.	.	.	.	no_record	259677	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	7	55268915	55268916	7p11.2	.	C	snv	T	GA.TC	het-ref	347	0.45	.	2	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C25	EX25	.	.	coding-synon	NM_005228.3	NP_005219.2	+	Y	c.2982C>T	p.(D994=) | p.(Asp994=)	GAC=>GAT	.	NM_005228.3(EGFR): c.2982C>T (p.(D994=))	;maf-5-some-pop	126396	0.134031	U	0.247	0.141773	13006	0.070429	PASS	351	8648	0.277636	1448	121388	0.133712	657	4736	2.74614e-01	2944	34020	1.38144e-01	rs2293347	.	4024	0.271900	-0.127	1.189	0.855	.	.	.	.	.	ENST00000275493: c.2982C>T (p.D994D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3762773	.	.	.	.	.	no_record	259679	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	7	81346684	81346685	7q21.11	.	T	snv	C	TG.GG	het-ref	277	0.48	.	2	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC10	IVS10	.	.	intron	NM_000601.4	NP_000592.3	-	Y	c.1272-4A>G	.	.	.	NM_000601.4(HGF): c.1272-4A>G	SingleClassTriAllelic;maf-5-some-pop	126380	0.805017	U	0.8839	0.798323	13006	0.753037	PASS	3171	8650	0.854104	39611	121372	0.805293	6303	14721	8.53688e-01	81524	199842	8.12207e-01	rs1800793	.	4024	0.860300	-1.819	-0.165	-0.280	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	43607	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
Pass	7	83590851	83590852	7q21.11	.	T	snv	C	AT.GT	het-ref	213	0.50	.	2	.	PASS	603961	P	614897(SK)	NN	Hypogonadotropic hypogonadism 16 with or without anosmia	AD	.	Endocrine; Genitourinary; Neurologic	Endocrine	22416012	.	10371	SEMA3A	C17E	EX17E	.	.	coding-synon	NM_006080.2	NP_006071.1	-	Y	c.2151A>G	p.(T717=) | p.(Thr717=)	ACA=>ACG	.	NM_006080.2(SEMA3A): c.2151A>G (p.(T717=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126374	0.613156	U	0.6915	0.612021	13006	0.583577	PASS	2147	8640	0.703009	23039	121366	0.613203	4303	12162	7.05289e-01	47112	151581	6.15872e-01	rs797821	.	4024	0.704000	-1.617	-1.352	-2.812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	194754	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	7	87138644	87138645	7q21.12	.	A	snv	G	AC.AT	het-ref	257	0.45	.	2	.	PASS	171050	C	120080(SK);612244(SK)	NN	Colchicine metabolism, association with	AD	.	General	Pharmacogenomic	21851199|18973929|17259950|7188928|7129432	.	5243	ABCB1	C25	EX27	ABC transporter;Predicted ATPase of the ABC class	PF00005.22;PF09818.4	coding-synon	NM_000927.4	NP_000918.2	-	Y	c.3435T>C	p.(I1145=) | p.(Ile1145=)	ATT=>ATC	.	NM_000927.4(ABCB1): c.3435T>C (p.(I1145=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,genotype-conflict	126374	0.507454	U	0.6022	0.604832	13006	0.576657	PASS	1695	8632	0.624537	16362	121366	0.503436	3496	10906	6.32745e-01	32702	123561	5.02154e-01	rs1045642	.	4024	0.601100	-0.716	-1.682	-1.747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	225939	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	7	87160617	87160618	7q21.12	.	A	snv	C	AG.AC	het-ref	156	0.47	.	2	.	PASS	171050	C	120080(SK);612244(SK)	NN	Colchicine metabolism, association with	AD	.	General	Pharmacogenomic	21851199|18973929|17259950|7188928|7129432	.	5243	ABCB1	C20	EX22	ABC transporter transmembrane region	PF00664.18	missense	NM_000927.4	NP_000918.2	-	Y	c.2677T>G	p.S893A | p.Ser893Ala	TCT=>GCT	P0=>NP	NM_000927.4(ABCB1): c.2677T>G (p.S893A)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126142	0.546162	U	0.4683	0.617013	13006	0.678072	PASS	929	8638	0.465270	19017	121134	0.543233	1970	8191	4.75337e-01	37325	131738	5.36834e-01	rs2032582	.	4024	0.442800	-0.187	2.078	0.319	1	0.01	0	0.001	neutral	.	.	.	.	.	CM033585	NM_000927.4(ABCB1): c.2677T>G (p.S893A)	"Inflammatory bowel disease, association with"	14610718	DP	no_record	166622	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	7	88956698	88956699	7q21.13	.	A	snv	G	GT.GC	het-ref	169	0.55	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	219578	ZNF804B	C3	EX3	.	.	coding-synon	NM_181646.2	NP_857597.1	+	Y	c.291A>G	p.(V97=) | p.(Val97=)	GTA=>GTG	.	NM_181646.2(ZNF804B): c.291A>G (p.(V97=))	;maf-5-some-pop,genotype-conflict	125774	0.234087	U	0.6716	0.30631	13002	0.179126	PASS	2136	8620	0.704060	4545	120766	0.231092	4129	11832	6.99539e-01	9243	56932	2.34392e-01	rs38971	.	4024	0.709700	0.528	-0.146	-0.110	.	.	.	.	.	ENST00000333190: c.291A>G (p.V97V)	prostate [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4966403	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	7	106508986	106508987	7q22.3	.	T	snv	C	GA.GA	hom-alt	661	1.00	.	0	.	PASS	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	C1	EX2	.	.	coding-synon	NM_002649.2	NP_002640.2	+	Y	c.981T>C	p.(D327=) | p.(Asp327=)	GAT=>GAC	.	NM_002649.2(PIK3CG): c.981T>C (p.(D327=))	;maf-5-some-pop	126166	0.949804	U	0.997	0.940895	13006	0.918730	PASS	4312	8644	0.998843	54751	121158	0.950173	8591	17211	9.98318e-01	111895	234544	9.53315e-01	rs849390	.	4024	0.997000	-3.265	0.015	-0.779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	7	106522591	106522592	7q22.3	.	A	snv	G	AG.CT	het-ref	190	0.44	.	2	.	PASS	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	C6	EX7	Phosphatidylinositol 3- and 4-kinase	PF00454.22	missense	NM_002649.2	NP_002640.2	+	Y	c.2569A>G	p.T857A | p.Thr857Ala	ACT=>GCT	P0=>NP	NM_002649.2(PIK3CG): c.2569A>G (p.T857A)	;maf-5-some-pop	126292	0.055823	U	0.0317	0.063099	13006	0.053437	PASS	8	8652	0.032362	266	121284	0.055523	8	402	2.74628e-02	455	11729	5.25022e-02	rs28763991	.	4024	0.033100	0.533	0.905	1.015	0.49	0.002	0.001	0.011	neutral	ENST00000440650: c.2569A>G (p.T857A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762311	.	.	.	.	.	.	.	.	.	Likely Benign
HHReport	7	116397571	116397572	7q31.2	.	A	snv	G	CA.TA	het-ref	245	0.50	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C6	EX7	IPT/TIG domain	PF01833.19	coding-synon	NM_001127500.1	NP_001120972.1	+	Y	c.1944A>G	p.(Q648=) | p.(Gln648=)	CAA=>CAG	.	NM_001127500.1(MET): c.1944A>G (p.(Q648=))	;maf-5-some-pop,maf-5-all-pops	125542	0.187818	U	0.2728	0.187899	11896	0.168712	PASS	393	8612	0.300511	2318	120534	0.187814	740	5066	2.93715e-01	4493	44933	1.82698e-01	rs13223756	.	4024	0.304400	0.477	-0.346	-1.499	.	.	.	.	.	ENST00000318493: c.1944A>G (p.Q648Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419559	.	.	.	.	.	no_record	93569	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	7	116435767	116435768	7q31.2	.	C	snv	T	GA.GT	het-ref	297	0.49	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C19	EX20	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_001127500.1	NP_001120972.1	+	Y	c.3912C>T	p.(D1304=) | p.(Asp1304=)	GAC=>GAT	.	NM_001127500.1(MET): c.3912C>T (p.(D1304=))	;maf-5-some-pop	125744	0.420028	U	0.4673	0.352236	11994	0.323495	PASS	884	8612	0.456224	11511	120736	0.422840	1800	7913	4.58831e-01	24180	106398	4.32284e-01	rs41736	.	4024	0.448600	-1.616	-1.191	-3.368	.	.	.	.	.	ENST00000318493: c.3912C>T (p.D1304D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150377	.	.	.	.	.	no_record	93574	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	7	116436021	116436022	7q31.2	.	G	snv	A	GC.AT	het-ref	284	0.47	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C20E	EX21E	.	.	coding-synon	NM_001127500.1	NP_001120972.1	+	Y	c.4071G>A	p.(A1357=) | p.(Ala1357=)	GCG=>GCA	.	NM_001127500.1(MET): c.4071G>A (p.(A1357=))	SingleClassTriAllelic;maf-5-some-pop	125738	0.421710	U	0.4673	0.353834	12220	0.322504	PASS	884	8606	0.456310	11606	120730	0.424526	1800	7910	4.58923e-01	24363	106754	4.34048e-01	rs2023748	.	4024	0.448600	-0.844	-2.469	-3.546	.	.	.	.	.	ENST00000318493: c.4071G>A (p.A1357A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150378	.	.	.	.	.	no_record	93575	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	7	116436096	116436097	7q31.2	.	G	snv	A	CC.TA	het-ref	268	0.46	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C20E	EX21E	.	.	coding-synon	NM_001127500.1	NP_001120972.1	+	Y	c.4146G>A	p.(P1382=) | p.(Pro1382=)	CCG=>CCA	.	NM_001127500.1(MET): c.4146G>A (p.(P1382=))	;maf-5-some-pop	125738	0.421989	U	0.4673	0.354633	12400	0.321048	PASS	884	8598	0.456850	11610	120730	0.424783	1800	7912	4.58826e-01	24372	106783	4.34250e-01	rs41737	.	4024	0.448600	-0.254	-0.042	-0.723	.	.	.	.	.	ENST00000318493: c.4146G>A (p.P1382P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150379	.	.	.	.	.	no_record	93576	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	7	124486979	124486980	7q31.33	.	T	snv	C	AA.GA	hom-alt	284	1.00	.	0	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC8	IVS12	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.1006+16A>G	.	.	.	NM_015450.2(POT1): c.1006+16A>G	;maf-5-some-pop,maf-5-all-pops	126166	0.696083	U	0.7986	0.721845	13006	0.710441	PASS	2779	8626	0.802226	29380	121158	0.695018	5482	13719	7.98824e-01	59030	169672	6.92895e-01	rs7794637	.	4024	0.799000	-2.871	-1.723	-1.794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	516585	criteria_provided,_single_submitter	Benign	Benign
Pass	7	124499001	124499002	7q31.33	.	A	snv	C	CT.TA	hom-alt	402	1.00	.	0	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC5	IVS9	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.702+9T>G	.	.	.	NM_015450.2(POT1): c.702+9T>G	MixedObserved;maf-5-some-pop,maf-5-all-pops	125756	0.589944	U	0.5089	0.582069	13006	0.097570	PASS	1053	8598	0.496046	21052	120748	0.590271	2033	8175	4.95515e-01	39733	135284	5.82809e-01	rs6977407	.	4024	0.496500	-1.294	-1.697	-1.537	.	.	.	.	.	ENST00000357628: c.702+9T>G (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5428438	.	.	.	.	.	no_record	516584	criteria_provided,_single_submitter	Benign	Benign
Pass	7	124499002	124499003	7q31.33	.	T	snv	A	TA.AC	hom-alt	407	1.00	.	0	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC5	IVS9	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.702+8A>T	.	.	.	NM_015450.2(POT1): c.702+8A>T	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|125804	0|0.589775	U	0.5099	0.582468	13006	0.150700	PASS	1054	8600	0.496047	21054	120796	0.590077	2034	8179	4.94977e-01	39722	135266	5.82405e-01	rs201732238|rs6959712	.	4024	0.496500	-0.522	-0.261	0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	516583	criteria_provided,_single_submitter	Benign	Benign
Pass	7	124537277	124537281	7q31.33	.	AAAG	del	.	AA.AA	het-ref	111	0.48	.	2	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	I5U1	IVS4	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.-39-15_-39-12delCTTT	.	.	.	NM_015450.2(POT1): c.-39-15_-39-12delCTTT	;	116456	0.001528	U	.	.	12364	0.000404	PASS	1	8362	0.018775	1	116456	0.001528	2	275	1.95507e-02	2	311	1.56046e-03	rs199955944	.	4024	0.026800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	516603	criteria_provided,_single_submitter	Likely_benign	Likely Benign
Pass	7	128843428	128843429	7q32.1	.	C	snv	T	CA.GG	het-ref	158	0.49	.	2	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	C2	EX2	.	.	missense	NM_005631.4	NP_005622.1	+	Y	c.536C>T	p.T179M | p.Thr179Met	ACG=>ATG	P0=>NP	NM_005631.4(SMO): c.536C>T (p.T179M)	;	86376	0.000938	U	0.0069	0.00139776	.	.	PASS	0	6420	0.009657	0	81368	0.000909	1	140	8.31255e-03	1	157	7.00887e-04	rs115491500	.	4024	0.008900	0.563	3.779	2.584	0.09	0.856	0.996	0.627	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	7	128846327	128846328	7q32.1	.	G	snv	C	GG.AT	hom-alt	592	1.00	.	0	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	C6	EX6	Frizzled/Smoothened family membrane region;Slime mold cyclic AMP receptor	PF01534.12;PF05462.6	coding-synon	NM_005631.4	NP_005622.1	+	Y	c.1164G>C	p.(G388=) | p.(Gly388=)	GGG=>GGC	.	NM_005631.4(SMO): c.1164G>C (p.(G388=))	;maf-5-some-pop,maf-5-all-pops	126402	0.795850	U	0.7718	0.75619	13006	0.789636	PASS	2555	8650	0.769480	38862	121394	0.797486	5130	13273	7.69538e-01	79023	196537	7.98172e-01	rs2228617	.	4024	0.755500	-0.216	2.176	1.256	.	.	.	.	.	ENST00000249373: c.1164G>C (p.G388G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4004294	.	.	.	.	.	no_record	403462	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	7	140449070	140449071	7q34	.	C	snv	G	GA.GT	het-ref	210	0.45	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC16	IVS16	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1992+16G>C	.	.	.	NM_004333.4(BRAF): c.1992+16G>C	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125764	0.214974	U	0.1825	0.348043	13006	0.315931	PASS	137	8612	0.180330	4146	120756	0.209455	308	3199	1.85794e-01	7371	48649	1.98481e-01	rs3789806	.	4024	0.183900	-0.322	0.210	0.392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	40393	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	7	140449149	140449150	7q34	.	T	snv	C	AT.CC	het-ref	233	0.46	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	C16	EX16	Protein kinase domain;Protein tyrosine kinase;Kinase-like	PF00069.20;PF07714.12;PF14531.1	coding-synon	NM_004333.4	NP_004324.2	-	Y	c.1929A>G	p.(G643=) | p.(Gly643=)	GGA=>GGG	.	NM_004333.4(BRAF): c.1929A>G (p.(G643=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125844	0.217881	U	0.1825	0.351038	13006	0.320006	PASS	139	8628	0.181154	4260	120836	0.212362	310	3220	1.86753e-01	7554	49388	2.01162e-01	rs9648696	.	4024	0.184100	-0.355	1.139	-0.010	.	.	.	.	.	ENST00000288602: c.1929A>G (p.G643G)	kidney [NS|NS|NS]	Wilms_tumour [NS|NS|NS]	CSV	4161857	.	.	.	.	.	no_record	40391	reviewed_by_expert_panel	Benign	Likely Benign
Pass	7	148543693	148543694	7q36.1	.	A	del	.	TT.AA	het-ref	205	0.53	.	2	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC1	IVS2	.	.	intron	NM_004456.4	NP_004447.2	-	Y	c.118-4delT	.	.	.	NM_004456.4(EZH2): c.118-4delT	MixedObserved;maf-5-some-pop	79605	0.057107	U	0.6974	0.761182	.	.	PASS	1582	7292	0.683077	24796	103532	0.713432	.	.	.	.	.	.	rs3214332	.	4024	0.685100	0.219	-0.498	-0.627	.	.	.	.	.	ENST00000320356: c.118-4delT (p.?)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_III|anaplastic|NS]	CSV	1735880	.	.	.	.	.	no_record	210966	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	7	150696110	150696111	7q36.1	.	T	snv	G	GA.CC	hom-alt	377	0.99	.	0	.	PASS	163729	C	104300(SK);145500(SK);163729(SK);189800(SK);601367(SK)	AD	.	.	.	.	.	.	.	4846	NOS3	C7	EX8	Nitric oxide synthase, oxygenase domain	PF02898.10	missense	NM_000603.4	NP_000594.2	+	Y	c.894T>G	p.D298E | p.Asp298Glu	GAT=>GAG	P-=>P-	NM_000603.4(NOS3): c.894T>G (p.D298E)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	124906	0.755848	U	0.87	0.823682	12992	0.746613	PASS	3464	8614	0.896564	34567	119898	0.753015	6865	15358	8.92181e-01	70003	183717	7.49706e-01	rs1799983	.	4024	0.881700	-0.143	-0.073	0.032	1	0.003	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	14015	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	7	150704249	150704250	7q36.1	.	C	snv	G	GC.GT	het-ref	191	0.48	.	2	.	PASS	163729	C	104300(SK);145500(SK);163729(SK);189800(SK);601367(SK)	AD	.	.	.	.	.	.	.	4846	NOS3	C16	EX17	Flavodoxin	PF00258.20	coding-synon	NM_000603.4	NP_000594.2	+	Y	c.1998C>G	p.(A666=) | p.(Ala666=)	GCC=>GCG	.	NM_000603.4(NOS3): c.1998C>G (p.(A666=))	SingleClassTriAllelic;maf-5-some-pop	125966	0.344990	U	0.3909	0.43131	13006	0.333154	PASS	585	8590	0.363912	8051	120958	0.341416	1140	6201	3.59770e-01	16646	84686	3.44813e-01	rs2566514	.	4024	0.357900	-0.293	-0.136	0.179	.	.	.	.	.	ENST00000297494: c.1998C>G (p.A666A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4415182	.	.	.	.	.	no_record	403249	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	7	151842396	151842397	7q36.1	.	C	snv	T	AG.AG	het-ref	182	0.44	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC53	IVS53	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.14032-17G>A	.	.	.	NM_170606.2(MLL3): c.14032-17G>A	;maf-5-some-pop	124222	0.074834	U	0.1577	0.158347	13006	0.116638	PASS	125	8606	0.164885	779	119214	0.071326	246	2868	1.66589e-01	1351	16553	6.78407e-02	rs2240819	.	4024	0.186600	-1.781	-3.923	-4.626	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	7	151859224	151859225	7q36.1	.	T	snv	C	CT.CT	het-ref	314	0.50	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C43	EX43	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.11437A>G	p.K3813E | p.Lys3813Glu	AAG=>GAG	P+=>P-	NM_170606.2(MLL3): c.11437A>G (p.K3813E)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	4.704	2.095	0.39	0.086	0.25	0.022	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	7	151860762	151860763	7q36.1	.	C	snv	T	GG.TC	het-ref	297	0.51	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C43	EX43	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.9899G>A	p.S3300N | p.Ser3300Asn	AGC=>AAC	P0=>P0	NM_170606.2(MLL3): c.9899G>A (p.S3300N)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.655	0.694	1.159	0.65	0.001	0	0.003	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	7	151873852	151873853	7q36.1	.	C	snv	T	GC.TG	het-ref	339	0.48	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C38	EX38	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.8685G>A	p.(Q2895=) | p.(Gln2895=)	CAG=>CAA	.	NM_170606.2(MLL3): c.8685G>A (p.(Q2895=))	;maf-5-some-pop,maf-5-all-pops	126286	0.254652	U	0.3016	0.382788	13006	0.341227	PASS	443	8642	0.315668	5155	121278	0.249361	871	5506	3.19337e-01	9403	59209	2.41132e-01	rs6464211	.	4024	0.336000	-1.256	-0.689	-1.511	.	.	.	.	.	ENST00000355193: c.8685G>A (p.Q2895Q)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762511	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	7	151874497	151874498	7q36.1	.	C	snv	T	GG.TG	het-ref	349	0.47	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C38	EX38	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.8040G>A	p.(Q2680=) | p.(Gln2680=)	CAG=>CAA	.	NM_170606.2(MLL3): c.8040G>A (p.(Q2680=))	;maf-5-some-pop	126226	0.074002	U	0.1587	0.158147	13006	0.116485	PASS	130	8648	0.166050	791	121218	0.070526	253	2891	1.67633e-01	1363	16630	6.76242e-02	rs10252263	.	4024	0.190600	-1.859	0.157	-0.689	.	.	.	.	.	ENST00000355193: c.8040G>A (p.Q2680Q)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009479	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	7	151882656	151882657	7q36.1	.	T	snv	G	TC.TT	het-ref	91	0.18	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C34	EX34	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.5068A>C	p.(R1690=) | p.(Arg1690=)	AGA=>CGA	.	NM_170606.2(MLL3): c.5068A>C (p.(R1690=))	;maf-5-some-pop	120386	0.084935	U	.	.	.	.	PASS	0	8498	0.196635	0	120386	0.084935	0	830	5.92519e-02	0	7027	3.17412e-02	rs78697077	.	4024	0.025300	0.523	4.843	1.889	.	.	.	.	.	ENST00000262189: c.5068A>C (p.R1690R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|M2|NS]	CSV	150424	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	7	151891358	151891359	7q36.1	.	A	del	.	TT.AA	het-ref	61	0.17	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC29	IVS29	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.4508-13delT	.	.	.	NM_170606.2(MLL3): c.4508-13delT	MixedObserved;	8569	0.004318	U	.	.	11922	0.084717	PASS	0	2416	0.157285	0	45112	0.189129	.	.	.	.	.	.	rs755118430	.	4024	0.430900	-1.335	-1.207	-1.290	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
InExcel	7	151927020	151927021	7q36.1	.	C	snv	A	CA.AG	het-ref	92	0.15	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	missense	NM_170606.2	NP_733751.2	-	Y	c.2963G>T	p.C988F | p.Cys988Phe	TGT=>TTT	P0=>NP	NM_170606.2(MLL3): c.2963G>T (p.C988F)	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	103606	0.106529	U	.	.	.	.	PASS	0	7906	0.114470	0	103606	0.106529	0	2285	2.28181e-01	0	25316	1.85210e-01	rs28522267	.	4024	0.491300	0.460	5.761	2.303	0	1	1	0.945	deleterious	ENST00000262189: c.2963G>T (p.C988F)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	150426	.	.	.	.	.	no_record	403019	criteria_provided,_single_submitter	Benign	Unknown
Pass	7	151927024	151927025	7q36.1	.	A	snv	G	GT.TG	het-ref	240	0.38	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	missense	NM_170606.2	NP_733751.2	-	Y	c.2959T>C	p.Y987H | p.Tyr987His	TAC=>CAC	P0=>P+	NM_170606.2(MLL3): c.2959T>C (p.Y987H)	;maf-5-some-pop,maf-5-all-pops	108266	0.472845	U	.	.	.	.	InbreedingCoeff_Filter	0	8474	0.488671	0	108266	0.472845	0	4494	4.02616e-01	0	60602	4.11816e-01	rs183684706	.	4024	0.465000	0.377	4.756	1.866	0	1	1	0.945	deleterious	ENST00000262189: c.2959T>C (p.Y987H)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	253767	.	.	.	.	.	.	.	.	.	Unknown
InExcel	7	151927025	151927026	7q36.1	.	T	snv	C	TA.GG	het-ref	95	0.15	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2958A>G	p.(P986=) | p.(Pro986=)	CCA=>CCG	.	NM_170606.2(MLL3): c.2958A>G (p.(P986=))	;maf-5-some-pop,maf-5-all-pops	95384	0.115648	U	.	.	.	.	PASS	0	7574	0.119488	0	95384	0.115648	0	2245	2.31110e-01	0	25476	1.92769e-01	rs28439884	.	4024	0.488600	0.377	-1.001	-0.745	.	.	.	.	.	ENST00000262189: c.2958A>G (p.P986P)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	150428	.	.	.	.	.	.	.	.	.	Unknown
InExcel	7	151927088	151927089	7q36.1	.	A	snv	G	AA.CT	het-ref	102	0.11	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2895T>C	p.(S965=) | p.(Ser965=)	AGT=>AGC	.	NM_170606.2(MLL3): c.2895T>C (p.(S965=))	SingleClassTriAllelic;	114050	0.017711	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	7932	0.103505	0	114050	0.017712	0	163	1.14050e-02	0	431	1.87154e-03	rs775426786	.	4024	0.035800	0.377	0.535	0.265	.	.	.	.	.	ENST00000355193: c.2895T>C (p.S965S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3304339	.	.	.	.	.	.	.	.	.	VUS
InExcel	7	151927126	151927127	7q36.1	.	A	snv	G	AA.CA	het-ref	151	0.28	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC17	IVS17	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2872-15T>C	.	.	.	NM_170606.2(MLL3): c.2872-15T>C	;maf-5-some-pop,maf-5-all-pops	96180	0.489291	U	.	.	.	.	InbreedingCoeff_Filter	0	7968	0.493097	1	96180	0.489291	0	4204	4.27496e-01	1	60196	4.58930e-01	rs62481502	.	4024	0.493500	0.377	3.234	0.763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
InExcel	7	151932964	151932965	7q36.1	.	C	snv	T	CC.GA	het-ref	79	0.13	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C16	EX16	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2706G>A	p.(S902=) | p.(Ser902=)	TCG=>TCA	.	NM_170606.2(MLL3): c.2706G>A (p.(S902=))	SingleClassTriAllelic;maf-5-some-pop	99684	0.321125	U	.	.	.	.	InbreedingCoeff_Filter	0	7006	0.262632	0	99684	0.321125	0	500	4.76644e-02	0	17413	1.40167e-01	rs142922667	.	4024	0.466700	-0.482	-1.147	-1.421	.	.	.	.	.	ENST00000355193: c.2706G>A (p.S902S)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4161999	.	.	.	.	.	.	.	.	.	Unknown
InExcel	7	151932996	151932997	7q36.1	.	C	snv	T	TC.TG	het-ref	40	0.08	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C16	EX16	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2674G>A	p.G892R | p.Gly892Arg	GGA=>AGA	P0=>P+	NM_170606.2(MLL3): c.2674G>A (p.G892R)	;maf-5-some-pop	98998	0.269288	U	.	.	.	.	InbreedingCoeff_Filter	0	7144	0.295213	0	98998	0.269288	0	450	4.32859e-02	0	5144	3.49262e-02	rs199831680	.	4024	0.070800	0.650	5.608	2.530	0	0.999	1	0.935	deleterious	ENST00000355193: c.2674G>A (p.G892R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	396784	.	.	.	.	.	.	.	.	.	Unknown
InExcel	7	151933032	151933033	7q36.1	.	G	snv	A	TT.GG	het-ref	35	0.11	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC15	IVS15	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2653-15C>T	.	.	.	NM_170606.2(MLL3): c.2653-15C>T	SingleClassTriAllelic;maf-5-some-pop	87100	0.174501	U	.	.	.	.	PASS	0	6476	0.140210	0	87100	0.174501	0	274	2.70697e-02	0	5852	4.47011e-02	rs113470386	.	4024	0.318600	-0.269	-1.269	-1.736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
InExcel	7	151935830	151935831	7q36.1	.	G	snv	A	CT.GG	het-ref	69	0.12	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C15	EX15	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2613C>T	p.(P871=) | p.(Pro871=)	CCC=>CCT	.	NM_170606.2(MLL3): c.2613C>T (p.(P871=))	;	106380	0.031294	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	7692	0.023141	0	106380	0.031293	0	22	1.52060e-03	0	316	1.53050e-03	rs62478303	.	4024	0.109800	0.650	4.054	2.749	.	.	.	.	.	ENST00000355193: c.2613C>T (p.P871P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5426312	.	.	.	.	.	.	.	.	.	Unknown
InExcel	7	151935852	151935853	7q36.1	.	T	snv	C	CT.CT	het-ref	40	0.08	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C15	EX15	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2591A>G	p.E864G | p.Glu864Gly	GAA=>GGA	P-=>P0	NM_170606.2(MLL3): c.2591A>G (p.E864G)	;maf-5-some-pop,maf-5-all-pops	93196	0.144223	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	6838	0.105440	0	93196	0.144223	0	199	1.88091e-02	0	5776	3.94913e-02	rs4024420	.	4024	0.235300	0.528	4.771	2.219	0.23	0.376	0.746	0.162	neutral	ENST00000355193: c.2591A>G (p.E864G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4594559	.	.	.	.	.	.	.	.	.	Unknown
InExcel	7	151944980	151944981	7q36.1	.	C	snv	A	CA.CC	het-ref	168	0.16	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC14	IVS14	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2532+6G>T	.	.	.	NM_170606.2(MLL3): c.2532+6G>T	SingleClassTriAllelic;maf-5-some-pop	103254	0.214616	U	.	.	.	.	InbreedingCoeff_Filter	0	6812	0.168820	0	98246	0.225556	0	565	4.34615e-02	0	20371	1.20504e-01	rs3888468	.	4024	0.449600	-0.894	-0.629	-0.179	.	.	.	.	.	ENST00000355193: c.2532+6G>T (p.?)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	5021551	.	.	.	.	.	no_record	218853	criteria_provided,_single_submitter	Benign	Benign
Pass	7	151945006	151945007	7q36.1	.	C	snv	T	AC.AG	het-ref	813	0.52	.	2	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2512G>A	p.G838S | p.Gly838Ser	GGT=>AGT	P0=>P0	NM_170606.2(MLL3): c.2512G>A (p.G838S)	;maf-5-some-pop,maf-5-all-pops	120998	0.494446	U	.	.	.	.	InbreedingCoeff_Filter	0	8628	0.497798	0	120998	0.494446	0	8265	4.98132e-01	0	114143	4.94053e-01	rs2479172	.	4024	0.498000	0.650	5.750	2.658	0.01	0.997	1	0.872	deleterious	ENST00000355193: c.2512G>A (p.G838S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4591269	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	7	151945071	151945071	7q36.1	.	.	ins	T	TG.TA	het-ref	430	0.19	.	2	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	PHD-finger;SET domain;F/Y-rich N-terminus;F/Y rich C-terminus;PHD-like zinc-binding domain;PHD-zinc-finger like domain	PF00628.24;PF00856.23;PF05964.9;PF05965.9;PF13771.1;PF13832.1	frameshift	NM_170606.2	NP_733751.2	-	Y	c.2447dupA	p.Y816*fs*1 | p.Tyr816*fs*1	.	.	NM_170606.2(MLL3): c.2447dupA (p.Y816*fs*1)	;	117646	0.490080	U	.	.	.	.	InbreedingCoeff_Filter	0	8492	0.498116	0	117648	0.490072	0	5743	4.98524e-01	0	80185	4.87453e-01	rs150073007	.	4024	0.499000	.	.	.	.	.	.	.	.	ENST00000262189: c.2447_2448insA (p.Y816fs*1)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	289942	.	.	.	.	.	no_record	403020	criteria_provided,_single_submitter	Benign	Likely Benign
InExcel	7	151945100	151945101	7q36.1	.	G	snv	C	GA.GA	het-ref	299	0.14	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2418C>G	p.(S806=) | p.(Ser806=)	TCC=>TCG	.	NM_170606.2(MLL3): c.2418C>G (p.(S806=))	MixedObserved;maf-5-some-pop,maf-5-all-pops	100712	0.415869	U	.	.	.	.	InbreedingCoeff_Filter	0	6446	0.407540	0	100712	0.415869	0	1593	1.35000e-01	0	38873	2.55256e-01	rs3896406	.	4024	0.434900	-0.806	-0.308	-0.402	.	.	.	.	.	ENST00000355193: c.2418C>G (p.S806S)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1496553	.	.	.	.	.	.	.	.	.	Unknown
Pass	7	151945139	151945140	7q36.1	.	C	snv	T	TG.GA	het-ref	772	0.35	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2379G>A	p.(S793=) | p.(Ser793=)	TCG=>TCA	.	NM_170606.2(MLL3): c.2379G>A (p.(S793=))	SingleClassTriAllelic;maf-5-some-pop	108468	0.456439	U	.	.	.	.	InbreedingCoeff_Filter	0	7976	0.478310	0	108468	0.456439	0	6057	4.66929e-01	0	73639	4.32463e-01	rs2537263	.	4024	0.465500	-0.312	-0.036	-0.077	.	.	.	.	.	ENST00000355193: c.2379G>A (p.S793S)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	452727	.	.	.	.	.	.	.	.	.	Unknown
Pass	7	151945166	151945167	7q36.1	.	G	snv	T	GG.GA	het-ref	741	0.40	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2352C>A	p.(S784=) | p.(Ser784=)	TCC=>TCA	.	NM_170606.2(MLL3): c.2352C>A (p.(S784=))	SingleClassTriAllelic;maf-5-some-pop	115256	0.477580	U	.	.	.	.	InbreedingCoeff_Filter	0	8302	0.487955	0	115256	0.477580	0	6948	4.87921e-01	0	93792	4.77085e-01	rs2537264	.	4024	0.487600	-0.300	-0.990	-1.541	.	.	.	.	.	ENST00000355193: c.2352C>A (p.S784S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4162015	.	.	.	.	.	.	.	.	.	Unknown
Pass	7	151945203	151945204	7q36.1	.	G	snv	A	AT.AT	het-ref	413	0.37	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2315C>T	p.S772L | p.Ser772Leu	TCA=>TTA	P0=>NP	NM_170606.2(MLL3): c.2315C>T (p.S772L)	;maf-5-some-pop,maf-5-all-pops	119336	0.486065	U	.	.	.	.	InbreedingCoeff_Filter	0	8294	0.483964	0	119336	0.486065	0	7821	4.96445e-01	0	100683	4.93157e-01	rs4024453	.	4024	0.499300	0.650	4.467	2.672	0.35	0.34	0.696	0.128	neutral	ENST00000355193: c.2315C>T (p.S772L)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	4162017	.	.	.	.	.	.	.	.	.	Unknown
InExcel	7	151945333	151945334	7q36.1	.	T	snv	C	AT.TT	het-ref	128	0.15	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2185A>G	p.N729D | p.Asn729Asp	AAT=>GAT	P0=>P-	NM_170606.2(MLL3): c.2185A>G (p.N729D)	;	108580	0.044806	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	7896	0.027989	0	108580	0.044806	0	1569	1.51888e-01	0	10784	6.74953e-02	rs4639425	.	4024	0.432900	-0.321	0.440	-0.168	0.5	0.019	0.066	0.011	neutral	ENST00000355193: c.2185A>G (p.N729D)	liver [NS|NS|NS]	carcinoma [NS|NS|NS]	RSS	1635197	.	.	.	.	.	.	.	.	.	Unknown
InExcel	7	151962175	151962176	7q36.1	.	T	snv	A	AA.GG	het-ref	203	0.14	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C8	EX8	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.1131A>T	p.(P377=) | p.(Pro377=)	CCA=>CCT	.	NM_170606.2(MLL3): c.1131A>T (p.(P377=))	;maf-5-some-pop,maf-5-all-pops	117236	0.455372	U	.	.	.	.	InbreedingCoeff_Filter	0	8030	0.441469	0	117236	0.455372	0	2972	2.92175e-01	0	70970	4.08188e-01	rs62478356	.	4024	0.393400	-0.472	0.452	0.708	.	.	.	.	.	ENST00000355193: c.1131A>T (p.P377P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4162021	.	.	.	.	.	.	.	.	.	Unknown
Pass	7	151970855	151970856	7q36.1	.	T	snv	A	GG.GC	het-ref	412	0.47	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C7	EX7	PHD-like zinc-binding domain;PHD-zinc-finger like domain	PF13771.1;PF13832.1	missense	NM_170606.2	NP_733751.2	-	Y	c.946A>T	p.T316S | p.Thr316Ser	ACC=>TCC	P0=>P0	NM_170606.2(MLL3): c.946A>T (p.T316S)	;maf-5-some-pop,maf-5-all-pops	119650	0.527606	U	.	.	.	.	InbreedingCoeff_Filter	305	8528	0.535765	3303	119650	0.527606	27	8634	5.01568e-01	379	123240	5.01542e-01	rs10454320	.	4024	0.499300	0.528	3.302	0.824	0.52	0.378	0.705	0.129	neutral	ENST00000355193: c.946A>T (p.T316S)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	4162023	.	.	.	.	.	.	.	.	.	Unknown
Pass	8	2832138	2832139	8p23.2	.	C	snv	G	CA.GA	het-ref	125	0.52	.	2	.	PASS	608397	P	.	NN	.	.	.	.	.	.	.	64478	CSMD1	C56	EX56	.	.	coding-synon	NM_033225.5	NP_150094.5	-	Y	c.8574G>C	p.(S2858=) | p.(Ser2858=)	TCG=>TCC	.	NM_033225.5(CSMD1): c.8574G>C (p.(S2858=))	;maf-5-some-pop,maf-5-all-pops	105460	0.791343	U	0.8046	0.750998	12098	0.799719	PASS	2369	6942	0.831173	31164	100452	0.793354	5346	13010	8.23418e-01	69551	176638	7.84256e-01	rs667595	.	4024	0.837500	-2.245	-4.205	-5.474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	15508199	15508200	8p22	.	T	snv	C	CT.AT	het-ref	166	0.50	.	2	.	PASS	601385	C	611093(MK)	NN	Mental retardation, autosomal recessive 7	AR	.	Neurologic	General	21739581|18455129|18452889	.	7991	TUSC3	IC2	IVS2	.	.	intron	NM_006765.3	NP_006756.2	+	Y	c.309-6T>C	.	.	.	NM_006765.3(TUSC3): c.309-6T>C	;maf-5-some-pop,maf-5-all-pops	126392	0.336200	U	0.4276	0.293131	13006	0.307166	PASS	749	8636	0.425544	7321	121384	0.337977	1522	7355	4.26476e-01	15295	84843	3.44725e-01	rs1035972	.	4024	0.449600	-0.256	0.171	0.081	.	.	.	.	.	ENST00000503731: c.309-6T>C (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3982433	.	.	.	.	.	no_record	95430	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
Pass	8	20110640	20110641	8p21.3	.	C	snv	T	TG.TC	het-ref	103	0.58	.	2	.	PASS	606551	P	133239(MK)	AD	.	.	.	.	.	.	.	11178	LZTS1	C2	EX2	.	.	coding-synon	NM_021020.2	NP_066300.1	-	Y	c.801G>A	p.(E267=) | p.(Glu267=)	GAG=>GAA	.	NM_021020.2(LZTS1): c.801G>A (p.(E267=))	;maf-5-some-pop,maf-5-all-pops	122520	0.350278	U	0.4623	0.358626	12978	0.365233	PASS	816	8544	0.440309	7521	117512	0.349922	1672	7598	4.42104e-01	14827	82924	3.41766e-01	rs2645386	.	4024	0.460700	0.561	3.158	2.659	.	.	.	.	.	ENST00000381569: c.801G>A (p.E267E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3982461	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	30924556	30924557	8p12	.	C	snv	T	TG.AC	hom-alt	515	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C5	EX6	3'-5' exonuclease	PF01612.15	coding-synon	NM_000553.4	NP_000544.2	+	Y	c.513C>T	p.(C171=) | p.(Cys171=)	TGC=>TGT	.	NM_000553.4(WRN): c.513C>T (p.(C171=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126282	0.702547	U	0.87	0.6873	13006	0.653698	PASS	3193	8646	0.860514	30437	121274	0.703176	6447	14917	8.65356e-01	63212	175211	7.12819e-01	rs1800389	.	.	.	-0.490	0.337	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	130763	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	8	30933816	30933817	8p12	.	T	del	.	CC.TT	het-ref	53	0.25	.	2	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC7	IVS8	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.839+14delT	.	.	.	NM_000553.4(WRN): c.839+14delT	MixedObserved;	285	0.007018	U	.	.	.	.	InbreedingCoeff_Filter	0	5408	0.386095	1	83326	0.403668	.	.	.	.	.	.	rs370040831	.	.	.	-0.394	0.873	0.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	8	30958353	30958354	8p12	.	T	del	.	TC.TT	hom-alt	265	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC16	IVS17	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.1982-11delT	.	.	.	NM_000553.4(WRN): c.1982-11delT	MixedObserved;|MixedObserved;maf-5-some-pop	0|125872	0|0.993811	U	1	0.98123	12518	0.978351	PASS	4287	8574	1.000000	59768	120864	0.994332	8597	17194	1.00000e+00	121778	244546	9.95700e-01	rs200855118|rs3087419	.	.	.	0.482	-1.258	-0.828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256707	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	8	30973956	30973957	8p12	.	G	snv	T	CT.AA	hom-alt	548	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C19	EX20	Helicase conserved C-terminal domain	PF00271.26	coding-synon	NM_000553.4	NP_000544.2	+	Y	c.2361G>T	p.(L787=) | p.(Leu787=)	CTG=>CTT	.	NM_000553.4(WRN): c.2361G>T (p.(L787=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126340	0.447602	U	0.624	0.471246	13006	0.448178	PASS	1654	8634	0.620222	12602	121332	0.446626	3430	10849	6.29365e-01	26162	111383	4.52872e-01	rs1800392	.	.	.	-0.312	0.450	0.735	.	.	.	.	.	ENST00000298139: c.2361G>T (p.L787L)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763318	.	.	.	.	.	no_record	130758	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	8	30999122	30999123	8p12	.	G	snv	A	AC.GT	hom-alt	641	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC24	IVS25	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.3138+7G>A	.	.	.	NM_000553.4(WRN): c.3138+7G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126296	0.449761	U	0.6419	0.494808	13006	0.466016	PASS	1727	8632	0.632414	12655	121288	0.447901	3564	11050	6.40803e-01	26164	111361	4.52382e-01	rs2737335	.	.	.	-0.269	-1.083	-1.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	130755	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	8	30999279	30999280	8p12	.	G	snv	T	TT.CT	hom-alt	465	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C25	EX26	.	.	missense	NM_000553.4	NP_000544.2	+	Y	c.3222G>T	p.L1074F | p.Leu1074Phe	TTG=>TTT	NP=>NP	NM_000553.4(WRN): c.3222G>T (p.L1074F)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125878	0.451040	U	0.6419	0.496006	13006	0.466938	PASS	1723	8618	0.632165	12654	120870	0.449177	3556	11029	6.40774e-01	26195	111370	4.53173e-01	rs1801195	.	.	.	-0.256	-0.190	0.093	0.88	0	0	0.000	neutral	ENST00000298139: c.3222G>T (p.L1074F)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3763319	.	.	.	.	.	no_record	130759	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	8	37693301	37693302	8p11.23	.	T	snv	C	AA.TC	hom-alt	212	1.00	.	0	.	PASS	606823	P	.	NN	.	.	.	.	.	.	.	25960	GPR124	IC13	IVS13	.	.	intron	NM_032777.9	NP_116166.9	+	Y	c.2050+14T>C	.	.	.	NM_032777.9(GPR124): c.2050+14T>C	;maf-5-some-pop	123282	0.954908	U	0.999	0.978834	12994	0.952132	PASS	4291	8590	0.999534	53867	118274	0.953895	8597	17200	9.99651e-01	110556	231498	9.54379e-01	rs10101560	.	4024	0.997800	-0.733	-0.403	-0.119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	8	68995467	68995468	8q13.2	.	C	snv	T	CT.TC	het-ref	177	0.50	.	2	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	IC17	IVS17	.	.	intron	NM_024870.2	NP_079146.2	+	Y	c.1879-7C>T	.	.	.	NM_024870.2(PREX2): c.1879-7C>T	;maf-5-some-pop,maf-5-all-pops	125616	0.525244	U	0.4732	0.522165	13004	0.541218	PASS	886	8614	0.458208	16678	120608	0.525371	1692	7537	4.58790e-01	31716	121111	5.18917e-01	rs1030752	.	4024	0.438400	0.655	0.030	-0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	8	68995632	68995633	8q13.2	.	A	snv	G	GT.TG	het-ref	147	0.48	.	2	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	IC18	IVS18	.	.	intron	NM_024870.2	NP_079146.2	+	Y	c.2027+10A>G	.	.	.	NM_024870.2(PREX2): c.2027+10A>G	;maf-5-some-pop,maf-5-all-pops	126016	0.525060	U	0.4732	0.522165	13006	0.542134	PASS	889	8602	0.459428	16755	121008	0.525180	1731	7659	4.61052e-01	32376	123116	5.21108e-01	rs1030753	.	4024	0.438600	0.533	0.027	0.137	.	.	.	.	.	ENST00000288368: c.2027+10A>G (p.?)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4767791	.	.	.	.	.	.	.	.	.	Benign
Pass	8	69020495	69020496	8q13.2	.	T	snv	C	AG.GC	het-ref	147	0.45	.	2	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	C24	EX24	.	.	coding-synon	NM_024870.2	NP_079146.2	+	Y	c.2868T>C	p.(S956=) | p.(Ser956=)	AGT=>AGC	.	NM_024870.2(PREX2): c.2868T>C (p.(S956=))	;maf-5-some-pop,maf-5-all-pops	126210	0.449560	U	0.4663	0.479832	13006	0.443872	PASS	917	8614	0.464012	12381	121202	0.448309	1867	8001	4.64688e-01	24786	109585	4.45641e-01	rs4260880	.	4024	0.456500	-0.256	0.001	-0.732	.	.	.	.	.	ENST00000288368: c.2868T>C (p.S956S)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3763384	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	95419697	95419698	8q22.1	.	A	snv	G	CA.TT	het-ref	184	0.45	.	2	.	PASS	604289	P	114500(MK);605027(MK)	AD	.	.	.	.	.	.	.	25788	RAD54B	C4	EX5	.	.	coding-synon	NM_012415.3	NP_036547.1	-	Y	c.750T>C	p.(N250=) | p.(Asn250=)	AAT=>AAC	.	NM_012415.3(RAD54B): c.750T>C (p.(N250=))	;maf-5-some-pop,maf-5-all-pops	126212	0.412734	U	0.4663	0.418131	13006	0.361141	PASS	936	8636	0.467230	10744	121204	0.412511	1890	8110	4.70691e-01	22607	103071	4.19616e-01	rs2291439	.	4024	0.479900	0.528	1.448	0.398	.	.	.	.	.	ENST00000336148: c.750T>C (p.N250N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3763459	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	108970366	108970367	8q23.1	.	A	snv	G	AC.GT	hom-alt	392	1.00	.	0	.	PASS	610575	P	.	NN	.	.	.	.	.	.	.	340419	RSPO2	C4	EX5	.	.	missense	NM_178565.4	NP_848660.3	-	Y	c.557T>C	p.L186P | p.Leu186Pro	CTG=>CCG	NP=>NP	NM_178565.4(RSPO2): c.557T>C (p.L186P)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126360	0.574881	U	0.6885	0.490216	13006	0.472859	PASS	1999	8630	0.682851	21431	121352	0.578375	4099	11877	6.88921e-01	44379	144550	5.87989e-01	rs601558	.	4024	0.683900	-0.213	3.232	1.487	0.38	0	0	0.018	neutral	ENST00000276659: c.557T>C (p.L186P)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5904899	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	8	117868531	117868533	8q24.11	.	AA	del	.	GT.aa	het-ref	19	0.66	.	2	(A)n|Simple_repeat|Simple_repeat|+|23	PASS	606462	C	614701(MK)	NN	Cornelia de Lange syndrome 	AD	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Neurologic	General	22633399	.	5885	RAD21	IC6	IVS7	.	.	intron	NM_006265.2	NP_006256.1	-	Y	c.815-6_815-5delTT	.	.	.	NM_006265.2(RAD21): c.815-6_815-5delTT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	3052	0.053080	0	36104	0.058498	.	.	.	.	.	.	rs754557045	.	4025	0.069500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	8	128751200	128751201	8q24.21	.	G	snv	A	CC.CA	het-ref	266	0.49	.	2	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	C2	EX2	Myc amino-terminal region	PF01056.13	coding-synon	NM_002467.4	NP_002458.2	+	Y	c.738G>A	p.(P246=) | p.(Pro246=)	CCG=>CCA	.	NM_002467.4(MYC): c.738G>A (p.(P246=))	SingleClassTriAllelic;maf-5-some-pop	108174	0.043273	U	0.0734	0.0625	12110	0.038398	PASS	29	7978	0.082602	127	103166	0.042340	49	1260	7.68761e-02	212	8156	3.73607e-02	rs2070582	.	4024	0.081000	0.561	-1.583	-1.277	.	.	.	.	.	ENST00000377970: c.738G>A (p.P246P)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019468	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	144940266	144940267	8q24.3	.	G	ref	G	AA.CC	het-alt	724	0.82	.	1	.	PASS	607553	P	.	NN	.	.	.	.	.	.	.	83481	EPPK1	C1E	EX1E	.	.	coding-synon	NM_031308.1	NP_112598.2	-	Y	c.7155T>C	p.(G2385=) | p.(Gly2385=)	GGT=>GGC	.	NM_031308.1(EPPK1): c.7155T>C (p.(G2385=))	;maf-5-some-pop	115380	0.873557	U	.	.	.	.	PASS	.	8234	0.836410	43101	115380	0.873557	.	.	.	.	.	.	rs28441354	.	.	.	0.591	1.614	2.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	144940299	144940300	8q24.3	.	G	ref	G	AC.CG	het-alt	468	0.34	.	1	.	PASS	607553	P	.	NN	.	.	.	.	.	.	.	83481	EPPK1	C1E	EX1E	Plectin repeat	PF00681.15	coding-synon	NM_031308.1	NP_112598.2	-	Y	c.7122T>C	p.(R2374=) | p.(Arg2374=)	CGT=>CGC	.	NM_031308.1(EPPK1): c.7122T>C (p.(R2374=))	;maf-5-some-pop,maf-5-all-pops	120552	0.495620	U	.	.	.	.	InbreedingCoeff_Filter	-2135	8610	0.495935	2	120552	0.495620	.	.	.	.	.	.	rs4977191	.	.	.	0.591	0.776	0.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	145737285	145737286	8q24.3	.	G	snv	A	CT.CA	het-ref	291	0.52	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC19	IVS19	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.3393+8C>T	.	.	.	NM_004260.3(RECQL4): c.3393+8C>T	;maf-5-some-pop,genotype-conflict	123206	0.464263	U	0.5357	0.400559	12804	0.349969	PASS	1033	8528	0.490385	13511	118198	0.466962	2121	8440	4.91155e-01	28758	115517	4.75735e-01	rs756627	.	.	.	0.462	-0.363	-0.373	.	.	.	.	.	ENST00000617875: c.3393+8C>T (p.?)	central_nervous_system [brain|NS|NS]	primitive_neuroectodermal_tumour-medulloblastoma [NS|NS|NS]	CSV	3765393	.	.	.	.	.	no_record	94894	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	8	145737513	145737514	8q24.3	.	G	snv	A	CC.CC	het-ref	339	0.52	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC18	IVS18	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.3236+13C>T	.	.	.	NM_004260.3(RECQL4): c.3236+13C>T	;maf-5-some-pop,maf-5-all-pops	102454	0.502772	U	0.503	0.433307	12140	0.393245	PASS	769	7154	0.474699	12092	97446	0.506342	1780	7553	4.63545e-01	27759	111263	4.90081e-01	rs4244610	.	.	.	-0.459	-1.019	-1.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	94893	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	8	145737635	145737636	8q24.3	.	A	ref	A	CA.GT	het-alt	360	0.51	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C18	EX18	.	.	coding-synon	NM_004260.3	NP_004251.3	-	Y	c.3127C>T	p.(L1043=) | p.(Leu1043=)	CTG=>TTG	.	NM_004260.3(RECQL4): c.3127C>T (p.(L1043=))	;maf-5-some-pop	123980	0.028255	U	0.7966	0.946086	12546	0.001594	PASS	-715	8568	0.219421	287	118972	0.027174	.	.	.	.	.	.	rs4925828	.	.	.	-0.215	1.854	0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	145737815	145737816	8q24.3	.	C	snv	T	CC.GC	het-ref	324	0.51	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C17	EX17	.	.	missense	NM_004260.3	NP_004251.3	-	Y	c.3014G>A	p.R1005Q | p.Arg1005Gln	CGG=>CAG	P+=>P0	NM_004260.3(RECQL4): c.3014G>A (p.R1005Q)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	120368	0.458004	U	0.4762	0.384385	12708	0.341911	PASS	807	8386	0.441212	12788	115360	0.461200	1675	7509	4.39277e-01	27626	112838	4.67211e-01	rs4251691	.	.	.	0.561	1.201	-0.271	.	.	.	.	.	ENST00000617875: c.3014G>A (p.R1005Q)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1569133	.	.	.	.	.	no_record	94891	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	8	145738581	145738583	8q24.3	.	GG	del	.	GT.GG	het-ref	114	0.72	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC14	IVS14	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.2463+18_2463+19delCC	.	.	.	NM_004260.3(RECQL4): c.2463+18_2463+19delCC	MixedObserved;	0	0	U	0.6349	0.539537	.	.	VQSRTrancheINDEL99.50to99.90	93	2674	0.366866	1356	32094	0.412133	.	.	.	.	.	.	rs796885693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	8	145739923	145739924	8q24.3	.	G	snv	A	GA.CG	het-ref	149	0.44	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC9	IVS9	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.1621-15C>T	.	.	.	NM_004260.3(RECQL4): c.1621-15C>T	;maf-5-some-pop	112884	0.476365	U	0.503	0.394569	12584	0.350524	PASS	885	8078	0.474622	12530	107876	0.480162	1887	7925	4.66891e-01	27923	112697	4.76835e-01	rs4244611	.	.	.	0.462	-0.172	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	94886	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	8	145741129	145741130	8q24.3	.	C	snv	T	CT.CA	het-ref	227	0.48	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC6	IVS6	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.1258+18G>A	.	.	.	NM_004260.3(RECQL4): c.1258+18G>A	;maf-5-some-pop,maf-5-all-pops	118700	0.468576	U	0.501	0.400958	12330	0.364964	PASS	886	8316	0.463564	12893	113692	0.471555	1886	7926	4.65523e-01	28289	114749	4.75336e-01	rs4251689	.	.	.	0.651	2.129	1.555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	94884	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	8	145741701	145741702	8q24.3	.	C	snv	G	GG.TC	het-ref	348	0.53	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C5	EX5	.	.	missense	NM_004260.3	NP_004251.3	-	Y	c.801G>C	p.E267D | p.Glu267Asp	GAG=>GAC	P-=>P-	NM_004260.3(RECQL4): c.801G>C (p.E267D)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	116754	0.438135	U	0.4821	0.447684	12244	0.391865	PASS	790	8040	0.445771	10522	111746	0.437707	1738	7557	4.47796e-01	23036	104414	4.37446e-01	rs4244612	.	.	.	0.655	-0.454	-0.467	.	.	.	.	.	ENST00000617875: c.801G>C (p.E267D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763202	.	.	.	.	.	no_record	94898	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	8	145741764	145741765	8q24.3	.	G	snv	A	AT.CT	het-ref	279	0.44	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C5	EX5	.	.	coding-synon	NM_004260.3	NP_004251.3	-	Y	c.738C>T	p.(S246=) | p.(Ser246=)	AGC=>AGT	.	NM_004260.3(RECQL4): c.738C>T (p.(S246=))	;maf-5-some-pop	119532	0.436519	U	0.4831	0.370008	12348	0.339164	PASS	827	8312	0.445019	11361	114524	0.439428	1783	7680	4.50229e-01	24752	106867	4.43992e-01	rs4244613	.	.	.	-1.047	-3.879	-3.985	.	.	.	.	.	ENST00000617875: c.738C>T (p.S246S)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763203	.	.	.	.	.	no_record	94897	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	8	145742513	145742514	8q24.3	.	A	ref	A	AG.CT	het-alt	226	0.53	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C4	EX4	.	.	missense	NM_004260.3	NP_004251.3	-	Y	c.274C>T	p.P92S | p.Pro92Ser	CCT=>TCT	NP=>P0	NM_004260.3(RECQL4): c.274C>T (p.P92S)	;maf-5-some-pop,genotype-conflict	121992	0.027912	U	0.8065	0.943291	12204	0.004834	PASS	-670	8428	0.197437	210	116984	0.026679	.	.	.	.	.	.	rs2721190	.	.	.	-0.124	0.235	-0.117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	8	145742878	145742879	8q24.3	.	T	snv	C	TA.TC	het-ref	197	0.51	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C3	EX3	DNA replication and checkpoint protein	PF11719.3	coding-synon	NM_004260.3	NP_004251.3	-	Y	c.132A>G	p.(E44=) | p.(Glu44=)	GAA=>GAG	.	NM_004260.3(RECQL4): c.132A>G (p.(E44=))	;maf-5-some-pop,maf-5-all-pops	90532	0.556323	U	0.5238	0.57508	10692	0.550692	PASS	768	6716	0.497171	12323	85524	0.555224	1889	7678	4.83989e-01	30107	110211	5.36510e-01	rs2306386	.	.	.	-0.854	-0.127	0.090	.	.	.	.	.	ENST00000617875: c.132A>G (p.E44E)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5452655	.	.	.	.	.	no_record	94885	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	9	5050705	5050706	9p24.1	.	C	snv	T	CA.GG	het-ref	280	0.46	.	2	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	C4	EX6	.	.	coding-synon	NM_004972.3	NP_004963.1	+	Y	c.489C>T	p.(H163=) | p.(His163=)	CAC=>CAT	.	NM_004972.3(JAK2): c.489C>T (p.(H163=))	;maf-5-some-pop,maf-5-all-pops	126140	0.326986	U	0.2708	0.358227	13006	0.356451	PASS	321	8630	0.270800	6646	121132	0.325694	660	4710	2.73742e-01	13013	79153	3.22297e-01	rs2230722	.	4024	0.262700	-0.521	-0.024	-0.438	.	.	.	.	.	ENST00000381652: c.489C>T (p.H163H)	oesophagus [lower_third|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	4432269	.	.	.	.	.	no_record	367122	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	9	5081779	5081780	9p24.1	.	G	snv	A	CT.GG	het-ref	211	0.47	.	2	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	C17	EX19	.	.	coding-synon	NM_004972.3	NP_004963.1	+	Y	c.2490G>A	p.(L830=) | p.(Leu830=)	CTG=>CTA	.	NM_004972.3(JAK2): c.2490G>A (p.(L830=))	;maf-5-some-pop,genotype-conflict	126370	0.536085	U	0.4395	0.616813	13006	0.624250	PASS	809	8646	0.433727	18091	121362	0.532753	1667	7546	4.38262e-01	35390	129563	5.26508e-01	rs2230724	.	4024	0.424200	-0.254	-0.459	-0.826	.	.	.	.	.	ENST00000381652: c.2490G>A (p.L830L)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763953	.	.	.	.	.	no_record	367129	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	9	5557671	5557672	9p24.1	.	T	snv	C	CT.CT	hom-alt	512	1.00	.	0	.	PASS	605723	P	.	NN	.	.	.	.	.	.	.	80380	PDCD1LG2	C4	EX5	.	.	missense	NM_025239.3	NP_079515.2	+	Y	c.686T>C	p.F229S | p.Phe229Ser	TTC=>TCC	NP=>P0	NM_025239.3(PDCD1LG2): c.686T>C (p.F229S)	;genotype-conflict	126402	0.999106	U	1	0.997804	13006	0.998770	PASS	4326	8652	1.000000	60595	121394	0.999160	8623	17246	1.00000e+00	122800	245824	9.99073e-01	rs7854303	.	4024	0.998500	-0.119	-0.103	-0.005	0.47	0	0	0.011	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	8389363	8389364	9p24.1	.	C	snv	G	TA.CC	het-ref	283	0.48	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	C26	EX37	Protein-tyrosine phosphatase	PF00102.22	coding-synon	NM_002839.3	NP_002830.1	-	Y	c.4254G>C	p.(G1418=) | p.(Gly1418=)	GGG=>GGC	.	NM_002839.3(PTPRD): c.4254G>C (p.(G1418=))	;maf-5-some-pop,maf-5-all-pops	126198	0.501434	U	0.6329	0.55631	13006	0.484699	PASS	1905	8642	0.659801	15446	121190	0.499167	3942	11541	6.72788e-01	30762	121095	4.95057e-01	rs2279776	.	4024	0.682200	-1.197	0.022	-0.464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	8436702	8436703	9p24.1	.	C	snv	G	AG.AA	het-ref	132	0.51	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC23	IVS34	.	.	intron	NM_002839.3	NP_002830.1	-	Y	c.3989-14G>C	.	.	.	NM_002839.3(PTPRD): c.3989-14G>C	;maf-5-some-pop,maf-5-all-pops	125550	0.603282	U	0.6329	0.622404	13004	0.588588	PASS	1740	8542	0.643877	22101	120542	0.602487	3512	10996	6.42065e-01	43877	145059	5.98107e-01	rs1359118	.	.	.	-0.225	0.638	0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	9	8518051	8518052	9p24.1	.	G	snv	C	CT.TC	het-ref	376	0.54	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	C10	EX21	Fibronectin type III domain	PF00041.16	missense	NM_002839.3	NP_002830.1	-	Y	c.1339C>G	p.Q447E | p.Gln447Glu	CAG=>GAG	P0=>P-	NM_002839.3(PTPRD): c.1339C>G (p.Q447E)	;maf-5-some-pop,genotype-conflict	126410	0.046325	U	0.121	0.0509185	13006	0.032370	PASS	67	8650	0.128671	198	121402	0.046136	146	2246	1.30218e-01	390	11117	4.51914e-02	rs10977171	.	4024	0.143900	0.467	5.996	2.484	0.35	0.07	0.025	0.026	neutral	ENST00000381196: c.1339C>G (p.Q447E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150577	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	32631368	32631369	9p21.1	.	C	snv	T	AG.GT	hom-alt	357	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	138474	TAF1L	C1E	EX1E	.	.	coding-synon	NM_153809.2	NP_722516.1	-	Y	c.4209G>A	p.(T1403=) | p.(Thr1403=)	ACG=>ACA	.	NM_153809.2(TAF1L): c.4209G>A (p.(T1403=))	SingleClassTriAllelic;maf-5-some-pop	126390	0.132305	U	0.3095	0.161542	13006	0.097417	PASS	416	8626	0.303965	1297	121382	0.131099	789	5175	3.00035e-01	2579	32327	1.31284e-01	rs10971047	.	4024	0.305200	0.195	-1.376	-0.367	.	.	.	.	.	ENST00000242310: c.4209G>A (p.T1403T)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009670	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	36840622	36840623	9p13.2	.	G	snv	A	TA.TA	hom-alt	349	1.00	.	0	.	PASS	167414	C	615545(SK)	NN	Pre-B cell acute lymphoblastic leukemia	AD	.	Oncologic	Oncologic	24013638	.	5079	PAX5	C10E	EX10E	Paired-box protein 2 C terminal	PF12403.3	coding-synon	NM_016734.1	NP_057953.1	-	Y	c.1110C>T	p.(Y370=) | p.(Tyr370=)	TAC=>TAT	.	NM_016734.1(PAX5): c.1110C>T (p.(Y370=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	56300	0.857407	U	0.8899	0.742013	12918	0.763121	PASS	1548	3988	0.882648	19823	51292	0.868673	5112	11629	8.78721e-01	69303	153983	8.79853e-01	rs3780135	.	4024	0.872000	0.563	0.612	0.617	.	.	.	.	.	ENST00000358127: c.1110C>T (p.Y370Y)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	4163845	.	.	.	.	.	no_record	134998	no_assertion_provided	not_provided	Likely Benign
Pass	9	80343587	80343587	9q21.2	.	.	ins	A	GG.AA	het-ref	168	0.70	.	2	.	PASS	600998	P	163000(MK);185300(MK)	AD	.	.	.	.	.	.	.	2776	GNAQ	IC5	IVS5	.	.	intron	NM_002072.3	NP_002063.2	-	Y	c.736-5_736-4insT	.	.	.	NM_002072.3(GNAQ): c.736-5_736-4insT	MixedObserved;rs-cluster-nonoverlapping-alleles	112374	0.061811	U	0.38	0.372005	.	.	InbreedingCoeff_Filter	4	8148	0.345729	172	113738	0.441409	.	.	.	.	.	.	rs5898555	.	4024	0.334000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	9	87563369	87563370	9q21.33	.	T	snv	C	CA.CC	het-ref	202	0.47	.	2	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC14	IVS17	.	.	intron	NM_006180.3	NP_006171.2	+	Y	c.1765-7T>C	.	.	.	NM_006180.3(NTRK2): c.1765-7T>C	;maf-5-some-pop	122892	0.063389	U	0.1389	0.0870607	13006	0.046133	PASS	53	8492	0.122115	389	117884	0.062383	129	2132	1.23838e-01	884	15963	6.49785e-02	rs2289658	.	.	.	-1.617	-0.763	-0.848	.	.	.	.	.	ENST00000376214: c.1765-7T>C (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019229	.	.	.	.	.	.	.	.	.	Benign
Pass	9	87563459	87563460	9q21.33	.	C	snv	A	AT.GT	het-ref	290	0.50	.	2	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	C15	EX18	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_006180.3	NP_006171.2	+	Y	c.1848C>A	p.(I616=) | p.(Ile616=)	ATC=>ATA	.	NM_006180.3(NTRK2): c.1848C>A (p.(I616=))	;maf-5-some-pop	126138	0.047218	U	0.0784	0.058107	13006	0.044133	PASS	18	8636	0.063571	207	121130	0.046768	42	1151	6.67633e-02	427	12012	4.87967e-02	rs2289657	.	.	.	-0.812	-0.388	-1.760	.	.	.	.	.	ENST00000376214: c.1848C>A (p.I616I)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	5019069	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	93637014	93637015	9q22.2	.	C	snv	T	CC.GA	het-ref	264	0.50	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C8	EX9	.	.	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1065C>T	p.(P355=) | p.(Pro355=)	CCC=>CCT	.	NM_003177.5(SYK): c.1065C>T (p.(P355=))	SingleClassTriAllelic;maf-5-some-pop	126406	0.183781	U	0.2321	0.195887	13006	0.164078	PASS	231	8650	0.226590	2647	121398	0.183281	459	4018	2.32955e-01	5981	47632	1.93459e-01	rs2290890	.	4024	0.220200	-1.149	-2.907	-2.770	.	.	.	.	.	ENST00000375754: c.1065C>T (p.P355P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419974	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	93639845	93639846	9q22.2	.	C	snv	G	CT.TT	het-ref	184	0.50	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC8	IVS9	.	.	intron	NM_003177.5	NP_003168.2	+	Y	c.1182-7C>G	.	.	.	NM_003177.5(SYK): c.1182-7C>G	SingleClassTriAllelic;maf-5-some-pop	125404	0.252424	U	0.5625	0.301518	13006	0.206905	PASS	1322	8596	0.555375	4341	120396	0.250382	2564	9442	5.48507e-01	8696	60752	2.47130e-01	rs290223	.	4024	0.566800	-0.345	0.399	-0.246	.	.	.	.	.	ENST00000375754: c.1182-7C>G (p.?)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	4407231	.	.	.	.	.	.	.	.	.	Benign
Pass	9	93639972	93639973	9q22.2	.	G	snv	C	CG.AT	het-ref	264	0.47	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C9	EX10	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1302G>C	p.(R434=) | p.(Arg434=)	CGG=>CGC	.	NM_003177.5(SYK): c.1302G>C (p.(R434=))	;maf-5-some-pop,maf-5-all-pops	126366	0.184005	U	0.2321	0.196486	13006	0.165231	PASS	226	8626	0.226640	2642	121358	0.183490	457	4017	2.32924e-01	5982	47673	1.93604e-01	rs2290888	.	4024	0.220400	-0.704	-1.053	-0.381	.	.	.	.	.	ENST00000375754: c.1302G>C (p.R434R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3764050	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	93640008	93640009	9q22.2	.	G	snv	A	CT.GT	het-ref	283	0.46	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C9	EX10	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1338G>A	p.(L446=) | p.(Leu446=)	CTG=>CTA	.	NM_003177.5(SYK): c.1338G>A (p.(L446=))	SingleClassTriAllelic;maf-5-some-pop	126392	0.183833	U	0.2321	0.196086	13006	0.164770	PASS	228	8646	0.226347	2642	121384	0.183327	458	4018	2.32955e-01	5986	47656	1.93528e-01	rs2290887	.	4024	0.220400	0.655	0.951	2.566	.	.	.	.	.	ENST00000375754: c.1338G>A (p.L446L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3764052	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	93641150	93641151	9q22.2	.	T	snv	C	AA.GT	het-ref	250	0.55	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1497T>C	p.(N499=) | p.(Asn499=)	AAT=>AAC	.	NM_003177.5(SYK): c.1497T>C (p.(N499=))	;maf-5-some-pop	126388	0.040645	U	0.2321	0.0720847	13006	0.010072	PASS	249	8632	0.235171	357	121380	0.039348	462	4041	2.34288e-01	642	9248	3.75620e-02	rs2306042	.	4024	0.231100	-0.250	-0.262	-0.898	.	.	.	.	.	ENST00000375751: c.1428T>C (p.N476N)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	150631	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	93641174	93641175	9q22.2	.	C	snv	T	TA.GC	het-ref	222	0.48	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1521C>T	p.(Y507=) | p.(Tyr507=)	TAC=>TAT	.	NM_003177.5(SYK): c.1521C>T (p.(Y507=))	;maf-5-some-pop,maf-5-all-pops	126392	0.184917	U	0.2321	0.198283	13006	0.167846	PASS	229	8644	0.226516	2669	121384	0.184365	459	4019	2.33013e-01	6033	47865	1.94436e-01	rs2306041	.	4024	0.219900	-0.340	-0.054	-0.688	.	.	.	.	.	ENST00000375754: c.1521C>T (p.Y507Y)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3764054	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	93641198	93641199	9q22.2	.	T	snv	C	CT.TC	het-ref	215	0.48	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1545T>C	p.(L515=) | p.(Leu515=)	CTT=>CTC	.	NM_003177.5(SYK): c.1545T>C (p.(L515=))	;maf-5-some-pop	126334	0.110580	U	0.2321	0.130791	13006	0.066585	PASS	227	8646	0.225885	1485	121326	0.109746	452	3999	2.31853e-01	3513	29933	1.21603e-01	rs2306040	.	4024	0.219200	0.459	0.338	0.499	.	.	.	.	.	ENST00000375754: c.1545T>C (p.L515L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419827	.	.	.	.	.	.	.	.	.	Likely Benign
HHReport	9	98209593	98209594	9q22.32	.	G	snv	A	AG.GG	het-ref	342	0.59	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C23E	EX23	.	.	missense	NM_000264.3	NP_000255.2	-	Y	c.3944C>T	p.P1315L | p.Pro1315Leu	CCC=>CTC	NP=>NP	NM_000264.3(PTCH1): c.3944C>T (p.P1315L)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	121042	0.385932	U	0.5863	0.396765	12568	0.299252	PASS	1380	8498	0.566722	9126	116034	0.385465	2725	9657	5.63682e-01	19289	94062	3.88850e-01	rs357564	.	4024	0.548700	0.655	5.147	2.506	0.02	0.642	0.994	0.608	deleterious	ENST00000331920: c.3944C>T (p.P1315L)	bone [fibula|NS|NS]	chondrosarcoma [central|NS|NS]	CSV	1638394	.	.	.	.	.	no_record	41663	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	9	98209593	98209594	9q22.32	.	G	snv	A	AG.GG	het-ref	342	0.59	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C23E	EX23	.	.	missense	NM_001083602.1	NP_001077071.1	-	N	c.3746C>T	p.P1249L | p.Pro1249Leu	CCC=>CTC	NP=>NP	NM_001083602.1(PTCH1): c.3746C>T (p.P1249L)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	121042	0.385932	U	0.5863	0.396765	12568	0.299252	PASS	1380	8498	0.566722	9126	116034	0.385465	2725	9657	5.63682e-01	19289	94062	3.88850e-01	rs357564	.	4024	0.548700	0.655	5.147	2.506	0.02	0.804	0.993	0.685	deleterious	ENST00000331920: c.3944C>T (p.P1315L)	bone [fibula|NS|NS]	chondrosarcoma [central|NS|NS]	CSV	1638394	.	.	.	.	.	no_record	41663	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	9	98211571	98211572	9q22.32	.	T	snv	A	TG.GG	het-ref	319	0.48	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C22	EX22	.	.	missense	NM_000264.3	NP_000255.2	-	Y	c.3583A>T	p.T1195S | p.Thr1195Ser	ACA=>TCA	P0=>P0	NM_000264.3(PTCH1): c.3583A>T (p.T1195S)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	28304	0.058790	U	0.1419	0.0784744	12868	0.041731	PASS	12	1088	0.176471	51	23296	0.054559	92	1445	1.30675e-01	212	5218	3.35774e-02	rs2236405	.	4024	0.133000	0.459	2.171	2.224	0.36	0.002	0.012	0.020	neutral	ENST00000331920: c.3583A>T (p.T1195S)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1463812	CM032347	NM_000264.3(PTCH1): c.3583A>T (p.T1195S)	Nevoid basal cell carcinoma syndrome	12925203	DM	no_record	135100	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	9	98211571	98211572	9q22.32	.	T	snv	A	TG.GG	het-ref	319	0.48	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C22	EX22	.	.	missense	NM_001083602.1	NP_001077071.1	-	N	c.3385A>T	p.T1129S | p.Thr1129Ser	ACA=>TCA	P0=>P0	NM_001083602.1(PTCH1): c.3385A>T (p.T1129S)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	28304	0.058790	U	0.1419	0.0784744	12868	0.041731	PASS	12	1088	0.176471	51	23296	0.054559	92	1445	1.30675e-01	212	5218	3.35774e-02	rs2236405	.	4024	0.133000	0.459	2.171	2.224	0.32	0.085	0.291	0.030	neutral	ENST00000331920: c.3583A>T (p.T1195S)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1463812	.	.	.	.	.	no_record	135100	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	9	98220321	98220322	9q22.32	.	A	snv	C	AG.AG	het-ref	285	0.47	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C18	EX18	Patched family	PF02460.13	coding-synon	NM_000264.3	NP_000255.2	-	Y	c.3141T>G	p.(L1047=) | p.(Leu1047=)	CTT=>CTG	.	NM_000264.3(PTCH1): c.3141T>G (p.(L1047=))	SingleClassTriAllelic;maf-5-some-pop	125866	0.025678	U	0.1101	0.067492	13006	0.035830	PASS	44	8626	0.099467	136	120858	0.023945	81	1719	9.96868e-02	231	5157	2.09627e-02	rs2066835	.	4024	0.093200	0.533	-0.097	-0.441	.	.	.	.	.	ENST00000331920: c.3141T>G (p.L1047L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419987	.	.	.	.	.	no_record	255681	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	9	98220321	98220322	9q22.32	.	A	snv	C	AG.AG	het-ref	285	0.47	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C18	EX18	Patched family	PF02460.13	coding-synon	NM_001083602.1	NP_001077071.1	-	N	c.2943T>G	p.(L981=) | p.(Leu981=)	CTT=>CTG	.	NM_001083602.1(PTCH1): c.2943T>G (p.(L981=))	SingleClassTriAllelic;maf-5-some-pop	125866	0.025678	U	0.1101	0.067492	13006	0.035830	PASS	44	8626	0.099467	136	120858	0.023945	81	1719	9.96868e-02	231	5157	2.09627e-02	rs2066835	.	4024	0.093200	0.533	-0.097	-0.441	.	.	.	.	.	ENST00000331920: c.3141T>G (p.L1047L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419987	.	.	.	.	.	no_record	255681	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	9	98229388	98229389	9q22.32	.	C	snv	G	CG.CG	het-ref	225	0.46	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.2560+9G>C	.	.	.	NM_000264.3(PTCH1): c.2560+9G>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	125894	0.359580	U	0.3383	0.390575	13006	0.453944	PASS	496	8550	0.341404	8491	120886	0.358296	1045	5967	3.46677e-01	16169	85078	3.46440e-01	rs2066829	.	4024	0.357400	-0.187	-0.361	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255677	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	9	98229388	98229389	9q22.32	.	C	snv	G	CG.CG	het-ref	225	0.46	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.2362+9G>C	.	.	.	NM_001083602.1(PTCH1): c.2362+9G>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	125894	0.359580	U	0.3383	0.390575	13006	0.453944	PASS	496	8550	0.341404	8491	120886	0.358296	1045	5967	3.46677e-01	16169	85078	3.46440e-01	rs2066829	.	4024	0.357400	-0.187	-0.361	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255677	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	9	98239146	98239147	9q22.32	.	A	snv	G	GC.AA	het-ref	162	0.49	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC10	IVS10	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.1504-8T>C	.	.	.	NM_000264.3(PTCH1): c.1504-8T>C	;maf-5-some-pop,genotype-conflict	115884	0.050110	U	0.1429	0.105032	13006	0.073812	PASS	85	7850	0.151210	329	110876	0.047630	166	2372	1.38406e-01	565	9766	3.99248e-02	rs2277184	.	4024	0.137200	-0.417	-0.091	-0.539	.	.	.	.	.	ENST00000331920: c.1504-8T>C (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	17610	.	.	.	.	.	no_record	255669	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
Pass	9	98239146	98239147	9q22.32	.	A	snv	G	GC.AA	het-ref	162	0.49	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC10	IVS10	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.1306-8T>C	.	.	.	NM_001083602.1(PTCH1): c.1306-8T>C	;maf-5-some-pop,genotype-conflict	115884	0.050110	U	0.1429	0.105032	13006	0.073812	PASS	85	7850	0.151210	329	110876	0.047630	166	2372	1.38406e-01	565	9766	3.99248e-02	rs2277184	.	4024	0.137200	-0.417	-0.091	-0.539	.	.	.	.	.	ENST00000331920: c.1504-8T>C (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	17610	.	.	.	.	.	no_record	255669	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
HHReport	9	101585530	101585531	9q22.33	.	T	snv	A	TA.TT	het-ref	208	0.46	.	2	.	PASS	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	IC1	IVS1	.	.	intron	NM_024642.4	NP_078918.3	+	Y	c.372-7T>A	.	.	.	NM_024642.4(GALNT12): c.372-7T>A	;maf-5-some-pop	126374	0.006940	U	0.0685	0.0155751	13006	0.000461	PASS	34	8646	0.079806	34	121366	0.006583	66	1387	8.04151e-02	66	1668	6.77371e-03	rs2295923	.	4024	0.091700	0.533	0.823	2.005	.	.	.	.	.	ENST00000375011: c.372-7T>A (p.?)	stomach [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	VUO	150648	.	.	.	.	.	no_record	416211	criteria_provided,_single_submitter	Benign	Benign
HHReport	9	101589210	101589211	9q22.33	.	C	snv	T	GC.GC	het-ref	245	0.50	.	2	.	PASS	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	C3	EX3	Glycosyl transferase family 2;Glycosyltransferase like family 2;Glycosyltransferase like family 2	PF00535.21;PF10111.4;PF13641.1	missense	NM_024642.4	NP_078918.3	+	Y	c.719C>T	p.P240L | p.Pro240Leu	CCG=>CTG	NP=>NP	NM_024642.4(GALNT12): c.719C>T (p.P240L)	;	31320	0.000798	U	0.0109	0.00219649	.	.	PASS	0	1200	0.009167	0	26312	0.000532	1	83	7.32827e-03	1	88	5.46312e-04	rs59362219	.	4024	0.010200	0.655	5.721	2.757	0	0.927	0.999	0.820	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	410589	criteria_provided,_multiple_submitters,_no_conflicts	Uncertain_significance	VUS
HHReport	9	101611334	101611335	9q22.33	.	G	snv	C	TC.GA	hom-alt	566	1.00	.	0	.	PASS	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	C10E	EX10E	Ricin-type beta-trefoil lectin domain	PF00652.17	coding-synon	NM_024642.4	NP_078918.3	+	Y	c.1707G>C	p.(S569=) | p.(Ser569=)	TCG=>TCC	.	NM_024642.4(GALNT12): c.1707G>C (p.(S569=))	SingleClassTriAllelic;maf-5-some-pop	126392	0.090370	U	0.2391	0.141573	13006	0.083192	PASS	321	8642	0.280606	715	121384	0.088257	685	4846	2.80993e-01	1379	21200	8.61110e-02	rs2273846	.	4024	0.293000	-1.202	-2.662	-2.515	.	.	.	.	.	ENST00000375011: c.1707G>C (p.S569S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763482	.	.	.	.	.	no_record	485634	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	9	133761000	133761001	9q34.12	.	A	snv	G	CC.GC	hom-alt	655	1.00	.	0	.	PASS	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	C11E	EX11E	F-actin binding	PF08919.5	coding-synon	NM_005157.4	NP_005148.2	+	Y	c.3324A>G	p.(P1108=) | p.(Pro1108=)	CCA=>CCG	.	NM_005157.4(ABL1): c.3324A>G (p.(P1108=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125362	0.553158	U	0.5952	0.654153	13006	0.584884	PASS	1541	8602	0.597303	18853	120354	0.548956	3154	10381	6.02566e-01	38686	134979	5.49531e-01	rs1056171	.	4024	0.593200	-1.204	-1.907	-2.191	.	.	.	.	.	ENST00000372348: c.3381A>G (p.P1127P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	5019120	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	133761000	133761001	9q34.12	.	A	snv	G	CC.GC	hom-alt	655	1.00	.	0	.	PASS	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	C11E	EX11E	F-actin binding	PF08919.5	coding-synon	NM_007313.2	NP_009297.2	+	N	c.3381A>G	p.(P1127=) | p.(Pro1127=)	CCA=>CCG	.	NM_007313.2(ABL1): c.3381A>G (p.(P1127=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125362	0.553158	U	0.5952	0.654153	13006	0.584884	PASS	1541	8602	0.597303	18853	120354	0.548956	3154	10381	6.02566e-01	38686	134979	5.49531e-01	rs1056171	.	4024	0.593200	-1.204	-1.907	-2.191	.	.	.	.	.	ENST00000372348: c.3381A>G (p.P1127P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	5019120	.	.	.	.	.	.	.	.	.	Likely Benign
HHReport	9	135773000	135773000	9q34.13	.	.	ins	AA	TG.AA	het-ref	25	0.42	.	2	.	PASS	605284	C	191100(MK);606690(MK);607341(MK)	AD	Tuberous sclerosis; Lymphangioleiomyomatosis	AD	Allelic with Focal cortical dysplasia of Taylor (AD)	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23909960|23852707|23851963|23846400|23845174|23796861|23743818|23158522|22490766|22189265|22161988|21813552|21266383|20301399|19419980|19332694|18722871|18032745|17304050|17005952|17003820|15955990|15257730|14985384|14421523|12112044|11829138|9924605|9863590|9579160|9242607|9132502|8782048|8592324|8534286|3210031|2823681|2706800	H62;H68;HT2	7248	TSC1	IC18	IVS20	.	.	intron	NM_000368.4	NP_000359.1	-	Y	c.2626-4_2626-3insTT	.	.	.	NM_000368.4(TSC1): c.2626-4_2626-3insTT	MixedObserved;clinically-assoc,has-omim-omia,submitted-by-lsdb|MixedObserved;rs-cluster-nonoverlapping-alleles	0|51608	0|0.439292	U	.	.	.	.	PASS	10	5654	0.138486	278	80186	0.153269	.	.	.	.	.	.	rs397514773|rs5901000	.	4024	0.103100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	495837	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	9	136913567	136913568	9q34.2	.	G	snv	A	AC.CC	het-ref	260	0.49	.	2	.	PASS	601541	P	.	NN	.	.	.	.	.	.	.	8019	BRD3	C5	EX6	.	.	coding-synon	NM_007371.3	NP_031397.1	-	Y	c.723C>T	p.(G241=) | p.(Gly241=)	GGC=>GGT	.	NM_007371.3(BRD3): c.723C>T (p.(G241=))	;	122534	0.008112	U	0.005	0.00559105	13004	0.001000	PASS	1	8326	0.009008	39	117526	0.008219	1	151	8.86566e-03	91	2466	1.05247e-02	rs150276875	.	4024	0.017400	0.561	-0.191	-0.140	.	.	.	.	.	ENST00000303407: c.723C>T (p.G241G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3982765	.	.	.	.	.	.	.	.	.	VUS
Pass	9	136915507	136915508	9q34.2	.	C	snv	T	GG.GG	het-ref	134	0.45	.	2	.	PASS	601541	P	.	NN	.	.	.	.	.	.	.	8019	BRD3	C4	EX5	.	.	coding-synon	NM_007371.3	NP_031397.1	-	Y	c.702G>A	p.(P234=) | p.(Pro234=)	CCG=>CCA	.	NM_007371.3(BRD3): c.702G>A (p.(P234=))	;maf-5-some-pop	123650	0.097509	U	0.1339	0.0902556	13004	0.075669	PASS	48	8536	0.127577	624	118642	0.097815	137	2248	1.30819e-01	1377	24359	1.00216e-01	rs2301576	.	4024	0.109100	-0.658	-0.779	-0.277	.	.	.	.	.	ENST00000303407: c.702G>A (p.P234P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4163509	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	9	139391635	139391636	9q34.3	.	G	snv	A	CC.TC	hom-alt	725	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C34E	EX34E	.	.	coding-synon	NM_017617.3	NP_060087.3	-	Y	c.6555C>T	p.(D2185=) | p.(Asp2185=)	GAC=>GAT	.	NM_017617.3(NOTCH1): c.6555C>T (p.(D2185=))	;maf-5-some-pop,genotype-conflict	124060	0.621812	U	0.9494	0.695088	12908	0.581267	PASS	3851	8574	0.947399	23581	119052	0.618730	7776	16355	9.50430e-01	49065	152091	6.21211e-01	rs2229974	.	4024	0.957000	0.561	-0.114	-0.091	.	.	.	.	.	ENST00000277541: c.6555C>T (p.D2185D)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3763781	.	.	.	.	.	no_record	286141	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	9	139397706	139397707	9q34.3	.	G	snv	A	AC.TC	hom-alt	512	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C27	EX27	NOTCH protein	PF07684.7	coding-synon	NM_017617.3	NP_060087.3	-	Y	c.5094C>T	p.(D1698=) | p.(Asp1698=)	GAC=>GAT	.	NM_017617.3(NOTCH1): c.5094C>T (p.(D1698=))	;maf-5-some-pop	124206	0.448658	U	0.9018	0.553514	12788	0.408039	PASS	3374	8584	0.885951	13074	119198	0.444252	6797	15297	8.88328e-01	27451	109894	4.48181e-01	rs10521	.	4024	0.896600	-0.258	-0.389	-0.816	.	.	.	.	.	ENST00000277541: c.5094C>T (p.D1698D)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1461158	.	.	.	.	.	no_record	384696	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	9	139405260	139405261	9q34.3	.	C	snv	T	TG.GG	hom-alt	447	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC16	IVS16	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.2588-4G>A	.	.	.	NM_017617.3(NOTCH1): c.2588-4G>A	SingleClassTriAllelic;maf-5-some-pop	121654	0.477181	U	0.872	0.585463	12200	0.454918	PASS	3203	8450	0.870769	14299	116646	0.472532	6518	14939	8.73728e-01	29398	112366	4.74370e-01	rs3125001	.	4024	0.875500	0.561	-0.369	-0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	281108	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	9	139407931	139407932	9q34.3	.	A	snv	G	TC.TT	hom-alt	488	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C14	EX14	.	.	coding-synon	NM_017617.3	NP_060087.3	-	Y	c.2265T>C	p.(N755=) | p.(Asn755=)	AAT=>AAC	.	NM_017617.3(NOTCH1): c.2265T>C (p.(N755=))	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123826	0.402961	U	0.7768	0.527756	12932	0.397464	PASS	2709	8568	0.795168	11097	118818	0.397701	5413	13661	7.94429e-01	23151	98027	4.00074e-01	rs2229971	.	4024	0.796500	-4.386	-0.216	-1.247	.	.	.	.	.	ENST00000277541: c.2265T>C (p.N755N)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763787	.	.	.	.	.	no_record	384703	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	9	139410176	139410177	9q34.3	.	T	snv	C	CG.GG	hom-alt	316	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC10	IVS10	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1670-9A>G	.	.	.	NM_017617.3(NOTCH1): c.1670-9A>G	;maf-5-some-pop,maf-5-all-pops	23532	0.468298	U	0.8323	0.58726	11712	0.396089	PASS	178	572	0.800699	1862	18524	0.436137	3683	8686	8.50735e-01	16164	61973	4.62685e-01	rs3124603	.	4020	0.866900	-2.525	-0.289	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	288086	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	9	139410423	139410424	9q34.3	.	A	snv	G	CC.GC	hom-alt	228	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC10	IVS10	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1669+9T>C	.	.	.	NM_017617.3(NOTCH1): c.1669+9T>C	;maf-5-some-pop	121834	0.870972	U	0.9147	0.883986	12320	0.873295	PASS	3717	8456	0.938150	44366	116826	0.870414	7458	15987	9.33493e-01	91728	209670	8.71628e-01	rs3125006	.	4024	0.935900	-4.193	-3.361	-3.952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	383780	criteria_provided,_single_submitter	Benign	Benign
Pass	9	139411713	139411714	9q34.3	.	T	snv	C	GG.GG	hom-alt	219	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC9	IVS9	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1555+10A>G	.	.	.	NM_017617.3(NOTCH1): c.1555+10A>G	;maf-5-some-pop,maf-5-all-pops	64294	0.552602	U	0.8353	0.605431	12236	0.427999	PASS	2115	5550	0.877477	8605	59286	0.548140	5365	12544	8.59767e-01	23340	90202	4.52558e-01	rs11145767	.	4014	0.872700	-0.971	-1.620	-1.708	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	286181	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	9	139412196	139412197	9q34.3	.	G	snv	A	CC.AC	hom-alt	297	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC8	IVS8	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1441+7C>T	.	.	.	NM_017617.3(NOTCH1): c.1441+7C>T	;maf-5-some-pop	123228	0.581678	U	0.9286	0.696286	12456	0.554432	PASS	3675	8546	0.926749	20955	118220	0.576823	7372	15924	9.26568e-01	43069	140254	5.76356e-01	rs9411208	.	4024	0.935600	-1.324	0.119	0.004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	384693	criteria_provided,_single_submitter	Benign	Benign
Pass	9	139418259	139418260	9q34.3	.	A	snv	G	GC.TT	hom-alt	520	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C3	EX3	.	.	coding-synon	NM_017617.3	NP_060087.3	-	Y	c.312T>C	p.(N104=) | p.(Asn104=)	AAT=>AAC	.	NM_017617.3(NOTCH1): c.312T>C (p.(N104=))	;maf-5-some-pop	115890	0.603227	U	0.8363	0.740016	12782	0.608668	PASS	3016	8232	0.856414	20621	110882	0.597049	6069	14333	8.46604e-01	43574	140189	5.87179e-01	rs4489420	.	4024	0.842900	-1.983	-0.457	-1.160	.	.	.	.	.	ENST00000277541: c.312T>C (p.N104N)	urinary_tract [bladder|NS|NS]	carcinoma [NS|NS|NS]	CSV	1756049	.	.	.	.	.	no_record	286142	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	9	139563143	139563144	9q34.3	.	C	snv	A	AC.GA	het-ref	90	0.47	.	2	.	PASS	608582	P	.	NN	.	.	.	.	.	.	.	51162	EGFL7	IC2	IVS5	.	.	intron	NM_016215.4	NP_057299.1	+	Y	c.197+19C>A	.	.	.	NM_016215.4(EGFL7): c.197+19C>A	;maf-5-some-pop,maf-5-all-pops	122586	0.180151	U	0.1379	0.151158	12986	0.186047	PASS	56	8426	0.112509	2093	117578	0.181386	89	1854	1.08408e-01	4089	42403	1.81770e-01	rs2297535	.	.	.	0.407	-1.080	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
HHReport	10	43595967	43595968	10q11.21	.	A	ref	A	GC.GC	het-alt	296	0.54	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C2	EX2	.	.	coding-synon	NM_020630.4	NP_065681.1	+	Y	c.135G>A	p.(A45=) | p.(Ala45=)	GCG=>GCA	.	NM_020630.4(RET): c.135G>A (p.(A45=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125932	0.262793	U	0.5268	0.753594	13006	0.190835	PASS	.	8612	0.450882	4598	120924	0.263471	.	.	.	.	.	.	rs1800858	.	.	.	-1.551	-1.845	-1.168	.	.	.	.	.	.	.	.	.	.	CM020759	NM_020975.4(RET): c.135G>A (p.A45A)	"Hirschsprung disease, association with"	10528857	DP	.	.	.	.	Likely Benign
Pass	10	43595967	43595968	10q11.21	.	A	ref	A	GC.GC	het-alt	296	0.54	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C2	EX2	.	.	coding-synon	NM_020975.4	NP_066124.1	+	N	c.135G>A	p.(A45=) | p.(Ala45=)	GCG=>GCA	.	NM_020975.4(RET): c.135G>A (p.(A45=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125932	0.262793	U	0.5268	0.753594	13006	0.190835	PASS	.	8612	0.450882	4598	120924	0.263471	.	.	.	.	.	.	rs1800858	.	.	.	-1.551	-1.845	-1.168	.	.	.	.	.	.	.	.	.	.	CM020759	NM_020975.4(RET): c.135G>A (p.A45A)	"Hirschsprung disease, association with"	10528857	DP	.	.	.	.	Likely Benign
HHReport	10	43606686	43606687	10q11.21	.	A	snv	G	GC.TT	hom-alt	532	1.00	.	0	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C7	EX7	.	.	coding-synon	NM_020630.4	NP_065681.1	+	Y	c.1296A>G	p.(A432=) | p.(Ala432=)	GCA=>GCG	.	NM_020630.4(RET): c.1296A>G (p.(A432=))	;maf-5-some-pop,maf-5-all-pops	126342	0.708806	U	0.8006	0.77516	13006	0.748578	PASS	2814	8638	0.807479	30695	121334	0.706068	5528	13805	8.00568e-01	60395	171112	6.95594e-01	rs1800860	.	4024	0.799700	-0.215	-0.011	0.030	.	.	.	.	.	ENST00000355710: c.1296A>G (p.A432A)	upper_aerodigestive_tract [mouth|tongue|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5983420	CM033447	NM_020975.4(RET): c.1296A>G (p.A432A)	"Hirschsprung disease, assoc. with"	14627689	DP	no_record	95995	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	10	43606686	43606687	10q11.21	.	A	snv	G	GC.TT	hom-alt	532	1.00	.	0	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C7	EX7	.	.	coding-synon	NM_020975.4	NP_066124.1	+	N	c.1296A>G	p.(A432=) | p.(Ala432=)	GCA=>GCG	.	NM_020975.4(RET): c.1296A>G (p.(A432=))	;maf-5-some-pop,maf-5-all-pops	126342	0.708806	U	0.8006	0.77516	13006	0.748578	PASS	2814	8638	0.807479	30695	121334	0.706068	5528	13805	8.00568e-01	60395	171112	6.95594e-01	rs1800860	.	4024	0.799700	-0.215	-0.011	0.030	.	.	.	.	.	ENST00000355710: c.1296A>G (p.A432A)	upper_aerodigestive_tract [mouth|tongue|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5983420	CM033447	NM_020975.4(RET): c.1296A>G (p.A432A)	"Hirschsprung disease, assoc. with"	14627689	DP	no_record	95995	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	10	43613842	43613843	10q11.21	.	G	ref	G	CT.CG	het-alt	250	0.50	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_020630.4	NP_065681.1	+	Y	c.2307T>G	p.(L769=) | p.(Leu769=)	CTT=>CTG	.	NM_020630.4(RET): c.2307T>G (p.(L769=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125900	0.259261	U	0.4742	0.71246	13006	0.197370	PASS	-1094	8586	0.500116	4524	120892	0.258090	.	.	.	.	.	.	rs1800861	.	.	.	0.655	1.069	1.339	.	.	.	.	.	.	.	.	.	.	CM014825	NM_020975.4(RET): c.2307T>G (p.L769L)	"Hirschsprung disease, association with"	10528857	DP	.	.	.	.	Likely Benign
Pass	10	43613842	43613843	10q11.21	.	G	ref	G	CT.CG	het-alt	250	0.50	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_020975.4	NP_066124.1	+	N	c.2307T>G	p.(L769=) | p.(Leu769=)	CTT=>CTG	.	NM_020975.4(RET): c.2307T>G (p.(L769=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125900	0.259261	U	0.4742	0.71246	13006	0.197370	PASS	-1094	8586	0.500116	4524	120892	0.258090	.	.	.	.	.	.	rs1800861	.	.	.	0.655	1.069	1.339	.	.	.	.	.	.	.	.	.	.	CM014825	NM_020975.4(RET): c.2307T>G (p.L769L)	"Hirschsprung disease, association with"	10528857	DP	.	.	.	.	Likely Benign
Pass	10	72358576	72358577	10q22.1	.	G	snv	A	GA.TG	hom-alt	427	1.00	.	0	.	PASS	170280	C	603553(MK);605027(MK)	NN	Hemophagocytic lymphohistiocytosis, familial, 2; Lymphoma, non-Hodgkin; Aplastic anemia, adult-onset 	AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic	Allergy/Immunology/Infectious; Hematologic; Oncologic	23443029|22359105|22186995|22029169|21959744|21936944|17873118|17311987|15728124|15659737|14757862|12358924|12229880|10583959	.	5551	PRF1	C2E	EX3E	.	.	coding-synon	NM_001083116.1	NP_001076585.1	-	Y	c.900C>T	p.(H300=) | p.(His300=)	CAC=>CAT	.	NM_001083116.1(PRF1): c.900C>T (p.(H300=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126364	0.638038	U	0.7341	0.695887	13006	0.662387	PASS	2531	8644	0.764808	24936	121356	0.635650	5032	13167	7.63393e-01	50565	156635	6.36200e-01	rs885822	.	4024	0.732100	-1.062	-3.744	-3.441	.	.	.	.	.	ENST00000373209: c.900C>T (p.H300H)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3765513	.	.	.	.	.	no_record	257409	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	10	73326578	73326579	10q22.1	.	C	snv	T	TC.TT	het-ref	313	0.48	.	2	.	PASS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	C6	EX7	Cadherin domain	PF00028.12	coding-synon	NM_022124.5	NP_071407.4	+	Y	c.510C>T	p.(S170=) | p.(Ser170=)	TCC=>TCT	.	NM_022124.5(CDH23): c.510C>T (p.(S170=))	;	125190	0.002764	U	0.0327	0.00658946	12446	0.000080	PASS	2	8608	0.027765	2	120182	0.002604	5	457	2.65050e-02	5	679	2.75913e-03	rs143341423	.	4024	0.027300	-0.254	0.445	0.286	.	.	.	.	.	ENST00000398809: c.510C>T (p.S170S)	skin [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	4498031	.	.	.	.	.	no_record	45966	criteria_provided,_single_submitter	Benign	VUS
Pass	10	73434887	73434888	10q22.1	.	G	snv	C	AG.CA	hom-alt	397	1.00	.	0	.	PASS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	C14	EX15	Cadherin domain	PF00028.12	missense	NM_022124.5	NP_071407.4	+	Y	c.1469G>C	p.G490A | p.Gly490Ala	GGC=>GCC	P0=>NP	NM_022124.5(CDH23): c.1469G>C (p.G490A)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125496	0.199225	U	0.2887	0.185304	12674	0.121193	PASS	394	8600	0.311279	2776	120488	0.199804	776	5195	3.01509e-01	5856	49484	2.01184e-01	rs1227049	.	4024	0.303200	0.655	5.548	2.693	.	.	.	.	.	ENST00000398860: c.1484G>C (p.G495A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3998079	.	.	.	.	.	no_record	45872	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	10	73450206	73450207	10q22.1	.	A	snv	C	CC.CC	het-ref	22	0.39	.	2	.	DUBIOUS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	IC18	IVS19	.	.	intron	NM_022124.5	NP_071407.4	+	Y	c.2060-18A>C	.	.	.	NM_022124.5(CDH23): c.2060-18A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4012	0.028700	-1.491	-1.639	-1.286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
Pass	10	76781905	76781908	10q22.2	.	GAA	del	.	ag.ga	hom-alt	321	1.00	.	0	GA-rich|Low_complexity|Low_complexity|+|105;trf	PASS	605880	P	603736(MK);606170(MK)	NN	Ohdo syndrome, SBBYS variant; Genitopatellar syndrome	AD	.	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Audiologic/Otolaryngologic; Endocrine	23236640|22265014|22077973|21412151|16761293|12949978|12210330|12210329	.	23522	KAT6B	C14	EX16	.	.	cds-del	NM_012330.3	NP_036462.2	+	Y	c.3289GAA[8>7] (std: c.3289GAA[7] alt: c.3310_3312delGAA )	p.E1091[14>13] (std: p.E1091[13] alt: p.E1104del ) | p.Glu1091[14>13] (std: p.Glu1091[13] alt: p.Glu1104del )	.	.	NM_012330.3(KAT6B): c.3289GAA[7] (p.E1091[13])	MixedObserved;maf-5-some-pop,maf-5-all-pops	4997	0.459676	U	0.373	0.458666	.	.	VQSRTrancheINDEL95.00to96.00	482	8232	0.365525	5316	113476	0.250670	.	.	.	.	.	.	rs71929101	.	4024	0.355600	.	.	.	.	.	.	.	.	ENST00000287239: c.3289_3291delGAA (p.E1097delE)	breast [NS|NS|NS]	carcinoma [ER-positive_carcinoma|NS|NS]	CSV	111693	.	.	.	.	.	no_record	211214	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
HHReport	10	88635778	88635779	10q23.2	.	C	snv	A	TG.CT	hom-alt	244	1.00	.	0	.	DUBIOUS	601299	C	174900(MK);610069(MK)	AD	Polyposis syndrome, hereditary mixed, 2; Polyposis, juvenile intestinal	AD	.	Oncologic	Oncologic	22810475|22171123|20843829|17873119|16525031|16152648|15235019|12136244|11381269|8037173|7582207|7059958|5483654|4544011|3707330	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	657	BMPR1A	C1	EX3	.	.	missense	NM_004329.2	NP_004320.2	+	Y	c.4C>A	p.P2T | p.Pro2Thr	CCT=>ACT	NP=>P0	NM_004329.2(BMPR1A): c.4C>A (p.P2T)	;maf-5-some-pop,maf-5-all-pops	126306	0.361527	U	0.7093	0.4998	13006	0.389513	PASS	2252	8646	0.719408	9160	121298	0.355818	4502	12432	7.21114e-01	18261	87521	3.55904e-01	rs11528010	.	4024	0.746000	-0.374	1.784	0.956	1	0	0	0.000	neutral	ENST00000224764: c.4C>A (p.P2T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752019	.	.	.	.	.	Paralog	41782	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Unknown
HHReport	10	88683121	88683122	10q23.2	.	T	snv	C	CA.TC	hom-alt	557	1.00	.	0	.	PASS	601299	C	174900(MK);610069(MK)	AD	Polyposis syndrome, hereditary mixed, 2; Polyposis, juvenile intestinal	AD	.	Oncologic	Oncologic	22810475|22171123|20843829|17873119|16525031|16152648|15235019|12136244|11381269|8037173|7582207|7059958|5483654|4544011|3707330	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	657	BMPR1A	IC9	IVS11	.	.	intron	NM_004329.2	NP_004320.2	+	Y	c.1343-11T>C	.	.	.	NM_004329.2(BMPR1A): c.1343-11T>C	;maf-5-some-pop,maf-5-all-pops	126294	0.359423	U	0.7004	0.496605	13006	0.389820	PASS	2247	8630	0.719930	9075	121286	0.353759	4499	12429	7.20940e-01	17968	86793	3.52616e-01	rs7074064	.	4024	0.745500	-0.181	-0.292	-0.146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259286	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	10	89720633	89720633	10q23.31	.	.	ins	T	tc.tt	het-ref	83	0.38	.	2	(T)n|Simple_repeat|Simple_repeat|+|30	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	IC7	IVS7	.	.	intron	NM_000314.4	NP_000305.3	+	Y	c.802-18_802-17insT	.	.	.	NM_000314.4(PTEN): c.802-18_802-17insT	;rs-cluster-nonoverlapping-alleles	38480	0.010915	U	.	.	.	.	PASS	3	2764	0.307164	22	47182	0.176169	.	.	.	.	.	.	rs762344516	.	4024	0.299000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	92831	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
InExcel	10	89720652	89720653	10q23.31	.	C	snv	A	GA.AA	het-ref	78	0.26	.	2	.	DUBIOUS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	C8	EX8	.	.	missense	NM_000314.4	NP_000305.3	+	Y	c.804C>A	p.D268E | p.Asp268Glu	GAC=>GAA	P-=>P-	NM_000314.4(PTEN): c.804C>A (p.D268E)	;clinically-assoc,submitted-by-lsdb	85912	0.000931	U	.	.	.	.	PASS	0	5446	0.000551	0	85912	0.000931	0	2	1.44279e-04	0	138	6.95558e-04	rs398123328	.	4024	2.000000	-0.469	0.015	0.202	1	0.012	0.001	0.001	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
Pass	10	90771828	90771829	10q23.31	.	T	snv	C	AC.TT	hom-alt	353	1.00	.	0	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	C7	EX7	.	.	coding-synon	NM_000043.4	NP_000034.1	+	Y	c.642T>C	p.(T214=) | p.(Thr214=)	ACT=>ACC	.	NM_000043.4(FAS): c.642T>C (p.(T214=))	;maf-5-some-pop,microattr-tpa,genotype-conflict	126200	0.756894	U	0.9573	0.775359	13006	0.695218	PASS	4183	8654	0.983129	35133	121192	0.756131	8354	16974	9.84114e-01	72996	188167	7.65137e-01	rs2234978	.	4024	0.982600	-2.209	-0.410	-0.415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	254734	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	10	104264106	104264107	10q24.32	.	C	snv	T	CG.GG	het-ref	210	0.51	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC1	IVS1	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.182+16C>T	.	.	.	NM_016169.3(SUFU): c.182+16C>T	;maf-5-some-pop,maf-5-all-pops	122594	0.482014	U	0.3065	0.396166	13006	0.479548	PASS	437	8380	0.318377	14438	117586	0.485670	910	5501	3.20833e-01	29023	115015	4.76138e-01	rs2274351	.	4024	0.321800	0.455	-0.208	0.003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	260689	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	10	104386933	104386934	10q24.32	.	T	snv	C	AT.CT	het-ref	207	0.44	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	C11	EX11	Suppressor of Fused Gli/Ci N terminal binding domain	PF12470.3	coding-synon	NM_016169.3	NP_057253.2	+	Y	c.1299T>C	p.(I433=) | p.(Ile433=)	ATT=>ATC	.	NM_016169.3(SUFU): c.1299T>C (p.(I433=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126366	0.162140	U	0.4335	0.246006	13006	0.128479	PASS	784	8638	0.423941	2233	121358	0.158679	1486	7153	4.14763e-01	4546	39264	1.59441e-01	rs17114803	.	4024	0.411300	0.459	0.602	0.717	.	.	.	.	.	ENST00000369902: c.1299T>C (p.I433I)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4767793	.	.	.	.	.	no_record	260687	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	10	104387018	104387019	10q24.32	.	T	snv	C	TT.CC	hom-alt	315	1.00	.	0	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC11	IVS11	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.1365+19T>C	.	.	.	NM_016169.3(SUFU): c.1365+19T>C	;maf-5-some-pop,maf-5-all-pops	126376	0.665008	U	0.75	0.719649	13006	0.681147	PASS	2405	8640	0.746644	26892	121368	0.662753	4809	12853	7.45188e-01	53795	162021	6.58001e-01	rs12414407	.	4024	0.740800	-0.642	1.729	0.680	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	260688	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	10	114925368	114925369	10q25.3	.	C	snv	A	CA.CC	het-ref	282	0.53	.	2	.	PASS	602228	C	125853(SK)	AD	.	.	.	.	.	.	.	6934	TCF7L2	C14E	EX14E	.	.	missense	NM_030756.4	NP_110383.2	+	Y	c.1429C>A	p.P477T | p.Pro477Thr	CCC=>ACC	NP=>P0	NM_030756.4(TCF7L2): c.1429C>A (p.P477T)	;maf-5-some-pop	125804	0.051056	U	0.2411	0.0696885	13006	0.021990	PASS	274	8618	0.258065	372	120796	0.050283	546	4377	2.53945e-01	771	12787	5.20093e-02	rs77961654	.	4024	0.249300	0.655	1.655	1.227	0.3	0.991	0.998	0.473	deleterious	ENST00000543371: c.1447C>A (p.P483T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021036	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	10	123298157	123298158	10q26.13	.	T	snv	C	AC.AC	hom-alt	637	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	C5	EX6	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF13895.1;PF13927.1	coding-synon	NM_000141.4	NP_000132.3	-	Y	c.696A>G	p.(V232=) | p.(Val232=)	GTA=>GTG	.	NM_000141.4(FGFR2): c.696A>G (p.(V232=))	SingleClassTriAllelic;maf-5-some-pop	126386	0.780300	U	0.9355	0.795327	13006	0.766723	PASS	3683	8644	0.923415	37171	121378	0.779680	7352	15919	9.23590e-01	75579	192307	7.81323e-01	rs1047100	.	4024	0.918200	-0.119	0.576	0.961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255319	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	11	320771	320772	11p15.5	.	A	snv	G	CC.CT	het-ref	158	0.45	.	2	dup	PASS	605579	P	614680(SK)	NN	.	.	.	.	.	.	.	10410	IFITM3	C1	EX1	.	.	coding-synon	NM_021034.2	NP_066362.2	-	Y	c.42T>C	p.(S14=) | p.(Ser14=)	AGT=>AGC	.	NM_021034.2(IFITM3): c.42T>C (p.(S14=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125570	0.129115	U	0.5278	0.236422	12184	0.100460	PASS	1367	8600	0.562209	2144	120562	0.124658	2701	9684	5.61912e-01	4309	31127	1.26554e-01	rs12252	.	4024	0.559900	-1.472	-3.123	-3.754	.	.	.	.	.	ENST00000399808: c.42T>C (p.S14S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752325	.	.	.	.	.	no_record	31527	no_assertion_criteria_provided	risk_factor	Likely Benign
InExcel	11	1651240	1651241	11p15.5	.	A	snv	C	gg.tg	het-ref	22	0.31	.	2	(CTGGGG)n|Simple_repeat|Simple_repeat|+|178;trf	DUBIOUS	.	.	.	.	.	.	.	.	.	.	.	439915	KRTAP5-5	C1E	EX1E	.	.	coding-synon	NM_001001480.2	NP_001001480.2	+	Y	c.171A>C	p.(G57=) | p.(Gly57=)	GGA=>GGC	.	NM_001001480.2(KRTAP5-5): c.171A>C (p.(G57=))	;	118094	0.002159	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8626	0.000348	0	118094	0.002159	0	1	6.01106e-05	0	440	1.98881e-03	rs754353217	.	4024	0.054900	-4.915	0.126	-0.955	.	.	.	.	.	ENST00000399676: c.171A>C (p.G57G)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	3808861	.	.	.	.	.	.	.	.	.	Unknown
Pass	11	9069045	9069046	11p15.4	.	G	snv	A	GC.TG	het-ref	207	0.48	.	2	.	PASS	611747	P	.	NN	.	.	.	.	.	.	.	57758	SCUBE2	C16	EX16	.	.	missense	NM_020974.2	NP_066025.2	-	Y	c.1859C>T	p.T620M | p.Thr620Met	ACG=>ATG	P0=>NP	NM_020974.2(SCUBE2): c.1859C>T (p.T620M)	;maf-5-some-pop,genotype-conflict	126334	0.154543	U	0.256	0.154353	12994	0.115053	PASS	345	8642	0.279333	1725	121326	0.154551	664	4805	2.78680e-01	3328	36856	1.50003e-01	rs3751055	.	4024	0.276800	0.655	2.479	0.594	.	.	.	.	.	ENST00000309263: c.1772C>T (p.T591M)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	147143	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	11	32417944	32417945	11p13	.	T	snv	C	CG.CG	het-ref	303	0.48	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C7	EX7	Wilm's tumour protein	PF02165.10	coding-synon	NM_001198551.1	NP_001185480.1	-	Y	c.471A>G	p.(R157=) | p.(Arg157=)	CGA=>CGG	.	NM_001198551.1(WT1): c.471A>G (p.(R157=))	;maf-5-some-pop	126080	0.237349	U	0.6984	0.33147	13002	0.130288	PASS	2079	8620	0.693155	4959	121072	0.233456	4176	11960	6.94299e-01	10439	59678	2.42672e-01	rs16754	.	4024	0.710000	-0.119	-0.899	-0.854	.	.	.	.	.	ENST00000379079: c.471A>G (p.R157R)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	1353507	.	.	.	.	.	no_record	198591	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	11	32417944	32417945	11p13	.	T	snv	C	CG.CG	het-ref	303	0.48	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C7	EX7	Wilm's tumour protein	PF02165.10	coding-synon	NM_024426.4	NP_077744.3	-	N	c.1107A>G	p.(R369=) | p.(Arg369=)	CGA=>CGG	.	NM_024426.4(WT1): c.1107A>G (p.(R369=))	;maf-5-some-pop	126080	0.237349	U	0.6984	0.33147	13002	0.130288	PASS	2079	8620	0.693155	4959	121072	0.233456	4176	11960	6.94299e-01	10439	59678	2.42672e-01	rs16754	.	4024	0.710000	-0.119	-0.899	-0.854	.	.	.	.	.	ENST00000379079: c.471A>G (p.R157R)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	1353507	.	.	.	.	.	no_record	198591	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	11	32456561	32456562	11p13	.	G	snv	A	GG.GG	het-ref	281	0.47	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C1	EX1	Wilm's tumour protein	PF02165.10	coding-synon	NM_024426.4	NP_077744.3	-	N	c.330C>T	p.(P110=) | p.(Pro110=)	CCC=>CCT	.	NM_024426.4(WT1): c.330C>T (p.(P110=))	;maf-5-some-pop,maf-5-all-pops	10004	0.314074	U	0.6855	0.303914	.	.	PASS	16	70	0.642857	285	4996	0.324259	1734	4984	6.91646e-01	4312	22175	2.74919e-01	rs1799925	.	4024	0.690100	0.306	2.024	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	193454	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	11	35308368	35308369	11p13	.	T	snv	C	GC.AC	hom-alt	353	1.00	.	0	.	PASS	600300	C	.	NN	.	.	.	.	.	.	.	6506	SLC1A2	C8	EX8	Sodium:dicarboxylate symporter family	PF00375.13	coding-synon	NM_004171.3	NP_004162.2	-	Y	c.1221A>G	p.(V407=) | p.(Val407=)	GTA=>GTG	.	NM_004171.3(SLC1A2): c.1221A>G (p.(V407=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126364	0.239665	U	0.1885	0.230431	13000	0.254769	PASS	185	8632	0.204703	3809	121356	0.240046	377	3529	2.04651e-01	7861	60156	2.44523e-01	rs1042113	.	4024	0.214700	-0.215	0.225	0.106	.	.	.	.	.	ENST00000278379: c.1221A>G (p.V407V)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3752347	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	11	44129289	44129290	11p11.2	.	C	snv	A	TC.GG	hom-alt	669	1.00	.	0	.	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	C2	EX2	.	.	coding-synon	NM_000401.3	NP_000392.3	+	Y	c.127C>A	p.(R43=) | p.(Arg43=)	CGG=>AGG	.	NM_000401.3(EXT2): c.127C>A (p.(R43=))	SingleClassTriAllelic;maf-5-some-pop	126366	0.035191	U	0.2788	0.0780751	13006	0.005843	PASS	342	8638	0.281431	370	121358	0.033422	680	4839	2.80587e-01	745	8511	3.45742e-02	rs4755228	.	4024	0.313100	0.650	4.333	1.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	195445	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	11	44129289	44129290	11p11.2	.	C	snv	A	TC.GG	hom-alt	669	1.00	.	0	.	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	C1	EX2	.	.	coding-synon	NM_207122.1	NP_997005.1	+	N	c.28C>A	p.(R10=) | p.(Arg10=)	CGG=>AGG	.	NM_207122.1(EXT2): c.28C>A (p.(R10=))	SingleClassTriAllelic;maf-5-some-pop	126366	0.035191	U	0.2788	0.0780751	13006	0.005843	PASS	342	8638	0.281431	370	121358	0.033422	680	4839	2.80587e-01	745	8511	3.45742e-02	rs4755228	.	4024	0.313100	0.650	4.333	1.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	195445	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	11	62293821	62293822	11q12.3	.	C	snv	T	AA.TT	het-ref	248	0.49	.	2	trf	PASS	103390	P	.	NN	.	.	.	.	.	.	.	79026	AHNAK	C3E	EX5E	.	.	coding-synon	NM_001620.1	NP_001611.1	-	Y	c.8067G>A	p.(K2689=) | p.(Lys2689=)	AAG=>AAA	.	NM_001620.1(AHNAK): c.8067G>A (p.(K2689=))	;maf-5-some-pop,genotype-conflict	126412	0.093654	U	0.2222	0.081869	13002	0.082987	PASS	288	8646	0.256188	749	121404	0.094140	573	4396	2.55107e-01	1477	23122	9.39033e-02	rs12366127	.	4024	0.234800	-1.676	-0.981	-2.529	.	.	.	.	.	ENST00000378024: c.8067G>A (p.K2689K)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4415231	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	11	64572601	64572602	11q13.1	.	G	snv	A	CC.TC	het-ref	251	0.45	.	2	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	coding-synon	NM_000244.3	NP_000235.2	-	Y	c.1269C>T	p.(D423=) | p.(Asp423=)	GAC=>GAT	.	NM_000244.3(MEN1): c.1269C>T (p.(D423=))	;maf-5-some-pop	125890	0.389952	U	0.372	0.307907	12996	0.304017	PASS	653	8614	0.382517	10125	120882	0.393351	1307	6631	3.84852e-01	20211	96630	3.92968e-01	rs2071313	.	4024	0.408800	-0.390	-0.047	-0.408	.	.	.	.	.	ENST00000312049: c.1254C>T (p.D418D)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752612	.	.	.	.	.	no_record	96249	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	11	64572601	64572602	11q13.1	.	G	snv	A	CC.TC	het-ref	251	0.45	.	2	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	coding-synon	NM_130799.2	NP_570711.1	-	N	c.1254C>T	p.(D418=) | p.(Asp418=)	GAC=>GAT	.	NM_130799.2(MEN1): c.1254C>T (p.(D418=))	;maf-5-some-pop	125890	0.389952	U	0.372	0.307907	12996	0.304017	PASS	653	8614	0.382517	10125	120882	0.393351	1307	6631	3.84852e-01	20211	96630	3.92968e-01	rs2071313	.	4024	0.408800	-0.390	-0.047	-0.408	.	.	.	.	.	ENST00000312049: c.1254C>T (p.D418D)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752612	.	.	.	.	.	no_record	96249	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	11	64577619	64577620	11q13.1	.	G	snv	C	CG.GG	het-ref	50	0.50	.	2	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	I5U1	IVS1	.	.	intron	NM_000244.3	NP_000235.2	-	Y	c.-23-16C>G	.	.	.	NM_000244.3(MEN1): c.-23-16C>G	;maf-5-some-pop,maf-5-all-pops	12848	0.256382	U	0.2718	0.17492	.	.	PASS	60	568	0.498239	333	7840	0.308418	449	2844	2.90086e-01	2310	18976	1.81307e-01	rs509606	.	4020	0.288300	-1.972	-1.922	-2.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	439889	criteria_provided,_single_submitter	Benign	Benign
HHReport	11	64577619	64577620	11q13.1	.	G	snv	C	CG.GG	het-ref	50	0.50	.	2	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	I5U1	IVS1	.	.	intron	NM_130799.2	NP_570711.1	-	N	c.-23-16C>G	.	.	.	NM_130799.2(MEN1): c.-23-16C>G	;maf-5-some-pop,maf-5-all-pops	12848	0.256382	U	0.2718	0.17492	.	.	PASS	60	568	0.498239	333	7840	0.308418	449	2844	2.90086e-01	2310	18976	1.81307e-01	rs509606	.	4020	0.288300	-1.972	-1.922	-2.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	439889	criteria_provided,_single_submitter	Benign	Benign
Pass	11	67352688	67352689	11q13.2	.	A	snv	G	AC.TC	het-ref	156	0.46	.	2	.	PASS	134660	C	.	NN	.	.	.	.	.	.	.	2950	GSTP1	C5	EX5	Glutathione S-transferase, C-terminal domain	PF00043.20	missense	NM_000852.3	NP_000843.1	+	Y	c.313A>G	p.I105V | p.Ile105Val	ATC=>GTC	NP=>NP	NM_000852.3(GSTP1): c.313A>G (p.I105V)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	124826	0.334249	U	0.1786	0.352636	12568	0.360837	PASS	150	8602	0.180656	7178	119818	0.333481	311	3071	1.78236e-01	15398	83108	3.38796e-01	rs1695	.	4024	0.189400	-2.931	-0.428	-0.473	1	0	0	0.000	neutral	ENST00000398606: c.313A>G (p.I105V)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752683	CM990713	NM_000852.3(GSTP1): c.313A>G (p.I105V)	"Oral cancer, association with"	10376763	DFP	no_record	37340	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	11	69462909	69462910	11q13.3	.	G	snv	A	CC.GT	het-ref	232	0.47	.	2	.	PASS	168461	C	114500(SK);193300(SK);254500(SK)	AD	.	.	.	.	.	.	.	595	CCND1	C4	EX4	Cyclin, C-terminal domain	PF02984.14	coding-synon	NM_053056.2	NP_444284.1	+	Y	c.723G>A	p.(P241=) | p.(Pro241=)	CCG=>CCA	.	NM_053056.2(CCND1): c.723G>A (p.(P241=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	125954	0.453475	U	0.5714	0.413538	12988	0.386742	PASS	1399	8622	0.569473	13016	120946	0.455129	2752	9765	5.66941e-01	26130	111484	4.53825e-01	rs9344	.	4024	0.556900	0.561	1.320	0.141	.	.	.	.	.	ENST00000227507: c.723G>A (p.P241P)	prostate [NS|NS|NS]	adenoma [NS|NS|NS]	CSV	1179751	.	.	.	.	.	no_record	13755	no_assertion_criteria_provided	risk_factor	Likely Benign
Pass	11	76227181	76227182	11q13.5	.	G	snv	A	CT.TA	het-ref	275	0.47	.	2	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC9	IVS10	.	.	intron	NM_020193.3	NP_064578.2	+	Y	c.1514-4G>A	.	.	.	NM_020193.3(C11orf30): c.1514-4G>A	;maf-5-some-pop,maf-5-all-pops	126198	0.643544	U	0.8006	0.636182	12984	0.549908	PASS	2905	8646	0.820958	25859	121190	0.643849	5772	14056	8.24592e-01	52418	156435	6.50701e-01	rs2508740	.	4024	0.809600	-0.381	-0.580	-1.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	11	76257214	76257215	11q13.5	.	T	snv	C	AC.GT	het-ref	432	0.50	.	2	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	C19	EX20	.	.	coding-synon	NM_020193.3	NP_064578.2	+	Y	c.3648T>C	p.(T1216=) | p.(Thr1216=)	ACT=>ACC	.	NM_020193.3(C11orf30): c.3648T>C (p.(T1216=))	SingleClassTriAllelic;maf-5-some-pop	126336	0.267034	U	0.1379	0.206869	12984	0.286275	PASS	68	8644	0.124942	4780	121328	0.269517	118	2088	1.21240e-01	9762	65966	2.68220e-01	rs3753051	.	4024	0.132500	0.528	1.761	2.322	.	.	.	.	.	ENST00000334736: c.3648T>C (p.T1216T)	stomach [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	VUO	147292	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	11	85977116	85977117	11q14.2	.	G	snv	A	TT.CA	het-ref	134	0.46	.	2	.	PASS	605984	P	.	NN	.	.	.	.	.	.	.	8726	EED	IC7	IVS7	.	.	intron	NM_003797.3	NP_003788.2	+	Y	c.727-8G>A	.	.	.	NM_003797.3(EED): c.727-8G>A	;maf-5-some-pop,maf-5-all-pops	126164	0.786286	U	0.7212	0.764976	12972	0.818378	PASS	2428	8652	0.744452	37842	121156	0.787167	4204	11309	7.36071e-01	67076	170740	7.80162e-01	rs10898460	.	.	.	-0.360	0.526	0.414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
HHReport	11	94197259	94197260	11q21	.	A	snv	G	TC.TA	het-ref	213	0.46	.	2	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC10	IVS11	.	.	intron	NM_005591.3	NP_005582.1	-	Y	c.1225+19T>C	.	.	.	NM_005591.3(MRE11A): c.1225+19T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125016	0.378728	U	0.4028	0.388778	12998	0.352131	PASS	764	8538	0.415203	8717	120008	0.378308	1468	6999	4.07392e-01	18125	93588	3.81553e-01	rs641936	.	4024	0.418000	-0.766	-2.678	-2.962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	193884	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	11	94212047	94212048	11q21	.	C	snv	T	TG.AA	het-ref	256	0.48	.	2	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC4	IVS5	.	.	intron	NM_005591.3	NP_005582.1	-	Y	c.403-6G>A	.	.	.	NM_005591.3(MRE11A): c.403-6G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125526	0.324745	U	0.3859	0.313099	12998	0.269580	PASS	735	8574	0.405762	6588	120518	0.325229	1406	6842	3.98300e-01	14112	81867	3.34525e-01	rs535801	.	4024	0.409000	-1.685	-1.531	-0.929	.	.	.	.	.	ENST00000323929: c.403-6G>A (p.?)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5430952	.	.	.	.	.	no_record	129623	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	11	99690285	99690286	11q22.1	.	T	snv	G	AA.CT	het-ref	315	0.68	.	2	.	PASS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	missense	NM_014361.3	NP_055176.1	+	Y	c.67T>G	p.S23A | p.Ser23Ala	TCT=>GCT	P0=>NP	NM_014361.3(CNTN5): c.67T>G (p.S23A)	SingleClassTriAllelic;maf-5-some-pop	119198	0.496527	U	.	.	.	.	InbreedingCoeff_Filter	174	8560	0.424416	2080	119198	0.496527	360	7129	4.24396e-01	4227	119331	4.94690e-01	rs10790978	.	4024	0.411800	-0.127	1.786	0.875	1	0	0	0.000	neutral	ENST00000524871: c.67T>G (p.S23A)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1476010	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	11	99690427	99690428	11q22.1	.	T	snv	G	GC.AG	het-ref	147	0.26	.	2	.	PASS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	missense	NM_014361.3	NP_055176.1	+	Y	c.209T>G	p.L70R | p.Leu70Arg	CTA=>CGA	NP=>P+	NM_014361.3(CNTN5): c.209T>G (p.L70R)	;maf-5-some-pop,maf-5-all-pops	117400	0.484906	U	.	.	.	.	InbreedingCoeff_Filter	0	8072	0.422324	1	117400	0.484906	0	5864	3.92188e-01	2	110845	4.77702e-01	rs7125822	.	4024	0.387200	-0.127	1.034	0.778	0.86	0	0	0.001	neutral	ENST00000524871: c.209T>G (p.L70R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3931469	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	11	99690460	99690461	11q22.1	.	A	snv	G	CA.TC	het-ref	49	0.13	.	2	.	DUBIOUS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	missense	NM_014361.3	NP_055176.1	+	Y	c.242A>G	p.N81S | p.Asn81Ser	AAT=>AGT	P0=>P0	NM_014361.3(CNTN5): c.242A>G (p.N81S)	;maf-5-some-pop,maf-5-all-pops	101874	0.361731	U	.	.	.	.	InbreedingCoeff_Filter	0	6140	0.235831	0	101874	0.361731	0	2171	1.60506e-01	0	58168	3.11866e-01	rs10893933	.	4024	0.141400	0.528	0.692	0.128	1	0.006	0.007	0.000	neutral	ENST00000524871: c.242A>G (p.N81S)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4592079	.	.	.	.	.	.	.	.	.	Unknown
Pass	11	102100428	102100429	11q22.2	.	C	snv	T	CA.TA	het-ref	156	0.51	.	2	.	PASS	606608	P	120433(MK)	AD	.	.	.	.	.	.	.	10413	YAP1	IC8	IVS8	.	.	intron	NM_001130145.2	NP_001123617.1	+	Y	c.1277-4C>T	.	.	.	NM_001130145.2(YAP1): c.1277-4C>T	;	125988	0.004492	U	0.0446	0.00898562	13004	0.000923	PASS	9	8650	0.053988	9	120980	0.004306	27	984	5.70501e-02	27	1089	4.43505e-03	rs116990751	.	.	.	-0.268	-0.106	-0.335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
HHReport	11	108121410	108121410	11q22.3	.	.	ins	T	CC.TT	het-ref	72	0.25	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC8	IVS9	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.1236-18_1236-17insT	.	.	.	NM_000051.3(ATM): c.1236-18_1236-17insT	MixedObserved;rs-cluster-nonoverlapping-alleles	57710	0.012493	U	0.3641	0.40595	.	.	InbreedingCoeff_Filter	17	6820	0.305718	241	94020	0.371719	.	.	.	.	.	.	rs34325032	.	4024	0.239600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	181847	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
HHReport	11	108151707	108151707	11q22.3	.	.	ins	A	TT.AA	het-ref	180	0.50	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC22	IVS23	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.3403-15_3403-14insA	.	.	.	NM_000051.3(ATM): c.3403-15_3403-14insA	InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,genotype-conflict,rs-cluster-nonoverlapping-alleles	120592	0.574026	U	0.4058	0.542133	12460	0.556180	PASS	602	8304	0.384513	18905	117198	0.567484	.	.	.	.	.	.	rs3218681	.	4024	0.405600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	181858	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
HHReport	11	108188266	108188267	11q22.3	.	T	del	.	GA.TT	het-ref	82	0.22	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC42	IVS43	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.6347+19delT	.	.	.	NM_000051.3(ATM): c.6347+19delT	MixedObserved;	29281	0.006796	U	.	.	.	.	InbreedingCoeff_Filter	0	6358	0.280591	470	91512	0.317794	.	.	.	.	.	.	rs766810400	.	4024	0.487600	0.164	-0.007	-0.020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	522241	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
InExcel	11	117079625	117079626	11q23.3	.	G	snv	C	GC.GG	het-ref	39	0.11	.	2	dup	DUBIOUS	604872	P	.	NN	.	.	.	.	.	.	.	9159	PCSK7	C11	EX13	Proprotein convertase P-domain	PF01483.15	missense	NM_004716.2	NP_004707.2	-	Y	c.1678C>G	p.R560G | p.Arg560Gly	CGC=>GGC	P+=>P0	NM_004716.2(PCSK7): c.1678C>G (p.R560G)	MixedObserved,SingleClassTriAllelic;	97528	0.010397	U	.	.	.	.	PASS	0	5800	0.023276	0	97528	0.010397	0	45	2.81426e-03	0	356	1.52444e-03	rs202038275	.	4024	0.016400	-0.362	1.519	1.207	0	0.996	1	0.906	deleterious	ENST00000320934: c.1678C>G (p.R560G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4597599	.	.	.	.	.	.	.	.	.	VUS
Pass	11	119148572	119148573	11q23.3	.	G	snv	T	AT.AT	hom-alt	327	1.00	.	0	.	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC7	IVS7	.	.	intron	NM_005188.3	NP_005179.2	+	Y	c.1095+19G>T	.	.	.	NM_005188.3(CBL): c.1095+19G>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125958	0.606194	U	0.879	0.728634	12988	0.624577	PASS	3353	8630	0.882619	23157	120950	0.601124	6666	15154	8.79717e-01	45063	144256	5.86922e-01	rs2510152	.	4024	0.885400	-0.256	0.027	-0.068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	55796	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	11	124742364	124742365	11q24.2	.	G	snv	A	GC.TG	het-ref	302	0.49	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C8	EX8	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin V-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF07686.12;PF13895.1;PF13927.1	missense	NM_022370.3	NP_071765.2	+	Y	c.1247G>A	p.R416H | p.Arg416His	CGT=>CAT	P+=>P+	NM_022370.3(ROBO3): c.1247G>A (p.R416H)	;maf-5-some-pop,genotype-conflict	125684	0.127009	U	0.2698	0.128794	12734	0.080493	PASS	306	8590	0.257276	1232	120676	0.126935	557	4361	2.52900e-01	2466	31599	1.28341e-01	rs3862618	.	4024	0.246800	-0.126	0.537	0.728	0.13	0.014	0.235	0.253	neutral	ENST00000397801: c.1247G>A (p.R416H)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752201	.	.	.	.	.	no_record	303235	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	11	124744694	124744695	11q24.2	.	T	snv	C	CC.CT	het-ref	105	0.48	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C13	EX13	.	.	missense	NM_022370.3	NP_071765.2	+	Y	c.1963T>C	p.S655P | p.Ser655Pro	TCT=>CCT	P0=>NP	NM_022370.3(ROBO3): c.1963T>C (p.S655P)	;	74524	0.000027	U	.	.	12254	0.000082	PASS	0	5764	0.000000	0	74524	0.000027	0	0	0.00000e+00	0	11	4.78911e-05	rs373747570	.	.	.	-0.256	0.996	0.210	0.3	0.256	0.767	0.055	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	11	124747836	124747837	11q24.2	.	G	snv	A	GC.GG	het-ref	207	0.48	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C21	EX21	.	.	coding-synon	NM_022370.3	NP_071765.2	+	Y	c.2991G>A	p.(A997=) | p.(Ala997=)	GCG=>GCA	.	NM_022370.3(ROBO3): c.2991G>A (p.(A997=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	95094	0.676078	U	0.4276	0.631989	11888	0.728802	PASS	621	5800	0.504655	19889	90086	0.678529	1422	6676	4.16158e-01	44329	137216	6.19788e-01	rs7933204	.	4024	0.414500	-0.254	-0.930	-0.532	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	303262	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	11	124750447	124750453	11q24.2	.	CGGAGT	del	.	gc.cg	het-ref	241	0.47	.	2	trf	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C27	EX27	.	.	cds-del	NM_022370.3	NP_071765.2	+	Y	c.4094GGAGTC[2>1] (std: c.4094GGAGTC[1] alt: c.4100_4105delGGAGTC )	p.R1363_S1364[3>2] (std: p.R1363_S1364[2] alt: p.R1367_S1368del ) | p.Arg1363_Ser1364[3>2] (std: p.Arg1363_Ser1364[2] alt: p.Arg1367_Ser1368del )	.	.	NM_022370.3(ROBO3): c.4094GGAGTC[1] (p.R1363_S1364[2])	MixedObserved;maf-5-some-pop,maf-5-all-pops	29508	0.370577	U	0.378	0.420727	11436	0.341203	PASS	58	1006	0.350895	1614	24500	0.360327	658	3684	3.41998e-01	7705	45882	3.03320e-01	rs71859853	.	4024	0.344400	.	.	.	.	.	.	.	.	ENST00000397801: c.4093_4098delCGGAGT (p.R1367_S1368delRS)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5825672	.	.	.	.	.	no_record	303279	criteria_provided,_single_submitter	Benign	Benign
Pass	11	125525194	125525195	11q24.2	.	A	snv	G	AG.TT	hom-alt	390	1.00	.	0	.	PASS	603078	P	.	NN	.	.	.	.	.	.	.	1111	CHEK1	C12E	EX13	.	.	missense	NM_001114121.2	NP_001107593.1	+	Y	c.1411A>G	p.I471V | p.Ile471Val	ATT=>GTT	NP=>NP	NM_001114121.2(CHEK1): c.1411A>G (p.I471V)	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126192	0.973120	U	1	0.985823	13000	0.973846	PASS	4324	8654	0.999653	57363	121184	0.972595	8617	17241	9.99594e-01	116453	239299	9.72879e-01	rs506504	.	4024	0.998000	-0.227	0.026	0.448	1	0.001	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	496139	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	12	463247	463248	12p13.33	.	G	snv	C	GC.AC	het-ref	318	0.51	.	2	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	C8	EX8	PHD-finger	PF00628.24	coding-synon	NM_001042603.1	NP_001036068.1	-	Y	c.1023C>G	p.(V341=) | p.(Val341=)	GTC=>GTG	.	NM_001042603.1(KDM5A): c.1023C>G (p.(V341=))	SingleClassTriAllelic;maf-5-some-pop	125734	0.005631	U	0.0486	0.0109824	12072	0.000249	PASS	21	8620	0.065777	21	120726	0.005409	47	1210	7.01856e-02	49	1447	5.87667e-03	rs2229352	.	4024	0.070600	-0.469	0.127	0.075	.	.	.	.	.	ENST00000399788: c.1023C>G (p.V341V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4418535	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	12	939301	939302	12p13.33	.	A	snv	G	GC.CA	hom-alt	338	1.00	.	0	.	PASS	605232	C	201300(MK);614492(MK)	AR	Pseudohypoaldosteronism, type IIC; Neuropathy, hereditary sensory and autonomic, type II	AD/AR	.	Neurologic; Renal	Neurologic; Renal	22934535|22910560|22266938|22080857|22073419|21768522|20323803|18521183|16946995|16636245|16534117|15911806|15060842|11498583|10869238|5455397	.	65125	WNK1	C4	EX4	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_213655.4	NP_998820.3	+	Y	c.1287A>G	p.(A429=) | p.(Ala429=)	GCA=>GCG	.	NM_213655.4(WNK1): c.1287A>G (p.(A429=))	;maf-5-some-pop,maf-5-all-pops	126368	0.743044	U	0.871	0.69349	13006	0.685530	PASS	3239	8648	0.865287	34121	121360	0.745089	6480	14954	8.66999e-01	69918	184549	7.49590e-01	rs10774466	.	4024	0.867300	-1.400	-2.298	-3.155	.	.	.	.	.	ENST00000537687: c.1287A>G (p.A429A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753538	.	.	.	.	.	no_record	261066	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	12	1040372	1040373	12p13.33	.	T	snv	C	CA.GA	het-ref	137	0.44	.	2	.	PASS	600392	P	.	NN	.	.	.	.	.	.	.	5893	RAD52	IC2	IVS3	.	.	intron	NM_134424.2	NP_602296.2	-	Y	c.186+13A>G	.	.	.	NM_134424.2(RAD52): c.186+13A>G	SingleClassTriAllelic;maf-5-some-pop	125784	0.548838	U	0.4623	0.544928	13006	0.551207	PASS	1006	8578	0.485778	18564	120776	0.549000	1885	8023	4.71886e-01	36537	131692	5.42420e-01	rs7303748	.	.	.	-2.497	-1.529	-1.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
HHReport	12	12870937	12870938	12p13.1	.	G	snv	A	GC.AG	het-ref	365	0.51	.	2	.	PASS	600778	C	610755(MK)	NN	Multiple endocrine neoplasia, type IV	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	22129891|21289244|20824794|20507346|17030811	FC59;H41;H54;H62;H68;HE15;MC58	1027	CDKN1B	C1	EX1	Cyclin-dependent kinase inhibitor	PF02234.14	coding-synon	NM_004064.3	NP_004055.1	+	Y	c.165G>A	p.(A55=) | p.(Ala55=)	GCG=>GCA	.	NM_004064.3(CDKN1B): c.165G>A (p.(A55=))	;	126366	0.003268	U	0.0208	0.00658946	.	.	PASS	3	8654	0.028080	4	121358	0.003131	4	500	2.89889e-02	7	750	3.04541e-03	rs16908375	.	4024	0.038300	-0.367	-2.884	-4.041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	239617	criteria_provided,_multiple_submitters,_no_conflicts	Benign	VUS
Pass	12	21644666	21644667	12p12.1	.	G	snv	A	GC.GA	hom-alt	379	1.00	.	0	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC1	IVS2	.	.	intron	NM_002907.3	NP_002898.2	-	Y	c.17-17C>T	.	.	.	NM_002907.3(RECQL): c.17-17C>T	;maf-5-some-pop,maf-5-all-pops	107156	0.464715	U	0.4623	0.373203	13004	0.366656	PASS	740	7510	0.469774	10633	102148	0.469202	1558	7113	4.49507e-01	22805	99359	4.49661e-01	rs10841834	.	.	.	-0.302	0.830	0.740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	12	25368461	25368462	12p12.1	.	C	snv	T	TC.CT	hom-alt	542	1.00	.	0	.	PASS	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	C4E	EX5	Elongation factor Tu GTP binding domain;Ras family	PF00009.22;PF00071.17	coding-synon	NM_033360.2	NP_203524.1	-	Y	c.483G>A	p.(R161=) | p.(Arg161=)	AGG=>AGA	.	NM_033360.2(KRAS): c.483G>A (p.(R161=))	;	126384	0.999462	U	1	0.997604	13006	0.998539	PASS	4327	8654	1.000000	60632	121376	0.999539	8624	17248	1.00000e+00	122932	245955	9.99630e-01	rs4362222	.	4024	0.999000	-0.332	2.341	1.061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	46538	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	12	46243405	46243406	12q12	.	A	snv	G	CC.GT	het-ref	288	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	196528	ARID2	C14	EX14	RFX DNA-binding domain	PF02257.10	missense	NM_152641.2	NP_689854.2	+	Y	c.1759A>G	p.S587G | p.Ser587Gly	AGT=>GGT	P0=>P0	NM_152641.2(ARID2): c.1759A>G (p.S587G)	;clinically-assoc,submitted-by-lsdb	126304	0.002668	U	0.0238	0.00519169	13006	0.000384	PASS	6	8640	0.030093	6	121296	0.002564	8	500	2.90192e-02	10	632	2.56961e-03	rs78128744	.	4024	0.034000	0.533	1.996	1.011	0.24	0.003	0.002	0.037	neutral	.	.	.	.	.	.	.	.	.	.	no_record	133559	no_assertion_provided	not_provided	VUS
Pass	12	49424533	49424534	12q13.12	.	G	snv	A	AG.GG	het-ref	337	0.53	.	2	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C41	EX41	.	.	coding-synon	NM_003482.3	NP_003473.3	-	Y	c.13689C>T	p.(P4563=) | p.(Pro4563=)	CCC=>CCT	.	NM_003482.3(MLL2): c.13689C>T (p.(P4563=))	;maf-5-some-pop	123838	0.095706	U	0.256	0.122804	12102	0.038093	PASS	297	8572	0.263532	1243	118830	0.094564	570	4428	2.57083e-01	2873	25091	1.02170e-01	rs11168830	.	4024	0.288000	-1.134	-0.428	0.030	.	.	.	.	.	ENST00000301067: c.13689C>T (p.P4563P)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753292	.	.	.	.	.	no_record	94169	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	12	49444544	49444545	12q13.12	.	G	snv	A	AT.AT	het-ref	394	0.53	.	2	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C11	EX11	.	.	coding-synon	NM_003482.3	NP_003473.3	-	Y	c.2826C>T	p.(I942=) | p.(Ile942=)	ATC=>ATT	.	NM_003482.3(MLL2): c.2826C>T (p.(I942=))	;maf-5-some-pop,maf-5-all-pops	124236	0.380534	U	0.4306	0.403554	12104	0.385410	PASS	720	8514	0.416021	8821	119228	0.379567	1515	7227	4.21252e-01	17605	91101	3.74775e-01	rs2241726	.	4024	0.408500	-0.360	0.077	-0.059	.	.	.	.	.	ENST00000301067: c.2015-8C>T (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	147497	.	.	.	.	.	no_record	94206	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	12	49445308	49445309	12q13.12	.	C	snv	T	AG.GG	het-ref	316	0.52	.	2	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C10	EX10	.	.	coding-synon	NM_003482.3	NP_003473.3	-	Y	c.2157G>A	p.(P719=) | p.(Pro719=)	CCG=>CCA	.	NM_003482.3(MLL2): c.2157G>A (p.(P719=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0.00000e+00	0	3	1.23037e-05	.	.	.	.	-1.214	-1.781	-1.994	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	12	52369299	52369300	12q13.13	.	C	snv	T	TG.CC	het-ref	274	0.45	.	2	.	PASS	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	IC2	IVS2	.	.	intron	NM_020328.3	NP_064733.3	+	Y	c.331+12C>T	.	.	.	NM_020328.3(ACVR1B): c.331+12C>T	;maf-5-some-pop,maf-5-all-pops	125028	0.288903	U	0.3056	0.29353	13006	0.231355	PASS	408	8546	0.316639	5997	120020	0.288710	840	5434	3.16335e-01	13701	73239	3.00727e-01	rs2242106	.	4024	0.331500	0.650	0.899	0.633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	12	56477693	56477694	12q13.2	.	A	snv	T	TG.GC	het-ref	256	0.46	.	2	.	PASS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC2	IVS2	.	.	intron	NM_001982.3	NP_001973.2	+	Y	c.234+8A>T	.	.	.	NM_001982.3(ERBB3): c.234+8A>T	;maf-5-some-pop,maf-5-all-pops	126392	0.616273	U	0.7808	0.592252	13006	0.495541	PASS	2664	8642	0.785929	24096	121384	0.617264	5288	13527	7.84265e-01	50149	154441	6.27172e-01	rs2271194	.	4024	0.759400	-1.147	-1.917	-1.723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
InExcel	12	64491002	64491002	12q14.2	.	.	ins	T	AG.TT	het-ref	27	0.20	.	2	.	PASS	606523	P	.	NN	.	.	.	.	.	.	.	57522	SRGAP1	IC14	IVS14	.	.	intron	NM_020762.2	NP_065813.1	+	Y	c.1679-19_1679-18insT	.	.	.	NM_020762.2(SRGAP1): c.1679-19_1679-18insT	MixedObserved;rs-cluster-nonoverlapping-alleles	71558	0.008245	U	.	.	.	.	PASS	0	5714	0.110431	0	82780	0.124656	.	.	.	.	.	.	rs765660234	.	4024	0.108800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	12	68552041	68552042	12q15	.	A	del	.	CT.AA	het-ref	129	0.53	.	2	.	PASS	147570	C	607948(SK);609135(SK);609423(SK);609532(SK);613254(SK)	NN	.	.	.	.	.	.	.	3458	IFNG	IC1	IVS1	.	.	intron	NM_000619.2	NP_000610.2	-	Y	c.115-3delT	.	.	.	NM_000619.2(IFNG): c.115-3delT	MixedObserved;	14156	0.010596	U	0.5863	0.625799	.	.	PASS	586	6482	0.583308	9527	91328	0.597309	.	.	.	.	.	.	rs2234686	.	4024	0.291000	-0.146	0.101	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	402962	criteria_provided,_single_submitter	Benign	Benign
Pass	12	71029732	71029733	12q15	.	C	snv	T	AT.CT	het-ref	118	0.42	.	2	.	PASS	176882	P	.	NN	.	.	.	.	.	.	.	5787	PTPRB	C2	EX2	Ricin-type beta-trefoil lectin domain	PF00652.17	missense	NM_001109754.2	NP_001103224.1	-	Y	c.169G>A	p.D57N | p.Asp57Asn	GAT=>AAT	P-=>P0	NM_001109754.2(PTPRB): c.169G>A (p.D57N)	;maf-5-some-pop	122294	0.156925	U	0.4028	0.253794	12436	0.108315	PASS	541	8390	0.358164	2226	117286	0.152789	1052	6054	3.53456e-01	4721	37828	1.54512e-01	rs2584021	.	4024	0.359300	0.563	1.957	0.714	0.36	0.005	0.002	0.020	neutral	ENST00000334414: c.169G>A (p.D57N)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753481	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	12	76449899	76449900	12q21.2	.	T	snv	C	TC.TT	hom-alt	408	1.00	.	0	.	PASS	164060	P	.	NN	.	.	.	.	.	.	.	4673	NAP1L1	C6	EX7	Nucleosome assembly protein (NAP)	PF00956.13	coding-synon	NM_004537.4	NP_004528.1	-	Y	c.471A>G	p.(K157=) | p.(Lys157=)	AAA=>AAG	.	NM_004537.4(NAP1L1): c.471A>G (p.(K157=))	SingleClassTriAllelic;maf-5-some-pop	125784	0.867241	U	0.999	0.920128	13002	0.857099	PASS	4294	8596	0.999535	45501	120776	0.865048	8578	17166	9.99418e-01	92049	211707	8.63976e-01	rs1059143	.	4024	0.997500	-0.748	-0.576	-0.696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	12	121416621	121416622	12q24.31	.	C	snv	G	CT.GA	het-ref	265	0.49	.	2	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C1	EX1	Hepatocyte nuclear factor 1 (HNF-1), N terminus	PF04814.8	coding-synon	NM_000545.5	NP_000536.5	+	Y	c.51C>G	p.(L17=) | p.(Leu17=)	CTC=>CTG	.	NM_000545.5(HNF1A): c.51C>G (p.(L17=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	122414	0.470387	U	0.3819	0.428514	12990	0.417475	PASS	658	8496	0.396893	13325	117406	0.472173	1328	6743	3.92674e-01	27609	114359	4.70215e-01	rs1169289	.	4024	0.383900	-2.001	0.039	-1.025	.	.	.	.	.	ENST00000257555: c.51C>G (p.L17L)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	430521	.	.	.	.	.	no_record	129234	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	12	121432116	121432117	12q24.31	.	G	snv	C	GG.CC	het-ref	226	0.41	.	2	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C4	EX4	Hepatocyte nuclear factor 1 (HNF-1), beta isoform C terminus	PF04812.8	coding-synon	NM_000545.5	NP_000536.5	+	Y	c.864G>C	p.(G288=) | p.(Gly288=)	GGG=>GGC	.	NM_000545.5(HNF1A): c.864G>C (p.(G288=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.181110	U	0.005	0.18111	13004	0.235774	PASS	0	5984	0.001003	3183	88434	0.278784	0	24	1.50075e-03	8875	59263	2.65499e-01	rs56348580	.	4024	0.002500	0.163	0.596	0.390	.	.	.	.	.	ENST00000257555: c.864G>C (p.G288G)	liver [NS|NS|NS]	other [adenoma|NS|NS]	CSV	5019699	CM067044	NM_000545.5(HNF1A): c.864G>C (p.G288G)	"Diabetes, MODY3"	16834925	DM	no_record	129236	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	12	121437113	121437114	12q24.31	.	G	snv	A	AC.GG	het-ref	326	0.49	.	2	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C8	EX8	Hepatocyte nuclear factor 1 (HNF-1), beta isoform C terminus	PF04812.8	coding-synon	NM_000545.5	NP_000536.5	+	Y	c.1545G>A	p.(T515=) | p.(Thr515=)	ACG=>ACA	.	NM_000545.5(HNF1A): c.1545G>A (p.(T515=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125696	0.137268	U	0.001	0.0628994	13004	0.140649	PASS	0	8618	0.000232	1602	120688	0.140354	0	5	2.90091e-04	3188	34503	1.40254e-01	rs55834942	.	4024	0.001700	-0.157	-1.625	-0.997	.	.	.	.	.	ENST00000257555: c.1545G>A (p.T515T)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1559373	.	.	.	.	.	no_record	129232	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	12	133202214	133202215	12q24.33	.	G	snv	A	GC.GC	hom-alt	429	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC47	IVS47	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.6657+16C>T	.	.	.	NM_006231.2(POLE): c.6657+16C>T	;maf-5-some-pop,maf-5-all-pops	125778	0.372426	U	0.6657	0.423323	13006	0.320314	PASS	2122	8630	0.700579	9098	120770	0.370315	4196	12006	6.96404e-01	18946	91845	3.75380e-01	rs5745075	.	4024	0.681200	-1.434	-0.654	-0.920	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	371835	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	12	133208885	133208886	12q24.33	.	C	snv	T	CA.GC	hom-alt	359	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC45	IVS45	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.6330+15G>A	.	.	.	NM_006231.2(POLE): c.6330+15G>A	;maf-5-some-pop,maf-5-all-pops	124040	0.496920	U	0.6736	0.565096	13006	0.480317	PASS	2137	8558	0.708927	14881	119032	0.494052	4272	12111	7.04128e-01	30611	120109	4.92331e-01	rs5745023	.	4024	0.686600	0.305	-0.628	-1.067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380218	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	12	133208978	133208979	12q24.33	.	T	snv	C	TC.GA	hom-alt	544	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C45	EX45	.	.	coding-synon	NM_006231.2	NP_006222.2	-	Y	c.6252A>G	p.(S2084=) | p.(Ser2084=)	TCA=>TCG	.	NM_006231.2(POLE): c.6252A>G (p.(S2084=))	;maf-5-some-pop,maf-5-all-pops	126346	0.640558	U	0.7788	0.699081	13006	0.642703	PASS	2872	8644	0.813281	25259	121338	0.638143	5728	14015	8.12746e-01	51967	158088	6.42175e-01	rs5745022	.	4024	0.794700	-3.008	-3.713	-2.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380217	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	12	133219830	133219831	12q24.33	.	T	snv	C	GA.GC	hom-alt	424	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C35	EX35	.	.	coding-synon	NM_006231.2	NP_006222.2	-	Y	c.4530A>G	p.(A1510=) | p.(Ala1510=)	GCA=>GCG	.	NM_006231.2(POLE): c.4530A>G (p.(A1510=))	;maf-5-some-pop,maf-5-all-pops	124888	0.507295	U	0.6736	0.605232	13006	0.522374	PASS	2140	8566	0.708032	15839	119880	0.503203	4270	12095	7.04180e-01	31845	121301	5.02723e-01	rs5744944	.	4024	0.687400	-1.752	-0.821	-2.108	.	.	.	.	.	ENST00000320574: c.4530A>G (p.A1510A)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4146901	.	.	.	.	.	no_record	380214	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	12	133233704	133233705	12q24.33	.	T	snv	C	CT.GG	hom-alt	494	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC29	IVS29	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.3582+17A>G	.	.	.	NM_006231.2(POLE): c.3582+17A>G	;	126350	0.971674	U	1	0.983826	13006	0.972936	PASS	4325	8654	0.999769	57239	121342	0.971172	8621	17244	9.99884e-01	115966	238802	9.70992e-01	rs5744889	.	4024	0.998000	-0.124	-0.023	-0.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380211	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	12	133235999	133236000	12q24.33	.	C	snv	T	GA.GT	hom-alt	546	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C26	EX26	DNA polymerase family B	PF00136.16	coding-synon	NM_006231.2	NP_006222.2	-	Y	c.3156G>A	p.(T1052=) | p.(Thr1052=)	ACG=>ACA	.	NM_006231.2(POLE): c.3156G>A (p.(T1052=))	;maf-5-some-pop,maf-5-all-pops	126340	0.506918	U	0.6736	0.605431	13006	0.522451	PASS	2164	8646	0.707842	16066	121332	0.502852	4292	12150	7.04593e-01	32434	123567	5.01925e-01	rs5744857	.	4024	0.687100	-2.000	-1.976	-3.001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380212	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	12	133237753	133237754	12q24.33	.	A	del	.	TG.AA	het-ref	36	0.29	.	2	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC24	IVS24	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.2865-4delT	.	.	.	NM_006231.2(POLE): c.2865-4delT	MixedObserved;	0	0	U	.	.	.	.	InbreedingCoeff_Filter	0	7622	0.446471	12	103024	0.453069	.	.	.	.	.	.	rs369732588	.	4024	0.242800	0.235	-0.336	0.115	.	.	.	.	.	ENST00000320574: c.2865-4delT (p.?)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5895362	.	.	.	.	.	.	.	.	.	Benign
Pass	13	19751656	19751657	13q12.11	.	G	snv	T	CC.CT	het-ref	123	0.44	.	2	.	PASS	602528	P	.	NN	.	.	.	.	.	.	.	7278	TUBA3C	C4	EX4	.	.	coding-synon	NM_006001.2	NP_005992.1	-	Y	c.466C>A	p.(R156=) | p.(Arg156=)	CGG=>AGG	.	NM_006001.2(TUBA3C): c.466C>A (p.(R156=))	;maf-5-some-pop	126106	0.043218	U	0.0129	0.0305511	13006	0.044518	PASS	1	8652	0.013754	166	121098	0.043741	3	192	1.11317e-02	296	10431	4.23714e-02	rs9507566	.	4024	0.011200	0.162	3.661	0.966	.	.	.	.	.	ENST00000400113: c.466C>A (p.R156R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753608	.	.	.	.	.	.	.	.	.	VUS
Pass	13	19751693	19751694	13q12.11	.	A	snv	G	CC.CC	het-ref	64	0.33	.	2	.	PASS	602528	P	.	NN	.	.	.	.	.	.	.	7278	TUBA3C	C4	EX4	.	.	coding-synon	NM_006001.2	NP_005992.1	-	Y	c.429T>C	p.(G143=) | p.(Gly143=)	GGT=>GGC	.	NM_006001.2(TUBA3C): c.429T>C (p.(G143=))	;maf-5-some-pop	123078	0.043476	U	0.0129	0.0305511	13006	0.043903	PASS	1	8646	0.013764	156	118070	0.044025	3	192	1.11485e-02	278	10086	4.14080e-02	rs9507567	.	4024	0.011200	-1.680	-1.690	-1.014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	13	28609824	28609825	13q12.2	.	A	snv	G	AT.GC	hom-alt	365	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC11	IVS11	.	.	intron	NM_004119.2	NP_004110.2	-	Y	c.1419-15T>C	.	.	.	NM_004119.2(FLT3): c.1419-15T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125460	0.695919	U	0.7351	0.563099	13006	0.616408	PASS	2374	8638	0.742996	30839	120452	0.701441	4473	11966	7.47595e-01	59595	161221	7.13790e-01	rs2491227	.	4024	0.721400	-0.119	0.083	0.485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	13	28610182	28610183	13q12.2	.	A	snv	G	CT.TA	hom-alt	325	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC10	IVS10	.	.	intron	NM_004119.2	NP_004110.2	-	Y	c.1310-3T>C	.	.	.	NM_004119.2(FLT3): c.1310-3T>C	;maf-5-some-pop,maf-5-all-pops	126242	0.693921	U	0.7351	0.563299	13006	0.616408	PASS	2376	8638	0.743459	30936	121234	0.699317	4802	12863	7.46114e-01	64072	174196	7.10621e-01	rs2491231	.	4024	0.721400	-0.468	0.844	0.617	.	.	.	.	.	ENST00000241453: c.1310-3T>C (p.?)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	3999060	.	.	.	.	.	.	.	.	.	Benign
Pass	13	28624293	28624294	13q12.2	.	G	snv	A	CC.TC	hom-alt	594	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	C6	EX6	.	.	missense	NM_004119.2	NP_004110.2	-	Y	c.680C>T	p.T227M | p.Thr227Met	ACG=>ATG	P0=>NP	NM_004119.2(FLT3): c.680C>T (p.T227M)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126374	0.597188	U	0.7688	0.558706	13006	0.522913	PASS	2539	8644	0.766890	22378	121366	0.598776	5046	13199	7.65337e-01	46008	148966	6.05189e-01	rs1933437	.	4024	0.730900	-0.311	1.607	0.687	0.03	0.803	0.999	0.667	deleterious	ENST00000241453: c.680C>T (p.T227M)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5019176	.	.	.	.	.	no_record	134447	no_assertion_provided	not_provided	Likely Benign
Pass	13	28636083	28636084	13q12.2	.	G	snv	A	GC.TC	hom-alt	510	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	C3	EX3	.	.	coding-synon	NM_004119.2	NP_004110.2	-	Y	c.288C>T	p.(D96=) | p.(Asp96=)	GAC=>GAT	.	NM_004119.2(FLT3): c.288C>T (p.(D96=))	;maf-5-some-pop	126416	0.981767	U	0.996	0.958067	13006	0.959942	PASS	4315	8654	0.998613	58666	121408	0.982744	8602	17224	9.98840e-01	119469	242440	9.85064e-01	rs7338903	.	4024	0.997500	0.508	0.158	0.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	13	28883060	28883061	13q12.2	.	G	snv	A	AC.TA	hom-alt	371	1.00	.	0	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	C28	EX28	.	.	coding-synon	NM_002019.4	NP_002010.2	-	Y	c.3639C>T	p.(Y1213=) | p.(Tyr1213=)	TAC=>TAT	.	NM_002019.4(FLT1): c.3639C>T (p.(Y1213=))	;maf-5-some-pop	126322	0.789680	U	1	0.730831	13006	0.646548	PASS	4314	8654	0.998498	39442	121314	0.792110	8601	17225	9.98667e-01	81945	198012	8.04534e-01	rs7993418	.	4024	0.997000	-1.322	-1.579	-1.877	.	.	.	.	.	ENST00000282397: c.3639C>T (p.Y1213Y)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	5021791	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	13	28886112	28886113	13q12.2	.	A	snv	G	TA.AT	hom-alt	342	1.00	.	0	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC26	IVS26	.	.	intron	NM_002019.4	NP_002010.2	-	Y	c.3492+17T>C	.	.	.	NM_002019.4(FLT1): c.3492+17T>C	SingleClassTriAllelic;maf-5-some-pop	126348	0.992141	U	1	0.974042	13006	0.975088	PASS	4323	8646	1.000000	59834	121340	0.992888	8620	17241	9.99942e-01	120922	243208	9.94057e-01	rs7328692	.	4024	0.998500	-0.119	-0.523	-0.236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
HHReport	13	32906728	32906729	13q13.1	.	A	snv	C	CA.AT	hom-alt	715	1.00	.	0	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C9	EX10	.	.	missense	NM_000059.3	NP_000050.2	+	Y	c.1114A>C	p.N372H | p.Asn372His	AAT=>CAT	P0=>P+	NM_000059.3(BRCA2): c.1114A>C (p.N372H)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125776	0.276794	U	0.2847	0.249401	12894	0.233209	PASS	347	8646	0.272843	4939	120768	0.277930	654	4624	2.68307e-01	10055	68695	2.79496e-01	rs144848	.	4024	0.265700	-0.250	0.020	-0.147	0.14	0.116	0.739	0.259	neutral	ENST00000544455: c.1114A>C (p.N372H)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	147663	CM002750	NM_000059.3(BRCA2): c.1114A>C (p.N372H)	"Breast cancer, association with"	11062481	DFP	no_record	9329	reviewed_by_expert_panel	Benign	Likely Benign
InExcel	13	32907535	32907535	13q13.1	.	.	ins	T	TC.TT	het-ref	50	0.14	.	2	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	IC9	IVS10	.	.	intron	NM_000059.3	NP_000050.2	+	Y	c.1909+11_1909+12insT	.	.	.	NM_000059.3(BRCA2): c.1909+11_1909+12insT	MixedObserved;clinically-assoc,submitted-by-lsdb	64378	0.187968	U	.	.	.	.	VQSRTrancheINDEL96.00to97.00	0	4866	0.062269	0	68792	0.063888	.	.	.	.	.	.	rs587780560	.	4024	0.041500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	220876	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely Benign
HHReport	13	32913054	32913055	13q13.1	.	A	snv	G	CT.TT	hom-alt	732	1.00	.	0	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C10	EX11	BRCA2 repeat	PF00634.13	coding-synon	NM_000059.3	NP_000050.2	+	Y	c.4563A>G	p.(L1521=) | p.(Leu1521=)	CTA=>CTG	.	NM_000059.3(BRCA2): c.4563A>G (p.(L1521=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	125962	0.992379	U	1	0.974042	13002	0.975773	PASS	4325	8652	0.999884	59672	120954	0.993138	8621	17243	9.99942e-01	121497	244277	9.94476e-01	rs206075	.	4024	0.999000	-0.213	0.602	0.599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	132779	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	13	32915004	32915005	13q13.1	.	G	snv	C	GT.TC	hom-alt	707	1.00	.	0	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C10	EX11	.	.	coding-synon	NM_000059.3	NP_000050.2	+	Y	c.6513G>C	p.(V2171=) | p.(Val2171=)	GTG=>GTC	.	NM_000059.3(BRCA2): c.6513G>C (p.(V2171=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125994	0.992262	U	1	0.973642	13006	0.975473	PASS	4320	8642	0.999884	59677	120986	0.993032	8269	16539	9.99940e-01	116135	233536	9.94303e-01	rs206076	.	4024	0.999000	-1.471	-1.732	-1.095	.	.	.	.	.	ENST00000544455: c.6513G>C (p.V2171V)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4147689	.	.	.	.	.	no_record	132780	reviewed_by_expert_panel	Benign	Likely Benign
DHReport	13	32930632	32930633	13q13.1	.	C	snv	T	AA.GC	het-ref	279	0.48	.	2	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C14	EX15	BRCA2, helical	PF09169.5	missense	NM_000059.3	NP_000050.2	+	Y	c.7504C>T	p.R2502C | p.Arg2502Cys	CGC=>TGC	P+=>P0	NM_000059.3(BRCA2): c.7504C>T (p.R2502C)	;clinically-assoc,submitted-by-lsdb	126032	0.000302	U	0	0.000399361	13006	0.001153	PASS	0	8642	0.000000	0	121024	0.000297	0	0	0.00000e+00	0	65	2.64026e-04	rs55716624	.	.	.	-0.143	0.173	0.107	0.14	0	0.001	0.249	neutral	.	.	.	.	.	CM012590	NM_000059.3(BRCA2): c.7504C>T (p.R2502C)	Breast and/or ovarian cancer	.	DM	no_record	41563	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Certain
Pass	13	41515370	41515371	13q14.11	.	C	snv	T	AG.GA	het-ref	209	0.46	.	2	.	PASS	189973	P	.	NN	.	.	.	.	.	.	.	1997	ELF1	C7	EX8	.	.	coding-synon	NM_172373.3	NP_758961.1	-	Y	c.942G>A	p.(S314=) | p.(Ser314=)	TCG=>TCA	.	NM_172373.3(ELF1): c.942G>A (p.(S314=))	;maf-5-some-pop	126400	0.141796	U	0.0843	0.132388	13006	0.189067	PASS	43	8652	0.084374	1414	121392	0.142184	72	1466	8.49954e-02	2685	34571	1.40405e-01	rs7987185	.	4024	0.100600	-0.294	-0.272	-0.119	.	.	.	.	.	ENST00000239882: c.942G>A (p.S314S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999084	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	13	103385298	103385299	13q33.1	.	A	snv	C	AG.AA	hom-alt	182	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	643677	CCDC168	C4E	EX4E	.	.	missense	NM_001146197.1	NP_001139669.1	-	Y	c.17748T>G	p.F5916L | p.Phe5916Leu	TTT=>TTG	NP=>NP	NM_001146197.1(CCDC168): c.17748T>G (p.F5916L)	;maf-5-some-pop	24842	0.986837	U	1	0.972843	4566	0.974157	PASS	311	622	1.000000	9737	19834	0.990370	5120	10240	1.00000e+00	73459	147656	9.94571e-01	rs7335290	.	4024	0.998500	-0.366	-2.356	-2.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	13	103504516	103504517	13q33.1	.	T	snv	C	CA.GG	het-ref	299	0.51	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C2	EX2	XPG N-terminal domain	PF00752.12	coding-synon	NM_000123.3	NP_000114.2	+	Y	c.138T>C	p.(H46=) | p.(His46=)	CAT=>CAC	.	NM_000123.3(ERCC5): c.138T>C (p.(H46=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126394	0.527667	U	0.25	0.493011	13006	0.611795	PASS	317	8646	0.266019	18075	121386	0.529097	633	4569	2.64992e-01	35633	128018	5.20009e-01	rs1047768	.	.	.	-1.444	-0.189	-0.522	.	.	.	.	.	ENST00000355739: c.138T>C (p.H46H)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753565	.	.	.	.	.	no_record	129009	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	13	103506685	103506686	13q33.1	.	C	snv	G	CT.TA	het-ref	225	0.46	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C4	EX4	.	.	coding-synon	NM_000123.3	NP_000114.2	+	Y	c.429C>G	p.(L143=) | p.(Leu143=)	CTC=>CTG	.	NM_000123.3(ERCC5): c.429C>G (p.(L143=))	;maf-5-some-pop	126370	0.011387	U	0.0149	0.0371406	13006	0.025296	PASS	1	8650	0.016763	47	121362	0.010324	4	323	1.87290e-02	65	2133	8.66193e-03	rs4140390	.	.	.	-0.795	0.447	0.888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	310912	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	VUS
Pass	13	103510735	103510736	13q33.1	.	C	snv	T	AG.GC	het-ref	295	0.45	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C6	EX6	.	.	missense	NM_000123.3	NP_000114.2	+	Y	c.640C>T	p.R214C | p.Arg214Cys	CGC=>TGC	P+=>P0	NM_000123.3(ERCC5): c.640C>T (p.R214C)	;clinically-assoc,submitted-by-lsdb	126352	0.002865	U	0.0149	0.00519169	13006	0.000308	PASS	1	8654	0.016755	2	121344	0.002769	4	323	1.87268e-02	8	692	2.81244e-03	rs56255799	.	.	.	-0.182	1.100	0.585	0	1	1	0.945	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	134180	criteria_provided,_single_submitter	Likely_benign	VUS
Pass	13	103513950	103513951	13q33.1	.	A	snv	G	TC.GC	het-ref	348	0.53	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C7	EX7	.	.	missense	NM_000123.3	NP_000114.2	+	Y	c.767A>G	p.Q256R | p.Gln256Arg	CAG=>CGG	P0=>P+	NM_000123.3(ERCC5): c.767A>G (p.Q256R)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126366	0.012796	U	0.0149	0.0373403	13006	0.025988	PASS	1	8650	0.016763	52	121358	0.011783	4	323	1.87268e-02	72	2438	9.90461e-03	rs4150313	.	.	.	0.455	4.597	2.121	0	0.996	1	0.906	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	134182	criteria_provided,_multiple_submitters,_no_conflicts	Likely_benign	VUS
Pass	13	103528001	103528002	13q33.1	.	G	snv	C	AA.AT	het-ref	336	0.48	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C15E	EX15E	.	.	missense	NM_000123.3	NP_000114.2	+	Y	c.3310G>C	p.D1104H | p.Asp1104His	GAT=>CAT	P-=>P+	NM_000123.3(ERCC5): c.3310G>C (p.D1104H)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126190	0.281005	U	0.4623	0.361422	13006	0.305782	PASS	1106	8630	0.506257	5378	121182	0.277682	2126	8536	4.95415e-01	10617	68103	2.76959e-01	rs17655	.	.	.	0.650	3.426	1.221	0.06	0.986	1	0.757	deleterious	ENST00000355739: c.3310G>C (p.D1104H)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753566	.	.	.	.	.	no_record	129011	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	13	110435230	110435231	13q34	.	C	snv	T	CG.CC	het-ref	320	0.53	.	2	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	missense	NM_003749.2	NP_003740.2	-	Y	c.3170G>A	p.G1057D | p.Gly1057Asp	GGC=>GAC	P0=>P-	NM_003749.2(IRS2): c.3170G>A (p.G1057D)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	31554	0.366388	U	0.3929	0.283347	11934	0.232613	PASS	170	1896	0.466772	1723	26546	0.382054	900	4696	4.01848e-01	9751	53126	3.50454e-01	rs1805097	.	4024	0.349700	0.644	0.768	0.922	0.53	0.029	0.205	0.009	neutral	ENST00000375856: c.3170G>A (p.G1057D)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753571	CM003938	NM_003749.2(IRS2): c.3170G>A (p.G1057D)	"Diabetes in overweight people, association with"	11030756	DP	no_record	8820	no_assertion_criteria_provided	risk_factor	Likely Benign
Pass	13	110435301	110435302	13q34	.	T	snv	C	gg.gg	het-ref	259	0.40	.	2	(CGG)n|Simple_repeat|Simple_repeat|+|117	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	coding-synon	NM_003749.2	NP_003740.2	-	Y	c.3099A>G	p.(P1033=) | p.(Pro1033=)	CCA=>CCG	.	NM_003749.2(IRS2): c.3099A>G (p.(P1033=))	;maf-5-some-pop,maf-5-all-pops	5008	0.275359	U	0.0595	0.275359	.	.	VQSRTrancheINDEL97.00to99.00	0	52	0.038462	108	5118	0.214732	0	72	2.07493e-02	799	8560	1.73525e-01	rs9583424	.	4024	0.072100	-1.876	-3.826	-3.715	.	.	.	.	.	ENST00000375856: c.3099A>G (p.P1033P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753572	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	13	110435727	110435728	13q34	.	C	snv	G	CG.GT	het-ref	304	0.51	.	2	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	coding-synon	NM_003749.2	NP_003740.2	-	Y	c.2673G>C	p.(T891=) | p.(Thr891=)	ACG=>ACC	.	NM_003749.2(IRS2): c.2673G>C (p.(T891=))	;maf-5-some-pop	28440	0.058826	U	0.0367	0.0269569	12142	0.018119	PASS	5	1218	0.091133	44	23432	0.065637	10	387	5.42169e-02	144	4962	4.42199e-02	rs75172981	.	4024	0.048000	-0.254	0.022	-0.452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	13	110435952	110435953	13q34	.	A	snv	G	CC.CA	hom-alt	592	1.00	.	0	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	coding-synon	NM_003749.2	NP_003740.2	-	Y	c.2448T>C	p.(C816=) | p.(Cys816=)	TGT=>TGC	.	NM_003749.2(IRS2): c.2448T>C (p.(C816=))	;maf-5-some-pop,maf-5-all-pops	24596	0.582371	U	0.4514	0.563898	12390	0.601776	PASS	97	812	0.539409	3255	19588	0.587094	1123	4925	4.67445e-01	24998	83847	5.87271e-01	rs4773092	.	4024	0.422000	-0.945	-0.272	-0.221	.	.	.	.	.	ENST00000375856: c.2448T>C (p.C816C)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	432101	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	13	110436231	110436232	13q34	.	G	snv	A	CC.CT	hom-alt	614	1.00	.	0	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	coding-synon	NM_003749.2	NP_003740.2	-	Y	c.2169C>T	p.(S723=) | p.(Ser723=)	AGC=>AGT	.	NM_003749.2(IRS2): c.2169C>T (p.(S723=))	;maf-5-some-pop,maf-5-all-pops	19372	0.555234	U	0.4514	0.559505	10348	0.639544	PASS	44	352	0.522727	2202	14364	0.553745	1071	4679	4.67433e-01	23301	78496	5.84648e-01	rs3742210	.	4024	0.421200	-2.019	-0.710	-1.113	.	.	.	.	.	ENST00000375856: c.2169C>T (p.S723S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3749236	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	20665789	20665790	14q11.2	.	T	snv	A	CA.CC	hom-alt	297	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	missense	NM_001005503.1	NP_001005503.1	+	Y	c.296T>A	p.I99N | p.Ile99Asn	ATC=>AAC	NP=>P0	NM_001005503.1(OR11G2): c.296T>A (p.I99N)	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126386	0.492270	U	0.5109	0.442692	13006	0.453944	PASS	1052	8640	0.492361	15019	121378	0.494315	2054	8452	4.90028e-01	31089	122796	4.98765e-01	rs4981822	.	4024	0.468900	0.528	4.498	1.955	0.02	0.533	0.851	0.563	deleterious	ENST00000357366: c.296T>A (p.I99N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999203	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	20665839	20665840	14q11.2	.	G	snv	A	CA.TC	hom-alt	396	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	missense	NM_001005503.1	NP_001005503.1	+	Y	c.346G>A	p.V116I | p.Val116Ile	GTC=>ATC	NP=>NP	NM_001005503.1(OR11G2): c.346G>A (p.V116I)	;maf-5-some-pop,maf-5-all-pops	126268	0.494908	U	0.5437	0.44988	13006	0.453560	PASS	1160	8632	0.521432	15122	121260	0.496767	2302	8937	5.18207e-01	31258	123119	5.00406e-01	rs4981088	.	4024	0.495300	0.650	1.513	2.414	0.14	0.052	0.007	0.253	neutral	ENST00000357366: c.346G>A (p.V116I)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999204	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	20665886	20665887	14q11.2	.	G	snv	C	TC.TT	hom-alt	314	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	coding-synon	NM_001005503.1	NP_001005503.1	+	Y	c.393G>C	p.(S131=) | p.(Ser131=)	TCG=>TCC	.	NM_001005503.1(OR11G2): c.393G>C (p.(S131=))	;maf-5-some-pop	126324	0.936813	U	0.7192	0.905751	13006	0.984315	PASS	2109	8618	0.703295	53784	121316	0.938096	4232	12126	7.03446e-01	108025	229677	9.33009e-01	rs4981823	.	4024	0.675900	-0.744	0.133	0.026	.	.	.	.	.	ENST00000357366: c.393G>C (p.S131S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999205	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	23548783	23548783	14q11.2	.	.	ins	GAACGT	GA.GA	het-ref	235	0.50	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	cds-ins	NM_014977.3	NP_055792.1	-	Y	c.1923ACGTTC[2>3] (std: c.1929_1934dupACGTTC alt: c.1934_1935insACGTTC )	p.R638_S639[5>6] (std: p.R646_S647dup alt: p.S647_A648insRS ) | p.Arg638_Ser639[5>6] (std: p.Arg646_Ser647dup alt: p.Ser647_Ala648insArgSer )	.	.	NM_014977.3(ACIN1): c.1929_1934dupACGTTC (p.R646_S647dup)	ObservedTooLong;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	125393	0.289554	U	0.4226	0.38778	12518	0.455983	VQSRTrancheINDEL99.00to99.50	764	8648	0.425532	5945	120400	0.301561	.	.	.	.	.	.	rs148403158	.	4024	0.420500	.	.	.	.	.	.	.	.	ENST00000262710: c.1934_1935insACGTTC (p.S647_A648insRS)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1162679	.	.	.	.	.	.	.	.	.	Benign
Pass	14	23549284	23549285	14q11.2	.	G	snv	A	GA.AC	het-ref	275	0.47	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	missense	NM_014977.3	NP_055792.1	-	Y	c.1433C>T	p.S478F | p.Ser478Phe	TCT=>TTT	P0=>NP	NM_014977.3(ACIN1): c.1433C>T (p.S478F)	;maf-5-some-pop,genotype-conflict	126282	0.053476	U	0.1389	0.0517173	13006	0.044057	PASS	55	8640	0.120370	207	121274	0.053548	122	2148	1.24565e-01	413	12878	5.23330e-02	rs3751501	.	4024	0.111300	0.650	3.140	2.821	.	.	.	.	.	ENST00000262710: c.1433C>T (p.S478F)	soft_tissue [striated_muscle|NS|NS]	rhabdomyosarcoma [alveolar|NS|NS]	VUO	4986737	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	23549318	23549319	14q11.2	.	A	snv	G	AG.TA	het-ref	302	0.47	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	missense	NM_014977.3	NP_055792.1	-	Y	c.1399T>C	p.S467P | p.Ser467Pro	TCT=>CCT	P0=>NP	NM_014977.3(ACIN1): c.1399T>C (p.S467P)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126320	0.422815	U	0.3948	0.428315	13006	0.445256	PASS	529	8632	0.353800	11058	121312	0.422588	1056	6035	3.49977e-01	21554	102009	4.14519e-01	rs1885097	.	4024	0.358800	0.528	-0.027	-0.196	.	.	.	.	.	ENST00000262710: c.1399T>C (p.S467P)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753892	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	23549382	23549383	14q11.2	.	G	snv	T	GG.GC	het-ref	303	0.53	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	coding-synon	NM_014977.3	NP_055792.1	-	Y	c.1335C>A	p.(A445=) | p.(Ala445=)	GCC=>GCA	.	NM_014977.3(ACIN1): c.1335C>A (p.(A445=))	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126274	0.053519	U	0.1389	0.0517173	13006	0.000231	PASS	55	8648	0.120259	209	121266	0.053593	122	2149	1.24594e-01	416	12897	5.24055e-02	rs45510791	.	4024	0.111300	0.650	-0.615	-0.531	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	23549784	23549785	14q11.2	.	T	snv	C	GG.AT	het-ref	341	0.48	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	missense	NM_014977.3	NP_055792.1	-	Y	c.933A>G	p.I311M | p.Ile311Met	ATA=>ATG	NP=>NP	NM_014977.3(ACIN1): c.933A>G (p.I311M)	;maf-5-some-pop,maf-5-all-pops	126388	0.445667	U	0.4554	0.500799	13006	0.493003	PASS	794	8644	0.430241	12364	121380	0.443393	1585	7366	4.27064e-01	23756	106428	4.32262e-01	rs3811182	.	4024	0.424000	-2.211	-0.283	-0.194	.	.	.	.	.	ENST00000262710: c.933A>G (p.I311M)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753894	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	23549878	23549881	14q11.2	.	TCC	del	.	ct.tc	het-ref	180	0.43	.	2	CT-rich|Low_complexity|Low_complexity|+|53;trf	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	cds-del	NM_014977.3	NP_055792.1	-	Y	c.822GGA[6>5] (std: c.822GGA[5] alt: c.837_839delGGA )	p.E270[12>11] (std: p.E270[11] alt: p.E281del ) | p.Glu270[12>11] (std: p.Glu270[11] alt: p.Glu281del )	.	.	NM_014977.3(ACIN1): c.822GGA[5] (p.E270[11])	MixedObserved;maf-5-some-pop	13895	0.039798	U	0.2073	0.107228	.	.	VQSRTrancheINDEL97.00to99.00	189	8640	0.204398	458	121296	0.073135	.	.	.	.	.	.	rs3841035	.	4024	0.180200	.	.	.	.	.	.	.	.	ENST00000262710: c.837_839delGGA (p.E281delE)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4592001	.	.	.	.	.	.	.	.	.	Benign
Pass	14	35873769	35873770	14q13.2	.	G	snv	A	TC.TC	het-ref	186	0.47	.	2	.	PASS	164008	C	612132(MK)	NN	Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency	AD	.	Allergy/Immunology/Infectious; Dental; Dermatologic; Gastrointestinal	Allergy/Immunology/Infectious	18412279|17931563|16769798|15337789|14523047	.	4792	NFKBIA	C1	EX1	.	.	coding-synon	NM_020529.2	NP_065390.1	-	Y	c.81C>T	p.(D27=) | p.(Asp27=)	GAC=>GAT	.	NM_020529.2(NFKBIA): c.81C>T (p.(D27=))	;maf-5-some-pop,maf-5-all-pops	87316	0.337430	U	0.2649	0.244409	12672	0.228693	PASS	262	6142	0.326604	4129	82308	0.343089	510	3853	2.62145e-01	8933	60008	2.84414e-01	rs1957106	.	.	.	0.313	0.869	0.672	.	.	.	.	.	NM_020529.1: c.81C>T (p.D27D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753951	.	.	.	.	.	no_record	313117	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	14	38061741	38061742	14q21.1	.	C	snv	T	GG.TA	het-ref	249	0.49	.	2	.	PASS	602294	C	.	NN	.	.	.	.	.	.	.	3169	FOXA1	C2E	EX2E	Forkhead N-terminal region	PF08430.7	missense	NM_004496.3	NP_004487.2	-	Y	c.247G>A	p.A83T | p.Ala83Thr	GCC=>ACC	NP=>P0	NM_004496.3(FOXA1): c.247G>A (p.A83T)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	124080	0.607390	U	0.8442	0.583067	12562	0.538688	PASS	3194	8598	0.863806	22511	119072	0.608413	6418	14875	8.64625e-01	47141	149313	6.16090e-01	rs7144658	.	4024	0.870800	0.511	1.200	0.784	0.07	0.139	0.783	0.331	neutral	ENST00000250448: c.247G>A (p.A83T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753953	.	.	.	.	.	.	.	.	.	Likely Benign
HHReport	14	75483811	75483812	14q24.3	.	T	snv	C	GA.TG	hom-alt	480	1.00	.	0	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C12E	EX13E	.	.	coding-synon	NM_001040108.1	NP_001035197.1	-	Y	c.4335A>G	p.(Q1445=) | p.(Gln1445=)	CAA=>CAG	.	NM_001040108.1(MLH3): c.4335A>G (p.(Q1445=))	;maf-5-some-pop,genotype-conflict	126392	0.564094	U	0.8393	0.580072	13006	0.501922	PASS	2969	8646	0.829054	20173	121384	0.563435	6020	14381	8.33778e-01	42434	141462	5.74456e-01	rs13712	.	4024	0.828000	-0.938	-0.109	-0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257253	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
DHReport	14	75513539	75513540	14q24.3	.	G	snv	A	CA.AA	het-ref	337	0.45	.	2	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C1	EX2	.	.	missense	NM_001040108.1	NP_001035197.1	-	Y	c.2819C>T	p.S940F | p.Ser940Phe	TCT=>TTT	P0=>NP	NM_001040108.1(MLH3): c.2819C>T (p.S940F)	;	121366	0.000041	U	.	.	.	.	PASS	0	8652	0.000578	0	121366	0.000041	0	7	4.05844e-04	0	7	2.84393e-05	rs746725349	.	.	.	0.650	0.927	0.857	0.01	0.707	0.983	0.661	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
HHReport	14	75513882	75513883	14q24.3	.	T	snv	C	GT.AA	hom-alt	698	1.00	.	0	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C1	EX2	.	.	missense	NM_001040108.1	NP_001035197.1	-	Y	c.2476A>G	p.N826D | p.Asn826Asp	AAC=>GAC	P0=>P-	NM_001040108.1(MLH3): c.2476A>G (p.N826D)	;maf-5-some-pop,genotype-conflict	126408	0.996543	U	1	0.990415	13006	0.988774	PASS	4327	8654	1.000000	60318	121400	0.996796	8624	17248	1.00000e+00	122457	245532	9.97392e-01	rs175081	.	4024	0.998500	-1.059	0.274	-0.121	0.23	0	0	0.042	neutral	.	.	.	.	.	.	.	.	.	.	no_record	257251	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	14	81610582	81610583	14q31.1	.	G	snv	C	GA.AT	hom-alt	568	1.00	.	0	.	PASS	603372	C	275200(MK);603372(MK);603373(MK);609152(MK)	AR	Hyperthyroidism, familial, gestational; Hyperthyroidism, nonautoimmune; Hypothyroidism, congenital, nongoitrous, 1	AD/AR	.	Endocrine	Endocrine	23698639|23563316|23412867|23329763|23154162|22876533|22763653|22405933|21714469|21677043|21283701|21186955|20718767|20146656|12050212|10487707|9854118|9385128|9329388|9185526|9100579|8954020|7920658|7800007|7528344	.	7253	TSHR	C10E	EX10E	.	.	missense	NM_000369.2	NP_000360.2	+	Y	c.2181G>C	p.E727D | p.Glu727Asp	GAG=>GAC	P-=>P-	NM_000369.2(TSHR): c.2181G>C (p.E727D)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126336	0.900234	U	0.8472	0.896765	13006	0.923343	PASS	2937	8642	0.825156	49233	121328	0.900377	5817	14142	8.20016e-01	98812	220175	8.95792e-01	rs1991517	.	.	.	-0.232	0.216	0.675	0.7	0.001	0	0.002	neutral	.	.	.	.	.	.	.	.	.	.	no_record	135400	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	14	95566097	95566108	14q32.13	.	CACACACACAC	del	.	ca.aA	het-ref	79	0.45	.	2	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.4206+9_4206+19delGTGTGTGTGTG	.	.	.	NM_177438.2(DICER1): c.4206+9_4206+19delGTGTGTGTGTG	MixedObserved;	110836	0.097513	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	89	7372	0.286761	178	111472	0.096957	690	2927	1.76581e-01	1701	13789	6.03315e-02	rs748368348	.	7464	0.094700	.	.	.	.	.	.	.	.	ENST00000343455: c.4206+9_4206+19delGTGTGTGTGTG (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4603892	.	.	.	.	.	no_record	477187	criteria_provided,_single_submitter	Benign	Benign
InExcel	14	95566103	95566104	14q32.13	.	C	del	.	ca.ac	het-ref	24	0.17	.	2	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.4206+13delG	.	.	.	NM_177438.2(DICER1): c.4206+13delG	MixedObserved;	0	0	U	.	.	.	.	VQSRTrancheINDEL97.00to99.00	15	2492	0.350321	462	58084	0.297070	.	.	.	.	.	.	rs35300142	.	5202	0.139300	-0.823	-0.779	-0.818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	14	102568295	102568296	14q32.31	.	G	snv	A	GC.GT	het-ref	149	0.48	.	2	.	PASS	140571	C	.	NN	.	.	.	.	.	.	.	3320	HSP90AA1	C2	EX2	.	.	coding-synon	NM_001017963.2	NP_001017963.2	-	Y	c.282C>T	p.(T94=) | p.(Thr94=)	ACC=>ACT	.	NM_001017963.2(HSP90AA1): c.282C>T (p.(T94=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126390	0.790909	U	0.7708	0.664537	13006	0.697678	PASS	2431	8640	0.754398	39833	121382	0.796123	4870	12994	7.53363e-01	82332	198588	8.06481e-01	rs10873531	.	4024	0.751500	-0.602	-0.312	-0.372	.	.	.	.	.	ENST00000334701: c.282C>T (p.T94T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753784	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	102568366	102568367	14q32.31	.	T	snv	A	CA.CA	het-ref	111	0.50	.	2	.	PASS	140571	C	.	NN	.	.	.	.	.	.	.	3320	HSP90AA1	C2	EX2	.	.	missense	NM_001017963.2	NP_001017963.2	-	Y	c.211A>T	p.M71L | p.Met71Leu	ATG=>TTG	NP=>NP	NM_001017963.2(HSP90AA1): c.211A>T (p.M71L)	;maf-5-some-pop	126404	0.862647	U	0.8194	0.801118	13006	0.818161	PASS	2788	8644	0.805877	45799	121396	0.865185	5529	13832	8.01948e-01	93795	214186	8.69869e-01	rs8005905	.	4024	0.804700	-3.168	-3.174	-3.338	.	.	.	.	.	ENST00000334701: c.211A>T (p.M71L)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5438547	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	14	104165863	104165864	14q32.33	.	C	snv	T	CC.GA	het-ref	203	0.52	.	2	.	PASS	600675	P	114480(SK);613972(SK)	AD	.	.	.	.	.	.	.	7517	XRCC3	C5	EX8	.	.	missense	NM_001100119.1	NP_001093589.1	-	Y	c.611G>A	p.R204Q | p.Arg204Gln	CGG=>CAG	P+=>P0	NM_001100119.1(XRCC3): c.611G>A (p.R204Q)	;	120550	0.000033	U	.	.	.	.	PASS	0	8610	0.000465	0	120550	0.000033	0	4	2.31965e-04	0	5	2.03290e-05	rs756095186	.	.	.	0.462	2.956	0.994	0.03	0.962	0.999	0.770	deleterious	ENST00000554913: c.611G>A (p.R204Q)	ovary [NS|NS|NS]	carcinoma [mixed_adenosquamous_carcinoma|NS|NS]	CSV	3983115	.	.	.	.	.	.	.	.	.	VUS
Pass	14	104165926	104165927	14q32.33	.	T	snv	C	GC.GT	het-ref	104	0.48	.	2	.	PASS	600675	P	114480(SK);613972(SK)	AD	.	.	.	.	.	.	.	7517	XRCC3	IC4	IVS7	.	.	intron	NM_001100119.1	NP_001093589.1	-	Y	c.562-14A>G	.	.	.	NM_001100119.1(XRCC3): c.562-14A>G	;maf-5-some-pop,maf-5-all-pops	124898	0.302431	U	0.3641	0.246805	13006	0.264340	PASS	538	8554	0.360182	5902	119890	0.304754	1123	6241	3.62764e-01	12306	75075	3.07937e-01	rs1799796	.	4024	0.351600	-2.905	-2.618	-2.452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	14	105239893	105239894	14q32.33	.	C	snv	T	CG.TC	het-ref	224	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX9	.	.	coding-synon	NM_001014431.1	NP_001014431.1	-	Y	c.726G>A	p.(E242=) | p.(Glu242=)	GAG=>GAA	.	NM_001014431.1(AKT1): c.726G>A (p.(E242=))	;maf-5-some-pop	102212	0.314542	U	0.6002	0.322484	13004	0.201630	PASS	1244	7370	0.587246	4960	97204	0.314133	2739	9429	5.80389e-01	12028	69118	2.97121e-01	rs1130233	.	4024	0.585000	0.561	0.705	2.198	.	.	.	.	.	ENST00000349310: c.726G>A (p.E242E)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	3765730	CM081515	NM_005163.2(AKT1): c.726G>A (p.E242E)	"Schizophrenia, familial, association with"	18497887	DFP	no_record	498670	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	14	105239893	105239894	14q32.33	.	C	snv	T	CG.TC	het-ref	224	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX10	.	.	coding-synon	NM_001014432.1	NP_001014432.1	-	N	c.726G>A	p.(E242=) | p.(Glu242=)	GAG=>GAA	.	NM_001014432.1(AKT1): c.726G>A (p.(E242=))	;maf-5-some-pop	102212	0.314542	U	0.6002	0.322484	13004	0.201630	PASS	1244	7370	0.587246	4960	97204	0.314133	2739	9429	5.80389e-01	12028	69118	2.97121e-01	rs1130233	.	4024	0.585000	0.561	0.705	2.198	.	.	.	.	.	ENST00000349310: c.726G>A (p.E242E)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	3765730	CM081515	NM_005163.2(AKT1): c.726G>A (p.E242E)	"Schizophrenia, familial, association with"	18497887	DFP	no_record	498670	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	14	105239893	105239894	14q32.33	.	C	snv	T	CG.TC	het-ref	224	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX9	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_005163.2	NP_005154.2	-	N	c.726G>A	p.(E242=) | p.(Glu242=)	GAG=>GAA	.	NM_005163.2(AKT1): c.726G>A (p.(E242=))	;maf-5-some-pop	102212	0.314542	U	0.6002	0.322484	13004	0.201630	PASS	1244	7370	0.587246	4960	97204	0.314133	2739	9429	5.80389e-01	12028	69118	2.97121e-01	rs1130233	.	4024	0.585000	0.561	0.705	2.198	.	.	.	.	.	ENST00000349310: c.726G>A (p.E242E)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	3765730	CM081515	NM_005163.2(AKT1): c.726G>A (p.E242E)	"Schizophrenia, familial, association with"	18497887	DFP	no_record	498670	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	15	67457334	67457335	15q22.33	.	A	snv	G	CT.CG	het-ref	285	0.48	.	2	.	PASS	603109	P	613795(MK)	NN	Aneurysms-osteoarthritis syndrome; Loeys-Dietz syndrome, type 1C	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal	Cardiovascular	22167769|21778426|21217753	.	4088	SMAD3	C2	EX2	MH1 domain	PF03165.11	coding-synon	NM_005902.3	NP_005893.1	+	Y	c.309A>G	p.(L103=) | p.(Leu103=)	CTA=>CTG	.	NM_005902.3(SMAD3): c.309A>G (p.(L103=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126384	0.862356	U	0.7619	0.834065	13000	0.880000	PASS	2497	8630	0.758633	45432	121376	0.863523	4935	13032	7.55653e-01	92899	213492	8.67099e-01	rs1065080	.	.	.	-0.215	0.513	0.478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	139217	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	15	75012984	75012985	15q24.1	.	T	snv	C	AA.GG	hom-alt	355	1.00	.	0	.	PASS	108330	C	.	NN	.	.	.	.	.	.	.	1543	CYP1A1	C6E	EX7E	Cytochrome P450	PF00067.17	missense	NM_000499.3	NP_000490.1	-	Y	c.1384A>G	p.I462V | p.Ile462Val	ATT=>GTT	NP=>NP	NM_000499.3(CYP1A1): c.1384A>G (p.I462V)	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,genotype-conflict,rs-cluster-nonoverlapping-alleles	126362	0.095583	U	0.252	0.133387	12986	0.027183	PASS	246	8644	0.243637	1417	121354	0.094022	508	4231	2.45475e-01	3519	26534	1.07790e-01	rs1048943	.	4024	0.248300	0.529	2.595	0.935	0.37	0.35	0.053	0.130	neutral	ENST00000395048: c.1384A>G (p.I462V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999600	CM940327	NM_000499.3(CYP1A1): c.1384A>G (p.I462V)	"Lung cancer, smoking induced, association with"	1722803	DFP	.	.	.	.	Likely Benign
Pass	15	80263216	80263217	15q25.1	.	C	snv	T	TG.CG	het-ref	153	0.45	.	2	.	PASS	601056	P	.	NN	.	.	.	.	.	.	.	597	BCL2A1	C1	EX1	Apoptosis regulator proteins, Bcl-2 family	PF00452.14	missense	NM_001114735.1	NP_001108207.1	-	Y	c.245G>A	p.G82D | p.Gly82Asp	GGC=>GAC	P0=>P-	NM_001114735.1(BCL2A1): c.245G>A (p.G82D)	;maf-5-some-pop	126410	0.233162	U	0.2063	0.203474	13006	0.199293	PASS	257	8654	0.240236	3648	121402	0.234387	506	4118	2.38752e-01	7231	56932	2.31331e-01	rs3826007	.	4024	0.230100	0.655	3.904	2.652	0	0.999	1	0.935	deleterious	ENST00000267953: c.245G>A (p.G82D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999615	CM064994	NM_004049.3(BCL2A1): c.245G>A (p.G82D)	"Colorectal cancer, increased risk, assoc. with"	17000706	DP	.	.	.	.	Likely Benign
HHReport	15	91295109	91295110	15q26.1	.	C	snv	T	TA.GG	het-ref	251	0.46	.	2	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	C3	EX4	.	.	missense	NM_000057.2	NP_000048.1	+	Y	c.893C>T	p.T298M | p.Thr298Met	ACG=>ATG	P0=>NP	NM_000057.2(BLM): c.893C>T (p.T298M)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126328	0.009159	U	0.0923	0.0229633	12990	0.000616	PASS	42	8654	0.090132	43	121320	0.008589	96	1666	9.66357e-02	102	2330	9.46977e-03	rs28384991	.	4024	0.091000	-0.946	0.118	-0.107	0.23	0.001	0	0.042	neutral	ENST00000355112: c.893C>T (p.T298M)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	VUO	147984	.	.	.	.	.	no_record	92397	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	15	91312822	91312823	15q26.1	.	T	snv	C	GT.GT	het-ref	215	0.49	.	2	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	IC11	IVS12	.	.	intron	NM_000057.2	NP_000048.1	+	Y	c.2555+7T>C	.	.	.	NM_000057.2(BLM): c.2555+7T>C	;maf-5-some-pop,maf-5-all-pops	121548	0.298516	U	0.3185	0.366613	12992	0.381927	PASS	399	8198	0.316785	5554	116540	0.295589	833	5382	3.13783e-01	10529	68191	2.78424e-01	rs3815003	.	4024	0.321100	0.482	1.388	0.826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	92392	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	16	1823739	1823740	16p13.3	.	G	snv	T	AT.GA	het-ref	118	0.52	.	2	.	PASS	610886	P	.	NN	.	.	.	.	.	.	.	197342	EME2	C2	EX2	ERCC4 domain	PF02732.10	missense	NM_001257370.1	NP_001244299.1	+	Y	c.282G>T	p.M94I | p.Met94Ile	ATG=>ATT	NP=>NP	NM_001257370.1(EME2): c.282G>T (p.M94I)	;	17674	0.000736	U	0.0079	0.00159744	.	.	PASS	0	342	0.014620	0	12666	0.000395	0	72	7.14286e-03	0	74	5.36566e-04	rs201737681	.	4024	0.008400	0.306	1.533	1.707	0.37	0.01	0.008	0.019	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	16	3639138	3639139	16p13.3	.	A	snv	G	CT.TT	het-ref	302	0.46	.	2	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C11	EX12	.	.	coding-synon	NM_032444.2	NP_115820.2	-	Y	c.4500T>C	p.(N1500=) | p.(Asn1500=)	AAT=>AAC	.	NM_032444.2(SLX4): c.4500T>C (p.(N1500=))	;maf-5-some-pop	126018	0.616674	U	0.7103	0.739617	12994	0.626597	PASS	2279	8636	0.723252	23691	121010	0.611586	4527	12439	7.21520e-01	46760	148380	6.03102e-01	rs3810812	.	4024	0.712000	-0.119	1.203	0.827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	262053	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	16	3639826	3639827	16p13.3	.	G	snv	A	GG.AA	het-ref	295	0.49	.	2	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C11	EX12	.	.	missense	NM_032444.2	NP_115820.2	-	Y	c.3812C>T	p.S1271F | p.Ser1271Phe	TCC=>TTC	P0=>NP	NM_032444.2(SLX4): c.3812C>T (p.S1271F)	;maf-5-some-pop,genotype-conflict	125964	0.064114	U	0.1429	0.0628994	12994	0.040557	PASS	141	8582	0.186320	333	120956	0.064164	300	3175	1.84464e-01	738	16208	6.60150e-02	rs3810813	.	4024	0.171000	0.655	2.019	2.884	0	0.996	0.999	0.906	deleterious	ENST00000294008: c.3812C>T (p.S1271F)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	1377772	.	.	.	.	.	no_record	262050	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	16	3656481	3656482	16p13.3	.	C	snv	T	CC.GC	het-ref	177	0.42	.	2	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C2	EX3	.	.	coding-synon	NM_032444.2	NP_115820.2	-	Y	c.753G>A	p.(A251=) | p.(Ala251=)	GCG=>GCA	.	NM_032444.2(SLX4): c.753G>A (p.(A251=))	SingleClassTriAllelic;maf-5-some-pop	126406	0.214476	U	0.2808	0.230831	12994	0.218947	PASS	437	8650	0.307861	2924	121398	0.213801	838	5206	3.01832e-01	5865	51965	2.12329e-01	rs8061528	.	4024	0.298500	-1.623	-3.059	-3.472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	262058	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	16	3781312	3781313	16p13.3	.	G	snv	A	TT.GA	het-ref	283	0.48	.	2	.	PASS	600140	C	180849(MK)	AD	Rubinstein-Taybi syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic ; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Hematologic; Cardiovascular; Oncologic; Ophthalmologic	23432975|22426292|21189944|21085895|20949605|20717166|20301699|19852432|18792986|16913274|15706485|13983033|10573006|7747773|7630403|7137629	.	1387	CREBBP	C30	EX30	.	.	coding-synon	NM_004380.2	NP_004371.2	-	Y	c.5052C>T	p.(S1684=) | p.(Ser1684=)	TCC=>TCT	.	NM_004380.2(CREBBP): c.5052C>T (p.(S1684=))	;maf-5-some-pop	122420	0.009075	U	0.1062	0.0217652	.	.	PASS	46	8468	0.108644	46	117412	0.008534	103	1877	1.09014e-01	104	2035	8.28340e-03	rs2072381	.	4024	0.122500	0.655	4.574	1.445	.	.	.	.	.	ENST00000262367: c.5052C>T (p.S1684S)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021088	.	.	.	.	.	no_record	95052	criteria_provided,_single_submitter	Benign	Likely Benign
InExcel	16	3808052	3808052	16p13.3	.	.	ins	A	TT.AA	het-ref	75	0.19	.	2	.	PASS	600140	C	180849(MK)	AD	Rubinstein-Taybi syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic ; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Hematologic; Cardiovascular; Oncologic; Ophthalmologic	23432975|22426292|21189944|21085895|20949605|20717166|20301699|19852432|18792986|16913274|15706485|13983033|10573006|7747773|7630403|7137629	.	1387	CREBBP	IC17	IVS17	.	.	intron	NM_004380.2	NP_004371.2	-	Y	c.3370-4_3370-3insT	.	.	.	NM_004380.2(CREBBP): c.3370-4_3370-3insT	MixedObserved;	25394	0.019178	U	.	.	.	.	PASS	0	6056	0.045079	0	79498	0.086858	.	.	.	.	.	.	rs777371170	.	4024	0.152100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	16	11349402	11349403	16p13.13	.	A	snv	C	AG.GG	hom-alt	160	1.00	.	0	.	PASS	603597	P	.	NN	.	.	.	.	.	.	.	8651	SOCS1	I5U1	IVS1	.	.	intron	NM_003745.1	NP_003736.1	-	Y	c.-50-18T>G	.	.	.	NM_003745.1(SOCS1): c.-50-18T>G	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	5008	0.978634	U	1	0.978634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs27829	.	.	.	-0.323	0.198	0.546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	16	14026006	14026007	16p13.12	.	G	snv	A	TC.TA	hom-alt	558	1.00	.	0	.	PASS	133520	C	278760(MK);610965(MK);615272(MK)	AR	Fanconi anemia, complementation group Q; Xeroderma pigmentosum, group F	AR	Allelic with XFE progeroid syndrome (AR)	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Dermatologic; Hematologic; Oncologic	23623386|20301571|17183314|10447254|8427828|3834095|3372781|2696553	.	2072	ERCC4	IC5	IVS5	.	.	intron	NM_005236.2	NP_005227.1	+	Y	c.974-7G>A	.	.	.	NM_005236.2(ERCC4): c.974-7G>A	SingleClassTriAllelic;maf-5-some-pop	126372	0.965364	U	0.7847	0.946486	12994	0.984608	PASS	2692	8648	0.787812	56802	121364	0.966143	5382	13591	7.88250e-01	115232	237821	9.66296e-01	rs254942	.	.	.	-0.254	-1.591	-1.804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259686	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	16	28617484	28617485	16p11.2	.	C	snv	T	CA.GA	hom-alt	176	1.00	.	0	dup	DUBIOUS	171150	P	.	NN	.	.	.	.	.	.	.	6817	SULT1A1	C6	EX7	.	.	missense	NM_177530.2	NP_803566.1	-	Y	c.667G>A	p.V223M | p.Val223Met	GTG=>ATG	NP=>NP	NM_177530.2(SULT1A1): c.667G>A (p.V223M)	;maf-5-some-pop	117542	0.971423	U	.	.	12986	0.872863	PASS	4301	8602	1.000000	55944	117542	0.971423	8604	17209	9.99942e-01	116403	236182	9.80847e-01	rs1801030	.	4022	0.998500	-0.848	0.654	0.299	0.04	0.004	0.001	0.349	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
Pass	16	48234326	48234327	16q12.1	.	C	snv	T	GA.GG	het-ref	231	0.48	.	2	.	PASS	607040	C	117800(NK)	AD	Apocrine gland secretion, variation in	AR	.	Dermatologic	General	19710689|16444273	.	85320	ABCC11	C14	EX15	.	.	missense	NM_032583.3	NP_115972.2	-	Y	c.1942G>A	p.V648I | p.Val648Ile	GTC=>ATC	NP=>NP	NM_032583.3(ABCC11): c.1942G>A (p.V648I)	;maf-5-some-pop,genotype-conflict	126110	0.044889	U	0.2996	0.0716853	13002	0.013229	PASS	471	8604	0.334612	506	121102	0.043781	963	5761	3.34631e-01	1061	10990	4.46559e-02	rs16945930	.	4024	0.378500	0.655	1.093	0.356	0.11	0.036	0.132	0.274	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	16	48258197	48258198	16q12.1	.	C	snv	T	CC.GA	hom-alt	586	1.00	.	0	.	PASS	607040	C	117800(NK)	AD	Apocrine gland secretion, variation in	AR	.	Dermatologic	General	19710689|16444273	.	85320	ABCC11	C4	EX5	.	.	missense	NM_032583.3	NP_115972.2	-	Y	c.538G>A	p.G180R | p.Gly180Arg	GGG=>AGG	P0=>P+	NM_032583.3(ABCC11): c.538G>A (p.G180R)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126146	0.228117	U	0.7798	0.300919	13000	0.098000	PASS	3405	8650	0.881965	5834	121138	0.225107	6646	15062	8.73666e-01	11509	54943	2.23433e-01	rs17822931	.	4024	0.922000	0.460	2.744	2.161	0	0.986	0.999	0.879	deleterious	ENST00000356608: c.538G>A (p.G180R)	soft_tissue [striated_muscle|NS|NS]	rhabdomyosarcoma [alveolar|NS|NS]	VUO	4987072	CM062373	NM_032583.3(ABCC11): c.538G>A (p.G180R)	"Earwax type, assoc. with"	16444273	DFP	no_record	3558	no_assertion_criteria_provided	Benign	Likely Benign
Pass	16	65016086	65016087	16q21	.	A	snv	C	TG.GA	hom-alt	484	1.00	.	0	.	PASS	600023	P	.	NN	.	.	.	.	.	.	.	1009	CDH11	C6	EX8	Cadherin domain	PF00028.12	missense	NM_001797.2	NP_001788.2	-	Y	c.1117T>G	p.S373A | p.Ser373Ala	TCA=>GCA	P0=>NP	NM_001797.2(CDH11): c.1117T>G (p.S373A)	SingleClassTriAllelic;maf-5-some-pop,microattr-tpa	126400	0.801922	U	0.995	0.745407	13006	0.692757	PASS	4315	8652	0.998729	40192	121392	0.804254	8596	17219	9.98434e-01	82773	199962	8.12523e-01	rs35213	.	4024	0.997000	-0.121	0.068	0.151	0.58	0.003	0	0.005	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
HHReport	16	68771371	68771372	16q22.1	.	C	snv	T	CC.CG	hom-alt	379	1.00	.	0	.	PASS	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	IC1	IVS1	.	.	intron	NM_004360.3	NP_004351.1	+	Y	c.48+6C>T	.	.	.	NM_004360.3(CDH1): c.48+6C>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	21322	0.799925	U	0.7688	0.763379	9830	0.860326	PASS	148	620	0.727419	5304	16314	0.811144	2978	7765	7.64422e-01	43188	104774	8.14956e-01	rs3743674	.	4024	0.768900	-1.988	-0.529	-0.174	.	.	.	.	.	ENST00000261769: c.48+6C>T (p.?)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5461723	.	.	.	.	.	no_record	136692	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	16	68857440	68857441	16q22.1	.	T	snv	C	GC.GG	hom-alt	562	1.00	.	0	.	PASS	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	C13	EX13	.	.	coding-synon	NM_004360.3	NP_004351.1	+	Y	c.2076T>C	p.(A692=) | p.(Ala692=)	GCT=>GCC	.	NM_004360.3(CDH1): c.2076T>C (p.(A692=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126378	0.657337	U	0.6448	0.71865	12996	0.716143	PASS	1761	8632	0.639944	26404	121370	0.654808	3636	11177	6.48619e-01	52683	159955	6.49996e-01	rs1801552	.	4024	0.642900	-0.213	0.311	0.396	.	.	.	.	.	ENST00000261769: c.2076T>C (p.A692A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3755010	.	.	.	.	.	no_record	142770	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	16	69745144	69745145	16q22.1	.	G	snv	A	AG.TT	het-ref	203	0.44	.	2	.	PASS	125860	C	125860(SK)	NN	.	.	.	.	.	.	.	1728	NQO1	C6E	EX6E	Flavodoxin-like fold	PF02525.12	missense	NM_000903.2	NP_000894.1	-	Y	c.559C>T	p.P187S | p.Pro187Ser	CCT=>TCT	NP=>P0	NM_000903.2(NQO1): c.559C>T (p.P187S)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126140	0.246900	U	0.4187	0.288938	12996	0.197368	PASS	874	8646	0.450150	4264	121132	0.245162	1773	7875	4.56734e-01	8997	61327	2.52065e-01	rs1800566	.	4024	0.458300	0.655	5.855	2.696	0.04	0.787	0.961	0.643	deleterious	ENST00000320623: c.559C>T (p.P187S)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	148097	CM950861	NM_000903.2(NQO1): c.559C>T (p.P187S)	"Lung cancer, smoking induced, association with"	8528266	DFP	no_record	16809	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	16	72821176	72821177	16q22.2	.	C	snv	G	TC.GT	het-ref	209	0.49	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C9E	EX10E	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.10998G>C	p.(T3666=) | p.(Thr3666=)	ACG=>ACC	.	NM_006885.3(ZFHX3): c.10998G>C (p.(T3666=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.557	1.465	1.029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	16	72821959	72821960	16q22.2	.	G	snv	C	CC.GG	het-ref	86	0.49	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C9E	EX10E	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.10215C>G	p.(P3405=) | p.(Pro3405=)	CCC=>CCG	.	NM_006885.3(ZFHX3): c.10215C>G (p.(P3405=))	SingleClassTriAllelic;	121264	0.002705	U	0.0337	0.00678914	.	.	PASS	1	8440	0.031043	1	116256	0.002529	7	521	3.04216e-02	7	606	2.53939e-03	rs190630380	.	4024	0.032600	-0.224	0.623	0.066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	16	72827757	72827758	16q22.2	.	T	snv	C	TC.CC	hom-alt	661	1.00	.	0	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.8823A>G	p.(G2941=) | p.(Gly2941=)	GGA=>GGG	.	NM_006885.3(ZFHX3): c.8823A>G (p.(G2941=))	MixedObserved;maf-5-some-pop,genotype-conflict	126412	0.878849	U	0.998	0.920727	12996	0.881579	PASS	4317	8654	0.998844	46916	121404	0.877121	8602	17226	9.98724e-01	94776	215585	8.75437e-01	rs699444	.	4024	0.996300	-0.119	1.700	1.644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	16	72829425	72829426	16q22.2	.	C	snv	T	AT.GG	het-ref	246	0.53	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.7155G>A	p.(P2385=) | p.(Pro2385=)	CCG=>CCA	.	NM_006885.3(ZFHX3): c.7155G>A (p.(P2385=))	;maf-5-some-pop	126398	0.026630	U	0.1032	0.0419329	12996	0.009926	PASS	40	8648	0.092507	112	121390	0.025999	85	1602	9.28803e-02	223	6136	2.49194e-02	rs62639997	.	4024	0.106600	0.561	-1.661	-2.109	.	.	.	.	.	ENST00000268489: c.7155G>A (p.P2385P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4417318	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	16	72832134	72832135	16q22.2	.	T	snv	A	TC.GC	hom-alt	362	1.00	.	0	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.4446A>T	p.(A1482=) | p.(Ala1482=)	GCA=>GCT	.	NM_006885.3(ZFHX3): c.4446A>T (p.(A1482=))	;maf-5-some-pop,genotype-conflict	126386	0.838147	U	0.9603	0.886182	12996	0.854801	PASS	4063	8654	0.968916	42712	121378	0.836165	8100	16716	9.69156e-01	86144	205261	8.33818e-01	rs740178	.	4024	0.956000	-1.220	-3.042	-2.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	16	72832618	72832619	16q22.2	.	A	del	.	TT.AA	het-ref	46	0.45	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	IC7	IVS8	.	.	intron	NM_006885.3	NP_008816.3	-	Y	c.3968-6delT	.	.	.	NM_006885.3(ZFHX3): c.3968-6delT	MixedObserved;	35043	0.017864	U	.	.	.	.	InbreedingCoeff_Filter	0	6006	0.272561	2	84684	0.406417	.	.	.	.	.	.	rs748528556	.	4024	0.247500	-0.368	2.063	1.111	.	.	.	.	.	ENST00000268489: c.3968-6delT (p.?)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5943577	.	.	.	.	.	.	.	.	.	Benign
Pass	16	72993489	72993490	16q22.3	.	C	snv	T	CA.GA	het-ref	344	0.54	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C1	EX2	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.555G>A	p.(S185=) | p.(Ser185=)	TCG=>TCA	.	NM_006885.3(ZFHX3): c.555G>A (p.(S185=))	;	120741	0.000008	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8624	0.000000	0	120742	0.000008	0	0	0.00000e+00	0	3	1.21952e-05	rs747235758	.	.	.	-1.086	-1.301	-0.909	.	.	.	.	.	ENST00000268489: c.555G>A (p.S185S)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1379734	.	.	.	.	.	.	.	.	.	VUS
Pass	16	72993830	72993831	16q22.3	.	A	snv	C	GG.GG	het-ref	313	0.48	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C1	EX2	.	.	missense	NM_006885.3	NP_008816.3	-	Y	c.214T>G	p.S72A | p.Ser72Ala	TCC=>GCC	P0=>NP	NM_006885.3(ZFHX3): c.214T>G (p.S72A)	SingleClassTriAllelic;maf-5-some-pop	101354	0.404829	U	0.2599	0.470447	12952	0.473904	PASS	219	7008	0.250000	8758	96346	0.401418	566	4328	2.64969e-01	18119	85853	3.86844e-01	rs7193297	.	4024	0.280100	-0.358	1.246	1.168	.	.	.	.	.	ENST00000268489: c.214T>G (p.S72A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1563502	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	16	81181782	81181783	16q23.2	.	T	snv	C	CA.GG	het-ref	192	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	114780	PKD1L2	C29	EX29	.	.	missense	NM_052892.3	NP_443124.3	-	Y	c.4933A>G	p.M1645V | p.Met1645Val	ATG=>GTG	NP=>NP	NM_052892.3(PKD1L2): c.4933A>G (p.M1645V)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	110480	0.147963	U	0.3125	0.178315	12066	0.108238	PASS	261	7796	0.286172	1249	105472	0.146522	550	4428	2.59160e-01	3014	33475	1.37365e-01	rs9921748	.	4024	0.264400	-2.955	-1.781	-3.778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	16	81181868	81181869	16q23.2	.	T	snv	C	TC.GA	het-ref	112	0.45	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	114780	PKD1L2	C29	EX29	.	.	missense	NM_052892.3	NP_443124.3	-	Y	c.4847A>G	p.Q1616R | p.Gln1616Arg	CAG=>CGG	P0=>P+	NM_052892.3(PKD1L2): c.4847A>G (p.Q1616R)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125388	0.135037	U	0.3125	0.178315	11996	0.109703	PASS	289	8598	0.267853	1425	120380	0.133236	574	4499	2.60933e-01	3190	34124	1.38680e-01	rs9921827	.	4024	0.264200	-0.757	3.041	0.420	.	.	.	.	.	ENST00000525539: c.4847A>G (p.Q1616R)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	4419109	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	16	88713235	88713236	16q24.3	.	A	snv	G	GT.CT	hom-alt	380	1.00	.	0	.	PASS	608508	C	233690(MK)	AR	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23910690|22924696|22876374|22562447|22336310|20407811|18422995|12073015|11060536|10759707|4384563|3368442|2770793|2713485|2243141|1415254	.	1535	CYBA	C4	EX4	Cytochrome Cytochrome b558 alpha-subunit	PF05038.8	missense	NM_000101.3	NP_000092.2	-	Y	c.214T>C	p.Y72H | p.Tyr72His	TAC=>CAC	P0=>P+	NM_000101.3(CYBA): c.214T>C (p.Y72H)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125796	0.689776	U	0.9157	0.664337	12996	0.621576	PASS	3586	8634	0.912323	29452	120788	0.690830	7196	15750	9.13891e-01	61167	171415	6.97501e-01	rs4673	.	4024	0.919000	0.448	2.070	0.616	0.4	0.999	1	0.506	deleterious	ENST00000261623: c.214T>C (p.Y72H)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3755197	.	.	.	.	.	no_record	2263	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	16	89805976	89805977	16q24.3	.	G	snv	A	AA.TG	hom-alt	346	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC39	IVS39	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.3935-16C>T	.	.	.	NM_000135.2(FANCA): c.3935-16C>T	;maf-5-some-pop,maf-5-all-pops	24726	0.435776	U	0.7073	0.538139	11744	0.347497	PASS	163	642	0.700935	1784	19718	0.409778	2723	7436	7.26598e-01	15261	62824	4.24825e-01	rs1061646	.	4024	0.749000	0.561	0.450	0.505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255264	criteria_provided,_single_submitter	Benign	Benign
Pass	16	89836322	89836323	16q24.3	.	C	snv	T	CA.CA	hom-alt	580	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C26	EX26	.	.	missense	NM_000135.2	NP_000126.2	-	Y	c.2426G>A	p.G809D | p.Gly809Asp	GGT=>GAT	P0=>P-	NM_000135.2(FANCA): c.2426G>A (p.G809D)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125746	0.476866	U	0.9881	0.666733	12996	0.430671	PASS	4197	8646	0.985427	16070	120738	0.468991	8363	16983	9.85093e-01	32766	115831	4.71042e-01	rs7195066	.	4024	0.982900	-1.562	-0.205	-0.200	0.3	0	0	0.029	neutral	ENST00000389301: c.2426G>A (p.G809D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	435949	.	.	.	.	.	no_record	134254	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	16	89838077	89838078	16q24.3	.	A	snv	G	CT.CA	hom-alt	486	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC23	IVS23	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.2151+8T>C	.	.	.	NM_000135.2(FANCA): c.2151+8T>C	;maf-5-some-pop,maf-5-all-pops	126382	0.436573	U	0.7242	0.559904	12996	0.374269	PASS	2437	8634	0.751564	12977	121374	0.431485	4805	12860	7.45594e-01	26883	107622	4.37111e-01	rs1800340	.	4024	0.760700	-0.483	-0.898	-1.473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255245	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	16	89838135	89838136	16q24.3	.	T	snv	C	CT.TG	het-ref	243	0.48	.	2	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C23	EX23	.	.	missense	NM_000135.2	NP_000126.2	-	Y	c.2101A>G	p.K701E | p.Lys701Glu	AAG=>GAG	P+=>P-	NM_000135.2(FANCA): c.2101A>G (p.K701E)	;clinically-assoc,submitted-by-lsdb	126420	0.000475	U	0.006	0.00119808	12996	0.000077	PASS	1	8654	0.005200	1	121412	0.000445	3	120	6.95733e-03	3	139	5.64421e-04	rs56369086	.	4024	0.008200	-0.388	-0.381	-0.757	0.65	0.012	0.009	0.004	neutral	.	.	.	.	.	.	.	.	.	.	no_record	134251	criteria_provided,_single_submitter	Likely_benign	VUS
Pass	16	89845193	89845194	16q24.3	.	A	snv	G	TA.CC	hom-alt	349	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC20	IVS20	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.1826+15T>C	.	.	.	NM_000135.2(FANCA): c.1826+15T>C	;maf-5-some-pop	126364	0.518257	U	0.9871	0.682508	12996	0.488150	PASS	4192	8652	0.984512	18057	121356	0.511479	8347	16970	9.83996e-01	36874	126799	5.15054e-01	rs1800337	.	4024	0.981600	-1.159	-0.850	-1.125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255241	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	16	89849479	89849480	16q24.3	.	C	snv	T	GC.GG	hom-alt	475	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C16	EX16	.	.	missense	NM_000135.2	NP_000126.2	-	Y	c.1501G>A	p.G501S | p.Gly501Ser	GGC=>AGC	P0=>P0	NM_000135.2(FANCA): c.1501G>A (p.G501S)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126136	0.504424	U	0.8671	0.624002	12996	0.482302	PASS	3176	8640	0.855093	16447	121128	0.499480	6297	14733	8.54682e-01	33734	123344	5.01468e-01	rs2239359	.	4024	0.835000	-1.234	-0.896	-1.689	0.91	0	0	0.000	neutral	ENST00000389301: c.1501G>A (p.G501S)	kidney [NS|NS|NS]	carcinoma [papillary_renal_cell_carcinoma|NS|NS]	VUO	4984954	.	.	.	.	.	no_record	134244	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	16	89866042	89866043	16q24.3	.	T	snv	C	CG.GA	hom-alt	360	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C9	EX9	.	.	missense	NM_000135.2	NP_000126.2	-	Y	c.796A>G	p.T266A | p.Thr266Ala	ACG=>GCG	P0=>NP	NM_000135.2(FANCA): c.796A>G (p.T266A)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126340	0.523492	U	0.9871	0.690495	12996	0.506002	PASS	4194	8652	0.984743	18422	121332	0.516599	8349	16972	9.84112e-01	37457	127801	5.19242e-01	rs7190823	.	4024	0.981600	-0.222	0.329	0.381	1	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	134294	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	16	89869760	89869761	16q24.3	.	T	snv	C	CA.AA	hom-alt	343	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC7	IVS7	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.710-12A>G	.	.	.	NM_000135.2(FANCA): c.710-12A>G	SingleClassTriAllelic;maf-5-some-pop	126318	0.706891	U	0.9911	0.842851	12996	0.695753	PASS	4237	8654	0.989600	31090	121310	0.701278	8425	17048	9.88519e-01	62427	171768	6.98051e-01	rs1800286	.	4024	0.986600	-0.235	-1.416	-1.083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255269	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
HHReport	17	7579471	7579472	17p13.1	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	missense	NM_000546.5	NP_000537.3	-	Y	c.215C>G	p.P72R | p.Pro72Arg	CCC=>CGC	NP=>P+	NM_000546.5(TP53): c.215C>G (p.P72R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.56	0.033	0.059	0.008	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	17	7579471	7579472	17p13.1	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	missense	NM_001126112.2	NP_001119584.1	-	N	c.215C>G	p.P72R | p.Pro72Arg	CCC=>CGC	NP=>P+	NM_001126112.2(TP53): c.215C>G (p.P72R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.56	0.033	0.059	0.008	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	17	7579471	7579472	17p13.1	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	missense	NM_001126113.2	NP_001119585.1	-	N	c.215C>G	p.P72R | p.Pro72Arg	CCC=>CGC	NP=>P+	NM_001126113.2(TP53): c.215C>G (p.P72R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.55	0.002	0	0.007	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	17	7579471	7579472	17p13.1	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	missense	NM_001126114.2	NP_001119586.1	-	N	c.215C>G	p.P72R | p.Pro72Arg	CCC=>CGC	NP=>P+	NM_001126114.2(TP53): c.215C>G (p.P72R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.55	0.145	0.232	0.019	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	17	7579471	7579472	17p13.1	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C1	EX3	.	.	missense	NM_001126118.1	NP_001119590.1	-	N	c.98C>G	p.P33R | p.Pro33Arg	CCC=>CGC	NP=>P+	NM_001126118.1(TP53): c.98C>G (p.P33R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.39	0.033	0.059	0.018	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	17	8108330	8108331	17p13.1	.	A	snv	G	CC.TG	het-ref	359	0.52	.	2	.	PASS	604970	P	.	NN	.	.	.	.	.	.	.	9212	AURKB	C8E	EX9E	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	missense	NM_004217.3	NP_004208.2	-	Y	c.893T>C	p.M298T | p.Met298Thr	ATG=>ACG	NP=>P0	NM_004217.3(AURKB): c.893T>C (p.M298T)	;maf-5-some-pop,maf-5-all-pops	125942	0.826793	U	0.5516	0.736022	13006	0.821851	PASS	1281	8598	0.548500	42303	120934	0.830552	2399	8726	5.50606e-01	80602	191311	8.32170e-01	rs1059476	.	4024	0.575800	-1.234	-0.114	-0.814	0.45	0	0	0.012	neutral	ENST00000585124: c.893T>C (p.M298T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4130880	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	17	8108338	8108339	17p13.1	.	G	snv	A	AC.GA	het-ref	358	0.52	.	2	.	PASS	604970	P	.	NN	.	.	.	.	.	.	.	9212	AURKB	C8E	EX9E	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_004217.3	NP_004208.2	-	Y	c.885C>T	p.(S295=) | p.(Ser295=)	TCC=>TCT	.	NM_004217.3(AURKB): c.885C>T (p.(S295=))	;maf-5-some-pop,maf-5-all-pops	125492	0.653340	U	0.5179	0.620807	13006	0.618330	PASS	1082	8610	0.503949	26011	120484	0.654693	2004	7922	5.06587e-01	49153	148353	6.57955e-01	rs2241909	.	4024	0.537000	-1.815	-1.228	-2.150	.	.	.	.	.	ENST00000585124: c.885C>T (p.S295S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3766233	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	17	12921090	12921091	17p12	.	C	snv	T	TA.AC	het-ref	131	0.46	.	2	.	PASS	605367	C	614731(SK);615440(MK)	NN	Combined oxidative phosphorylation deficiency 17	AR	.	Biochemical; Cardiovascular; Neurologic	Biochemical; Cardiovascular	23849775	.	60528	ELAC2	C1	EX1	.	.	coding-synon	NM_018127.6	NP_060597.4	-	Y	c.174G>A	p.(V58=) | p.(Val58=)	GTG=>GTA	.	NM_018127.6(ELAC2): c.174G>A (p.(V58=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	95000	0.007147	U	0.0506	0.0101837	.	.	PASS	14	6876	0.076353	14	89992	0.006978	38	1039	6.18379e-02	38	1224	5.34727e-03	rs2286334	.	4024	0.059100	0.655	0.876	1.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	382955	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	17	15961365	15961366	17p12	.	C	snv	G	GT.TG	het-ref	285	0.48	.	2	.	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	C38	EX39	.	.	missense	NM_006311.3	NP_006302.2	-	Y	c.6023G>C	p.R2008T | p.Arg2008Thr	AGA=>ACA	P+=>P0	NM_006311.3(NCOR1): c.6023G>C (p.R2008T)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.655	3.576	1.363	0.26	0.004	0.012	0.034	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
HHReport	17	29508774	29508775	17q11.2	.	G	snv	A	CT.TA	het-ref	213	0.45	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C7	EX7	.	.	coding-synon	NM_000267.3	NP_000258.1	+	Y	c.702G>A	p.(L234=) | p.(Leu234=)	CTG=>CTA	.	NM_000267.3(NF1): c.702G>A (p.(L234=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126260	0.618399	U	0.5506	0.511781	12998	0.574396	PASS	1363	8650	0.556647	24613	121252	0.622802	2707	9659	5.60202e-01	50357	154487	6.27950e-01	rs1801052	.	4024	0.563600	-2.242	-2.259	-3.805	.	.	.	.	.	ENST00000358273: c.702G>A (p.L234L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3755377	.	.	.	.	.	no_record	183825	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	17	29508774	29508775	17q11.2	.	G	snv	A	CT.TA	het-ref	213	0.45	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C7	EX7	.	.	coding-synon	NM_001042492.2	NP_001035957.1	+	N	c.702G>A	p.(L234=) | p.(Leu234=)	CTG=>CTA	.	NM_001042492.2(NF1): c.702G>A (p.(L234=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126260	0.618399	U	0.5506	0.511781	12998	0.574396	PASS	1363	8650	0.556647	24613	121252	0.622802	2707	9659	5.60202e-01	50357	154487	6.27950e-01	rs1801052	.	4024	0.563600	-2.242	-2.259	-3.805	.	.	.	.	.	ENST00000358273: c.702G>A (p.L234L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3755377	.	.	.	.	.	no_record	183825	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	17	29553484	29553485	17q11.2	.	G	snv	A	CC.AT	het-ref	206	0.48	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C18	EX18	.	.	coding-synon	NM_000267.3	NP_000258.1	+	Y	c.2034G>A	p.(P678=) | p.(Pro678=)	CCG=>CCA	.	NM_000267.3(NF1): c.2034G>A (p.(P678=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125942	0.387266	U	0.5258	0.496805	13006	0.416346	PASS	1231	8594	0.533279	9925	120934	0.382729	2333	8947	5.19812e-01	19270	92408	3.76862e-01	rs2285892	.	4024	0.530300	-0.300	-1.454	-2.418	.	.	.	.	.	ENST00000358273: c.2034G>A (p.P678P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009864	.	.	.	.	.	no_record	183826	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	17	29553484	29553485	17q11.2	.	G	snv	A	CC.AT	het-ref	206	0.48	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C18	EX18	.	.	coding-synon	NM_001042492.2	NP_001035957.1	+	N	c.2034G>A	p.(P678=) | p.(Pro678=)	CCG=>CCA	.	NM_001042492.2(NF1): c.2034G>A (p.(P678=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125942	0.387266	U	0.5258	0.496805	13006	0.416346	PASS	1231	8594	0.533279	9925	120934	0.382729	2333	8947	5.19812e-01	19270	92408	3.76862e-01	rs2285892	.	4024	0.530300	-0.300	-1.454	-2.418	.	.	.	.	.	ENST00000358273: c.2034G>A (p.P678P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009864	.	.	.	.	.	no_record	183826	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	17	29654875	29654876	17q11.2	.	T	snv	A	TC.CT	het-ref	189	0.48	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC37	IVS37	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.5546+19T>A	.	.	.	NM_000267.3(NF1): c.5546+19T>A	;maf-5-some-pop,maf-5-all-pops	125188	0.532200	U	0.371	0.431909	13006	0.516223	PASS	531	8480	0.353302	18196	120180	0.536379	1085	6101	3.54627e-01	37119	131238	5.36291e-01	rs2285894	.	4024	0.343400	-0.265	-1.310	-1.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257294	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	17	29654875	29654876	17q11.2	.	T	snv	A	TC.CT	het-ref	189	0.48	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC38	IVS38	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.5609+19T>A	.	.	.	NM_001042492.2(NF1): c.5609+19T>A	;maf-5-some-pop,maf-5-all-pops	125188	0.532200	U	0.371	0.431909	13006	0.516223	PASS	531	8480	0.353302	18196	120180	0.536379	1085	6101	3.54627e-01	37119	131238	5.36291e-01	rs2285894	.	4024	0.343400	-0.265	-1.310	-1.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257294	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	17	37868714	37868715	17q12	.	C	snv	T	CA.GA	het-ref	217	0.47	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC8	IVS12	.	.	intron	NM_001005862.1	NP_001005862.1	+	Y	c.1058+14C>T	.	.	.	NM_001005862.1(ERBB2): c.1058+14C>T	;maf-5-some-pop,maf-5-all-pops	121264	0.599156	U	0.3988	0.444489	13006	0.512302	PASS	577	8290	0.381062	22309	116256	0.605818	1140	6214	3.64629e-01	46936	147218	6.07852e-01	rs4252627	.	4024	0.391400	-0.216	-0.189	-0.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	17	37868714	37868715	17q12	.	C	snv	T	CA.GA	het-ref	217	0.47	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC9	IVS9	.	.	intron	NM_004448.2	NP_004439.2	+	N	c.1148+14C>T	.	.	.	NM_004448.2(ERBB2): c.1148+14C>T	;maf-5-some-pop,maf-5-all-pops	121264	0.599156	U	0.3988	0.444489	13006	0.512302	PASS	577	8290	0.381062	22309	116256	0.605818	1140	6214	3.64629e-01	46936	147218	6.07852e-01	rs4252627	.	4024	0.391400	-0.216	-0.189	-0.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	17	37884036	37884037	17q12	.	C	snv	G	GG.CC	het-ref	316	0.52	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	C26E	EX30E	.	.	missense	NM_001005862.1	NP_001005862.1	+	Y	c.3418C>G	p.P1140A | p.Pro1140Ala	CCC=>GCC	NP=>NP	NM_001005862.1(ERBB2): c.3418C>G (p.P1140A)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125262	0.600789	U	0.4018	0.452077	13006	0.513532	PASS	611	8588	0.375757	23415	120254	0.606982	1167	6298	3.65993e-01	48130	149768	6.11757e-01	rs1058808	.	4024	0.397600	0.450	4.777	2.326	0.19	0.324	0.921	0.151	neutral	ENST00000269571: c.3508C>G (p.P1170A)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	5436892	.	.	.	.	.	no_record	134082	no_assertion_provided	not_provided	Likely Benign
Pass	17	37884036	37884037	17q12	.	C	snv	G	GG.CC	het-ref	316	0.52	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	C27E	EX27E	.	.	missense	NM_004448.2	NP_004439.2	+	N	c.3508C>G	p.P1170A | p.Pro1170Ala	CCC=>GCC	NP=>NP	NM_004448.2(ERBB2): c.3508C>G (p.P1170A)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125262	0.600789	U	0.4018	0.452077	13006	0.513532	PASS	611	8588	0.375757	23415	120254	0.606982	1167	6298	3.65993e-01	48130	149768	6.11757e-01	rs1058808	.	4024	0.397600	0.450	4.777	2.326	0.2	0.324	0.921	0.151	neutral	ENST00000269571: c.3508C>G (p.P1170A)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	5436892	CM087578	NM_004448.2(ERBB2): c.3508C>G (p.P1170A)	"Lung cancer, incr. risk in females, non-smokers and non-drinkers"	19055823	DP	no_record	134082	no_assertion_provided	not_provided	Likely Benign
Pass	17	38556769	38556770	17q21.2	.	T	snv	C	CA.AA	het-ref	323	0.49	.	2	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC22	IVS22	.	.	intron	NM_001067.3	NP_001058.2	-	Y	c.2799+11A>G	.	.	.	NM_001067.3(TOP2A): c.2799+11A>G	;maf-5-some-pop	120380	0.796478	U	0.7867	0.812899	11780	0.861545	PASS	2161	8156	0.731486	36759	115372	0.795765	4456	12186	7.36581e-01	73620	184534	7.88445e-01	rs471692	.	4024	0.723900	-0.821	-1.117	-1.531	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	17	40475055	40475056	17q21.2	.	G	snv	A	AC.CC	het-ref	333	0.48	.	2	.	PASS	102582	P	147060(MK);615952(MK)	AD	Hyper-IgE recurrent infection syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Musculoskeletal; Oncologic	Allergy/Immunology/Infectious; Cardiovascular; Oncologic	22751495|22084479|21703716|17942886|17881745|17676033|10053178|6806658|5059313|4161105	.	6774	STAT3	C19	EX20	SH2 domain	PF00017.19	coding-synon	NM_139276.2	NP_644805.1	-	Y	c.1854C>T	p.(G618=) | p.(Gly618=)	GGC=>GGT	.	NM_139276.2(STAT3): c.1854C>T (p.(G618=))	;	126408	0.003884	U	0.0337	0.00758786	.	.	PASS	11	8650	0.044277	11	121400	0.003731	8	665	3.85552e-02	9	843	3.42413e-03	rs117691970	.	4024	0.042200	-0.274	-1.100	-2.970	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	323243	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	VUS
HHReport	17	41223093	41223094	17q21.31	.	T	snv	C	AC.CT	het-ref	385	0.52	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C14	EX15	.	.	missense	NM_007294.3	NP_009225.1	-	Y	c.4837A>G	p.S1613G | p.Ser1613Gly	AGT=>GGT	P0=>P0	NM_007294.3(BRCA1): c.4837A>G (p.S1613G)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict|;clinically-assoc,has-omim-omia,submitted-by-lsdb	126368|0	0.349820|0	U	0.372	0.355831	13006	0.298170	PASS	642	8612	0.380516	7852	121360	0.349572	1285	6528	3.78523e-01	16323	87283	3.54601e-01	rs1799966|rs397509199	.	4024	0.370500	0.533	0.264	0.128	0.24	0.006	0.012	0.037	neutral	ENST00000471181: c.4900A>G (p.S1634G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3755559	.	.	.	.	.	no_record	41827	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	17	41234469	41234470	17q21.31	.	A	snv	G	GA.GA	het-ref	390	0.47	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C11	EX12	.	.	coding-synon	NM_007294.3	NP_009225.1	-	Y	c.4308T>C	p.(S1436=) | p.(Ser1436=)	TCT=>TCC	.	NM_007294.3(BRCA1): c.4308T>C (p.(S1436=))	MixedObserved;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126386	0.342831	U	0.371	0.336262	13006	0.279563	PASS	637	8638	0.377749	7653	121378	0.343102	1276	6504	3.77087e-01	15965	85980	3.49274e-01	rs1060915	.	4024	0.368300	0.533	-0.053	0.129	.	.	.	.	.	ENST00000471181: c.4308T>C (p.S1436S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4416374	.	.	.	.	.	no_record	125703	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	17	41243999	41244000	17q21.31	.	T	snv	C	CT.TC	het-ref	405	0.51	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	.	.	missense	NM_007294.3	NP_009225.1	-	Y	c.3548A>G	p.K1183R | p.Lys1183Arg	AAA=>AGA	P+=>P+	NM_007294.3(BRCA1): c.3548A>G (p.K1183R)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125780	0.349149	U	0.371	0.352636	13006	0.295248	PASS	632	8508	0.382699	7768	120772	0.349005	1272	6502	3.77848e-01	16165	86829	3.53368e-01	rs16942	.	4024	0.368500	-0.726	-0.684	-0.437	1	0.001	0	0.000	neutral	ENST00000357654: c.3548A>G (p.K1183R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	148277	.	.	.	.	.	no_record	41818	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	17	41244434	41244435	17q21.31	.	T	snv	C	CT.CT	het-ref	417	0.49	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	.	.	missense	NM_007294.3	NP_009225.1	-	Y	c.3113A>G	p.E1038G | p.Glu1038Gly	GAA=>GGA	P-=>P0	NM_007294.3(BRCA1): c.3113A>G (p.E1038G)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126350	0.342580	U	0.371	0.335663	13006	0.279025	PASS	638	8648	0.377660	7641	121342	0.342866	1276	6507	3.77261e-01	15910	85785	3.49026e-01	rs16941	.	4024	0.368300	0.455	-0.304	0.112	0.06	0.033	0.022	0.324	neutral	ENST00000471181: c.3113A>G (p.E1038G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3755562	CM032861	NM_007294.3(BRCA1): c.3113A>G (p.E1038G)	"Endometriosis, association with ?"	12568865	DP	no_record	41815	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	17	41244935	41244936	17q21.31	.	G	snv	A	AC.GA	het-ref	413	0.50	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	missense	NM_007294.3	NP_009225.1	-	Y	c.2612C>T	p.P871L | p.Pro871Leu	CCG=>CTG	NP=>NP	NM_007294.3(BRCA1): c.2612C>T (p.P871L)	MixedObserved,FlankMismatchGenomeLonger;clinically-assoc,has-omim-omia,submitted-by-lsdb|MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict,rs-cluster-nonoverlapping-alleles	0|126364	0|0.415356	U	0.371	0.54393	13006	0.493157	PASS	637	8642	0.378037	11586	121356	0.410050	1274	6507	3.77349e-01	22183	99097	4.03158e-01	rs397508986|rs799917	.	4024	0.370500	-0.524	1.726	0.938	1	0	0	0.000	neutral	ENST00000357654: c.2612C>T (p.P871L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	148278	CM096315	NM_007294.3(BRCA1): c.2612C>T (p.P871L)	"Cervical cancer, decreased risk, association with"	19482343	DFP	no_record	41812	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	17	41245236	41245237	17q21.31	.	A	snv	G	CA.TG	het-ref	382	0.46	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	coding-synon	NM_007294.3	NP_009225.1	-	Y	c.2311T>C	p.(L771=) | p.(Leu771=)	TTG=>CTG	.	NM_007294.3(BRCA1): c.2311T>C (p.(L771=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126328	0.341698	U	0.371	0.335264	13006	0.277641	PASS	638	8632	0.378475	7603	121320	0.341963	1277	6508	3.77407e-01	15828	85559	3.48191e-01	rs16940	.	4024	0.368300	-0.441	-0.467	-0.828	.	.	.	.	.	ENST00000471181: c.2311T>C (p.L771L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3755565	.	.	.	.	.	no_record	125554	reviewed_by_expert_panel	Benign	Likely Benign
HHReport	17	41245465	41245466	17q21.31	.	G	snv	A	TC.CT	het-ref	410	0.51	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	coding-synon	NM_007294.3	NP_009225.1	-	Y	c.2082C>T	p.(S694=) | p.(Ser694=)	AGC=>AGT	.	NM_007294.3(BRCA1): c.2082C>T (p.(S694=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126272	0.347797	U	0.371	0.336462	13004	0.295678	PASS	638	8630	0.378331	7796	121264	0.348265	1275	6504	3.77218e-01	16184	86878	3.53326e-01	rs1799949	.	4024	0.368500	-0.340	-0.216	-0.084	.	.	.	.	.	ENST00000357654: c.2082C>T (p.S694S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	148280	.	.	.	.	.	no_record	125536	reviewed_by_expert_panel	Benign	Likely Benign
Pass	17	45369776	45369777	17q21.32	.	A	snv	G	GA.TG	het-ref	162	0.42	.	2	.	PASS	173470	C	173470(MK);187800(MK);273800(MK);608446(SK)	AD;AR	Glanzmann thrombasthenia	AD/AR	.	Hematologic	Hematologic	23929305|23253071|23146053|22890234|22250950|22102273|21917754|20345392|20081061|20020534|19408193|19336737|18065693|16721604|16463284|11723016|11425767|10583927|10559451|9845537|9700201|9351872|9160670|8878424|8471765|8093349|7694683|7193688|2565345|2428841|2392682|2257303|2014236|1967954|1602006|1438206|1430225|1371279	.	3690	ITGB3	C10	EX10	.	.	coding-synon	NM_000212.2	NP_000203.2	+	Y	c.1533A>G	p.(E511=) | p.(Glu511=)	GAA=>GAG	.	NM_000212.2(ITGB3): c.1533A>G (p.(E511=))	;maf-5-some-pop,maf-5-all-pops	126022	0.287148	U	0.3313	0.28734	13006	0.283946	PASS	499	8614	0.347225	5006	121014	0.287140	997	5948	3.44932e-01	10071	70036	2.85563e-01	rs4642	.	4024	0.315900	-0.355	2.116	1.283	.	.	.	.	.	ENST00000262017: c.1533A>G (p.E511E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1383908	.	.	.	.	.	no_record	255536	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	17	45369788	45369789	17q21.32	.	G	snv	A	CG.GA	het-ref	147	0.42	.	2	.	PASS	173470	C	173470(MK);187800(MK);273800(MK);608446(SK)	AD;AR	Glanzmann thrombasthenia	AD/AR	.	Hematologic	Hematologic	23929305|23253071|23146053|22890234|22250950|22102273|21917754|20345392|20081061|20020534|19408193|19336737|18065693|16721604|16463284|11723016|11425767|10583927|10559451|9845537|9700201|9351872|9160670|8878424|8471765|8093349|7694683|7193688|2565345|2428841|2392682|2257303|2014236|1967954|1602006|1438206|1430225|1371279	.	3690	ITGB3	C10	EX10	.	.	coding-synon	NM_000212.2	NP_000203.2	+	Y	c.1545G>A	p.(R515=) | p.(Arg515=)	CGG=>CGA	.	NM_000212.2(ITGB3): c.1545G>A (p.(R515=))	;maf-5-some-pop,maf-5-all-pops	125902	0.287303	U	0.3313	0.28734	13006	0.283869	PASS	500	8606	0.347548	5006	120894	0.287301	997	5947	3.44874e-01	10066	69968	2.85570e-01	rs4634	.	4024	0.315900	0.462	0.837	0.591	.	.	.	.	.	ENST00000262017: c.1545G>A (p.R515R)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1383912	.	.	.	.	.	no_record	255537	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	17	56435884	56435885	17q22	.	G	snv	T	CA.TC	het-ref	349	0.51	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C8	EX9	.	.	missense	NM_017763.4	NP_060233.3	-	Y	c.1252C>A	p.L418M | p.Leu418Met	CTG=>ATG	NP=>NP	NM_017763.4(RNF43): c.1252C>A (p.L418M)	;maf-5-some-pop,maf-5-all-pops	122970	0.397292	U	0.4494	0.399561	13006	0.373751	PASS	909	8460	0.466430	9443	117962	0.397196	1828	7907	4.60459e-01	19799	96295	3.94435e-01	rs2526374	.	4024	0.462700	0.195	2.132	2.179	0	0.674	0.978	0.684	deleterious	ENST00000407977: c.1252C>A (p.L418M)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4130449	.	.	.	.	.	no_record	403384	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	17	56439994	56439995	17q22	.	C	snv	T	CA.AC	het-ref	173	0.52	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C5	EX6	.	.	coding-synon	NM_017763.4	NP_060233.3	-	Y	c.597G>A	p.(V199=) | p.(Val199=)	GTG=>GTA	.	NM_017763.4(RNF43): c.597G>A (p.(V199=))	;	125700	0.002395	U	0.0159	0.00359425	13006	0.000231	PASS	5	8650	0.016532	5	120692	0.002345	6	242	1.43331e-02	8	467	1.91840e-03	rs77499318	.	4024	0.008000	-0.320	0.697	0.305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	17	56448296	56448297	17q22	.	C	snv	T	GG.GG	het-ref	265	0.44	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C2	EX3	.	.	missense	NM_017763.4	NP_060233.3	-	Y	c.350G>A	p.R117H | p.Arg117His	CGC=>CAC	P+=>P+	NM_017763.4(RNF43): c.350G>A (p.R117H)	SingleClassTriAllelic;maf-5-some-pop,microattr-tpa	121350	0.166642	U	0.373	0.226238	13006	0.134707	PASS	647	8606	0.384848	2007	116342	0.164077	1301	6583	3.86508e-01	4012	37598	1.57424e-01	rs2257205	.	4024	0.377700	0.655	1.772	2.555	0.02	0.362	0.968	0.498	deleterious	ENST00000407977: c.350G>A (p.R117H)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3755721	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	17	56492799	56492800	17q22	.	T	snv	C	AA.AG	het-ref	308	0.42	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C1	EX2	.	.	missense	NM_017763.4	NP_060233.3	-	Y	c.139A>G	p.I47V | p.Ile47Val	ATT=>GTT	NP=>NP	NM_017763.4(RNF43): c.139A>G (p.I47V)	;maf-5-some-pop,maf-5-all-pops	126364	0.403572	U	0.5258	0.373802	13006	0.328310	PASS	1201	8620	0.524942	10490	121356	0.404801	2312	8921	5.17279e-01	22003	101383	4.11815e-01	rs3744093	.	4024	0.496300	0.533	0.617	0.973	0.38	0.001	0.001	0.018	neutral	ENST00000407977: c.139A>G (p.I47V)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	5618411	.	.	.	.	.	no_record	403385	criteria_provided,_single_submitter	Benign	Likely Benign
HHReport	17	59760995	59760996	17q23.2	.	A	snv	G	TC.TA	het-ref	311	0.46	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C19E	EX20E	.	.	coding-synon	NM_032043.2	NP_114432.2	-	Y	c.3411T>C	p.(Y1137=) | p.(Tyr1137=)	TAT=>TAC	.	NM_032043.2(BRIP1): c.3411T>C (p.(Y1137=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125994	0.595179	U	0.754	0.620807	13004	0.606044	PASS	2283	8638	0.722968	22043	120986	0.594118	4451	12327	7.15272e-01	45314	146251	5.97294e-01	rs4986763	.	4024	0.698600	0.460	1.710	1.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	183702	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	17	59763346	59763347	17q23.2	.	A	snv	G	TG.GG	het-ref	329	0.48	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C18	EX19	.	.	missense	NM_032043.2	NP_114432.2	-	Y	c.2755T>C	p.S919P | p.Ser919Pro	TCA=>CCA	P0=>NP	NM_032043.2(BRIP1): c.2755T>C (p.S919P)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126398	0.598435	U	0.755	0.627796	13006	0.613409	PASS	2290	8648	0.723520	22365	121390	0.597224	4456	12337	7.15271e-01	46002	147651	5.99822e-01	rs4986764	.	4024	0.698300	-0.802	-0.085	0.011	0.51	0	0	0.009	neutral	.	.	.	.	.	.	.	.	.	.	no_record	133756	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	17	59763464	59763465	17q23.2	.	T	snv	C	GA.TC	hom-alt	615	1.00	.	0	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C18	EX19	.	.	coding-synon	NM_032043.2	NP_114432.2	-	Y	c.2637A>G	p.(E879=) | p.(Glu879=)	GAA=>GAG	.	NM_032043.2(BRIP1): c.2637A>G (p.(E879=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126316	0.722608	U	0.9127	0.815096	13006	0.734276	PASS	3465	8654	0.893344	32088	121308	0.718790	6863	15374	8.91350e-01	64801	176173	7.15877e-01	rs4986765	.	4024	0.867800	-0.733	0.234	0.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	183703	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	17	59885812	59885813	17q23.2	.	A	snv	T	AA.AT	het-ref	226	0.47	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC6	IVS7	.	.	intron	NM_032043.2	NP_114432.2	-	Y	c.918+15T>A	.	.	.	NM_032043.2(BRIP1): c.918+15T>A	;clinically-assoc,submitted-by-lsdb	125866	0.003130	U	0.0427	0.00858626	.	.	PASS	7	8630	0.039513	7	120858	0.002904	10	700	4.06080e-02	10	725	2.95764e-03	rs117820198	.	4024	0.035800	0.472	0.656	0.075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	136583	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
HHReport	17	63533767	63533768	17q24.1	.	G	snv	A	CG.GG	het-ref	310	0.47	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C5	EX6	Axin beta-catenin binding domain	PF08833.5	coding-synon	NM_004655.3	NP_004646.3	-	Y	c.1386C>T	p.(P462=) | p.(Pro462=)	CCC=>CCT	.	NM_004655.3(AXIN2): c.1386C>T (p.(P462=))	;maf-5-some-pop,maf-5-all-pops	62022	0.609300	U	0.3472	0.446086	12804	0.540066	PASS	239	3290	0.396960	11148	57014	0.623636	811	4533	3.50689e-01	34060	108815	6.02139e-01	rs1133683	.	4024	0.312900	0.650	-0.080	0.088	.	.	.	.	.	ENST00000307078: c.1386C>T (p.P462P)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3749411	.	.	.	.	.	no_record	259510	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	17	63533788	63533789	17q24.1	.	T	snv	C	CC.GG	het-ref	332	0.47	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C5	EX6	Axin beta-catenin binding domain	PF08833.5	coding-synon	NM_004655.3	NP_004646.3	-	Y	c.1365A>G	p.(P455=) | p.(Pro455=)	CCA=>CCG	.	NM_004655.3(AXIN2): c.1365A>G (p.(P455=))	;maf-5-some-pop	47776	0.913911	U	0.8264	0.909744	12702	0.910880	PASS	871	2448	0.848448	17839	42768	0.914399	4064	9859	8.24745e-01	67530	149405	9.02444e-01	rs9915936	.	4024	0.807200	-0.124	-1.318	-0.818	.	.	.	.	.	ENST00000307078: c.1365A>G (p.P455P)	large_intestine [colon|transverse|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3755754	.	.	.	.	.	no_record	259509	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
HHReport	17	63534301	63534302	17q24.1	.	A	snv	G	AG.AG	het-ref	205	0.41	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC4	IVS5	.	.	intron	NM_004655.3	NP_004646.3	-	Y	c.1200+19T>C	.	.	.	NM_004655.3(AXIN2): c.1200+19T>C	MixedObserved;	125334	0.003543	U	0.0427	0.0103834	13006	0.000231	PASS	9	8636	0.040065	9	120326	0.003258	20	727	4.21743e-02	20	821	3.35310e-03	rs116931989	.	4024	0.044500	-0.466	-1.139	-0.772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	516712	criteria_provided,_single_submitter	Likely_benign	Likely Benign
HHReport	17	63534302	63534303	17q24.1	.	A	snv	C	GA.GG	het-ref	208	0.42	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC4	IVS5	.	.	intron	NM_004655.3	NP_004646.3	-	Y	c.1200+18T>G	.	.	.	NM_004655.3(AXIN2): c.1200+18T>G	;	125350	0.003534	U	0.0427	0.0103834	13006	0.000231	PASS	9	8636	0.040065	9	120342	0.003249	20	727	4.21743e-02	20	820	3.34888e-03	rs117258157	.	4024	0.044500	-0.994	-0.449	-0.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
HHReport	17	63554590	63554591	17q24.1	.	G	snv	A	AG.CA	het-ref	380	0.52	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C1	EX2	.	.	missense	NM_004655.3	NP_004646.3	-	Y	c.148C>T	p.P50S | p.Pro50Ser	CCT=>TCT	NP=>P0	NM_004655.3(AXIN2): c.148C>T (p.P50S)	;maf-5-some-pop	124164	0.468244	U	0.3234	0.33766	13006	0.394818	PASS	467	8620	0.322042	14394	119156	0.473732	950	5573	3.23673e-01	29214	114976	4.75693e-01	rs2240308	.	4024	0.293700	0.561	0.711	0.980	0.53	0.007	0.013	0.007	neutral	ENST00000307078: c.148C>T (p.P50S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4000258	.	.	.	.	.	no_record	259511	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	17	66519857	66519857	17q24.2	.	.	ins	T	TC.TT	het-ref	169	0.47	.	2	.	PASS	188830	C	101800(MK);160980(MK);188550(MK);188830(MK);255960(MK);610489(MK)	AD;AR	Pigmented nodular adrenocortical disease, primary, 1; Carney complex; Myxoma, intracardiac; Acrodysostosis 1, with/without hormone resistance 	AD	.	Cardiovascular; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Endocrine; Oncologic	22464252|22464250|21651393|20507346|20301463|12213893|11549623|10974026|10973256|10523219|9805140|9415461|9215269|6329005|4010501|3465316|3365080|2605794|2586567|1571257|1263542|579530	.	5573	PRKAR1A	IC2	IVS3	.	.	intron	NM_212472.1	NP_997637.1	+	Y	c.349-9_349-8insT	.	.	.	NM_212472.1(PRKAR1A): c.349-9_349-8insT	;maf-5-some-pop,maf-5-all-pops	126142	0.222503	U	0.1845	0.22524	12518	0.226793	PASS	123	8620	0.151972	3141	121134	0.222390	211	2574	1.49287e-01	6289	54326	2.21017e-01	rs35723852	.	4024	0.157300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	41046	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
Pass	17	78820328	78820329	17q25.3	.	C	snv	T	GG.GT	het-ref	222	0.50	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C11	EX11	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.1269C>T	p.(G423=) | p.(Gly423=)	GGC=>GGT	.	NM_020761.2(RPTOR): c.1269C>T (p.(G423=))	;maf-5-some-pop,maf-5-all-pops	126352	0.572116	U	0.4345	0.436701	13006	0.496156	PASS	857	8634	0.444753	21174	121344	0.577705	1751	7715	4.47558e-01	43800	144161	5.85992e-01	rs3751945	.	.	.	0.467	-1.023	-0.386	.	.	.	.	.	ENST00000306801: c.1269C>T (p.G423G)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3755999	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	17	78854222	78854223	17q25.3	.	A	snv	G	CA.GC	het-ref	119	0.41	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C14	EX14	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.1518A>G	p.(Q506=) | p.(Gln506=)	CAA=>CAG	.	NM_020761.2(RPTOR): c.1518A>G (p.(Q506=))	;maf-5-some-pop,maf-5-all-pops	126028	0.253785	U	0.3879	0.248003	13006	0.223051	PASS	672	8616	0.384749	4137	121020	0.254024	1316	6607	3.83326e-01	8576	63417	2.57669e-01	rs2289759	.	.	.	-0.964	-0.329	-0.561	.	.	.	.	.	ENST00000306801: c.1518A>G (p.Q506Q)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3756001	CM092499	NM_020761.2(RPTOR): c.1518A>G (p.Q506Q)	"Altered splicing, association with ?"	19388141	FP	.	.	.	.	Likely Benign
Pass	17	78857711	78857712	17q25.3	.	C	snv	T	TG.GG	het-ref	259	0.53	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C16	EX16	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.1782C>T	p.(C594=) | p.(Cys594=)	TGC=>TGT	.	NM_020761.2(RPTOR): c.1782C>T (p.(C594=))	;	120438	0.000017	U	.	.	.	.	PASS	0	8600	0.000233	0	120438	0.000017	0	2	1.16023e-04	0	2	8.13650e-06	rs767341540	.	.	.	-0.259	-0.449	-1.281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	17	78896528	78896529	17q25.3	.	C	snv	T	AC.GT	het-ref	118	0.41	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C22	EX22	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.2526C>T	p.(T842=) | p.(Thr842=)	ACC=>ACT	.	NM_020761.2(RPTOR): c.2526C>T (p.(T842=))	;maf-5-some-pop,maf-5-all-pops	61108	0.357024	U	0.1964	0.245407	12938	0.272608	PASS	59	3194	0.274264	2824	56100	0.366988	294	2759	1.92077e-01	8555	57282	2.87872e-01	rs2271603	.	.	.	-1.080	-3.030	-1.570	.	.	.	.	.	ENST00000306801: c.2526C>T (p.T842T)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	437758	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	17	78919557	78919558	17q25.3	.	C	snv	T	GC.GT	het-ref	170	0.48	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C26	EX26	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.3117C>T	p.(A1039=) | p.(Ala1039=)	GCC=>GCT	.	NM_020761.2(RPTOR): c.3117C>T (p.(A1039=))	;maf-5-some-pop,maf-5-all-pops	126134	0.360133	U	0.4544	0.374601	13006	0.362217	PASS	905	8634	0.465138	7932	121126	0.359535	1638	7333	4.50651e-01	15112	84645	3.51478e-01	rs1567962	.	.	.	0.655	-0.537	-0.037	.	.	.	.	.	ENST00000306801: c.3117C>T (p.A1039A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4000341	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	17	78921116	78921117	17q25.3	.	C	snv	T	AA.GG	het-ref	250	0.52	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C27	EX27	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.3231C>T	p.(N1077=) | p.(Asn1077=)	AAC=>AAT	.	NM_020761.2(RPTOR): c.3231C>T (p.(N1077=))	;maf-5-some-pop	124612	0.271812	U	0.2044	0.197684	13006	0.236737	PASS	165	8612	0.195657	4843	119604	0.274916	313	2994	1.94390e-01	8858	61559	2.69910e-01	rs4969231	.	.	.	-1.492	-1.052	-2.134	.	.	.	.	.	ENST00000306801: c.3231C>T (p.N1077N)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1387173	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	17	78935196	78935197	17q25.3	.	C	snv	T	CG.GT	het-ref	126	0.44	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C31	EX31	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.3609C>T	p.(R1203=) | p.(Arg1203=)	CGC=>CGT	.	NM_020761.2(RPTOR): c.3609C>T (p.(R1203=))	;maf-5-some-pop	25968	0.325863	U	0.5546	0.309505	12674	0.250197	PASS	100	656	0.573171	1190	20960	0.329771	1593	5674	5.52698e-01	10019	52960	3.56619e-01	rs9899178	.	.	.	-0.186	-1.020	-0.395	.	.	.	.	.	ENST00000306801: c.3609C>T (p.R1203R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4130785	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	18	14851755	14851756	18p11.21	.	G	snv	A	AC.GC	het-ref	29	0.18	.	2	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	374860	ANKRD30B	C36E	EX36E	CCDC144C protein coiled-coil region	PF14915.1	coding-synon	NM_001145029.1	NP_001138501.1	+	Y	c.3456G>A	p.(T1152=) | p.(Thr1152=)	ACG=>ACA	.	NM_001145029.1(ANKRD30B): c.3456G>A (p.(T1152=))	SingleClassTriAllelic;maf-5-some-pop	74312	0.247591	U	0.4157	0.528554	.	.	PASS	129	5304	0.170814	3188	69304	0.227288	734	3122	2.55650e-01	11942	37070	2.46748e-01	rs9676225	.	4024	0.402100	-2.900	-0.553	-0.696	.	.	.	.	.	ENST00000358984: c.3456G>A (p.T1152T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4130926	.	.	.	.	.	.	.	.	.	Likely Benign
InExcel	18	18619416	18619416	18q11.1	.	.	ins	A	AG.AA	het-ref	45	0.17	.	2	.	PASS	601702	P	.	NN	.	.	.	.	.	.	.	6093	ROCK1	IC9	IVS9	.	.	intron	NM_005406.2	NP_005397.1	-	Y	c.1051+16_1051+17insT	.	.	.	NM_005406.2(ROCK1): c.1051+16_1051+17insT	MixedObserved;	48017	0.023471	U	.	.	.	.	PASS	0	3548	0.134442	0	57392	0.162131	.	.	.	.	.	.	rs773222097	.	4024	0.400100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	18	61322994	61322995	18q21.33	.	T	snv	C	AG.AG	het-ref	383	0.46	.	2	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	C7E	EX8E	Serpin (serine protease inhibitor)	PF00079.15	missense	NM_006919.2	NP_008850.1	-	Y	c.1069A>G	p.T357A | p.Thr357Ala	ACT=>GCT	P0=>NP	NM_006919.2(SERPINB3): c.1069A>G (p.T357A)	;maf-5-some-pop	126262	0.145832	U	0.4405	0.192492	13006	0.085038	PASS	807	8604	0.435960	1917	121254	0.143905	1688	7597	4.40917e-01	4183	36619	1.49042e-01	rs1065205	.	4024	0.446800	-1.855	-0.962	-1.670	0.8	0	0	0.001	neutral	ENST00000283752: c.1069A>G (p.T357A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4000445	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	18	61326628	61326628	18q21.33	.	.	ins	T	AA.TT	hom-alt	396	1.00	.	0	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	intron	NM_006919.2	NP_008850.1	-	Y	c.351+4_351+5insA	.	.	.	NM_006919.2(SERPINB3): c.351+4_351+5insA	;	126158	0.997543	U	1	0.994808	12518	0.993370	PASS	4296	8602	0.999419	60291	121150	0.997656	8586	17181	9.99476e-01	122153	244815	9.97901e-01	rs11370831	.	4024	0.990300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	19	2223326	2223327	19p13.3	.	G	snv	A	CC.GA	het-ref	204	0.48	.	2	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	C25	EX25	.	.	coding-synon	NM_032482.2	NP_115871.1	+	Y	c.3438G>A	p.(P1146=) | p.(Pro1146=)	CCG=>CCA	.	NM_032482.2(DOT1L): c.3438G>A (p.(P1146=))	;maf-5-some-pop	125204	0.062650	U	0.122	0.124002	12324	0.077004	PASS	95	8600	0.146628	446	120196	0.060094	194	2568	1.48921e-01	874	14208	5.82706e-02	rs2286329	.	.	.	-2.105	-3.592	-4.716	.	.	.	.	.	ENST00000398665: c.3438G>A (p.P1146P)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021077	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	19	2226771	2226772	19p13.3	.	G	snv	C	AG.TC	het-ref	345	0.50	.	2	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	C27	EX27	.	.	missense	NM_032482.2	NP_115871.1	+	Y	c.4252G>C	p.V1418L | p.Val1418Leu	GTC=>CTC	NP=>NP	NM_032482.2(DOT1L): c.4252G>C (p.V1418L)	;maf-5-some-pop,maf-5-all-pops	103578	0.191711	U	0.25	0.255791	12200	0.189426	PASS	279	7680	0.283203	1912	98570	0.188455	589	4219	2.78005e-01	3540	34211	1.69432e-01	rs2302061	.	.	.	-0.216	-0.206	-0.033	1	0	0	0.000	neutral	ENST00000398665: c.4252G>C (p.V1418L)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3756557	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	19	3110348	3110349	19p13.3	.	T	snv	G	CC.GG	het-ref	125	0.43	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC2	IVS2	.	.	intron	NM_002067.2	NP_002058.2	+	Y	c.321+18T>G	.	.	.	NM_002067.2(GNA11): c.321+18T>G	;maf-5-some-pop,maf-5-all-pops	121338	0.416638	U	0.4048	0.344249	13000	0.366077	PASS	729	8458	0.414519	10433	116330	0.419754	1410	6939	4.06693e-01	21486	100321	4.17041e-01	rs11085000	.	4024	0.393400	0.166	-0.469	-0.627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	258546	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	19	3119238	3119239	19p13.3	.	C	snv	T	AC.AT	het-ref	332	0.53	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	C6	EX6	ADP-ribosylation factor family;G-protein alpha subunit	PF00025.16;PF00503.15	coding-synon	NM_002067.2	NP_002058.2	+	Y	c.771C>T	p.(T257=) | p.(Thr257=)	ACC=>ACT	.	NM_002067.2(GNA11): c.771C>T (p.(T257=))	;maf-5-some-pop,maf-5-all-pops	126324	0.423205	U	0.4058	0.348842	13006	0.382208	PASS	761	8626	0.416531	11356	121316	0.426275	1441	7025	4.07388e-01	23046	105006	4.26881e-01	rs4900	.	4024	0.396900	0.491	0.720	0.075	.	.	.	.	.	ENST00000078429: c.771C>T (p.T257T)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3756588	.	.	.	.	.	no_record	258548	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	19	4099186	4099187	19p13.3	.	T	snv	C	GA.TC	hom-alt	357	1.00	.	0	.	PASS	601263	P	615280(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|21178588|20358587|20301365|18042262|16439621|8456719	.	5605	MAP2K2	IC7	IVS7	.	.	intron	NM_030662.3	NP_109587.1	-	Y	c.919+12A>G	.	.	.	NM_030662.3(MAP2K2): c.919+12A>G	;maf-5-some-pop	82212	0.771870	U	0.9216	0.773562	12690	0.744129	PASS	2659	6164	0.930402	22409	77204	0.771761	6446	14002	9.21669e-01	58750	154567	7.53023e-01	rs350911	.	4024	0.938400	-0.349	-0.288	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	40835	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	19	4101061	4101062	19p13.3	.	G	snv	T	TC.AT	het-ref	231	0.48	.	2	.	PASS	601263	P	615280(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|21178588|20358587|20301365|18042262|16439621|8456719	.	5605	MAP2K2	C6	EX6	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_030662.3	NP_109587.1	-	Y	c.660C>A	p.(I220=) | p.(Ile220=)	ATC=>ATA	.	NM_030662.3(MAP2K2): c.660C>A (p.(I220=))	;maf-5-some-pop,maf-5-all-pops	67842	0.538767	U	0.625	0.433307	12990	0.417937	PASS	847	4350	0.661609	8097	62834	0.547172	2440	8330	5.92377e-01	23429	96372	4.78282e-01	rs10250	.	4024	0.610300	0.561	0.062	-0.031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	40816	reviewed_by_expert_panel	Benign	Likely Benign
Pass	19	10602425	10602426	19p13.2	.	G	snv	A	TC.GG	het-ref	365	0.50	.	2	.	PASS	606016	P	.	NN	.	.	.	.	.	.	.	9817	KEAP1	C2	EX3	.	.	coding-synon	NM_203500.1	NP_987096.1	-	Y	c.1152C>T	p.(P384=) | p.(Pro384=)	CCC=>CCT	.	NM_203500.1(KEAP1): c.1152C>T (p.(P384=))	;	41476	0.000313	U	0.003	0.000599042	12882	0.000233	PASS	0	1952	0.004098	0	36468	0.000274	0	48	3.91773e-03	0	52	2.96357e-04	rs201119783	.	4024	0.002700	-1.740	-0.943	-2.178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	19	11105607	11105608	19p13.2	.	T	snv	C	CA.GC	het-ref	286	0.52	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	C8	EX10	.	.	coding-synon	NM_001128844.1	NP_001122316.1	+	Y	c.1524T>C	p.(H508=) | p.(His508=)	CAT=>CAC	.	NM_001128844.1(SMARCA4): c.1524T>C (p.(H508=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	124940	0.334393	U	0.2639	0.311502	13006	0.328310	PASS	222	8536	0.238285	6930	119932	0.335348	449	4030	2.34112e-01	13798	80555	3.27963e-01	rs7935	.	4024	0.239100	-2.223	-0.319	-1.566	.	.	.	.	.	ENST00000358026: c.1524T>C (p.H508H)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4131184	.	.	.	.	.	no_record	126359	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	19	11105607	11105608	19p13.2	.	T	snv	C	CA.GC	het-ref	286	0.52	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	C8	EX9	HSA	PF07529.8	coding-synon	NM_001128849.1	NP_001122321.1	+	N	c.1524T>C	p.(H508=) | p.(His508=)	CAT=>CAC	.	NM_001128849.1(SMARCA4): c.1524T>C (p.(H508=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	124940	0.334393	U	0.2639	0.311502	13006	0.328310	PASS	222	8536	0.238285	6930	119932	0.335348	449	4030	2.34112e-01	13798	80555	3.27963e-01	rs7935	.	4024	0.239100	-2.223	-0.319	-1.566	.	.	.	.	.	ENST00000358026: c.1524T>C (p.H508H)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4131184	.	.	.	.	.	no_record	126359	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	19	15273380	15273381	19p13.12	.	A	snv	G	GG.TG	het-ref	113	0.45	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC31	IVS31	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5816-8T>C	.	.	.	NM_000435.2(NOTCH3): c.5816-8T>C	SingleClassTriAllelic;maf-5-some-pop	125458	0.874293	U	0.8016	0.86901	13006	0.923266	PASS	2767	8558	0.806497	46287	120450	0.874512	5503	13775	8.01058e-01	92095	211805	8.63904e-01	rs4809030	.	4024	0.797200	-2.438	-0.298	-0.955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256145	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	19	15276918	15276919	19p13.12	.	G	snv	A	GT.TG	het-ref	163	0.46	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC29	IVS29	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5363-17C>T	.	.	.	NM_000435.2(NOTCH3): c.5363-17C>T	;maf-5-some-pop	125630	0.871520	U	0.8006	0.866613	13006	0.922190	PASS	2743	8592	0.802025	46080	120622	0.871723	5457	13726	7.98580e-01	91270	210453	8.61813e-01	rs2074619	.	4024	0.797000	-0.165	-1.185	-1.859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256141	criteria_provided,_single_submitter	Benign	Benign
Pass	19	15278056	15278057	19p13.12	.	A	snv	G	CT.AC	het-ref	239	0.44	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC29	IVS29	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5362+3T>C	.	.	.	NM_000435.2(NOTCH3): c.5362+3T>C	;maf-5-some-pop,genotype-conflict	126336	0.873908	U	0.8016	0.870008	13006	0.923651	PASS	2800	8626	0.807443	46647	121328	0.874069	5523	13817	8.01078e-01	92365	212328	8.63958e-01	rs1548555	.	4024	0.797200	-0.186	0.487	0.618	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256140	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	19	15285051	15285052	19p13.12	.	T	snv	C	TC.GG	het-ref	296	0.51	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C25	EX25	NOTCH protein	PF06816.8	coding-synon	NM_000435.2	NP_000426.2	-	Y	c.4563A>G	p.(P1521=) | p.(Pro1521=)	CCA=>CCG	.	NM_000435.2(NOTCH3): c.4563A>G (p.(P1521=))	;maf-5-some-pop	93348	0.880737	U	0.8006	0.871805	12862	0.926139	PASS	1896	5818	0.818838	34152	88340	0.881243	4817	12115	8.01363e-01	79323	182960	8.62645e-01	rs1044006	.	4024	0.797000	-0.320	-1.685	-1.429	.	.	.	.	.	ENST00000263388: c.4563A>G (p.P1521P)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1480700	.	.	.	.	.	no_record	256138	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	19	15292436	15292437	19p13.12	.	T	snv	C	CC.GG	hom-alt	460	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C17	EX17	.	.	coding-synon	NM_000435.2	NP_000426.2	-	Y	c.2742A>G	p.(P914=) | p.(Pro914=)	CCA=>CCG	.	NM_000435.2(NOTCH3): c.2742A>G (p.(P914=))	;maf-5-some-pop,maf-5-all-pops	24410	0.789021	U	0.8284	0.739018	12276	0.790486	PASS	206	658	0.803951	6280	19402	0.801928	3360	8310	8.10415e-01	48026	118414	8.03657e-01	rs1043997	.	4024	0.822100	-2.251	-4.386	-4.375	.	.	.	.	.	ENST00000263388: c.2742A>G (p.P914P)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4131309	.	.	.	.	.	no_record	256130	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	19	15300068	15300069	19p13.12	.	T	snv	C	GA.GG	hom-alt	617	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC7	IVS7	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.1192+15A>G	.	.	.	NM_000435.2(NOTCH3): c.1192+15A>G	;maf-5-some-pop,maf-5-all-pops	126250	0.857109	U	0.869	0.854233	13006	0.889051	PASS	3244	8634	0.867732	44782	121242	0.857228	6421	14885	8.63299e-01	88901	208528	8.47716e-01	rs10423702	.	4024	0.863100	0.260	-0.794	-0.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256118	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	19	15302843	15302844	19p13.12	.	T	snv	C	GG.GC	hom-alt	602	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C4	EX4	.	.	coding-synon	NM_000435.2	NP_000426.2	-	Y	c.606A>G	p.(A202=) | p.(Ala202=)	GCA=>GCG	.	NM_000435.2(NOTCH3): c.606A>G (p.(A202=))	;maf-5-some-pop	125330	0.858031	U	0.871	0.855831	13006	0.889282	PASS	3238	8624	0.867347	44532	120322	0.858122	6419	14878	8.63694e-01	88822	208202	8.48391e-01	rs1043994	.	4024	0.862800	-4.680	-1.208	-2.590	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256148	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	19	15303224	15303225	19p13.12	.	G	snv	A	GC.GT	hom-alt	626	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C3	EX3	.	.	coding-synon	NM_000435.2	NP_000426.2	-	Y	c.303C>T	p.(T101=) | p.(Thr101=)	ACC=>ACT	.	NM_000435.2(NOTCH3): c.303C>T (p.(T101=))	;maf-5-some-pop,maf-5-all-pops	116356	0.183996	U	0.3899	0.224042	12982	0.183408	PASS	521	8402	0.359438	2021	111348	0.182195	985	5916	3.45480e-01	4011	41665	1.73714e-01	rs3815188	.	4024	0.349400	-1.047	-0.018	-0.552	.	.	.	.	.	ENST00000263388: c.303C>T (p.T101T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019657	.	.	.	.	.	no_record	256131	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	19	17941293	17941294	19p13.11	.	T	snv	C	GC.CT	het-ref	134	0.51	.	2	.	PASS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC21	IVS22	.	.	intron	NM_000215.3	NP_000206.2	-	Y	c.3096+18A>G	.	.	.	NM_000215.3(JAK3): c.3096+18A>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	105636	0.410816	U	0.4702	0.434305	13000	0.347923	PASS	724	6866	0.491116	7873	100628	0.409647	1699	7570	4.60126e-01	17241	88712	3.76629e-01	rs2302603	.	4024	0.456800	-0.642	-0.460	-0.484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36421	criteria_provided,_single_submitter	Benign	Benign
Pass	19	18271302	18271303	19p13.11	.	C	snv	T	CC.GA	het-ref	124	0.49	.	2	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C2	EX3	.	.	coding-synon	NM_005027.2	NP_005018.1	+	Y	c.345C>T	p.(P115=) | p.(Pro115=)	CCC=>CCT	.	NM_005027.2(PIK3R2): c.345C>T (p.(P115=))	SingleClassTriAllelic;	120082	0.000008	U	.	.	.	.	PASS	0	8620	0.000000	0	120082	0.000008	0	0	0.00000e+00	0	1	4.06577e-06	rs755095052	.	.	.	-1.610	-3.114	-3.525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
InExcel	19	18279518	18279519	19p13.11	.	A	snv	C	CC.CC	het-ref	36	0.23	.	2	.	DUBIOUS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	intron	NM_005027.2	NP_005018.1	+	Y	c.1809-17A>C	.	.	.	NM_005027.2(PIK3R2): c.1809-17A>C	SingleClassTriAllelic;	104416	0.000010	U	.	.	12990	0	PASS	0	8010	0.000000	0	104416	0.000010	0	0	0.00000e+00	0	1	4.31507e-06	rs199501065	.	4060	0.217000	-0.753	-0.719	-0.755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
InExcel	19	18279521	18279522	19p13.11	.	G	snv	C	CC.CC	het-ref	25	0.14	.	2	.	DUBIOUS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	intron	NM_005027.2	NP_005018.1	+	Y	c.1809-14G>C	.	.	.	NM_005027.2(PIK3R2): c.1809-14G>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4044	0.208400	-1.973	-1.984	-2.005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	19	18279637	18279638	19p13.11	.	T	snv	C	AG.GG	hom-alt	514	1.00	.	0	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C14	EX15	SH2 domain	PF00017.19	coding-synon	NM_005027.2	NP_005018.1	+	Y	c.1911T>C	p.(S637=) | p.(Ser637=)	AGT=>AGC	.	NM_005027.2(PIK3R2): c.1911T>C (p.(S637=))	;maf-5-some-pop	124354	0.879296	U	0.9365	0.86242	13006	0.851069	PASS	3717	8566	0.930890	46269	119346	0.880004	7431	15973	9.30177e-01	93730	212341	8.81456e-01	rs273269	.	4024	0.936100	-2.028	-2.347	-1.891	.	.	.	.	.	ENST00000222254: c.1911T>C (p.S637S)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4131467	.	.	.	.	.	no_record	518294	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	19	41759631	41759634	19q13.2	.	CCC	del	.	GA.CC	het-alt	89	0.78	.	1	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC17	IVS17	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.2036+19_2036+21delCCC	.	.	.	NM_021913.3(AXL): c.2036+19_2036+21delCCC	MixedObserved;maf-5-some-pop,maf-5-all-pops	51335	0.533905	U	0.5109	0.403754	.	.	VQSRTrancheINDEL97.00to99.00	399	4330	0.542725	3654	52242	0.485931	793	4651	3.69420e-01	7395	50889	3.22961e-01	rs68001077	.	4027	0.294500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
InExcel	19	41759631	41759634	19q13.2	.	CCC	rep	CC	GA.CC	het-alt	14	0.12	.	2	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC17	IVS17	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.2036+19C[3>2] (std: c.2036+19C[2] alt: c.2036+21delC )	.	.	.	NM_021913.3(AXL): c.2036+19C[2]	.	.	.	.	.	.	.	.	VQSRTrancheINDEL97.00to99.00	10	4330	0.052656	112	52242	0.082367	6	2792	2.21763e-01	131	36291	2.30317e-01	.	.	4027	0.049600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	19	41762524	41762525	19q13.2	.	A	snv	G	GC.CT	het-ref	188	0.47	.	2	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC18	IVS18	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.2196+9A>G	.	.	.	NM_021913.3(AXL): c.2196+9A>G	;maf-5-some-pop,maf-5-all-pops	126102	0.142186	U	0.2778	0.150958	13006	0.140012	PASS	370	8604	0.291376	1381	121094	0.141824	736	4969	2.88392e-01	2847	34774	1.41439e-01	rs2304232	.	4024	0.277800	-0.353	-1.268	-1.195	.	.	.	.	.	ENST00000301178: c.2196+9A>G (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019815	.	.	.	.	.	.	.	.	.	Benign
Pass	19	44055725	44055726	19q13.31	.	T	snv	C	TC.GG	hom-alt	299	1.00	.	0	.	PASS	194360	C	.	NN	.	.	.	.	.	.	.	7515	XRCC1	C10	EX10	.	.	missense	NM_006297.2	NP_006288.2	-	Y	c.1196A>G	p.Q399R | p.Gln399Arg	CAG=>CGG	P0=>P+	NM_006297.2(XRCC1): c.1196A>G (p.Q399R)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125894	0.685640	U	0.7649	0.739617	13006	0.709211	PASS	2358	8628	0.742119	28521	120886	0.683404	4741	12795	7.42342e-01	57451	167030	6.80999e-01	rs25487	.	4024	0.737600	-0.119	1.657	0.842	.	.	.	.	.	ENST00000262887: c.1196A>G (p.Q399R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3756906	.	.	.	.	.	no_record	225976	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	19	45923652	45923653	19q13.32	.	A	snv	G	AC.TT	hom-alt	374	1.00	.	0	.	PASS	126380	C	610758(MK)	NN	Cerebrooculofacioskeletal syndrome 4	AR	.	Craniofacial; Musculoskeletal; Neurologic; Renal	General	23623389|17273966	.	2067	ERCC1	C3	EX4	Binding domain of DNA repair protein Ercc1 (rad10/Swi10)	PF03834.9	coding-synon	NM_001983.3	NP_001974.1	-	Y	c.354T>C	p.(N118=) | p.(Asn118=)	AAT=>AAC	.	NM_001983.3(ERCC1): c.354T>C (p.(N118=))	;maf-5-some-pop,genotype-conflict	123014	0.514998	U	0.7381	0.66893	13006	0.540058	PASS	2305	8578	0.736535	16939	118006	0.508466	4612	12624	7.34210e-01	34298	122024	4.99047e-01	rs11615	.	4024	0.749500	-1.608	-1.441	-1.965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	225945	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	19	50804976	50804977	19q13.33	.	C	snv	T	AG.GG	het-ref	203	0.45	.	2	.	PASS	608568	C	600652(MK);614369(UK)	NN	Deafness, autosomal dominant 4; Deafness, autosomal dominant 4B; Peripheral neuropathy, myopathy, hoarseness, and hearing loss	AD	.	Audiologic/Otolaryngologic; Musculoskeletal; Neurologic	General	21480433|21368133|16222661|15015131|11938438|7655461	.	79784	MYH14	C39	EX40	Myosin tail	PF01576.14	coding-synon	NM_001145809.1	NP_001139281.1	+	Y	c.5529C>T	p.(S1843=) | p.(Ser1843=)	AGC=>AGT	.	NM_001145809.1(MYH14): c.5529C>T (p.(S1843=))	;maf-5-some-pop	125322	0.006814	U	0.0903	0.01877	12564	0.000239	PASS	26	8616	0.080896	26	120314	0.006317	61	1386	8.03758e-02	62	1524	6.19794e-03	rs12610591	.	4024	0.090000	-0.218	-0.202	-0.206	.	.	.	.	.	ENST00000262269: c.5529C>T (p.S1843S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3681008	.	.	.	.	.	no_record	226746	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
Pass	20	20032997	20032998	20p11.23	.	T	snv	C	AG.CG	het-ref	109	0.47	.	2	.	PASS	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	missense	NM_016652.4	NP_057736.4	-	Y	c.472A>G	p.T158A | p.Thr158Ala	ACT=>GCT	P0=>NP	NM_016652.4(CRNKL1): c.472A>G (p.T158A)	;maf-5-some-pop,microattr-tpa,genotype-conflict	126016	0.510261	U	0.7024	0.51897	13006	0.463709	PASS	2294	8622	0.730457	16019	121008	0.509900	4611	12579	7.29979e-01	33128	126152	5.13280e-01	rs2255255	.	.	.	-0.119	-0.069	-0.461	0.21	0	0	0.044	neutral	ENST00000377340: c.472A>G (p.T158A)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1565881	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	20	20033136	20033137	20p11.23	.	T	snv	A	GC.TG	hom-alt	493	0.99	.	0	.	PASS	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	missense	NM_016652.4	NP_057736.4	-	Y	c.333A>T	p.Q111H | p.Gln111His	CAA=>CAT	P0=>P+	NM_016652.4(CRNKL1): c.333A>T (p.Q111H)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126324	0.654658	U	0.9375	0.700879	13006	0.590958	PASS	3828	8650	0.940347	26482	121316	0.652750	7662	16255	9.42537e-01	54685	161903	6.57554e-01	rs2255258	.	4024	0.938900	-0.257	-0.750	-0.422	0.77	0	0	0.001	neutral	ENST00000377340: c.333A>T (p.Q111H)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4134300	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	20	20033241	20033242	20p11.23	.	A	snv	T	GT.AC	het-ref	176	0.48	.	2	.	PASS	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	coding-synon	NM_016652.4	NP_057736.4	-	Y	c.228T>A	p.(V76=) | p.(Val76=)	GTT=>GTA	.	NM_016652.4(CRNKL1): c.228T>A (p.(V76=))	;maf-5-some-pop,maf-5-all-pops	124692	0.511725	U	0.7024	0.51897	13004	0.463780	PASS	2275	8532	0.732185	15842	119684	0.511422	4593	12530	7.30527e-01	32961	125725	5.13373e-01	rs2273057	.	4024	0.733600	-0.313	-0.261	-0.404	.	.	.	.	.	ENST00000377340: c.228T>A (p.V76V)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3758475	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	20	31024273	31024274	20q11.21	.	T	snv	C	AG.AA	hom-alt	690	1.00	.	0	.	PASS	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	C13E	EX13E	.	.	coding-synon	NM_015338.5	NP_056153.2	+	Y	c.3759T>C	p.(S1253=) | p.(Ser1253=)	AGT=>AGC	.	NM_015338.5(ASXL1): c.3759T>C (p.(S1253=))	MixedObserved;maf-5-some-pop,maf-5-all-pops	126262	0.417830	U	0.7411	0.405751	13006	0.320083	PASS	2587	8640	0.769907	11590	121254	0.418328	5218	13368	7.75406e-01	23890	104345	4.24287e-01	rs4911231	.	4024	0.770100	0.459	0.273	0.081	.	.	.	.	.	ENST00000375687: c.3759T>C (p.S1253S)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4134435	.	.	.	.	.	no_record	338113	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	20	40743828	40743829	20q12	.	A	snv	G	CA.GA	het-ref	180	0.45	.	2	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	IC23	IVS23	.	.	intron	NM_133170.3	NP_573400.3	-	Y	c.3156+10T>C	.	.	.	NM_133170.3(PTPRT): c.3156+10T>C	;maf-5-some-pop,maf-5-all-pops	125568	0.531863	U	0.5258	0.55651	12332	0.564953	PASS	1245	8580	0.547319	17023	120560	0.530839	2500	9345	5.42494e-01	34646	130184	5.30160e-01	rs2076248	.	.	.	-0.215	-0.252	-0.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	20	41306488	41306488	20q12	.	.	ins	A	GG.AA	het-alt	79	0.41	.	1	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	IC7	IVS7	.	.	intron	NM_133170.3	NP_573400.3	-	Y	c.1153+17_1153+18insT	.	.	.	NM_133170.3(PTPRT): c.1153+17_1153+18insT	MixedObserved,InconsistentAlleles;rs-cluster-nonoverlapping-alleles	111210	0.130060	U	0.377	0.419728	.	.	PASS	196	7812	0.439196	2918	107324	0.446042	.	.	.	.	.	.	rs111229158	.	4024	0.389400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	20	41306488	41306488	20q12	.	.	ins	AA	GG.AA	het-alt	95	0.49	.	2	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	IC7	IVS7	.	.	intron	NM_133170.3	NP_573400.3	-	Y	c.1153+17_1153+18insTT	.	.	.	NM_133170.3(PTPRT): c.1153+17_1153+18insTT	MixedObserved,InconsistentAlleles;rs-cluster-nonoverlapping-alleles	111210	0.451947	U	0.5069	0.477236	.	.	PASS	153	7812	0.416667	2623	107324	0.427733	.	.	.	.	.	.	rs111229158	.	4024	0.419700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	20	41306599	41306600	20q12	.	A	snv	G	AC.TC	het-ref	284	0.47	.	2	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	C7	EX7	Fibronectin type III domain	PF00041.16	coding-synon	NM_133170.3	NP_573400.3	-	Y	c.1059T>C	p.(D353=) | p.(Asp353=)	GAT=>GAC	.	NM_133170.3(PTPRT): c.1059T>C (p.(D353=))	;maf-5-some-pop,maf-5-all-pops	125732	0.378726	U	0.3462	0.384784	12316	0.381211	PASS	552	8588	0.356195	8843	120724	0.378475	1142	6248	3.62329e-01	18299	93711	3.80927e-01	rs2425516	.	4024	0.386900	-3.342	-0.030	-1.131	.	.	.	.	.	NM_133170.2: c.1059T>C (p.D353D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3758576	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	20	43964406	43964407	20q13.12	.	G	snv	C	CA.CA	hom-alt	361	1.00	.	0	.	PASS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	intron	NM_002999.3	NP_002990.2	-	Y	c.199+15C>G	.	.	.	NM_002999.3(SDC4): c.199+15C>G	;maf-5-some-pop	126166	0.770897	U	0.9554	0.769369	13006	0.728049	PASS	4013	8632	0.963971	36247	121158	0.770960	8047	16653	9.66063e-01	74070	190017	7.73880e-01	rs2072791	.	.	.	-0.216	-0.566	-0.363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	20	46279836	46279839	20q13.12	.	CAG	del	.	aa.ca	het-ref	160	0.81	.	2	(CAG)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	601937	P	.	NN	.	.	.	.	.	.	.	8202	NCOA3	C18	EX20	.	.	cds-del	NM_181659.2	NP_858045.1	+	Y	c.3765GCA[9>8] (std: c.3765GCA[8] alt: c.3789_3791delGCA )	p.Q1248[29>28] (std: p.Q1248[28] alt: p.Q1276del ) | p.Gln1248[29>28] (std: p.Gln1248[28] alt: p.Gln1276del )	.	.	NM_181659.2(NCOA3): c.3765GCA[8] (p.Q1248[28])	MixedObserved;	30731	0.031369	U	.	.	12096	0.355324	PASS	121	7764	0.223854	2836	106396	0.279776	.	.	.	.	.	.	rs147879509	.	.	.	.	.	.	.	.	.	.	.	ENST00000371998: c.3763_3765delCAG (p.Q1255delQ)	liver [NS|NS|NS]	carcinoma [NS|NS|NS]	VUO	128730	.	.	.	.	.	.	.	.	.	Benign
Pass	20	54961462	54961463	20q13.2	.	T	snv	C	AA.GC	hom-alt	699	1.00	.	0	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	C2	EX5	.	.	missense	NM_198433.1	NP_940835.1	-	Y	c.169A>G	p.I57V | p.Ile57Val	ATT=>GTT	NP=>NP	NM_198433.1(AURKA): c.169A>G (p.I57V)	;maf-5-some-pop,genotype-conflict	126414	0.848253	U	0.877	0.84984	13006	0.837767	PASS	3337	8654	0.877629	43734	121406	0.848187	6666	15159	8.78885e-01	89212	209460	8.50551e-01	rs1047972	.	4024	0.883700	-1.117	0.735	-0.000	1	0.001	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	20	54961540	54961541	20q13.2	.	A	snv	T	AA.TT	hom-alt	599	1.00	.	0	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	C2	EX5	.	.	missense	NM_198433.1	NP_940835.1	-	Y	c.91T>A	p.F31I | p.Phe31Ile	TTT=>ATT	NP=>NP	NM_198433.1(AURKA): c.91T>A (p.F31I)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126348	0.274892	U	0.6587	0.309704	13006	0.188221	PASS	1974	8648	0.678423	5537	121340	0.273455	3947	11682	6.77296e-01	11395	68179	2.76894e-01	rs2273535	.	4024	0.683600	-0.371	-1.449	-1.226	0.47	0.001	0	0.011	neutral	ENST00000395909: c.91T>A (p.F31I)	skin [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	3736282	CM042940	NM_198433.1(AURKA): c.91T>A (p.F31I)	"Oesophageal cancer, association with"	15087379	DFP	no_record	6642	no_assertion_criteria_provided	risk_factor	Likely Benign
Pass	20	56136535	56136536	20q13.31	.	A	snv	G	CT.CC	hom-alt	494	1.00	.	0	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C1	EX2	.	.	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.69A>G	p.(L23=) | p.(Leu23=)	CTA=>CTG	.	NM_002591.3(PCK1): c.69A>G (p.(L23=))	SingleClassTriAllelic;maf-5-some-pop	126140	0.451681	U	0.377	0.396965	13006	0.447947	PASS	641	8618	0.381527	12821	121132	0.453943	1257	6592	3.82367e-01	25624	110785	4.50653e-01	rs1042521	.	4024	0.395100	-0.215	1.426	1.312	.	.	.	.	.	ENST00000319441: c.69A>G (p.L23L)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4134687	.	.	.	.	.	no_record	338868	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	20	56137797	56137798	20q13.31	.	G	snv	A	TC.CC	het-ref	230	0.47	.	2	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.453G>A	p.(S151=) | p.(Ser151=)	TCG=>TCA	.	NM_002591.3(PCK1): c.453G>A (p.(S151=))	;maf-5-some-pop	125676	0.375489	U	0.0308	0.295128	13006	0.412733	PASS	9	8638	0.036119	9355	120668	0.378825	15	604	3.50307e-02	19366	92512	3.77887e-01	rs1062600	.	4024	0.030300	-0.182	-1.716	-2.116	.	.	.	.	.	ENST00000319441: c.453G>A (p.S151S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	4134688	.	.	.	.	.	no_record	338875	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	20	56137806	56137807	20q13.31	.	A	snv	G	TC.AA	het-ref	224	0.45	.	2	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.462A>G	p.(S154=) | p.(Ser154=)	TCA=>TCG	.	NM_002591.3(PCK1): c.462A>G (p.(S154=))	;maf-5-some-pop	125772	0.407205	U	0.0308	0.313299	13006	0.449639	PASS	9	8638	0.036119	11110	120764	0.411099	16	607	3.52088e-02	22787	100286	4.09321e-01	rs1042523	.	4024	0.030600	-3.430	-0.577	-1.018	.	.	.	.	.	ENST00000319441: c.462A>G (p.S154S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	4134690	.	.	.	.	.	no_record	338876	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	20	56137833	56137834	20q13.31	.	A	snv	G	TC.CC	het-ref	243	0.48	.	2	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.489A>G	p.(S163=) | p.(Ser163=)	TCA=>TCG	.	NM_002591.3(PCK1): c.489A>G (p.(S163=))	;maf-5-some-pop	126088	0.410483	U	0.0308	0.314097	13006	0.449562	PASS	9	8634	0.036136	11492	121080	0.414470	16	608	3.52586e-02	23011	100811	4.10535e-01	rs1062601	.	4024	0.030300	-1.785	-2.004	-1.316	.	.	.	.	.	ENST00000319441: c.489A>G (p.S163S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3722977	.	.	.	.	.	no_record	338877	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	20	56137894	56137895	20q13.31	.	G	snv	C	CA.TG	hom-alt	570	1.00	.	0	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	missense	NM_002591.3	NP_002582.3	+	Y	c.550G>C	p.V184L | p.Val184Leu	GTG=>CTG	NP=>NP	NM_002591.3(PCK1): c.550G>C (p.V184L)	;maf-5-some-pop,genotype-conflict	126314	0.846248	U	0.7798	0.846046	13006	0.901199	PASS	2642	8644	0.783549	43693	121306	0.846257	5296	13509	7.83767e-01	87445	206921	8.40978e-01	rs707555	.	4024	0.786800	-0.120	3.984	1.304	1	0	0	0.000	neutral	ENST00000319441: c.550G>C (p.V184L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3736801	.	.	.	.	.	no_record	338879	criteria_provided,_single_submitter	Benign	Likely Benign
Pass	20	56139402	56139403	20q13.31	.	T	snv	C	GG.GT	hom-alt	629	1.00	.	0	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C6	EX7	Phosphoenolpyruvate carboxykinase	PF00821.13	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.1140T>C	p.(G380=) | p.(Gly380=)	GGT=>GGC	.	NM_002591.3(PCK1): c.1140T>C (p.(G380=))	;maf-5-some-pop	126360	0.756015	U	0.7728	0.786941	13006	0.802245	PASS	2599	8644	0.777071	34885	121352	0.754738	5222	13414	7.77984e-01	69226	183954	7.47252e-01	rs2070756	.	4024	0.777600	-1.653	-0.985	-1.206	.	.	.	.	.	ENST00000319441: c.1140T>C (p.G380G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419746	.	.	.	.	.	no_record	338889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	20	57478806	57478807	20q13.32	.	C	snv	T	AT.CT	het-ref	290	0.47	.	2	.	PASS	139320	C	102200(MK);103580(MK);166350(MK);174800(MK);219080(MK);603233(MK);612462(MK);612463(MK)	AD	Pseudohypoparathyroidism, type IA; Pseudohypoparathyroidism, type IB; Pseudohypoparathyroidism, type IC; Progressive osseous heteroplasia; McCune-Albright syndrome	AD	.	Dermatologic; Endocrine; Musculoskeletal; Oncologic; Renal	Endocrine; Oncologic; Renal	22640971|21816789|21488135|21357941|20480732|19858129|18553568|18416659|18397987|17651445|17405850|16984995|16060910|15711092|15537666|15126527|15001590|14561710|14557424|13005676|12858292|12727968|12624854|12605446|12414879|12407707|12024004|11788646|11784876|11600516|11583302|11406605|11397863|11297617|11095461|11073544|11067869|11029463|10998448|10646121|10356155|10190480|9506752|9226216|8421479|8126161|8126048|7980957|7739708|7671486|6265935|5906056|3126297|3093862|2829196|2273209|2122458|2109828|1955519|1944469|1621772|1594625|1424186|1400888|1346061|1083395|0614538|431133|219790|198661	.	2778	GNAS	C5	EX5	G-protein alpha subunit	PF00503.15	coding-synon	NM_001077488.2	NP_001070956.1	+	Y	c.396C>T	p.(I132=) | p.(Ile132=)	ATC=>ATT	.	NM_001077488.2(GNAS): c.396C>T (p.(I132=))	;maf-5-some-pop,maf-5-all-pops	126388	0.551176	U	0.6716	0.644369	13006	0.579425	PASS	1705	8628	0.630158	18875	121380	0.547331	3636	11149	6.46469e-01	37660	133380	5.41623e-01	rs7121	.	4024	0.664000	-1.760	-1.518	-2.651	.	.	.	.	.	ENST00000371100: c.2322C>T (p.I774I)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3758661	.	.	.	.	.	no_record	197681	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	20	57484876	57484877	20q13.32	.	C	snv	T	GC.CA	het-ref	282	0.47	.	2	.	PASS	139320	C	102200(MK);103580(MK);166350(MK);174800(MK);219080(MK);603233(MK);612462(MK);612463(MK)	AD	Pseudohypoparathyroidism, type IA; Pseudohypoparathyroidism, type IB; Pseudohypoparathyroidism, type IC; Progressive osseous heteroplasia; McCune-Albright syndrome	AD	.	Dermatologic; Endocrine; Musculoskeletal; Oncologic; Renal	Endocrine; Oncologic; Renal	22640971|21816789|21488135|21357941|20480732|19858129|18553568|18416659|18397987|17651445|17405850|16984995|16060910|15711092|15537666|15126527|15001590|14561710|14557424|13005676|12858292|12727968|12624854|12605446|12414879|12407707|12024004|11788646|11784876|11600516|11583302|11406605|11397863|11297617|11095461|11073544|11067869|11029463|10998448|10646121|10356155|10190480|9506752|9226216|8421479|8126161|8126048|7980957|7739708|7671486|6265935|5906056|3126297|3093862|2829196|2273209|2122458|2109828|1955519|1944469|1621772|1594625|1424186|1400888|1346061|1083395|0614538|431133|219790|198661	.	2778	GNAS	IC10	IVS10	.	.	intron	NM_001077488.2	NP_001070956.1	+	Y	c.842+18C>T	.	.	.	NM_001077488.2(GNAS): c.842+18C>T	;	125952	0.000254	U	0.002	0.000399361	.	.	PASS	0	8624	0.002783	0	120944	0.000248	0	58	3.36427e-03	0	77	3.13983e-04	rs182674093	.	4024	0.002500	0.460	-1.818	-1.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	21	37507500	37507501	21q22.12	.	G	snv	A	CT.CA	het-ref	204	0.48	.	2	.	PASS	603608	P	.	NN	.	.	.	.	.	.	.	874	CBR3	C1	EX1	.	.	missense	NM_001236.3	NP_001227.1	+	Y	c.11G>A	p.C4Y | p.Cys4Tyr	TGC=>TAC	P0=>P0	NM_001236.3(CBR3): c.11G>A (p.C4Y)	;maf-5-some-pop,maf-5-all-pops	22718	0.518003	U	0.4335	0.366813	12112	0.372275	PASS	193	1512	0.571429	2055	17710	0.560757	989	4336	4.53177e-01	10473	47302	4.38209e-01	rs8133052	.	4024	0.410300	0.655	0.732	0.375	0.18	0.001	0	0.056	neutral	ENST00000290354: c.11G>A (p.C4Y)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	444425	CM102483	NM_001236.3(CBR3): c.11G>A (p.C4Y)	"Reduced catalytic efficiency, association with"	20007405	FP	.	.	.	.	Likely Benign
Pass	21	37518705	37518706	21q22.12	.	G	snv	A	CT.TG	het-ref	219	0.48	.	2	.	PASS	603608	P	.	NN	.	.	.	.	.	.	.	874	CBR3	C3E	EX3E	.	.	missense	NM_001236.3	NP_001227.1	+	Y	c.730G>A	p.V244M | p.Val244Met	GTG=>ATG	NP=>NP	NM_001236.3(CBR3): c.730G>A (p.V244M)	;maf-5-some-pop,maf-5-all-pops	126324	0.376255	U	0.4048	0.427117	13006	0.398739	PASS	766	8632	0.418095	8824	121316	0.374155	1549	7212	4.18135e-01	17426	90325	3.66936e-01	rs1056892	.	4024	0.447800	0.655	1.339	0.567	0.09	0.239	0.62	0.321	neutral	ENST00000290354: c.730G>A (p.V244M)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	3758864	CM057648	NM_001236.3(CBR3): c.730G>A (p.V244M)	"Increased catalytic efficiency, association with"	15537833	FP	no_record	225941	reviewed_by_expert_panel	drug_response	Likely Benign
Pass	21	42845373	42845374	21q22.3	.	G	snv	A	TC.CC	hom-alt	492	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C9	EX9	Trypsin	PF00089.21	coding-synon	NM_001135099.1	NP_001128571.1	-	Y	c.888C>T	p.(G296=) | p.(Gly296=)	GGC=>GGT	.	NM_001135099.1(TMPRSS2): c.888C>T (p.(G296=))	;maf-5-some-pop,maf-5-all-pops	108898	0.253274	U	0.249	0.209465	12920	0.206734	PASS	275	7476	0.288256	3334	103890	0.255386	580	4451	2.64060e-01	7106	56371	2.38727e-01	rs2298659	.	4024	0.281600	-0.143	-3.999	-3.916	.	.	.	.	.	ENST00000398585: c.888C>T (p.G296G)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1483963	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	21	42845382	42845383	21q22.3	.	A	snv	G	AC.AT	het-ref	239	0.50	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C9	EX9	Trypsin	PF00089.21	coding-synon	NM_001135099.1	NP_001128571.1	-	Y	c.879T>C	p.(I293=) | p.(Ile293=)	ATT=>ATC	.	NM_001135099.1(TMPRSS2): c.879T>C (p.(I293=))	;maf-5-some-pop,maf-5-all-pops	112170	0.490844	U	0.121	0.366214	12924	0.493191	PASS	70	7354	0.151210	13305	107162	0.496669	141	2218	1.30871e-01	28152	112106	4.74230e-01	rs17854725	.	4024	0.153300	-0.755	-1.885	-1.236	.	.	.	.	.	ENST00000398585: c.879T>C (p.I293I)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1483964	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	21	42848560	42848562	21q22.3	.	AG	del	.	AC.GG	hom-alt	344	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC7	IVS7	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.795-15_795-14delCT	.	.	.	NM_001135099.1(TMPRSS2): c.795-15_795-14delCT	MixedObserved;maf-5-some-pop	125674	0.902207	U	0.6548	0.813299	12512	0.914562	PASS	1897	8630	0.664542	50542	120666	0.905897	3851	11514	6.68253e-01	101843	221313	9.00290e-01	rs140530035	.	4024	0.678400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	21	42852496	42852497	21q22.3	.	C	snv	T	CA.CT	hom-alt	671	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C6	EX6	Scavenger receptor cysteine-rich domain;Scavenger receptor cysteine-rich domain	PF00530.13;PF15494.1	missense	NM_001135099.1	NP_001128571.1	-	Y	c.589G>A	p.V197M | p.Val197Met	GTG=>ATG	NP=>NP	NM_001135099.1(TMPRSS2): c.589G>A (p.V197M)	;maf-5-some-pop,maf-5-all-pops	125450	0.250602	U	0.3621	0.261382	13006	0.241350	PASS	628	8620	0.382019	4139	120442	0.250154	1270	6580	3.81892e-01	8117	60284	2.45182e-01	rs12329760	.	4024	0.407100	0.561	2.119	2.392	0.01	0.96	0.997	0.808	deleterious	ENST00000332149: c.478G>A (p.V160M)	stomach [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	VUO	149228	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	22	22127164	22127165	22q11.21	.	G	snv	A	TC.TC	het-ref	140	0.44	.	2	.	PASS	176948	C	.	NN	.	.	.	.	.	.	.	5594	MAPK1	C7	EX7	.	.	coding-synon	NM_002745.4	NP_002736.3	-	Y	c.963C>T	p.(D321=) | p.(Asp321=)	GAC=>GAT	.	NM_002745.4(MAPK1): c.963C>T (p.(D321=))	;maf-5-some-pop	126380	0.001432	U	0.0159	0.00379393	13006	0.000077	PASS	1	8652	0.014679	1	121372	0.001335	1	262	1.51919e-02	1	330	1.34114e-03	rs1803545	.	4024	0.008400	-0.982	0.137	-0.747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	22	23653879	23653880	22q11.23	.	G	snv	A	CC.CA	hom-alt	232	0.90	.	0	dup	DUBIOUS	151410	C	608232(MK);613065(MK)	NN	CML treatment, response to	AD	.	General	Pharmacogenomic	17684099|14534339|12654249|11423618	.	613	BCR	IC18	IVS18	.	.	intron	NM_004327.3	NP_004318.3	+	Y	c.3183-4G>A	.	.	.	NM_004327.3(BCR): c.3183-4G>A	;maf-5-some-pop,maf-5-all-pops	90034	0.421718	U	0.6339	0.459465	.	.	VQSRTrancheSNP99.60to99.80	971	6074	0.596641	6021	85026	0.419495	2188	8401	5.62693e-01	14346	82994	3.81620e-01	rs180801	.	4024	0.424200	-1.515	-1.000	-0.835	.	.	.	.	.	ENST00000305877: c.3183-4G>A (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4002111	.	.	.	.	.	.	.	.	.	Benign
InExcel	22	39387557	39387558	22q13.1	.	C	snv	T	TA.GA	het-ref	197	0.30	.	2	dup	PASS	607110	P	.	NN	.	.	.	.	.	.	.	9582	APOBEC3B	C6	EX6	.	.	coding-synon	NM_004900.4	NP_004891.4	+	Y	c.945C>T	p.(Y315=) | p.(Tyr315=)	TAC=>TAT	.	NM_004900.4(APOBEC3B): c.945C>T (p.(Y315=))	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	117514	0.472871	U	.	.	12964	0.483647	InbreedingCoeff_Filter	643	7552	0.504899	9636	117514	0.472871	1635	7866	5.24470e-01	20885	112260	4.72193e-01	rs1065184	.	3554	0.471000	0.407	-0.761	-1.013	.	.	.	.	.	ENST00000333467: c.945C>T (p.Y315Y)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3759194	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	22	41537233	41537234	22q13.2	.	G	snv	T	TG.TT	hom-alt	503	1.00	.	0	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC10	IVS10	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.2053+8G>T	.	.	.	NM_001429.3(EP300): c.2053+8G>T	MixedObserved;maf-5-some-pop	126402	0.988086	U	1	0.961661	.	.	PASS	4326	8654	0.999884	59464	121394	0.989176	8622	17246	9.99884e-01	121094	244017	9.91641e-01	rs6002267	.	4024	0.997800	-1.382	-0.271	-0.259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	93732	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	22	41545024	41545024	22q13.2	.	.	ins	T	TG.TT	het-ref	35	0.22	.	2	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC12	IVS12	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.2242-18_2242-17insT	.	.	.	NM_001429.3(EP300): c.2242-18_2242-17insT	.	.	.	.	.	.	.	.	PASS	0	6344	0.270334	1	94006	0.251058	.	.	.	.	.	.	.	.	4024	0.398100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
InExcel	22	41550984	41550984	22q13.2	.	.	ins	T	AC.TT	het-ref	35	0.14	.	2	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC16	IVS16	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.3143-15_3143-14insT	.	.	.	NM_001429.3(EP300): c.3143-15_3143-14insT	MixedObserved;	91742	0.020307	U	.	.	.	.	PASS	0	6640	0.013404	0	94518	0.028566	.	.	.	.	.	.	rs778546367	.	4024	0.170000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	194724	criteria_provided,_single_submitter	Benign	Benign
Pass	22	41551038	41551039	22q13.2	.	T	snv	A	AC.TT	hom-alt	464	1.00	.	0	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	C17	EX17	.	.	coding-synon	NM_001429.3	NP_001420.2	+	Y	c.3183T>A	p.(T1061=) | p.(Thr1061=)	ACT=>ACA	.	NM_001429.3(EP300): c.3183T>A (p.(T1061=))	;maf-5-some-pop,maf-5-all-pops	126402	0.657909	U	0.8175	0.673922	13006	0.583115	PASS	2834	8650	0.806821	26868	121394	0.657248	5704	13999	8.11724e-01	55720	163639	6.64567e-01	rs20552	.	4024	0.810900	-1.337	-0.929	-0.839	.	.	.	.	.	ENST00000263253: c.3183T>A (p.T1061T)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4767796	.	.	.	.	.	no_record	93738	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	22	41569608	41569609	22q13.2	.	C	snv	T	TC.TT	hom-alt	395	1.00	.	0	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC28	IVS28	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.4618-18C>T	.	.	.	NM_001429.3(EP300): c.4618-18C>T	;maf-5-some-pop,genotype-conflict	124172	0.306679	U	0.4712	0.264177	13004	0.258151	PASS	960	8368	0.479326	6155	119164	0.308466	1891	8035	4.68568e-01	12314	74282	3.03029e-01	rs2076578	.	4024	0.491100	0.655	1.126	1.373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	93742	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
Pass	22	42522612	42522613	22q13.2	.	G	ref	G	GG.TC	het-alt	251	0.56	.	1	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C9E	EX9E	.	.	missense	NM_000106.5	NP_000097.3	-	Y	c.1457G>C	p.S486T | p.Ser486Thr	AGC=>ACC	P0=>P0	NM_000106.5(CYP2D6): c.1457G>C (p.S486T)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	121276	0.546687	U	0.2956	0.401158	12980	0.591680	PASS	.	8314	0.701347	18154	116268	0.544440	.	.	.	.	.	.	rs1135840	.	.	.	-0.315	-0.224	-0.465	.	.	.	.	.	.	.	.	.	.	CM931123	NM_000106.4(CYP2D6): c.1457G>C (p.S486T)	Poor metaboliser, association with	8287064	FP	.	.	.	.	Likely Benign
Pass	22	42523002	42523003	22q13.2	.	A	snv	G	AG.AG	hom-alt	25	1.00	.	0	dup	DUBIOUS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	IC7	IVS7	.	.	intron	NM_000106.5	NP_000097.3	-	Y	c.1174-9T>C	.	.	.	NM_000106.5(CYP2D6): c.1174-9T>C	;maf-5-some-pop,maf-5-all-pops	48756	0.059767	U	.	.	.	.	PASS	170	1880	0.209574	1097	48756	0.059767	3359	7563	7.13221e-01	19706	49426	3.20428e-01	rs4987144	.	3920	0.228800	-1.172	-0.563	-0.768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	22	42525131	42525132	22q13.2	.	G	ref	G	GA.AC	het-alt	360	0.75	.	1	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C3	EX3	.	.	coding-synon	NM_000106.5	NP_000097.3	-	Y	c.408G>C	p.(V136=) | p.(Val136=)	GTG=>GTC	.	NM_000106.5(CYP2D6): c.408G>C (p.(V136=))	;maf-5-some-pop,maf-5-all-pops	120514	0.550625	U	0.2907	0.400958	12388	0.607120	PASS	.	8336	0.712932	18312	115506	0.548526	.	.	.	.	.	.	rs1058164	.	.	.	-2.920	-0.545	-0.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	22	42525755	42525756	22q13.2	.	G	snv	A	CC.AA	het-ref	445	0.65	.	2	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C2	EX2	.	.	coding-synon	NM_000106.5	NP_000097.3	-	Y	c.336C>T	p.(F112=) | p.(Phe112=)	TTC=>TTT	.	NM_000106.5(CYP2D6): c.336C>T (p.(F112=))	;maf-5-some-pop	120348	0.081372	U	0.5704	0.166933	12934	0.042833	PASS	1392	8432	0.556214	1639	115340	0.077657	2928	9675	5.67382e-01	3445	18563	7.69451e-02	rs1081003	.	4020	0.496300	-1.610	-0.200	-0.441	.	.	.	.	.	ENST00000360608: c.336C>T (p.F112F)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3785566	.	.	.	.	.	.	.	.	.	Likely Benign
Pass	22	42526693	42526694	22q13.2	.	G	snv	A	TG.GT	het-ref	475	0.65	.	2	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C1	EX1	.	.	missense	NM_000106.5	NP_000097.3	-	Y	c.100C>T	p.P34S | p.Pro34Ser	CCA=>TCA	NP=>P0	NM_000106.5(CYP2D6): c.100C>T (p.P34S)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	100846	0.246257	U	0.5714	0.238019	12990	0.188530	PASS	1376	7870	0.590978	3570	95838	0.246687	2921	9645	5.73084e-01	7559	48922	2.06804e-01	rs1065852	.	4014	0.504000	0.484	4.426	2.218	.	.	.	.	.	ENST00000360608: c.100C>T (p.P34S)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4999521	CM900081	NM_000106.5(CYP2D6): c.100C>T (p.P34S)	"Poor metaboliser, association with"	2211621	FP	Paralog	16893	criteria_provided,_single_submitter	Likely_benign	Likely Benign
Pass	X	1317403	1317404	Xp22.33	.	T	snv	C	CG.GT	het-ref	190	0.64	.	2	.	PASS	300357|400023	P	.	NN	.	.	.	.	.	.	.	64109	CRLF2	IC5	IVS5	.	.	intron	NM_022148.2	NP_071431.2	-	Y	c.646+15A>G	.	.	.	NM_022148.2(CRLF2): c.646+15A>G	SingleClassTriAllelic;maf-5-some-pop	125690	0.478996	U	0.3462	0.507788	12668	0.551547	PASS	613	8580	0.368648	14106	120682	0.477801	1163	6296	3.65155e-01	27620	115182	4.69433e-01	rs9778721	.	4024	0.358800	-1.436	0.614	-0.346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	X	39922906	39922907	Xp11.4	.	G	snv	A	CT.TT	hom-alt	265	1.00	.	0	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C7	EX8	.	.	coding-synon	NM_001123385.1	NP_001116857.1	-	Y	c.3801C>T	p.(N1267=) | p.(Asn1267=)	AAC=>AAT	.	NM_001123385.1(BCOR): c.3801C>T (p.(N1267=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.529	1.219	1.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
Pass	X	39932906	39932907	Xp11.4	.	T	snv	C	CC.GC	hom-alt	316	1.00	.	0	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C3	EX4	.	.	coding-synon	NM_001123385.1	NP_001116857.1	-	Y	c.1692A>G	p.(A564=) | p.(Ala564=)	GCA=>GCG	.	NM_001123385.1(BCOR): c.1692A>G (p.(A564=))	;maf-5-some-pop,genotype-conflict	91316	0.277717	U	0.6937	0.523974	10561	0.361519	PASS	1168	6601	0.711104	4014	87541	0.267098	2115	9041	7.03963e-01	6699	44406	2.49371e-01	rs6520618	.	4024	0.691400	-1.163	-3.590	-3.727	.	.	.	.	.	ENST00000378444: c.1692A>G (p.A564A)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019635	.	.	.	.	.	no_record	95766	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	X	39933338	39933339	Xp11.4	.	A	snv	G	CC.TC	hom-alt	389	0.99	.	0	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C3	EX4	.	.	coding-synon	NM_001123385.1	NP_001116857.1	-	Y	c.1260T>C	p.(D420=) | p.(Asp420=)	GAT=>GAC	.	NM_001123385.1(BCOR): c.1260T>C (p.(D420=))	;maf-5-some-pop,genotype-conflict	90884	0.895570	U	0.9594	0.903046	10561	0.895749	PASS	2187	6596	0.974378	22091	87109	0.895246	4009	12492	9.72897e-01	45661	159614	8.97030e-01	rs5917933	.	4024	0.966200	-1.146	-0.575	-1.121	.	.	.	.	.	ENST00000378444: c.1260T>C (p.D420D)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4156839	.	.	.	.	.	no_record	95764	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
Pass	X	44935924	44935926	Xp11.3	.	TT	del	.	CC.TT	het-alt	25	0.22	.	1	.	PASS	300128	P	300867(MK)	XD	Kabuki syndrome 2	XL	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic	General	23076834|22197486	.	7403	KDM6A	IC17	IVS17	.	.	intron	NM_021140.2	NP_066963.2	+	Y	c.2703-17_2703-16delTT	.	.	.	NM_021140.2(KDM6A): c.2703-17_2703-16delTT	MixedObserved;maf-5-some-pop,maf-5-all-pops	1427	0.731605	U	0.4424	0.276556	.	.	PASS	91	5722	0.465571	212	71820	0.334127	.	.	.	.	.	.	rs200364326	.	4204	0.363100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	167213	criteria_provided,_single_submitter	Likely_benign	Benign
Pass	X	44935924	44935926	Xp11.3	.	TT	rep	T	CC.TT	het-alt	75	0.67	.	2	.	PASS	300128	P	300867(MK)	XD	Kabuki syndrome 2	XL	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic	General	23076834|22197486	.	7403	KDM6A	IC17	IVS17	.	.	intron	NM_021140.2	NP_066963.2	+	Y	c.2703-17T[2>1] (std: c.2703-17T[1] alt: c.2703-16delT )	.	.	.	NM_021140.2(KDM6A): c.2703-17T[1]	.	.	.	.	0.0039	0.00874172	.	.	PASS	-18	253	0.731225	710	1362	0.649780	.	.	.	.	.	.	.	.	4204	0.192100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
Pass	X	53228147	53228148	Xp11.22	.	C	snv	A	GG.CC	hom-alt	315	0.99	.	0	.	PASS	314690	C	300534(MK)	XL;XR	Mental retardation, X-linked, syndromic, Claes-Jensen type	XL	.	Craniofacial; Genitourinary; Musculoskeletal; Neurologic	General	22611640|22326837|21575681|19826449|18697827|18203167|16538222|15586325|10982473	.	8242	KDM5C	IC15	IVS15	.	.	intron	NM_004187.3	NP_004178.2	-	Y	c.2243+11G>T	.	.	.	NM_004187.3(KDM5C): c.2243+11G>T	;maf-5-some-pop	91104	0.885285	U	0.7029	0.730331	10563	0.782922	PASS	1266	6557	0.735855	21579	87329	0.891983	2334	9490	7.41638e-01	45551	160718	9.01861e-01	rs1977364	.	4024	0.725400	0.425	-0.612	-0.653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	94872	criteria_provided,_single_submitter	Benign	Benign
Pass	X	76937962	76937963	Xq21.1	.	G	snv	C	CT.CT	hom-alt	389	1.00	.	0	.	PASS	300032	C	300448(MK);301040(MK);309580(MK)	XD;XL	Mental retardation-hypotonic facies syndrome, X-linked; Juberg-Marsidi syndrome; Carpenter-Waziri syndrome; Holmes-Gang syndrome; Smith-Fineman-Myers syndrome; Alpha-thalassemia/mental retardation syndrome 	XL	.	Craniofacial; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Renal	General	22089611|20301622|19764021|17579672|16955409|16813605|16688741|16222662|16100724|15508018|11449489|11050622|10751095|10398237|10398234|8644709|7726225|6711605|6682021|6267462|3239563|1684092	.	546	ATRX	C9	EX9	.	.	missense	NM_000489.3	NP_000480.2	-	Y	c.2785C>G	p.Q929E | p.Gln929Glu	CAG=>GAG	P0=>P-	NM_000489.3(ATRX): c.2785C>G (p.Q929E)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	91434	0.398965	U	0.4725	0.552318	10558	0.508335	PASS	454	6627	0.449223	5293	87659	0.392361	839	5788	4.50113e-01	9326	66364	3.73274e-01	rs3088074	.	4024	0.447100	-0.273	0.582	0.607	1	0	0	0.000	neutral	ENST00000373344: c.2785C>G (p.Q929E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3759543	.	.	.	.	.	no_record	93135	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
